Trait_category,Trait,Protein,Protein_definition,sample_size,Estimated_effect,se,lowerCI,upperCI,Pvalue
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PLA2G7,Platelet-activating factor acetylhydrolase,39854,-0.106753675362937,0.0025821767623873,-0.111814741817216,-0.101692608908658,0
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FGFBP1,Fibroblast growth factor-binding protein 1,39909,-0.099957157190281,0.00274216641345737,-0.105331803360657,-0.0945825110199045,1.4065361195544e-279
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,LDLR,Low-density lipoprotein receptor,39878,-0.13800334582768,0.00455458376810806,-0.146930330013172,-0.129076361642188,3.77444102368471e-196
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FGFBP3,Fibroblast growth factor-binding protein 3,37384,-0.0766755340986478,0.00319504089798293,-0.0829378142586944,-0.0704132539386013,1.14965474622773e-124
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TFPI,Tissue factor pathway inhibitor,39839,-0.0645800757442128,0.0027571565480615,-0.0699841025784134,-0.0591760489100123,2.54861705453389e-119
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TNFSF10,Tumor necrosis factor ligand superfamily member 10,40054,-0.0418876621979223,0.0022946126748813,-0.0463851030406896,-0.0373902213551549,1.0389905940302e-73
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,C4BPB,C4b-binding protein beta chain,39909,-0.060838089728641,0.00350823030213197,-0.0677142211208197,-0.0539619583364623,9.27498839394131e-67
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MAMDC4,Apical endosomal glycoprotein,37364,0.0818368577416121,0.00491691894293474,0.07219969661346,0.0914740188697642,1.37404451325089e-61
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MET,Hepatocyte growth factor receptor,39875,-0.025823405019161,0.00172894196143521,-0.029212131263574,-0.022434678774748,4.18062148644529e-50
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IL17RB,Interleukin-17 receptor B,39640,-0.0709845815129648,0.0047683419051074,-0.0803305316469753,-0.0616386313789543,8.7614056399421e-50
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,APCS,Serum amyloid P-component,37329,-0.0453576889295647,0.00307754896767748,-0.0513896849062125,-0.0393256929529168,8.77849205812791e-49
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FGA,Fibrinogen alpha chain,37145,-0.039894968599955,0.00271776693798833,-0.0452217917984121,-0.0345681454014979,2.09285669367563e-48
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,LGALS9,Galectin-9,39855,-0.0407895724136284,0.0027927344822612,-0.0462633319988604,-0.0353158128283965,5.27007353471151e-48
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,C9,Complement component C9,37441,-0.0682026535763767,0.00468833024659658,-0.077391780859706,-0.0590135262930474,1.38400665430272e-47
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PLA2G10,Group 10 secretory phospholipase A2,39745,0.0737317418050552,0.00523178668626266,0.0634774398999803,0.08398604371013,7.80679312524522e-45
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,LTA4H,Leukotriene A-4 hydrolase,40026,-0.0731989457645869,0.00519874081493784,-0.0833884777618651,-0.0630094137673088,9.25092160069261e-45
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ST6GAL1,"Beta-galactoside alpha-2,6-sialyltransferase 1",40048,-0.0357485820509754,0.00256815656161067,-0.0407821689117323,-0.0307149951902185,8.57078823461201e-44
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CFHR4,Complement factor H-related protein 4,37405,-0.0866795359050428,0.00636605591560304,-0.0991570054996248,-0.0742020663104609,6.08225296799569e-42
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PLTP,Phospholipid transfer protein,39972,0.0425660315650398,0.00318516009803418,0.0363231177728928,0.0488089453571868,1.61597357069014e-40
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CFP,Properdin,37449,-0.0271973411853688,0.00204823713511878,-0.0312118859702016,-0.023182796400536,5.48045453756866e-40
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NRP2,Neuropilin-2,39854,-0.0324363403077508,0.00253071120979232,-0.0373965342789437,-0.0274761463365578,2.01035082125367e-37
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PTPRS,Receptor-type tyrosine-protein phosphatase S,40048,-0.0271432576580833,0.00216882383206172,-0.0313941523689243,-0.0228923629472423,9.02694410251594e-36
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ITIH4,Inter-alpha-trypsin inhibitor heavy chain H4,37449,-0.0286771117925091,0.00231205875850578,-0.0332087469591804,-0.0241454766258378,3.8861373507047e-35
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TNFSF12,Tumor necrosis factor ligand superfamily member 12,40054,-0.0316787687037531,0.00256072374453272,-0.0366977872430372,-0.026659750164469,5.39688217957466e-35
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CD72,B-cell differentiation antigen CD72,37120,-0.0451201692572474,0.00368133013584639,-0.0523355763235063,-0.0379047621909885,2.378973724949e-34
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GP1BA,Platelet glycoprotein Ib alpha chain,39813,-0.03447048255863,0.00289468210792393,-0.0401440594901609,-0.0287969056270991,1.47361571332572e-32
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PAMR1,Inactive serine protease PAMR1,39854,-0.0292894198591528,0.00246047020085521,-0.034111941452829,-0.0244668982654766,1.54809339073696e-32
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,LGALS1,Galectin-1,39864,-0.0350701881901708,0.00298080315631559,-0.0409125623765494,-0.0292278140037923,7.96338504295632e-32
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SMOC1,SPARC-related modular calcium-binding protein 1,40026,-0.0339126997337873,0.0029041030562522,-0.0396047417240416,-0.028220657743533,2.21992674115696e-31
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DPT,Dermatopontin,40048,-0.0275181436276585,0.00238203297188681,-0.0321869282525566,-0.0228493590027603,9.47861566943419e-31
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ALPI,Intestinal-type alkaline phosphatase,37052,0.123627316567119,0.0107167308299175,0.102622524140481,0.144632108993757,1.2196952959788e-30
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CD22,B-cell receptor CD22,40054,-0.0409334862854496,0.00356526861602093,-0.0479214127728506,-0.0339455597980486,2.15051917170603e-30
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,LPA,Apolipoprotein(a),37182,-0.178765548331377,0.0155800458064472,-0.209302438112014,-0.148228658550741,2.47400745247254e-30
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MOG,Myelin-oligodendrocyte glycoprotein,40026,-0.0322138274384971,0.00282491397096237,-0.0377506588215834,-0.0266769960554109,5.23211122379155e-30
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NOTCH1,Neurogenic locus notch homolog protein 1,40048,-0.0158090029612306,0.00139281894357363,-0.018538928090635,-0.0130790778318263,9.56800208774273e-30
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CA14,Carbonic anhydrase 14,40026,-0.0353036267322735,0.00311993181961871,-0.0414186930987261,-0.0291885603658208,1.42057546599368e-29
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,APOA1,Apolipoprotein A-I,37449,0.0273121413618367,0.00242092300246522,0.0225671322770049,0.0320571504466685,2.18291635548557e-29
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PDCD1,Programmed cell death protein 1,39994,-0.0408434429122279,0.00364006126326743,-0.047977962988232,-0.0337089228362237,4.14385776972572e-29
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CCL22,C-C motif chemokine 22,39682,-0.0502409852169156,0.00447876767672004,-0.0590193698632869,-0.0414626005705443,4.30399042349267e-29
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IGSF9,Protein turtle homolog A,37433,0.0818846731562515,0.0073084710201244,0.0675600699568077,0.0962092763556954,5.21985075150355e-29
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CD83,CD83 antigen,39862,-0.0326364171524953,0.00291529211972573,-0.0383503897071577,-0.0269224445978328,5.53418367071498e-29
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CD4,T-cell surface glycoprotein CD4,39835,-0.0286399867494712,0.00256522085924965,-0.0336678196336005,-0.0236121538653418,7.75839394984363e-29
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,LILRA2,Leukocyte immunoglobulin-like receptor subfamily A member 2,39854,-0.0356442746531358,0.0032075025789349,-0.0419309797078482,-0.0293575695984234,1.3834700651068e-28
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SNCA,Alpha-synuclein,37120,-0.114228480812107,0.0103009286712142,-0.134418301007687,-0.0940386606165275,1.88897911318043e-28
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TFPI2,Tissue factor pathway inhibitor 2,39860,-0.03952892613605,0.0035672373670943,-0.0465207113755548,-0.0325371408965452,1.96626555665389e-28
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,LAG3,Lymphocyte activation gene 3 protein,39784,-0.0399049592629357,0.00361787342014525,-0.0469959911664204,-0.032813927359451,3.46605628722744e-28
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CLEC4G,C-type lectin domain family 4 member G,39862,-0.0324657464686176,0.00294959332169893,-0.0382469493791476,-0.0266845435580877,4.46587791534387e-28
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CFHR5,Complement factor H-related protein 5,37263,-0.040161762766467,0.00366399661226955,-0.0473431961265154,-0.0329803294064187,7.70859424684987e-28
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TREML2,Trem-like transcript 2 protein,39854,-0.0322310944605545,0.00294429730635699,-0.0380019171810142,-0.0264602717400948,8.62354344491153e-28
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MARCO,Macrophage receptor MARCO,39864,-0.0254476414126711,0.00233316880929644,-0.0300206522788921,-0.0208746305464501,1.33614778164864e-27
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CDHR5,Cadherin-related family member 5,39864,-0.0373944009002553,0.00345061162470796,-0.0441575996846829,-0.0306312021158277,2.85785751030733e-27
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,KLK14,Kallikrein-14,40026,-0.0433208545341209,0.00401270756701419,-0.0511857613654687,-0.0354559477027731,4.45123091337498e-27
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PYY,Peptide YY,37017,0.0881048353534343,0.00820827648397073,0.0720166134448517,0.104193057262017,9.12947050732121e-27
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SSC5D,Soluble scavenger receptor cysteine-rich domain-containing protein SSC5D,39927,-0.0402741744777097,0.00378288412089211,-0.0476886273546582,-0.0328597216007612,2.2186450253022e-26
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,EPCAM,Epithelial cell adhesion molecule,39863,0.0898491715611391,0.00846517856015114,0.0732574215832428,0.106440921539035,3.13676310461652e-26
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IGFBP1,Insulin-like growth factor-binding protein 1,40013,-0.115872126235086,0.0109229737672013,-0.1372811548188,-0.0944630976513713,3.33219519540771e-26
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TPK1,Thiamin pyrophosphokinase 1,37433,-0.0259598408964084,0.00244660174549662,-0.0307551803175818,-0.021164501475235,3.37051334148244e-26
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ALCAM,CD166 antigen,40048,-0.0182672537995754,0.00172596316732462,-0.0216501416075317,-0.0148843659916192,4.31132617217034e-26
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FCER2,Low affinity immunoglobulin epsilon Fc receptor,39854,-0.0449344056853477,0.00424603909848201,-0.0532566423183725,-0.036612169052323,4.3740433238886e-26
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GIP,Gastric inhibitory polypeptide,37039,0.0408745484352778,0.00386205570428727,0.0333049192548747,0.0484441776156809,4.51634866394491e-26
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,APOF,Apolipoprotein F,37441,-0.0242406761559147,0.0022969714955658,-0.0287427402872237,-0.0197386120246058,6.17843920770774e-26
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,APOA4,Apolipoprotein A-IV,37449,0.0328861399853104,0.00313912221104491,0.0267334604516624,0.0390388195189584,1.39044666438611e-25
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TNFRSF8,Tumor necrosis factor receptor superfamily member 8,40005,-0.0414278848472153,0.00395621097868842,-0.0491820583654446,-0.033673711328986,1.40874163428431e-25
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CD300E,CMRF35-like molecule 2,39987,-0.0357345129020194,0.00341996395992567,-0.0424376422634738,-0.0290313835405651,1.78962773794882e-25
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CFH,Complement factor H,36759,-0.0216018584224042,0.00208876859670217,-0.0256958448719404,-0.0175078719728679,5.70039399766653e-25
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IGFBPL1,Insulin-like growth factor-binding protein-like 1,39864,0.0301555335150752,0.00292526790129359,0.0244220084285398,0.0358890586016107,7.70255013173644e-25
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CTSF,Cathepsin F,39909,0.037016577256047,0.00359890830602019,0.0299627169762474,0.0440704375358465,9.77606258207884e-25
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ASGR2,Asialoglycoprotein receptor 2,37441,-0.0230610581165347,0.00224789908300011,-0.0274669403192149,-0.0186551759138545,1.32657890374903e-24
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TNF,Tumor necrosis factor,39551,-0.034610489685149,0.00338399803826907,-0.0412431258401564,-0.0279778535301417,1.77863520448183e-24
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NCAN,Neurocan core protein,40005,-0.0332073545898741,0.00326247049860649,-0.0396017967671428,-0.0268129124126053,2.92518106305209e-24
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CHRDL1,Chordin-like protein 1,39904,-0.0276541968836407,0.00272887281637168,-0.0330027876037292,-0.0223056061635522,4.61555718199086e-24
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,39581,-0.0492100340993943,0.0048619599731904,-0.0587394756468475,-0.0396805925519411,5.25769269338126e-24
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SDC4,Syndecan-4,39864,-0.0406929857994782,0.00403922383094997,-0.0486098645081401,-0.0327761070908162,8.43738180632849e-24
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,RTBDN,Retbindin,39784,-0.0263095310725533,0.00261201743058964,-0.031429085236509,-0.0211899769085976,8.61341923636263e-24
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SERPINA3,Alpha-1-antichymotrypsin,37403,-0.0129202804259024,0.00128284841993867,-0.0154346633289822,-0.0104058975228226,8.94855380498703e-24
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TNFRSF9,Tumor necrosis factor receptor superfamily member 9,39745,-0.0344710139463366,0.00342540988980759,-0.0411848173303595,-0.0277572105623138,9.45306793834093e-24
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CD38,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1,39784,-0.0269117854857517,0.00268269340751601,-0.0321698645644831,-0.0216537064070204,1.30068269542987e-23
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ACAN,Aggrecan core protein,39726,-0.0251640746032347,0.00250885518260184,-0.0300814307611343,-0.0202467184453351,1.32159986943967e-23
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,VASN,Vasorin,39638,-0.024382166810261,0.0024348730226491,-0.0291545179346532,-0.0196098156858687,1.55948670585043e-23
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DLL1,Delta-like protein 1,39909,-0.0253020945048185,0.00252894388468524,-0.0302588245188015,-0.0203453644908354,1.69775381018298e-23
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,C2,Complement C2,39904,-0.0209348694100684,0.00210385176681675,-0.0250584188730292,-0.0168113199471076,2.92360932095256e-23
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CRIP2,Cysteine-rich protein 2,39745,-0.0316418396788198,0.00319062892989354,-0.0378954723814112,-0.0253882069762285,4.09412754760726e-23
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FCRL1,Fc receptor-like protein 1,39864,-0.0384323950575334,0.00390804663538905,-0.046092166462896,-0.0307726236521709,9.30715346930461e-23
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SEMA4C,Semaphorin-4C,39784,-0.0247624420486244,0.00252458782338781,-0.0297106341824645,-0.0198142499147843,1.19960975145284e-22
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CCN1,CCN family member 1,39754,-0.0666677665749112,0.00680123748786363,-0.079998192051124,-0.0533373410986985,1.27559220885414e-22
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SDC1,Syndecan-1,39864,-0.0346289423745408,0.00353724725396398,-0.0415619469923102,-0.0276959377567714,1.44103360816276e-22
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,BPIFA2,BPI fold-containing family A member 2,36589,0.094308061313017,0.00963130666487056,0.0754307002498707,0.113185422376163,1.46643663093094e-22
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CST3,Cystatin-C,39893,-0.0230650410201503,0.00236611134382578,-0.0277026192540489,-0.0184274627862518,2.16931474472339e-22
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TNFRSF13B,Tumor necrosis factor receptor superfamily member 13B,39881,-0.0274978704347354,0.00283116531964649,-0.0330469544612425,-0.0219487864082283,3.06986005678781e-22
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MAN1A2,"Mannosyl-oligosaccharide 1,2-alpha-mannosidase IB",37039,-0.0223654518694473,0.00230340585098249,-0.026880127337373,-0.0178507764015216,3.25284477799401e-22
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,AGRN,Agrin,39927,-0.0281587701158356,0.00290317064769783,-0.0338489845853233,-0.0224685556463478,3.49166190439238e-22
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TNFRSF4,Tumor necrosis factor receptor superfamily member 4,40036,-0.0307818930914501,0.00319929617541799,-0.0370525135952694,-0.0245112725876309,7.42694644873194e-22
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,BCAN,Brevican core protein,39745,-0.0284637118531975,0.00296013111098699,-0.034265568830732,-0.022661854875663,7.87179680912938e-22
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CDNF,Cerebral dopamine neurotrophic factor,39784,-0.0269819086047983,0.00281321636557758,-0.0324958126813304,-0.0214680045282663,9.97442958661356e-22
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GGH,Gamma-glutamyl hydrolase,39569,-0.0288893394568468,0.00301848422685549,-0.0348055685414836,-0.0229731103722101,1.21512662812258e-21
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,B4GAT1,"Beta-1,4-glucuronyltransferase 1",39854,-0.0207274694630596,0.00216782758878409,-0.0249764115370764,-0.0164785273890427,1.32695582454281e-21
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CKAP4,Cytoskeleton-associated protein 4,39987,-0.0216022382924771,0.00226057044533718,-0.026032956365338,-0.0171715202196162,1.3947544722775e-21
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IL1RL2,Interleukin-1 receptor-like 2,39583,-0.0337757534430185,0.00354017817664874,-0.04071450266925,-0.0268370042167869,1.62243024307585e-21
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,LRIG1,Leucine-rich repeats and immunoglobulin-like domains protein 1,39980,-0.0288280257378707,0.00302238042005629,-0.0347518913611811,-0.0229041601145604,1.65644749927226e-21
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CYTL1,Cytokine-like protein 1,37433,-0.0192859802327209,0.00203040874766555,-0.0232655813781454,-0.0153063790872964,2.47864195540154e-21
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PTPRF,Receptor-type tyrosine-protein phosphatase F,40048,-0.0241159475950029,0.00254572820330471,-0.0291055748734801,-0.0191263203165257,3.08331247146222e-21
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NPDC1,Neural proliferation differentiation and control protein 1,39864,-0.0248630374964748,0.00262727219387414,-0.0300124909964681,-0.0197135839964815,3.38522952108582e-21
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PLA2G1B,Phospholipase A2,40027,-0.0341716609738565,0.00363623481949784,-0.0412986812200722,-0.0270446407276407,6.3156471158754e-21
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TNFRSF13C,Tumor necrosis factor receptor superfamily member 13C,39583,-0.0347142868921912,0.00371139036628816,-0.041988612010116,-0.0274399617742664,9.60391446791663e-21
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,RARRES2,Retinoic acid receptor responder protein 2,39945,-0.039224877552114,0.00420135141584248,-0.0474595263271653,-0.0309902287770628,1.12568514824156e-20
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,LAMP3,Lysosome-associated membrane glycoprotein 3,40036,-0.0415381638155474,0.00446588853747535,-0.050291305348999,-0.0327850222820957,1.56234863636743e-20
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,EFNA1,Ephrin-A1,39822,-0.0217563848597275,0.00234366218148788,-0.0263499627354438,-0.0171628069840113,1.85389881543633e-20
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CXCL10,C-X-C motif chemokine 10,39927,-0.0544675539391959,0.0058680500696483,-0.0659689320757065,-0.0429661758026852,1.87017286154619e-20
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SEMA4D,Semaphorin-4D,40005,-0.0247102363317587,0.00266316547935724,-0.0299300406712989,-0.0194904319922185,1.93178312253282e-20
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PODXL2,Podocalyxin-like protein 2,39909,-0.0226886260242704,0.0024467575829236,-0.0274842708868007,-0.0178929811617402,2.03654596128745e-20
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MERTK,Tyrosine-protein kinase Mer,40054,-0.0207700143127939,0.00225590960281039,-0.0251915971343023,-0.0163484314912856,3.75765337201115e-20
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,OXT,Oxytocin-neurophysin 1,40005,0.113406866004877,0.0123241033820979,0.0892516233759652,0.137562108633789,3.93338188600253e-20
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CLPS,Colipase,39832,-0.056441723539258,0.00615589750358737,-0.0685072826462892,-0.0443761644322267,5.35828245748604e-20
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CTSL,Cathepsin L1,39864,-0.0194681939652878,0.00212760308020252,-0.0236382960024848,-0.0152980919280909,6.34902178543719e-20
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,C1RL,Complement C1r subcomponent-like protein,37428,-0.0155725143010497,0.00170700838315839,-0.0189182507320402,-0.0122267778700593,8.34650541126233e-20
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MMP12,Macrophage metalloelastase,39896,-0.0406595601990057,0.00446890208783529,-0.0494186082911629,-0.0319005121068486,1.02294811979215e-19
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CHI3L1,Chitinase-3-like protein 1,39541,0.0608961144005109,0.00669817298064955,0.0477676953584378,0.0740245334425841,1.0921455062497e-19
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TIMD4,T-cell immunoglobulin and mucin domain-containing protein 4,39927,-0.0348423994410931,0.00383391911659163,-0.0423568809096127,-0.0273279179725735,1.12488241677936e-19
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PTGDS,Prostaglandin-H2 D-isomerase,39758,-0.022879656499005,0.00252450307810847,-0.0278276825320976,-0.0179316304659124,1.41382605130841e-19
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,P4HB,Protein disulfide-isomerase,39772,-0.0312178149968102,0.00346545654274551,-0.0380101098205914,-0.024425520173029,2.32628320477433e-19
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,RELT,Tumor necrosis factor receptor superfamily member 19L,39854,-0.0213057668954755,0.00236631326289138,-0.0259437408907427,-0.0166677929002084,2.42192081642457e-19
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,HMOX2,Heme oxygenase 2,39485,-0.0378938670943394,0.00421282116314545,-0.0461509965741045,-0.0296367376145743,2.63157630614708e-19
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CD59,CD59 glycoprotein,39169,-0.016902886523808,0.00187977076461125,-0.020587237222446,-0.0132185358251699,2.70747664336721e-19
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,BPIFB1,BPI fold-containing family B member 1,39782,0.0505687097694873,0.00563838299979688,0.0395174790898855,0.0616199404490892,3.32973899468155e-19
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CD86,T-lymphocyte activation antigen CD86,37378,-0.0231876625255049,0.00260246592039371,-0.0282884957294765,-0.0180868293215332,5.75435273565367e-19
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ICAM1,Intercellular adhesion molecule 1,39818,-0.0224900224803043,0.00253044481358965,-0.02744969431494,-0.0175303506456685,6.88942567349745e-19
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GFAP,Glial fibrillary acidic protein,39449,-0.0345284382240033,0.0038923331677914,-0.0421574112328744,-0.0268994652151321,8.03178280410117e-19
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,COL15A1,Collagen alpha-1(XV) chain,37433,-0.0196444513861711,0.00222024106544326,-0.0239961238744399,-0.0152927788979023,1.00089104863942e-18
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PROC,Vitamin K-dependent protein C,39904,-0.0202988075091669,0.00229489661030569,-0.024796804865366,-0.0158008101529677,1.0072491206657e-18
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,RGMB,RGM domain family member B,40005,-0.019996355803271,0.00226748515135497,-0.0244406266999268,-0.0155520849066153,1.27388628579174e-18
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IFI30,Gamma-interferon-inducible lysosomal thiol reductase,37081,-0.0302694605751983,0.00343267817754269,-0.0369975098031819,-0.0235414113472146,1.3092305971038e-18
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GCG,Pro-glucagon,39473,0.0960505075098418,0.0109293792940789,0.0746289240934471,0.117472090926236,1.67437279911043e-18
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SERPINA7,Thyroxine-binding globulin,37449,-0.0144651066884327,0.00164652589085329,-0.0176922974345052,-0.0112379159423602,1.74538426116288e-18
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,RTN4IP1,"Reticulon-4-interacting protein 1, mitochondrial",37408,-0.0712209117169624,0.00811016350538901,-0.0871168321875248,-0.0553249912463999,1.80154186123516e-18
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CSF1,Macrophage colony-stimulating factor 1,39927,-0.0204257128924093,0.00233278998958823,-0.0249979812720022,-0.0158534445128164,2.22302323129637e-18
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NOS3,"Nitric oxide synthase, endothelial",39485,-0.0398024076842634,0.0045490060685465,-0.0487184595786145,-0.0308863557899122,2.35465686265162e-18
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ITIH3,Inter-alpha-trypsin inhibitor heavy chain H3,39927,-0.029781868484042,0.00342298440368242,-0.0364909179152596,-0.0230728190528245,3.6180509088819e-18
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CD5,T-cell surface glycoprotein CD5,39999,-0.025360090556298,0.00292527547472278,-0.0310936304867546,-0.0196265506258413,4.75510350035884e-18
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CXCL13,C-X-C motif chemokine 13,40005,-0.0452705448478055,0.00523290422633276,-0.0555270371314177,-0.0350140525641933,5.5724368775312e-18
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ANGPTL2,Angiopoietin-related protein 2,39873,-0.0303006811723095,0.00350380586989436,-0.0371681406773025,-0.0234332216673166,5.73423571704662e-18
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TNFRSF14,Tumor necrosis factor receptor superfamily member 14,39881,-0.0225775719448593,0.00261360940066277,-0.0277002463701584,-0.0174548975195603,6.22727160622276e-18
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TAFA5,Chemokine-like protein TAFA-5,39784,-0.0261836995376767,0.00303483570057489,-0.0321319775108035,-0.0202354215645499,6.84178941684868e-18
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ITGA5,Integrin alpha-5,39854,-0.0190018507302822,0.00220631438507401,-0.0233262269250273,-0.0146774745355372,7.80725181835108e-18
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SPOCK1,Testican-1,39745,-0.0194507376108062,0.00225842739292679,-0.0238772553009427,-0.0150242199206697,7.81002177556813e-18
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PRSS8,Prostasin,39801,0.0306553953556341,0.00356965310951521,0.0236588752609842,0.0376519154502839,9.67573818336473e-18
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IL16,Pro-interleukin-16,40054,-0.0314814444414093,0.00366676506397863,-0.0386683039668074,-0.0242945849160112,9.84520484393673e-18
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SEPTIN9,Septin-9,39784,-0.0216880530967441,0.00252607054494617,-0.0266391513648386,-0.0167369548286496,9.85355698023709e-18
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FCAMR,High affinity immunoglobulin alpha and immunoglobulin mu Fc receptor,37433,-0.0539491354076017,0.00631243750423689,-0.066321512915906,-0.0415767578992974,1.40324688267281e-17
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MTIF3,"Translation initiation factor IF-3, mitochondrial",37378,-0.0658760578470769,0.0077807954433918,-0.0811264169161248,-0.050625698778029,2.78738238738764e-17
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CALB2,Calretinin,39485,-0.0219861751657285,0.00259995619838824,-0.0270820893145695,-0.0168902610168876,2.99968040333966e-17
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FGFBP2,Fibroblast growth factor-binding protein 2,37433,0.0371685911219069,0.00440910906683707,0.0285267373509062,0.0458104448929075,3.80369733837447e-17
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CRHBP,Corticotropin-releasing factor-binding protein,39858,-0.0210248035173841,0.00249803472970988,-0.0259209515876155,-0.0161286554471527,4.20230845364554e-17
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GOLM2,Protein GOLM2,40005,-0.016545156656198,0.00196977188672002,-0.0204059095541693,-0.0126844037582268,4.85130974004202e-17
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ACVRL1,Serine/threonine-protein kinase receptor R3,39716,-0.0173427552374029,0.0020661007366346,-0.0213923126812068,-0.0132931977935991,5.09333248208117e-17
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SCARB2,Lysosome membrane protein 2,39482,-0.0214481219854775,0.00255524037301033,-0.0264563931165777,-0.0164398508543772,5.10703712137381e-17
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FOLR2,Folate receptor beta,40005,-0.0215152393273345,0.00256443852647817,-0.0265415388392317,-0.0164889398154372,5.2662470195236e-17
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CA6,Carbonic anhydrase 6,39813,0.0472511838820136,0.00565870003645016,0.0361601318105713,0.0583422359534559,7.36958047337764e-17
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,HS3ST3B1,Heparan sulfate glucosamine 3-O-sulfotransferase 3B1,39784,-0.0283932939085,0.00340635458639051,-0.0350697488978254,-0.0217168389191746,8.34867512261606e-17
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CCL18,C-C motif chemokine 18,39711,-0.0523032335140858,0.00628443576525221,-0.0646207276139801,-0.0399857394141915,9.29513855483014e-17
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,LCN2,Neutrophil gelatinase-associated lipocalin,39368,-0.0270804393223235,0.00325380478816545,-0.0334578967071278,-0.0207029819375192,9.30811776624758e-17
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MECR,"Enoyl-[acyl-carrier-protein] reductase, mitochondrial",37039,-0.0674360988654702,0.00812360029622665,-0.0833583554460744,-0.0515138422848659,1.12982597516885e-16
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GRN,Progranulin,39783,-0.0182186005189236,0.00219689199964737,-0.0225245088382324,-0.0139126921996147,1.1927165042146e-16
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,HHEX,Hematopoietically-expressed homeobox protein HHEX,37384,-0.0564389553157443,0.00681287404915362,-0.0697921884520854,-0.0430857221794032,1.30051276261898e-16
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MIA,Melanoma-derived growth regulatory protein,39909,-0.0266802855907152,0.00322159383776028,-0.0329946095127253,-0.020365961668705,1.3090710067574e-16
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DDC,Aromatic-L-amino-acid decarboxylase,39842,0.0358714889350484,0.00433312612877112,0.027378561722657,0.0443644161474398,1.34580308752269e-16
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SEZ6L,Seizure 6-like protein,39909,-0.019857356497392,0.0023991974029095,-0.0245597834070947,-0.0151549295876894,1.36538228150209e-16
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CTSS,Cathepsin S,36540,-0.0179721391222411,0.00217273696611927,-0.0222307035758349,-0.0137135746686474,1.45221220285095e-16
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,THBS2,Thrombospondin-2,39854,0.0263665387011401,0.00320668162901468,0.0200814427082713,0.0326516346940088,2.146943194577e-16
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CD160,CD160 antigen,40054,-0.0327441550040966,0.00399449010745983,-0.0405733556147179,-0.0249149543934754,2.6402021194889e-16
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MRC1,Macrophage mannose receptor 1,37441,-0.0200256039695722,0.00244680503087412,-0.0248213418300855,-0.0152298661090589,2.9790059918975e-16
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,THBD,Thrombomodulin,39864,-0.0197976249730531,0.00242335668670322,-0.0245474040789914,-0.0150478458671148,3.32593361285071e-16
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,VWC2,Brorin,39680,-0.0279903366743168,0.00342689758437775,-0.0347070559396972,-0.0212736174089364,3.37486883108514e-16
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CNDP1,Beta-Ala-His dipeptidase,39927,0.0329929157157327,0.0040580010831432,0.0250392335927721,0.0409465978386934,4.59067397282417e-16
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NUCB2,Nucleobindin-2,39991,-0.0271242553639588,0.00333639274624078,-0.0336635851465907,-0.0205849255813268,4.60912937303771e-16
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,HLA_E,,39862,-0.0198016467195116,0.00243754540282761,-0.0245792357090537,-0.0150240577299695,4.85314658367899e-16
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FCN2,Ficolin-2,39806,-0.0293301273304736,0.00361079957965701,-0.0364072945066014,-0.0222529601543459,4.88276257399812e-16
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SPINK2,Serine protease inhibitor Kazal-type 2,37120,-0.0263485155167908,0.0032436813975107,-0.0327061310559118,-0.0199908999776698,4.94676163418221e-16
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FST,Follistatin,39904,-0.0372082347236603,0.00458264373449447,-0.0461902164432694,-0.0282262530040511,5.0232335356014e-16
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,LILRB4,Leukocyte immunoglobulin-like receptor subfamily B member 4,39583,-0.0302831597503253,0.00373032890964114,-0.037594604413222,-0.0229717150874287,5.08379826790526e-16
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,HYOU1,Hypoxia up-regulated protein 1,40048,-0.0155168527142615,0.00191311194618563,-0.0192665521287853,-0.0117671532997377,5.38656575398894e-16
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SELL,L-selectin,37449,-0.01627815940416,0.002008490953543,-0.0202148016731043,-0.0123415171352157,5.73800819355008e-16
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DPY30,Protein dpy-30 homolog,39975,-0.0427072893452094,0.00527502013670044,-0.0530463288131423,-0.0323682498772766,6.07532364815763e-16
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NCR1,Natural cytotoxicity triggering receptor 1,39831,-0.0255525547420452,0.0031586645376795,-0.031743537235897,-0.0193615722481934,6.40930191140865e-16
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,COL18A1,Collagen alpha-1(XVIII) chain,39889,-0.0161936050244809,0.0020102623020826,-0.0201337191365628,-0.012253490912399,8.47039753800432e-16
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,APBB1IP,Amyloid beta A4 precursor protein-binding family B member 1-interacting protein,39784,-0.0322509200170826,0.00400776170000818,-0.0401061329490986,-0.0243957070850665,9.07033074140083e-16
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PTPRR,Receptor-type tyrosine-protein phosphatase R,37384,-0.0255136051584544,0.00317079452271644,-0.0317283624229786,-0.0192988478939302,9.23014805825936e-16
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CCL23,C-C motif chemokine 23,39927,-0.0294814092296146,0.003665100302936,-0.0366650058233692,-0.0222978126358601,9.31107362004197e-16
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SERPINF2,Alpha-2-antiplasmin,37220,-0.00961497719595786,0.0011989775071623,-0.011964973109996,-0.00726498128191977,1.15139283272073e-15
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FXN,"Frataxin, mitochondrial",40026,-0.0522422020368505,0.00653636308508675,-0.0650534736836206,-0.0394309303900805,1.41039692487216e-15
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ANGPTL7,Angiopoietin-related protein 7,40026,0.0264908206802999,0.00331779688828318,0.0199879387792649,0.0329937025813349,1.50562016441327e-15
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FLT4,Vascular endothelial growth factor receptor 3,39909,-0.0241489268329318,0.0030299423149966,-0.0300876137703251,-0.0182102398955384,1.69142329408503e-15
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,C1S,Complement C1s subcomponent,37449,-0.0148129760847786,0.00186004175288736,-0.0184586579204378,-0.0111672942491194,1.80042468286569e-15
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CD14,Monocyte differentiation antigen CD14,39560,-0.0290654722982647,0.00365194729856684,-0.0362232890034557,-0.0219076555930737,1.8537066568383e-15
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PALM,Paralemmin-1,37295,-0.0200985982076251,0.00252616838219376,-0.0250498882367249,-0.0151473081785253,1.91601477512706e-15
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CCL7,C-C motif chemokine 7,39862,-0.0412273872755712,0.00518858859724417,-0.0513970209261698,-0.0310577536249726,2.05739126047801e-15
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,LRRC25,Leucine-rich repeat-containing protein 25,39784,-0.0275014420187655,0.00346133745380567,-0.0342856634282246,-0.0207172206093064,2.06562904613411e-15
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GM2A,Ganglioside GM2 activator,37174,-0.0254886150889914,0.00321122500938692,-0.0317826161073898,-0.019194614070593,2.22999668126991e-15
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SLITRK1,SLIT and NTRK-like protein 1,37052,-0.0225167384501757,0.00283755924446332,-0.0280783545693238,-0.0169551223310276,2.26948943872574e-15
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NUDT16,U8 snoRNA-decapping enzyme,37362,-0.0620907254686769,0.00784738996945746,-0.0774716098088135,-0.0467098411285403,2.72308148452955e-15
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MPI,Mannose-6-phosphate isomerase,39784,-0.0608154555537717,0.00770169945553448,-0.0759107864866193,-0.0457201246209242,3.05764210998344e-15
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MEP1A,Meprin A subunit alpha,37378,0.0501541809171462,0.00636124314536625,0.0376861443522284,0.0626222174820641,3.40336312508785e-15
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,C3,Complement C3,36812,-0.0323184703629478,0.00409998721914378,-0.0403544453124696,-0.024282495413426,3.46244779417188e-15
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CXCL17,C-X-C motif chemokine 17,40054,-0.0300979536599359,0.00382155129334457,-0.0375881941948912,-0.0226077131249805,3.59781737433442e-15
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DUT,"Deoxyuridine 5'-triphosphate nucleotidohydrolase, mitochondrial",37378,-0.0713841870000293,0.00910453708307618,-0.0892290796828586,-0.0535392943172,4.82196892206159e-15
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TNFRSF1B,Tumor necrosis factor receptor superfamily member 1B,39854,-0.0240016226638083,0.00309912397176782,-0.0300759056484732,-0.0179273396791434,1.01565871773917e-14
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,AHNAK,Neuroblast differentiation-associated protein AHNAK,37039,-0.0214811497961346,0.00277649482027378,-0.0269230796438712,-0.016039219948398,1.0935464546095e-14
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CD79B,B-cell antigen receptor complex-associated protein beta chain,40054,-0.0288414930101572,0.00372879795133383,-0.0361499369947715,-0.0215330490255429,1.09638210701908e-14
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CD46,Membrane cofactor protein,39773,-0.0194831910714372,0.00252375171844853,-0.0244297444395963,-0.014536637703278,1.23282817192768e-14
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,LRG1,Leucine-rich alpha-2-glycoprotein,37449,-0.0174336918082368,0.002258067672553,-0.0218595044464407,-0.013007879170033,1.23826416555351e-14
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CANT1,Soluble calcium-activated nucleotidase 1,39812,-0.0136901821599534,0.00177601423728072,-0.0171711700650236,-0.0102091942548832,1.34910701605398e-14
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PCSK9,Proprotein convertase subtilisin/kexin type 9,40048,-0.0269176600930702,0.00349285807009956,-0.0337636619104653,-0.020071658275675,1.36800420229288e-14
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,AGRP,Agouti-related protein,40054,-0.0365762929140658,0.00476232122742145,-0.0459104425198119,-0.0272421433083198,1.6769076370016e-14
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PRDX3,"Thioredoxin-dependent peroxide reductase, mitochondrial",39583,-0.0494899769707643,0.00645240075798336,-0.0621366824564117,-0.0368432714851169,1.82024620113085e-14
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TINAGL1,Tubulointerstitial nephritis antigen-like,39840,-0.0151472335793524,0.00198315271040116,-0.0190342128917386,-0.0112602542669661,2.33157302248195e-14
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CPB2,Carboxypeptidase B2,37420,-0.0153003928055659,0.00200646188065286,-0.0192330580916455,-0.0113677275194863,2.59112897826201e-14
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SIGLEC8,Sialic acid-binding Ig-like lectin 8,37039,-0.0310918183883034,0.00408231598495709,-0.0390931577188193,-0.0230904790577875,2.78983182309781e-14
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CEACAM1,Carcinoembryonic antigen-related cell adhesion molecule 1,39883,-0.0160204456983661,0.00210689954979961,-0.0201499688159733,-0.0118909225807588,3.03456791597841e-14
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,BLNK,B-cell linker protein,37052,-0.0264426260045607,0.00347700317262719,-0.03325755222291,-0.0196276997862114,3.04140974356689e-14
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,LGALS3,Galectin-3,39897,-0.0199046765308348,0.00262529487385837,-0.0250502544835972,-0.0147590985780724,3.59174720587241e-14
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NFU1,"NFU1 iron-sulfur cluster scaffold homolog, mitochondrial",37378,-0.0694761002254377,0.00918470485089305,-0.0874781217331881,-0.0514740787176873,4.15015960830351e-14
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NT5E,5'-nucleotidase,39909,-0.0372137162928457,0.00492884805326409,-0.0468742584772433,-0.0275531741084481,4.57957382407328e-14
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,INHBB,Inhibin beta B chain,37120,-0.0331588425051095,0.00440230300624699,-0.0417873563973536,-0.0245303286128654,5.31341608902142e-14
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SDHB,Succinate dehydrogenase,37378,-0.0468750709719258,0.00623701812080539,-0.0590996264887044,-0.0346505154551472,6.01981776437143e-14
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TMSB10,Thymosin beta-10,39854,-0.0515240762505204,0.00687945102496497,-0.0650078002594518,-0.0380403522415891,7.27052242772401e-14
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,COLEC12,Collectin-12,39858,-0.0165786529408581,0.00221392561168621,-0.0209179471397631,-0.0122393587419531,7.33756587274835e-14
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CLEC11A,C-type lectin domain family 11 member A,39818,-0.0315299799472398,0.00421131461756453,-0.0397841565976663,-0.0232758032968134,7.41592974881792e-14
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ASPN,Asporin,37433,-0.0179457836774398,0.00239758888723429,-0.022645057896419,-0.0132465094584606,7.5989114972761e-14
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SIGLEC1,Sialoadhesin,39927,-0.0278569543746959,0.00372271800933918,-0.0351534816730006,-0.0205604270763911,7.64225399365024e-14
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",39784,-0.0226724718356829,0.0030315627490019,-0.0286143348237266,-0.0167306088476392,7.89042153454956e-14
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,LTBP3,Latent-transforming growth factor beta-binding protein 3,39473,-0.036660044154367,0.00490236746467807,-0.046268684385136,-0.0270514039235979,7.94510755734178e-14
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CD302,CD302 antigen,39784,-0.0193695808871797,0.00259178303929966,-0.024449475644207,-0.0142896861301524,8.2168677893888e-14
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CD274,Programmed cell death 1 ligand 1,39745,-0.0223102557025319,0.00298714584151375,-0.0281650615518988,-0.0164554498531649,8.51596634165955e-14
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CDH17,Cadherin-17,39864,0.0442180905260468,0.00592107726944118,0.0326127790779421,0.0558234019741515,8.56710424437658e-14
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,POLR2F,"DNA-directed RNA polymerases I, II, and III subunit RPABC2",39784,-0.0217126487934917,0.0029078011047072,-0.0274119389587178,-0.0160133586282656,8.62650108784854e-14
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TMPRSS15,Enteropeptidase,39784,0.0593324323095353,0.00794952929915498,0.0437513548831916,0.0749135097358791,8.85087670636627e-14
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ACHE,Acetylcholinesterase,37120,0.0216348239018457,0.00290930098495564,0.0159325939713327,0.0273370538323588,1.09788113953779e-13
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SETMAR,Histone-lysine N-methyltransferase SETMAR,39695,-0.019633748011517,0.00264915149004138,-0.0248260849319981,-0.0144414110910359,1.31345601470778e-13
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,EFNA4,Ephrin-A4,39716,-0.0182569673488237,0.00246449227077409,-0.0230873721995409,-0.0134265624981064,1.34665901076642e-13
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FGF21,Fibroblast growth factor 21,40007,0.0786591185959336,0.0106184326307038,0.0578469906397542,0.099471246552113,1.34763105751056e-13
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SSC4D,Scavenger receptor cysteine-rich domain-containing group B protein,39842,-0.0748833925745908,0.010109738418005,-0.0946984798738806,-0.0550683052753011,1.35576085745018e-13
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SIGLEC10,Sialic acid-binding Ig-like lectin 10,39862,-0.0216295658752952,0.00292102837351535,-0.0273547814873853,-0.0159043502632051,1.37906932761908e-13
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PZP,Pregnancy zone protein,37449,-0.0361698716650721,0.00488700175208439,-0.0457483950991575,-0.0265913482309867,1.42840012587987e-13
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GBP1,Guanylate-binding protein 1,37372,-0.0418014963446815,0.0056492954195269,-0.0528741153669542,-0.0307288773224088,1.44852508782724e-13
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,LILRB1,Leukocyte immunoglobulin-like receptor subfamily B member 1,40048,-0.0180006801582634,0.00243941830278519,-0.0227819400317224,-0.0132194202848044,1.67106911907056e-13
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ADGRG1,Adhesion G-protein coupled receptor G1,39784,0.0356756452303838,0.00485240211116777,0.0261649370924949,0.0451863533682726,2.04503499952278e-13
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IL12A_IL12B,Interleukin-12,39784,-0.0482817915962281,0.0065718868373554,-0.0611626897974447,-0.0354008933950116,2.12976148879971e-13
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PTPRN2,Receptor-type tyrosine-protein phosphatase N2,39678,-0.0208445996515018,0.00283831805863534,-0.0264077030464271,-0.0152814962565766,2.17405048876211e-13
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ADA2,Adenosine deaminase 2,39778,-0.0269533154235687,0.0036737787276998,-0.0341539217298603,-0.019752709117277,2.29522291043723e-13
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GADD45GIP1,Growth arrest and DNA damage-inducible proteins-interacting protein 1,37039,-0.034595970695395,0.00471673038522868,-0.0438407622504432,-0.0253511791403468,2.35137365546706e-13
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,HAVCR2,Hepatitis A virus cellular receptor 2,39854,-0.0219297144599194,0.00299449590923422,-0.0277989264420185,-0.0160605024778203,2.53389806483296e-13
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FABP5,Fatty acid-binding protein 5,39968,-0.0444401643019089,0.00607081932725114,-0.0563389701833212,-0.0325413584204967,2.59111414372006e-13
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SCGB1A1,Uteroglobin,39899,-0.0356665994592225,0.00487680737533818,-0.0452251419148853,-0.0261080570035596,2.72535463957371e-13
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IGFBP6,Insulin-like growth factor-binding protein 6,39821,-0.017965427732292,0.00245898928307675,-0.0227850467271225,-0.0131458087374616,2.88175319125364e-13
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CIRBP,Cold-inducible RNA-binding protein,37378,-0.0625916287563332,0.00857049776166631,-0.0793898043691992,-0.0457934531434672,2.96831219586765e-13
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ACP5,Tartrate-resistant acid phosphatase type 5,39915,-0.0215642140085975,0.0029542414055898,-0.0273545271635535,-0.0157739008536415,3.02567119330793e-13
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IL2RA,Interleukin-2 receptor subunit alpha,39728,-0.0254996139704321,0.00349401689717157,-0.0323478870888884,-0.0186513408519758,3.0572315601088e-13
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,UNC5D,Netrin receptor UNC5D,37052,-0.017260948580269,0.00236494125030029,-0.0218962334308576,-0.0126256637296805,3.07230538844257e-13
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TGFA,Protransforming growth factor alpha,39862,-0.029777641847836,0.00408655268591636,-0.037787285112232,-0.0217679985834399,3.32360123862318e-13
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SIGLEC5,Sialic acid-binding Ig-like lectin 5,39854,-0.0768000743466039,0.0105621378840755,-0.0975018645993919,-0.0560982840938158,3.72623707725168e-13
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DEFA1_DEFA1B,Neutrophil defensin 1,39533,-0.0324490071048078,0.00447048919863648,-0.0412111659341353,-0.0236868482754803,4.09792972671441e-13
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SFTPA2,Pulmonary surfactant-associated protein A2,39473,-0.0317680460389627,0.00439358289968475,-0.0403794685223448,-0.0231566235555805,5.03326216535007e-13
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FABP4,"Fatty acid-binding protein, adipocyte",40048,-0.0312246551749891,0.00432408915739261,-0.0396998699234786,-0.0227494404264996,5.38635305789258e-13
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,AXL,Tyrosine-protein kinase receptor UFO,39927,-0.0175125121669252,0.00242929738812292,-0.0222739350476461,-0.0127510892862043,5.89242506434406e-13
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DSCAM,Down syndrome cell adhesion molecule,37408,-0.0225963081256134,0.00313584329640075,-0.0287425609865589,-0.0164500552646679,6.07480018031356e-13
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,BLMH,Bleomycin hydrolase,40048,-0.0204584609414826,0.00285061096284683,-0.0260456584286624,-0.0148712634543028,7.44198044245251e-13
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,BRK1,Protein BRICK1,39485,-0.0284765037141291,0.00396949572249071,-0.0362567153302109,-0.0206962920980474,7.61998131278113e-13
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FN1,Fibronectin,37449,-0.0169798466577483,0.00236716150975719,-0.0216194832168724,-0.0123402100986242,7.71219681651817e-13
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,OPTC,Opticin,39784,-0.0280914929514707,0.00393687085347766,-0.035807759824287,-0.0203752260786545,1.00601242500255e-12
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TRIAP1,TP53-regulated inhibitor of apoptosis 1,40026,-0.0404274512169523,0.00566993665773481,-0.0515405270661126,-0.0293143753677921,1.04508303912835e-12
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MSR1,Macrophage scavenger receptor types I and II,40005,-0.0289547449545208,0.00406690560371222,-0.0369258799377967,-0.0209836099712448,1.12798979918679e-12
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,RSPO3,R-spondin-3,40026,-0.0170854057317402,0.0024002768190816,-0.0217899482971402,-0.0123808631663403,1.14025499563439e-12
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GCHFR,GTP cyclohydrolase 1 feedback regulatory protein,36760,-0.0313880327288197,0.00440972867752716,-0.0400311009367729,-0.0227449645208664,1.15377360200758e-12
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TCN2,Transcobalamin-2,40008,-0.018508858844956,0.0026054671677522,-0.0236155744937503,-0.0134021431961617,1.2638893384775e-12
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ADAM8,Disintegrin and metalloproteinase domain-containing protein 8,39981,-0.0177206026105162,0.0024973617264158,-0.0226154315942912,-0.0128257736267412,1.3402646742772e-12
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MAD1L1,Mitotic spindle assembly checkpoint protein MAD1,39679,-0.0293385113782865,0.00413638101990221,-0.0374458181772948,-0.0212312045792781,1.36995266840855e-12
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TGFBI,Transforming growth factor-beta-induced protein ig-h3,39801,-0.0169267127257799,0.0023865963803557,-0.0216044416312771,-0.0122489838202828,1.37337453591885e-12
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SYAP1,Synapse-associated protein 1,37120,-0.0361775332267376,0.00512058040664379,-0.0462138708237594,-0.0261411956297158,1.68485122720189e-12
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CSTB,Cystatin-B,39615,-0.0266331812575445,0.00377477123739628,-0.0340317328828413,-0.0192346296322478,1.79047430013319e-12
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TNFRSF17,Tumor necrosis factor receptor superfamily member 17,37120,-0.0243589732902914,0.00346155570944444,-0.0311436224808025,-0.0175743240997803,2.06071470043446e-12
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TIMP3,Metalloproteinase inhibitor 3,39927,-0.0811832130295581,0.0115505931848572,-0.103822375671878,-0.0585440503872379,2.17176106321201e-12
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ITGAL,Integrin alpha-L,37052,-0.0266649660643802,0.00380017443512998,-0.034113307957235,-0.0192166241715255,2.38134851820409e-12
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DPEP2,Dipeptidase 2,39784,-0.0181999860648761,0.00259535779243514,-0.023286887338049,-0.0131130847917032,2.43481559396029e-12
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,BST2,Bone marrow stromal antigen 2,40005,-0.0332195016034435,0.00473960719488016,-0.0425091317054086,-0.0239298715014784,2.49675698756428e-12
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TIMP4,Metalloproteinase inhibitor 4,39854,0.0244786582993156,0.00349363712550465,0.0176311295333265,0.0313261870653047,2.53846311120564e-12
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CD163,Scavenger receptor cysteine-rich type 1 protein M130,39927,-0.0265077954989383,0.00378868436792083,-0.0339336168600632,-0.0190819741378135,2.72659816240485e-12
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CXCL11,C-X-C motif chemokine 11,40005,-0.0484702287760915,0.00692913478603737,-0.0620513329567247,-0.0348891245954582,2.75406621321597e-12
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GFRA1,GDNF family receptor alpha-1,40007,-0.0167604852967688,0.00239611657501769,-0.0214568737838035,-0.0120640968097341,2.75955164011056e-12
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DUSP13,Dual specificity protein phosphatase 13 isoform A,37364,-0.0261338009932659,0.00373886524851162,-0.0334619768803487,-0.0188056251061831,2.88266193206408e-12
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,EPHB6,Ephrin type-B receptor 6,39709,-0.0187777783019494,0.00269138900223076,-0.0240529007463217,-0.0135026558575771,3.1352176103734e-12
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CCN5,CCN family member 5,39854,-0.0238766556994162,0.003426859163698,-0.0305932996602643,-0.0171600117385681,3.35196841910903e-12
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CFI,Complement factor I,37449,-0.0123516914890329,0.00177484453230271,-0.0158303867723462,-0.0088729962057196,3.57618478201498e-12
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,WFDC2,WAP four-disulfide core domain protein 2,39013,-0.0221538803917136,0.0031860980548848,-0.0283986325792878,-0.0159091282041393,3.71437473239015e-12
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,LBP,Lipopolysaccharide-binding protein,39927,-0.0358616418042776,0.00516176988872093,-0.0459787107861706,-0.0257445728223845,3.85957891127351e-12
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CXCL6,C-X-C motif chemokine 6,40054,-0.0474810603041455,0.00683937351411568,-0.0608862323918122,-0.0340758882164788,4.00379941872111e-12
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,LMNB2,Lamin-B2,37384,-0.0168445063215815,0.00243112524042189,-0.0216095117928084,-0.0120795008503546,4.43985339395699e-12
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TNFAIP8L2,Tumor necrosis factor alpha-induced protein 8-like protein 2,37120,-0.0395566376203549,0.00571960988443302,-0.0507670729938436,-0.0283462022468661,4.85977680112539e-12
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CD244,Natural killer cell receptor 2B4,40054,-0.0164234550166081,0.00238031901218507,-0.0210888802804908,-0.0117580297527254,5.40479691734977e-12
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IL18BP,Interleukin-18-binding protein,39927,-0.0181231377087087,0.00263335438489465,-0.0232845123031022,-0.0129617631143152,6.11354185884981e-12
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TPD52L2,Tumor protein D54,37120,-0.0668752222229737,0.00971919634125964,-0.0859248470518426,-0.0478255973941048,6.22180435637874e-12
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MFGE8,Lactadherin,39854,0.0267512623869173,0.00389662128176699,0.019113884674654,0.0343886400991806,6.88177338684968e-12
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,KLK10,Kallikrein-10,39852,-0.0241124186908112,0.00351289879264419,-0.0309977003243938,-0.0172271370572286,6.94357365853841e-12
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CLEC7A,C-type lectin domain family 7 member A,40054,-0.0349243482889233,0.00510120487077859,-0.0449227098356494,-0.0249259867421973,7.85093887163514e-12
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ANGPTL4,Angiopoietin-related protein 4,39904,-0.0275953662159394,0.00403120971172851,-0.0354965372509272,-0.0196941951809515,7.90090168914409e-12
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IL15,Interleukin-15,39862,0.0197857227784151,0.00289123004684317,0.0141189118866025,0.0254525336702277,8.01651050656403e-12
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IL18R1,Interleukin-18 receptor 1,40054,-0.0198356690513919,0.00290054919968065,-0.025520745482766,-0.0141505926200178,8.28352693853504e-12
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,METAP1D,"Methionine aminopeptidase 1D, mitochondrial",39862,-0.0506439851337191,0.00740711947282685,-0.0651619393004597,-0.0361260309669784,8.36737841379838e-12
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,LONP1,"Lon protease homolog, mitochondrial",37039,-0.0528003506779468,0.00775787931448924,-0.0680057941343457,-0.0375949072215479,1.04669439559004e-11
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CXCL3,C-X-C motif chemokine 3,39855,-0.0574674680074898,0.00844532952978379,-0.0740203138858661,-0.0409146221291136,1.04894236885204e-11
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NFASC,Neurofascin,40054,0.0167844196958209,0.00246856432000098,0.011946033628619,0.0216228057630229,1.08829328801908e-11
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DAB2,Disabled homolog 2,40026,-0.0675190281157279,0.0099369639306215,-0.086995477419746,-0.0480425788117098,1.12300468660215e-11
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PGF,Placenta growth factor,40054,-0.015558717542815,0.002292378303148,-0.0200517790169851,-0.0110656560686449,1.18337338422687e-11
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ECHS1,"Enoyl-CoA hydratase, mitochondrial",37039,-0.0584961533849624,0.00863414632087334,-0.0754190801738742,-0.0415732265960507,1.2970966615792e-11
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SEMA3G,Semaphorin-3G,37120,-0.0264128544240973,0.00389956098997359,-0.0340559939644455,-0.018769714883749,1.31195143909718e-11
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TNFRSF1A,Tumor necrosis factor receptor superfamily member 1A,39854,-0.0165620066810107,0.00244606638137839,-0.0213562967885123,-0.011767716573509,1.32461443878874e-11
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CD1C,T-cell surface glycoprotein CD1c,39909,-0.0141540740088584,0.00209159328765639,-0.0182535968526649,-0.0100545511650519,1.3591171272601e-11
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CLSTN3,Calsyntenin-3,37384,-0.0181903756445742,0.002688151669652,-0.0234591529170921,-0.0129215983720562,1.37015454441072e-11
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GAL,Galanin peptides,39927,0.0387480525859269,0.00573711293377034,0.027503311235737,0.0499927939361168,1.4882914375232e-11
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TIE1,Tyrosine-protein kinase receptor Tie-1,40048,-0.0247201493868892,0.00366017071789815,-0.0318940839939696,-0.0175462147798088,1.48898878278556e-11
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SF3B4,Splicing factor 3B subunit 4,39784,-0.043837522765475,0.0065103082456556,-0.0565977269269599,-0.03107731860399,1.71227643821142e-11
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,RNASE4,Ribonuclease 4,37047,-0.0155482994135658,0.00231349243936775,-0.0200827445947265,-0.011013854232405,1.88281552297549e-11
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CD27,CD27 antigen,39909,-0.0232897977156908,0.00346872035342935,-0.0300884896084123,-0.0164911058229692,1.95398200442928e-11
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,LILRB2,Leukocyte immunoglobulin-like receptor subfamily B member 2,39958,-0.0205787428464804,0.00306620001092202,-0.0265884948678875,-0.0145689908250732,1.99089914803768e-11
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,COQ7,"5-demethoxyubiquinone hydroxylase, mitochondrial",37039,-0.027339330340969,0.00407298635935962,-0.0353223836053139,-0.0193562770766241,1.99345873994739e-11
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NPTXR,Neuronal pentraxin receptor,39864,-0.0203483534972372,0.00303251109366295,-0.0262920752408166,-0.0144046317536578,2.01061440101118e-11
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,EGFR,Epidermal growth factor receptor,40048,-0.00957300572224556,0.0014290220001528,-0.0123738888425451,-0.00677212260194607,2.16777584508113e-11
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,BTN2A1,Butyrophilin subfamily 2 member A1,39927,-0.0148999766002101,0.00222580949812481,-0.0192625632165347,-0.0105373899838855,2.24059046016728e-11
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FRZB,Secreted frizzled-related protein 3,39691,-0.0157083566058903,0.00234703402629936,-0.020308543297437,-0.0111081699143435,2.26207957068587e-11
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TNFRSF19,Tumor necrosis factor receptor superfamily member 19,40026,-0.0177285122953553,0.00264966929145835,-0.0229218641066137,-0.012535160484097,2.29179107305422e-11
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DNAJB1,DnaJ homolog subfamily B member 1,39784,-0.0516469245142766,0.00774777638068893,-0.0668325662204269,-0.0364612828081263,2.7144558816923e-11
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,KDR,Vascular endothelial growth factor receptor 2,39909,-0.0151555300364783,0.00227640413001045,-0.0196172821312987,-0.0106937779416578,2.87239163586203e-11
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,EFEMP1,EGF-containing fibulin-like extracellular matrix protein 1,39910,-0.0178324949722576,0.00267977254494191,-0.0230848491603438,-0.0125801407841715,2.93503210345303e-11
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PPP3R1,Calcineurin subunit B type 1,39745,-0.0246044248263965,0.00369830446761213,-0.0318531015829163,-0.0173557480698767,2.96776934846193e-11
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,RETN,Resistin,39786,-0.0241648886253093,0.00363397122935847,-0.0312874722348519,-0.0170423050157667,3.03204347132197e-11
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,KLRD1,Natural killer cells antigen CD94,40054,-0.0270259826289759,0.00407163488955943,-0.0350063870125124,-0.0190455782454394,3.28900816991504e-11
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PTN,Pleiotrophin,39581,-0.0298403029877225,0.00449580836509402,-0.0386520873833067,-0.0210285185921382,3.29796482940741e-11
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ROBO1,Roundabout homolog 1,39881,-0.0139553812155822,0.00210497797348269,-0.0180811380436082,-0.00982962438755612,3.4710608304825e-11
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,VASP,Vasodilator-stimulated phosphoprotein,37441,-0.0430119597482715,0.00649131103342875,-0.0557349293737918,-0.0302889901227511,3.57709042445608e-11
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,LCP1,Plastin-2,37433,-0.0276337676850536,0.00417145443275017,-0.035809818373244,-0.0194577169968633,3.6157517812446e-11
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SFRP1,Secreted frizzled-related protein 1,39685,-0.0250595516924906,0.00378611641240523,-0.0324803398608049,-0.0176387635241764,3.73761328294546e-11
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DPP4,Dipeptidyl peptidase 4,39571,-0.0176730657170203,0.0026705726021926,-0.0229073880173178,-0.0124387434167228,3.76617137937258e-11
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CD200,OX-2 membrane glycoprotein,39862,-0.0151627592125735,0.002291560663083,-0.0196542181122162,-0.0106713003129308,3.7875149230503e-11
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CDH15,Cadherin-15,39969,0.031565411368526,0.00477257441278839,0.0222111655194607,0.0409196572175912,3.86060405583922e-11
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ADAMTSL2,ADAMTS-like protein 2,37433,0.0186636996183774,0.00282357668933592,0.013129489307279,0.0241979099294758,3.988130477606e-11
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DIPK2B,Divergent protein kinase domain 2B,37120,-0.0166794710777142,0.0025240526127825,-0.0216266141987679,-0.0117323279566605,4.03858234563077e-11
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ABHD14B,Protein ABHD14B,39683,-0.0337837184182053,0.00511850295499567,-0.0438159842099968,-0.0237514526264138,4.23334108590622e-11
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PLAU,Urokinase-type plasminogen activator,39854,-0.0167884599919467,0.0025474897476721,-0.021781539897384,-0.0117953800865094,4.52969372332278e-11
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IST1,IST1 homolog,37283,-0.0585111835721606,0.00887962286686461,-0.0759152443912153,-0.041107122753106,4.58157188162876e-11
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ZFYVE19,Abscission/NoCut checkpoint regulator,37378,-0.0531457145935912,0.00808513338476543,-0.0689925760277314,-0.0372988531594509,5.10301731959313e-11
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,KIT,Mast/stem cell growth factor receptor Kit,39904,-0.0168490047884907,0.00256373918712147,-0.0218739335952488,-0.0118240759817326,5.11586850239114e-11
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PHACTR2,Phosphatase and actin regulator 2,37408,-0.0669393333564874,0.0101951601877936,-0.0869218473245629,-0.0469568193884119,5.36420331518155e-11
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,OSCAR,Osteoclast-associated immunoglobulin-like receptor,39881,-0.0193511696657254,0.00295235067431041,-0.0251377769873738,-0.013564562344077,5.7534866120325e-11
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,AMBP,Protein AMBP,39999,-0.0112797072096396,0.00172134227808573,-0.0146535380746876,-0.00790587634459159,5.81561283273095e-11
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IL6R,Interleukin-6 receptor subunit alpha,39801,-0.0196213477463241,0.00299948675489375,-0.0255003417859159,-0.0137423537067324,6.27305720118482e-11
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PON2,Serum paraoxonase/arylesterase 2,39581,-0.0200685756435051,0.00307205453825149,-0.026089802538478,-0.0140473487485322,6.66123547905978e-11
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DTX3,Probable E3 ubiquitin-protein ligase DTX3,39784,-0.0135963936963247,0.00208176422828332,-0.0176766515837601,-0.00951613580888942,6.72263971636693e-11
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ACOT13,Acyl-coenzyme A thioesterase 13,37378,-0.0663354025244663,0.0101562181790571,-0.0862415901554182,-0.0464292148935145,6.7440647165081e-11
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SBSN,Suprabasin,37416,-0.0197024177487528,0.0030187134935417,-0.0256190961960946,-0.0137857393014111,6.95980777610757e-11
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GATD3,"Glutamine amidotransferase-like class 1 domain-containing protein 3B, mitochondrial",37039,-0.0450548823612387,0.00691103935619602,-0.0586005194993829,-0.0315092452230945,7.32278940280535e-11
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ADGRE1,Adhesion G protein-coupled receptor E1,37378,-0.0310787006021573,0.00477242379099551,-0.0404326512325085,-0.0217247499718061,7.6705809759425e-11
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CRIM1,Cysteine-rich motor neuron 1 protein,39927,-0.011695405603719,0.00179673418928386,-0.0152170046147153,-0.0081738065927226,7.77600382878708e-11
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,HCLS1,Hematopoietic lineage cell-specific protein,40054,-0.0324915255851345,0.00499338116581658,-0.042278552670135,-0.022704498500134,7.89586043652199e-11
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SYT1,Synaptotagmin-1,37384,-0.0214145992506786,0.00329199062033131,-0.027866900866528,-0.0149622976348293,8.03943518147972e-11
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FABP6,Gastrotropin,39560,-0.0313563783116717,0.00482699678310901,-0.0408172920065654,-0.021895464616778,8.49402800402619e-11
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CXCL9,C-X-C motif chemokine 9,39927,-0.0377320090212596,0.00581056471447693,-0.0491207158616344,-0.0263433021808848,8.62161113708921e-11
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,KIAA0319,Dyslexia-associated protein KIAA0319,37384,-0.017463568514054,0.00269356451497516,-0.0227429549634053,-0.0121841820647027,9.27663789085152e-11
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CD300C,CMRF35-like molecule 6,40005,-0.0191959814459653,0.00296127250581022,-0.0250000755573533,-0.0133918873345772,9.29279812726649e-11
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TST,Thiosulfate sulfurtransferase,39451,-0.044215982524272,0.0068217371639639,-0.0575865873656412,-0.0308453776829027,9.34606804852909e-11
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,AIFM1,"Apoptosis-inducing factor 1, mitochondrial",39759,-0.060393906841891,0.0093232629163727,-0.0786675021579815,-0.0421203115258005,9.58248285196327e-11
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NID1,Nidogen-1,39888,-0.0216764282769455,0.00334853327228071,-0.0282395534906157,-0.0151133030632753,9.85989159301992e-11
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CCL17,C-C motif chemokine 17,39832,-0.0520076660277389,0.00803867536189906,-0.067763469737061,-0.0362518623184167,1.01066444416334e-10
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IL18,Interleukin-18,39792,-0.0262424908112262,0.00406134894066294,-0.0342027347349255,-0.0182822468875268,1.06663339768592e-10
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,LGALS4,Galectin-4,39858,0.0303897189874292,0.00470328694514126,0.0211712765749523,0.0396081613999061,1.06750622893066e-10
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CHRDL2,Chordin-like protein 2,39864,0.0324547417186997,0.00502310425856972,0.022609457371903,0.0423000260654963,1.06951145509894e-10
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PPP2R5A,Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit alpha isoform,37378,-0.067967398107663,0.0105449271039492,-0.0886354552314034,-0.0472993409839225,1.19124798952269e-10
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MAX,Protein max,39485,-0.0606199742221536,0.00940673475598478,-0.0790571743438838,-0.0421827741004234,1.19522780507177e-10
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DTYMK,Thymidylate kinase,37433,-0.0392034528022885,0.00610340164235292,-0.0511661200213002,-0.0272407855832768,1.37874781747342e-10
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,HS6ST1,Heparan-sulfate 6-O-sulfotransferase 1,40026,-0.0193817732718188,0.0030196631968457,-0.0253003131376363,-0.0134632334060012,1.41435391625812e-10
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SKAP1,Src kinase-associated phosphoprotein 1,39709,-0.0411226142686045,0.00641145755265746,-0.0536890710718132,-0.0285561574653959,1.45836217291207e-10
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,KLK6,Kallikrein-6,39885,-0.0168726832186116,0.0026355694690173,-0.0220383993778856,-0.0117069670593377,1.57709637711055e-10
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,LTA,Lymphotoxin-alpha,39862,-0.0225169499009084,0.00351782027362742,-0.0294118776372182,-0.0156220221645987,1.58840374518006e-10
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CNPY4,Protein canopy homolog 4,39784,-0.0431789406394451,0.00675326951522619,-0.0564153488892885,-0.0299425323896018,1.66336603518905e-10
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,BTN3A2,Butyrophilin subfamily 3 member A2,39862,-0.0209438475294449,0.00327664006549033,-0.027366062057806,-0.0145216330010839,1.68407028701474e-10
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MINK1,Misshapen-like kinase 1,37384,-0.0527951311879767,0.00826247261378633,-0.068989577510998,-0.0366006848649555,1.71602749037215e-10
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NPC2,NPC intracellular cholesterol transporter 2,37264,-0.0168963840951212,0.00264482406750819,-0.0220802392674372,-0.0117125289228051,1.7308796288616e-10
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,STXBP1,Syntaxin-binding protein 1,37408,-0.044258430662474,0.0069583827926926,-0.0578968609361515,-0.0306200003887965,2.07628079726231e-10
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GP5,Platelet glycoprotein V,37120,-0.0204851465273309,0.00322110648751033,-0.0267985152428511,-0.0141717778118106,2.08833671604528e-10
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,B2M,Beta-2-microglobulin,37449,-0.0173822781032763,0.00273750065831186,-0.0227477793935676,-0.0120167768129851,2.2261323379664e-10
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,S100A14,Protein S100-A14,37408,0.0288550956272817,0.00454533322202701,0.0199462425121087,0.0377639487424546,2.24661276189524e-10
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SLC39A5,Zinc transporter ZIP5,39862,0.029838929222022,0.00470866953648207,0.0206099369305172,0.0390679215135269,2.40517678248418e-10
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MEGF9,Multiple epidermal growth factor-like domains protein 9,39998,-0.0119451903794635,0.00188687082689482,-0.0156434572001774,-0.00824692355874966,2.50516781740889e-10
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,COL3A1,Collagen alpha-1(III) chain,37433,0.0130804175310255,0.0020667295949142,0.00902962752499368,0.0171312075370574,2.54444068130213e-10
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CAPG,Macrophage-capping protein,39735,-0.0327199844346965,0.00517346003080246,-0.0428599660950693,-0.0225800027743237,2.60707780301282e-10
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,VSIG4,V-set and immunoglobulin domain-containing protein 4,39827,-0.0214291561508839,0.00339204571507855,-0.0280775657524378,-0.0147807465493299,2.7291521690869e-10
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CYB5R2,NADH-cytochrome b5 reductase 2,37216,-0.0313292430362363,0.0049594068348109,-0.0410496804324657,-0.0216088056400069,2.74908173879585e-10
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,QPCT,Glutaminyl-peptide cyclotransferase,39858,-0.0148877948104146,0.00235769524128334,-0.0195088774833299,-0.0102667121374993,2.78087842301166e-10
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IL12RB1,Interleukin-12 receptor subunit beta-1,39583,-0.0207678872295372,0.00329046640937363,-0.0272172013919096,-0.0143185730671649,2.83687604644042e-10
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,RILPL2,RILP-like protein 2,37433,-0.055401229678391,0.00878140809954173,-0.0726127895534928,-0.0381896698032892,2.89706252872748e-10
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IL13RA1,Interleukin-13 receptor subunit alpha-1,39593,-0.0127196963403638,0.00201723939387224,-0.0166734855523534,-0.00876590712837422,2.94934166862885e-10
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ICAM3,Intercellular adhesion molecule 3,40048,-0.014223966124053,0.00225704752442893,-0.0186477792719337,-0.00980015297617226,3.01382452975108e-10
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MYL3,Myosin light chain 3,37039,0.040733274096191,0.00646700018600713,0.0280579537316171,0.053408594460765,3.09820450595822e-10
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CCL27,C-C motif chemokine 27,39864,-0.0350913875030342,0.00557374448561241,-0.0460159266948345,-0.0241668483112339,3.13713002976734e-10
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SERPING1,Plasma protease C1 inhibitor,37420,-0.0105336911203023,0.001673000139932,-0.013812771394569,-0.00725461084603554,3.14255475409733e-10
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CFB,Complement factor B,37216,-0.0184111889649828,0.00293038693094553,-0.0241547473496361,-0.0126676305803296,3.42735115415552e-10
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,REG3A,Regenerating islet-derived protein 3-alpha,40048,-0.0328529558538875,0.00523020929997303,-0.0431041660818346,-0.0226017456259403,3.44137299229872e-10
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PGD,"6-phosphogluconate dehydrogenase, decarboxylating",37433,-0.0301650588259201,0.00480317797043766,-0.0395792876479779,-0.0207508300038623,3.48381474583923e-10
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IL12B,Interleukin-12 subunit beta,40054,-0.0292717702093723,0.00466535793043669,-0.0384158717530282,-0.0201276686657164,3.60175198852549e-10
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ZBTB17,Zinc finger and BTB domain-containing protein 17,39581,-0.0226886795496927,0.00362040254484767,-0.0297846685375942,-0.0155926905617913,3.77917140924052e-10
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PEBP1,Phosphatidylethanolamine-binding protein 1,39854,-0.0321526727626591,0.00513443190200422,-0.0422161592905873,-0.0220891862347308,3.89355412097576e-10
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,THPO,Thrombopoietin,39581,-0.0212971938664582,0.00340360547381563,-0.0279682605951368,-0.0146261271377795,4.01984796696906e-10
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,HPCAL1,Hippocalcin-like protein 1,40054,-0.0413527195132573,0.00661127866589035,-0.0543108256984024,-0.0283946133281122,4.07819019898256e-10
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,EFCAB14,EF-hand calcium-binding domain-containing protein 14,37378,-0.0144074747179046,0.00230562316204488,-0.0189264961155125,-0.00988845332029659,4.25917590892242e-10
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,INSL5,Insulin-like peptide INSL5,37378,0.0538399458216321,0.00861792908432789,0.0369488048163494,0.0707310868269147,4.29761325974854e-10
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CSF3R,Granulocyte colony-stimulating factor receptor,37052,-0.0173901233107863,0.00278512149456496,-0.0228489614401336,-0.0119312851814389,4.39777855927292e-10
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SOST,Sclerostin,39842,-0.0212003677738513,0.0034124182865863,-0.0278887076155605,-0.0145120279321422,5.33677949349335e-10
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PENK,Proenkephalin-A,37120,-0.0161189285982271,0.00259440116841638,-0.0212039548883232,-0.011033902308131,5.35487751412585e-10
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CCL3,C-C motif chemokine 3,39862,-0.0347476025276176,0.00559382920036889,-0.0457115077603407,-0.0237836972948946,5.36845920966579e-10
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,XG,Glycoprotein Xg,39981,-0.0166436646186703,0.00268028558556442,-0.0218970243663766,-0.0113903048709641,5.43998836410229e-10
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,BID,BH3-interacting domain death agonist,39862,-0.0365709278758001,0.00589097325020197,-0.0481172354461959,-0.0250246203054042,5.50001482379165e-10
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,OXCT1,"Succinyl-CoA:3-ketoacid coenzyme A transferase 1, mitochondrial",37039,-0.0386868451888043,0.00623185358049998,-0.0509012782065842,-0.0264724121710243,5.53016034357601e-10
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,LAMA4,Laminin subunit alpha-4,39927,-0.0186087703001684,0.00299853304521694,-0.0244858950687936,-0.0127316455315432,5.56978936731799e-10
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DNAJA2,DnaJ homolog subfamily A member 2,40005,-0.0454821434424934,0.0073355404374576,-0.0598598026999103,-0.0311044841850765,5.77463371119164e-10
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,UBE2L6,Ubiquitin/ISG15-conjugating enzyme E2 L6,37433,-0.0343654684446904,0.00554210033582769,-0.0452279851029127,-0.0235029517864681,5.78046293326826e-10
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TIA1,Nucleolysin TIA-1 isoform p40,39370,-0.0680057424163733,0.0109806493260057,-0.0895278150953445,-0.046483669737402,6.04275736890966e-10
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PRAP1,Proline-rich acidic protein 1,37433,0.0221400840418931,0.00358118470987512,0.0151209620105378,0.0291592060732483,6.49698475684106e-10
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PPY,Pancreatic prohormone,39822,0.0552090614707096,0.00893173333233533,0.0377028641393323,0.0727152588020868,6.51513726507968e-10
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PSAP,Prosaposin,37343,-0.0153675422203119,0.0024859715266368,-0.02024004641252,-0.0104950380281038,6.52413752971422e-10
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NT5C1A,Cytosolic 5'-nucleotidase 1A,37384,-0.0168090850856992,0.00272498305731677,-0.0221500518780401,-0.0114681182933584,7.09013711171514e-10
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GPA33,Cell surface A33 antigen,39784,0.0722492680466668,0.011722971667511,0.0492722435783451,0.0952262925149885,7.30747825672139e-10
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SCGB3A2,Secretoglobin family 3A member 2,39904,0.0424122130500831,0.00688249652823054,0.0289225198547512,0.055901906245415,7.33945052611081e-10
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NCAM1,Neural cell adhesion molecule 1,39927,-0.0164630852316908,0.00267175714904075,-0.0216997292438107,-0.011226441219571,7.35936863144906e-10
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TXNDC5,Thioredoxin domain-containing protein 5,40005,-0.0376119591488597,0.0061042065499415,-0.0495762039867451,-0.0256477143109744,7.37006199049534e-10
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NOMO1,Nodal modulator 1,39854,-0.0129993444558514,0.00211360550487443,-0.0171420112454053,-0.0088566776662975,7.91666912645609e-10
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CLTA,Clathrin light chain A,39581,-0.0255277550498565,0.00415568457198906,-0.0336728968109551,-0.017382613288758,8.3004421102292e-10
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CD300A,CMRF35-like molecule 8,37120,-0.0157899525270392,0.00257473582649959,-0.0208364347469784,-0.0107434703071,8.88831779237991e-10
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CLEC6A,C-type lectin domain family 6 member A,39473,-0.0253703636483287,0.00414345070803502,-0.0334915270360773,-0.01724920026058,9.40258549191146e-10
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IFNLR1,Interferon lambda receptor 1,39862,-0.0203999744830421,0.00333186472295259,-0.0269304293400292,-0.013869519626055,9.41567186860227e-10
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,STK11,Serine/threonine-protein kinase STK11,39581,-0.0400053022994588,0.00654478431119096,-0.052833079549393,-0.0271775250495245,1.00368691970679e-09
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NME3,Nucleoside diphosphate kinase 3,39881,-0.0129885443097725,0.0021254811181349,-0.0171544873013169,-0.00882260131822812,1.01380883016588e-09
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,COX5B,"Cytochrome c oxidase subunit 5B, mitochondrial",39784,-0.0381644024897317,0.00624540852638315,-0.0504054032014427,-0.0259234017780207,1.01445073975499e-09
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CCL26,C-C motif chemokine 26,39862,-0.0465494056660907,0.00762381737802683,-0.0614920877270233,-0.0316067236051581,1.04657633908579e-09
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CR1,Complement receptor type 1,37416,-0.019361573380569,0.0031709429368377,-0.0255766215367709,-0.0131465252243671,1.04991454489214e-09
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FLI1,Friend leukemia integration 1 transcription factor,39473,-0.0599524998923261,0.0098233514138933,-0.0792062686635569,-0.0406987311210952,1.06516125668448e-09
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ERBB3,Receptor tyrosine-protein kinase erbB-3,39805,-0.0104977023985981,0.00172036412919426,-0.0138696160918189,-0.00712578870537738,1.07155438014879e-09
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ROBO2,Roundabout homolog 2,40005,-0.0123514730136478,0.0020250184245408,-0.0163205091257478,-0.00838243690154781,1.0886861521787e-09
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,YAP1,Transcriptional coactivator YAP1,37384,-0.0138237650683373,0.00226810511868759,-0.018269251100965,-0.00937827903570963,1.1251612561755e-09
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CGREF1,Cell growth regulator with EF hand domain protein 1,39864,0.0227418216711851,0.00373424002280306,0.0154227112264911,0.0300609321158791,1.15433571932673e-09
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CXCL12,Stromal cell-derived factor 1,39583,-0.0216528522249504,0.00355757779043575,-0.0286257046942045,-0.0146799997556963,1.18156237097063e-09
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CLEC4A,C-type lectin domain family 4 member A,39862,0.0188153188089446,0.00309598908622241,0.0127471801999487,0.0248834574179405,1.24977805277247e-09
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,40030,-0.0143896904113023,0.00236804538947616,-0.0190310593746756,-0.00974832144792906,1.25501619005765e-09
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DSC2,Desmocollin-2,39669,-0.0180059724660977,0.00296473220967095,-0.0238168475970527,-0.0121950973351426,1.28105525507377e-09
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PBXIP1,Pre-B-cell leukemia transcription factor-interacting protein 1,37378,-0.0159998941291572,0.00263429129871265,-0.0211631050746339,-0.0108366831836804,1.28349166918502e-09
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,LAIR1,Leukocyte-associated immunoglobulin-like receptor 1,39858,-0.020410998417512,0.00336393858801003,-0.0270043180500116,-0.0138176787850123,1.32770294133358e-09
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NPL,N-acetylneuraminate lyase,37433,-0.0237267595918921,0.00391291782178735,-0.0313960785225953,-0.0160574406611889,1.36555662044839e-09
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IGSF8,Immunoglobulin superfamily member 8,39864,-0.0162757416875861,0.00269292340088127,-0.0215538715533134,-0.0109976118218588,1.53776033506295e-09
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GSR,"Glutathione reductase, mitochondrial",37399,-0.0120815999475141,0.00200433387640711,-0.016010094345272,-0.00815310554975613,1.70591389122772e-09
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MDK,Midkine,39839,-0.0271602714259898,0.00451013999141538,-0.036000145809164,-0.0183203970428157,1.7599784611951e-09
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,AHSG,Alpha-2-HS-glycoprotein,37441,-0.0142758259048366,0.0023715514470953,-0.0189240667411434,-0.00962758506852984,1.79338396405544e-09
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CCL20,C-C motif chemokine 20,40054,-0.0451985041950616,0.00750978235785654,-0.0599176776164604,-0.0304793307736627,1.79706249358889e-09
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SNX15,Sorting nexin-15,37120,-0.0288792560837973,0.00479895829856086,-0.0382852143489766,-0.019473297818618,1.81446114991941e-09
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NOTCH2,Neurogenic locus notch homolog protein 2,37433,-0.011609073998058,0.00193417398761125,-0.015400055013776,-0.00781809298233994,1.99767141049361e-09
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CRYBB1,Beta-crystallin B1,37433,-0.0354307686119814,0.00592051645719882,-0.0470349808680911,-0.0238265563558717,2.22654561417752e-09
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,UFD1,Ubiquitin recognition factor in ER-associated degradation protein 1,37378,-0.0750025034786049,0.0125345926443372,-0.0995703050615058,-0.0504347018957041,2.23721769891757e-09
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ERN1,Serine/threonine-protein kinase/endoribonuclease IRE1,37364,0.0200700529319783,0.00335421894856597,0.013495783792789,0.0266443220711676,2.23886710016172e-09
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,LY9,T-lymphocyte surface antigen Ly-9,39695,-0.015131106460953,0.00253034733861871,-0.0200905872446457,-0.0101716256772603,2.28140134967088e-09
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,VAMP8,Vesicle-associated membrane protein 8,37052,-0.0468969676594045,0.00787111383547198,-0.0623243507769295,-0.0314695845418794,2.6167402909424e-09
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CRELD2,Protein disulfide isomerase CRELD2,39904,-0.0276419946497048,0.00464305646176379,-0.0367423853147619,-0.0185416039846478,2.68096460829544e-09
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MCFD2,Multiple coagulation factor deficiency protein 2,39784,-0.0238120482879451,0.00400085457996134,-0.0316537232646693,-0.0159703733112209,2.70873522135542e-09
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CD28,T-cell-specific surface glycoprotein CD28,39473,-0.0186952326801326,0.0031412043095089,-0.0248519931267701,-0.0125384722334952,2.71196068315117e-09
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,OGFR,Opioid growth factor receptor,39784,-0.0173657781858329,0.00291808415412288,-0.0230852231279137,-0.011646333243752,2.7195191668981e-09
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,YTHDF3,YTH domain-containing family protein 3,39583,-0.0452854066962603,0.00761047115648692,-0.0602019301629747,-0.030368883229546,2.73155938946118e-09
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MTDH,Protein LYRIC,37052,-0.0489450594064358,0.0082340685237829,-0.0650838337130502,-0.0328062850998213,2.84802710190077e-09
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SCGB3A1,Secretoglobin family 3A member 1,37120,0.0129310525782431,0.00217945239949544,0.00865932587523199,0.0172027792812541,3.04558873723614e-09
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PARP1,Poly [ADP-ribose] polymerase 1,39862,-0.0288376224216117,0.00487758352644226,-0.0383976861334385,-0.0192775587097849,3.44275761584113e-09
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CCL8,C-C motif chemokine 8,39999,-0.031774690852291,0.00537713628648115,-0.042313877973794,-0.0212355037307879,3.50646475576746e-09
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PDIA4,Protein disulfide-isomerase A4,37433,-0.0322642309813973,0.00546647957630291,-0.042978530950951,-0.0215499310118436,3.67254601316293e-09
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,LTBP2,Latent-transforming growth factor beta-binding protein 2,40048,-0.0162160760948601,0.00274824083079355,-0.0216026281232154,-0.0108295240665047,3.69565993479277e-09
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PTPRC,Receptor-type tyrosine-protein phosphatase C,37433,-0.0116772126507715,0.00198225946404768,-0.015562441200305,-0.0077919841012381,3.93289358952853e-09
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,AREG,Amphiregulin,39784,0.0245333435353228,0.00417491764702113,0.0163505049471614,0.0327161821234843,4.27741861709117e-09
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CTRL,Chymotrypsin-like protease CTRL-1,37384,-0.0344015381589264,0.00585364490584421,-0.0458746821743811,-0.0229283941434718,4.27752476277212e-09
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NECTIN4,Nectin-4,39909,-0.0154110635694569,0.0026230264898768,-0.0205521954896154,-0.0102699316492983,4.3043504189886e-09
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IFNGR2,Interferon gamma receptor 2,39745,0.0272096128165776,0.00463776022037145,0.0181196027846496,0.0362996228485056,4.52648920395425e-09
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FAS,Tumor necrosis factor receptor superfamily member 6,39998,-0.0166460037504344,0.00284352284549798,-0.0222193085276104,-0.0110726989732583,4.89177262352265e-09
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MSLN,Mesothelin,39762,-0.0274122606350497,0.0046856660014635,-0.0365961659979182,-0.0182283552721812,5.00512078744264e-09
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,HNRNPUL1,Heterogeneous nuclear ribonucleoprotein U-like protein 1,37408,-0.0248285458524686,0.00424563017115736,-0.033149980987937,-0.0165071107170002,5.08915650376748e-09
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FCGR3B,Low affinity immunoglobulin gamma Fc region receptor III-B,39877,-0.0256389138832979,0.00438880916301023,-0.034240979842798,-0.0170368479237979,5.26145666528978e-09
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,LYN,Tyrosine-protein kinase Lyn,39784,-0.0441259007878252,0.00755850501085602,-0.058940570609103,-0.0293112309665474,5.38867240733559e-09
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TNFRSF21,Tumor necrosis factor receptor superfamily member 21,40005,-0.0139338775271923,0.00238690115177799,-0.0186122037846772,-0.00925555126970743,5.39598614887515e-09
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TCL1A,T-cell leukemia/lymphoma protein 1A,39726,-0.0493171124511895,0.00845443198570665,-0.0658877991431746,-0.0327464257592045,5.54043585507962e-09
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PRKG1,cGMP-dependent protein kinase 1,37120,-0.065730614374337,0.0112731282342324,-0.0878259457134325,-0.0436352830352415,5.64690695380849e-09
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FKBPL,FK506-binding protein-like,37378,-0.030840408929453,0.0052964768596918,-0.0412215035744489,-0.0204593142844571,5.91787850189407e-09
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,F2R,Proteinase-activated receptor 1,39904,-0.0303298577613045,0.0052120232288737,-0.040545423289897,-0.0201142922327121,6.0253609321318e-09
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SIRPB1,Signal-regulatory protein beta-1,39831,-0.0229261458969001,0.00395025099394089,-0.0306686378450242,-0.015183653948776,6.608930468896e-09
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,APOE,Apolipoprotein E,37449,0.0373930869998362,0.00644929352099952,0.0247524716986771,0.0500337023009952,6.85963937148812e-09
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ANPEP,Aminopeptidase N,39887,-0.0143960742836326,0.00249071844789194,-0.0192778824415008,-0.0095142661257644,7.61393940608147e-09
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,HEPH,Hephaestin,37433,0.0135124794425096,0.00234204539337427,0.00892207047149601,0.0181028884135232,8.12319571358024e-09
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FETUB,Fetuin-B,39904,-0.0173106599174146,0.00300118228432143,-0.0231929771946846,-0.0114283426401446,8.17206829661669e-09
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SIRT2,NAD-dependent protein deacetylase sirtuin-2,39784,-0.0456822008060788,0.00792181583963993,-0.061208959851773,-0.0301554417603845,8.23702419663832e-09
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GYS1,"Glycogen [starch] synthase, muscle",39581,-0.0480525024333553,0.00833324174449614,-0.0643856562525677,-0.0317193486141428,8.25209482324684e-09
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CD300LF,CMRF35-like molecule 1,40026,-0.0306347430974516,0.00532095027999201,-0.0410638056462359,-0.0202056805486672,8.6978390205974e-09
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PKD2,Polycystin-2,37017,-0.0305419567128147,0.00531247503971316,-0.0409544077906525,-0.0201295056349769,9.17113429420334e-09
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GNLY,Granulysin,39854,-0.0260745237121164,0.00453971239870438,-0.034972360013577,-0.0171766874106558,9.43400979657855e-09
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ANXA11,Annexin A11,39825,-0.0341991950072473,0.00595548179898801,-0.0458719393332638,-0.0225264506812308,9.50005499006859e-09
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SNAP25,Synaptosomal-associated protein 25,36987,-0.024202208606718,0.00421540157632186,-0.0324643956963089,-0.0159400215171271,9.59890005339395e-09
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,LEFTY2,Left-right determination factor 2,40007,-0.0273011680699795,0.00475579064719148,-0.0366225177384748,-0.0179798184014842,9.60267744877444e-09
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,WFIKKN1,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 1",39695,-0.0205908595230733,0.00358714496021957,-0.0276216636451037,-0.013560055401043,9.63072858947549e-09
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SPINT1,Kunitz-type protease inhibitor 1,39790,-0.0132871813377022,0.00231530410321321,-0.0178251773800001,-0.00874918529540429,9.70551791078871e-09
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CTSE,Cathepsin E,37120,0.0269471240313863,0.00470503299816574,0.0177252593549815,0.0361689887077912,1.04257934881799e-08
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,KIFBP,KIF-binding protein,39784,-0.0424465265403576,0.00741280572950857,-0.0569756257701944,-0.0279174273105208,1.04613726325167e-08
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CA4,Carbonic anhydrase 4,40048,-0.0119527838053764,0.00208754596760286,-0.016044373901878,-0.00786119370887478,1.04798510299299e-08
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SPRY2,Protein sprouty homolog 2,39583,-0.0473331547723154,0.00827017890002218,-0.0635427054163588,-0.0311236041282719,1.06345739878373e-08
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TBCA,Tubulin-specific chaperone A,37120,-0.044068938414423,0.00769924307147038,-0.059159454834505,-0.028978421994341,1.06422019672089e-08
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CCL24,C-C motif chemokine 24,39904,-0.0420884819647558,0.0073557952239012,-0.0565058406036022,-0.0276711233259095,1.07274059703806e-08
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CSF3,Granulocyte colony-stimulating factor,39583,-0.0244616248811036,0.0042804124411893,-0.0328512332658346,-0.0160720164963726,1.11835290421901e-08
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MMP7,Matrilysin,39559,-0.0251863724749316,0.00441562379619525,-0.0338409951154743,-0.0165317498343889,1.19191184485237e-08
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GPC5,Glypican-5,39745,-0.0284006785674569,0.00498063610276342,-0.0381627253288732,-0.0186386318060406,1.2036056226931e-08
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CXCL5,C-X-C motif chemokine 5,39801,-0.0578449039481109,0.0101581570030891,-0.0777548916741656,-0.0379349162220563,1.25967175088353e-08
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SERPINC1,Antithrombin-III,37420,-0.00737349987495053,0.00129509655293414,-0.00991188911870143,-0.00483511063119962,1.27117625123655e-08
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NDUFB7,NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 7,37378,-0.045109721592892,0.00792868407637991,-0.0606499423825966,-0.0295695008031874,1.30105000556188e-08
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CLEC4M,C-type lectin domain family 4 member M,37406,-0.0244825912465969,0.00430324689828474,-0.032916955167235,-0.0160482273259588,1.30178324912145e-08
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CD48,CD48 antigen,39904,-0.0146882006678286,0.00258223198744179,-0.0197493753632145,-0.00962702597244269,1.30639102560278e-08
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PHLDB1,Pleckstrin homology-like domain family B member 1,37378,-0.0269235622073002,0.00473843592827633,-0.0362108966267218,-0.0176362277878786,1.35914245735801e-08
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MYOM3,Myomesin-3,37120,0.0473591121303489,0.00834055940337186,0.0310116156997401,0.0637066085609578,1.39000331708153e-08
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PVR,Poliovirus receptor,40005,0.0188143501204271,0.00331400454984756,0.0123189012027259,0.0253097990381283,1.39251221863814e-08
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FCRL2,Fc receptor-like protein 2,39986,-0.0234348222912459,0.00412892045489186,-0.031527506382834,-0.0153421381996579,1.40436881774991e-08
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,LATS1,Serine/threonine-protein kinase LATS1,37052,-0.0434389079693816,0.00766077821052985,-0.0584540332620201,-0.0284237826767431,1.45538368564347e-08
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CEP20,Centrosomal protein 20,39473,-0.0372789011685382,0.00659068779901712,-0.0501966492546118,-0.0243611530824647,1.57383338539971e-08
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ORM1,Alpha-1-acid glycoprotein 1,37385,-0.00999148820807237,0.00176721396493669,-0.0134552275793483,-0.00652774883679645,1.60105551817477e-08
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CGA,Glycoprotein hormones alpha chain,39854,-0.0445102848016488,0.00788112289016766,-0.0599572856663774,-0.0290632839369202,1.65366131835847e-08
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PIK3IP1,Phosphoinositide-3-kinase-interacting protein 1,39854,-0.0127670145138983,0.00226113725468072,-0.0171988435330725,-0.00833518549472409,1.6674241439794e-08
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MSMB,Beta-microseminoprotein,39776,-0.0336342572061461,0.00598050607675751,-0.0453560491165908,-0.0219124652957014,1.89742725264692e-08
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,KYNU,Kynureninase,40054,-0.0227957866023635,0.00405397194562982,-0.030741571615798,-0.0148500015889291,1.90685800776938e-08
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PTPRK,Receptor-type tyrosine-protein phosphatase kappa,37378,-0.0106815682238227,0.00190134297407191,-0.0144082004530037,-0.00695493599464175,1.97099094303727e-08
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CD70,CD70 antigen,39862,-0.0210961110016501,0.0037646558447969,-0.028474836457452,-0.0137173855458482,2.13247574248675e-08
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FSHB,Follitropin subunit beta,37039,-0.0325504656171251,0.00581302053798914,-0.0439439858715838,-0.0211569453626664,2.19168931964829e-08
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NT5C3A,Cytosolic 5'-nucleotidase 3A,39825,-0.0440706963454385,0.00788086744268244,-0.0595171965330961,-0.0286241961577809,2.28000758540441e-08
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TNFRSF11A,Tumor necrosis factor receptor superfamily member 11A,40054,-0.0180708704658736,0.00323569366193984,-0.0244128300432757,-0.0117289108884715,2.376596497274e-08
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SIT1,Signaling threshold-regulating transmembrane adapter 1,39583,-0.027283058436356,0.00488607126645919,-0.036859758118616,-0.017706358754096,2.3915375776683e-08
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GRPEL1,"GrpE protein homolog 1, mitochondrial",39784,-0.0305710625215884,0.00547698698886119,-0.0413059570197563,-0.0198361680234204,2.42023316654702e-08
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CLEC4C,C-type lectin domain family 4 member C,39862,-0.0228637616965383,0.00409898113608568,-0.0308977647232663,-0.0148297586698104,2.4736239759725e-08
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NAGK,N-acetyl-D-glucosamine kinase,37022,-0.0284990250017744,0.00511322691557475,-0.0385209497563009,-0.0184771002472479,2.54449026034097e-08
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CXCL16,C-X-C motif chemokine 16,40030,-0.0115409258682422,0.00207153916067163,-0.0156011426231586,-0.00748070911332578,2.57048887831398e-08
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,HNMT,Histamine N-methyltransferase,39665,-0.0229048693273053,0.00411883738409439,-0.0309777906001303,-0.0148319480544803,2.72573606619233e-08
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,USO1,General vesicular transport factor p115,39784,-0.0445573457235295,0.00801310934484065,-0.0602630400394172,-0.0288516514076419,2.73238953348787e-08
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SERPINB8,Serpin B8,40054,-0.0272952293366892,0.00491005583619793,-0.0369189387756372,-0.0176715198977413,2.75534941665012e-08
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CD63,CD63 antigen,39716,-0.025469474293122,0.00458593471423185,-0.0344579063330164,-0.0164810422532276,2.83977777487033e-08
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,LAP3,Cytosol aminopeptidase,39583,-0.0240556689130621,0.00434258877075037,-0.0325671429037328,-0.0155441949223914,3.08243781542594e-08
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,LTBR,Tumor necrosis factor receptor superfamily member 3,39782,-0.0131959637420576,0.00238761889684388,-0.0178756967798716,-0.00851623070424362,3.31187741901802e-08
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,UBXN1,UBX domain-containing protein 1,37120,-0.0341525333633671,0.00618293197643526,-0.0462710800371803,-0.022033986689554,3.38225526042895e-08
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,LZTFL1,Leucine zipper transcription factor-like protein 1,37120,-0.0354825197564561,0.00642737225503004,-0.048080169376315,-0.0228848701365972,3.44324350681889e-08
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SEZ6L2,Seizure 6-like protein 2,39784,-0.0118279708363791,0.00214462310442863,-0.0160314321210592,-0.007624509551699,3.53858502432054e-08
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IDO1,"Indoleamine 2,3-dioxygenase 1",37039,-0.0310852324349139,0.00564146940104642,-0.0421425124609649,-0.0200279524088629,3.65297903709071e-08
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PTRHD1,Putative peptidyl-tRNA hydrolase PTRHD1,37120,-0.0297410417144571,0.00540306105772443,-0.040331041387597,-0.0191510420413172,3.77138496641202e-08
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ANGPT2,Angiopoietin-2,40026,0.0186840400622118,0.00339543728436456,0.0120289829848573,0.0253390971395663,3.79723944802293e-08
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SOD1,Superoxide dismutase [Cu-Zn],39483,-0.0236728318851575,0.00431688477478686,-0.0321339260437398,-0.0152117377265753,4.22802166513203e-08
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PPIB,Peptidyl-prolyl cis-trans isomerase B,39833,-0.0469610860046109,0.00856645425082415,-0.0637513363362262,-0.0301708356729956,4.26980072441155e-08
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ENPP6,Glycerophosphocholine cholinephosphodiesterase ENPP6,37039,0.0175566334598162,0.00320678352868745,0.0112713377435888,0.0238419291760436,4.45917075251258e-08
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MAN2B2,Epididymis-specific alpha-mannosidase,37433,0.0286030921525564,0.00524052211734905,0.0183316688025523,0.0388745155025606,4.89811844284761e-08
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CHAD,Chondroadherin,37120,-0.0244977443437377,0.00448901910483131,-0.0332962217892071,-0.0156992668982683,4.92224191438625e-08
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ZBP1,Z-DNA-binding protein 1,37052,-0.0199994253496756,0.00366709067044305,-0.027186923063744,-0.0128119276356072,5.02045542561048e-08
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GZMA,Granzyme A,40054,-0.0164311809728775,0.00301459747002414,-0.0223397920141248,-0.0105225699316302,5.09515115644307e-08
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MPO,Myeloperoxidase,39854,-0.0220037246807756,0.00403830629259209,-0.0299188050142561,-0.0140886443472951,5.14747226084207e-08
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PRRT3,Proline-rich transmembrane protein 3,37039,-0.0175260545794342,0.00322078202140009,-0.0238387873413784,-0.01121332181749,5.37621975976188e-08
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SCRN1,Secernin-1,39862,-0.0272726412008166,0.00501368276892499,-0.0370994594279096,-0.0174458229737236,5.41713675751143e-08
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TALDO1,Transaldolase,37411,-0.0216346813888832,0.0039774526599745,-0.0294304886024332,-0.0138388741753332,5.44089484960588e-08
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PDCD5,Programmed cell death protein 5,40005,-0.028067498675904,0.0051637568518877,-0.0381884621056039,-0.017946535246204,5.54417539744078e-08
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PARK7,Parkinson disease protein 7,39854,-0.0254083982196192,0.00467460533883887,-0.0345706246837433,-0.016246171755495,5.54710053258069e-08
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,LGMN,Legumain,39927,-0.0173954314586065,0.00320322785727429,-0.0236737580588641,-0.0111171048583489,5.69824985307731e-08
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CD6,T-cell differentiation antigen CD6,40036,-0.0253693838764927,0.00467456288794791,-0.0345315271368706,-0.0162072406161148,5.80968962599513e-08
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ACY1,Aminoacylase-1,39864,0.0298584588387349,0.00550519732457523,0.0190682720825674,0.0406486455949023,5.92297578287036e-08
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,LMNB1,Lamin-B1,37344,-0.027977255746929,0.00515792539386783,-0.0380867895189099,-0.017867721974948,5.92420890860469e-08
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CACNB3,Voltage-dependent L-type calcium channel subunit beta-3,37408,-0.0407915592341483,0.00752501295690609,-0.0555405846296843,-0.0260425338386124,6.03503498936984e-08
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,WNT9A,Protein Wnt-9a,39583,-0.0135994023560056,0.00251048419319161,-0.0185199513746612,-0.0086788533373501,6.14833633790853e-08
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SHISA5,Protein shisa-5,37433,-0.0110401967431746,0.0020380824474811,-0.0150348383402376,-0.00704555514611168,6.165663560589e-08
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CKB,Creatine kinase B-type,37433,-0.0280194907871543,0.00517294073204364,-0.0381584546219598,-0.0178805269523487,6.17954768546591e-08
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SMPDL3A,Acid sphingomyelinase-like phosphodiesterase 3a,39900,0.0310568361300231,0.00574148057878791,0.0198035341955988,0.0423101380644474,6.42127509420851e-08
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CHGB,Secretogranin-1,39948,-0.0189382479964346,0.00351407170806829,-0.0258258285442484,-0.0120506674486207,7.17443615058311e-08
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NXPH1,Neurexophilin-1,39485,-0.0180521671974043,0.00335036951517378,-0.0246188914471449,-0.0114854429476637,7.22331564607688e-08
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NDUFA5,NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 5,37023,-0.0174688382872496,0.00324219630033088,-0.0238235430358981,-0.0111141335386011,7.24869518247112e-08
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NELL2,Protein kinase C-binding protein NELL2,39927,-0.0135259251897823,0.00251173879500907,-0.0184489332280001,-0.00860291715156449,7.34285497271411e-08
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CLU,Clusterin,37449,-0.0152497219171619,0.00283376655510906,-0.0208039043651757,-0.00969553946914818,7.51218240124496e-08
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TNFSF11,Tumor necrosis factor ligand superfamily member 11,39862,-0.0295032841196333,0.00548492700114123,-0.0402537410418701,-0.0187528271973965,7.59638277483083e-08
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MYBPC1,"Myosin-binding protein C, slow-type",37433,0.0326649282264192,0.00607435933967009,0.0207591839206659,0.0445706725321726,7.67741280153695e-08
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,VMO1,Vitelline membrane outer layer protein 1 homolog,39784,-0.0319383485693759,0.00593982535084938,-0.0435804062570407,-0.0202962908817111,7.68117462671836e-08
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,BAP18,Chromatin complexes subunit BAP18,37384,-0.0311402793884476,0.00579208257800141,-0.0424927612413304,-0.0197877975355649,7.7272499569535e-08
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DBI,Acyl-CoA-binding protein,39789,-0.038203422293023,0.00712172127168372,-0.0521619959855231,-0.0242448486005229,8.23749049120858e-08
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MPRIP,Myosin phosphatase Rho-interacting protein,37334,-0.021430471124212,0.00399620736393196,-0.0292630375575187,-0.0135979046909054,8.3339573909794e-08
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,AGR2,Anterior gradient protein 2 homolog,39360,0.0479125749134543,0.00893545263112491,0.0303990877564495,0.0654260620704591,8.34501348764075e-08
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IGFBP2,Insulin-like growth factor-binding protein 2,40008,-0.0296844410732746,0.00553646896297988,-0.0405359202407152,-0.0188329619058341,8.36131023794659e-08
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,WFIKKN2,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 2",39881,-0.0159105869906098,0.002967558832999,-0.0217270023032879,-0.0100941716779318,8.36743208532389e-08
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NINJ1,Ninjurin-1,39473,-0.026912944440599,0.0050352760957007,-0.0367820855881724,-0.0170438032930257,9.17485033086766e-08
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ARSB,Arylsulfatase B,39784,-0.0263712633975085,0.00493447797163432,-0.0360428402219118,-0.0166996865731053,9.20238613279997e-08
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,AGER,Advanced glycosylation end product-specific receptor,39813,-0.0188161453216697,0.00353221469117131,-0.0257392861163655,-0.0118930045269739,1.0119735951916e-07
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CCDC80,Coiled-coil domain-containing protein 80,39864,-0.0155229496891041,0.00291416554734737,-0.021234714161905,-0.00981118521630326,1.01353620722431e-07
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SELE,E-selectin,40048,0.0236408232336544,0.00443938516610867,0.0149396283080814,0.0323420181592273,1.02162420383641e-07
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IFNGR1,Interferon gamma receptor 1,39927,-0.00958198805346987,0.00180076868843815,-0.0131114946828086,-0.00605248142413109,1.04551726218169e-07
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PCDH9,Protocadherin-9,37378,-0.0157365828477031,0.00295829568597168,-0.0215348423922076,-0.00993832330319859,1.05725843112818e-07
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,HEPACAM2,HEPACAM family member 2,37384,0.0198189409945422,0.00372615411386081,0.012515678931375,0.0271222030577094,1.06075229069834e-07
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MRPL58,"Peptidyl-tRNA hydrolase ICT1, mitochondrial",37408,-0.0332690194484012,0.00625835179540957,-0.045535388967404,-0.0210026499293985,1.07792117034413e-07
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DNAJB6,DnaJ homolog subfamily B member 6,37009,-0.040524353613245,0.00762615173409944,-0.0554716110120799,-0.0255770962144101,1.09075489040392e-07
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FADD,FAS-associated death domain protein,39864,-0.0364358276834409,0.00686044453800752,-0.0498822989779356,-0.0229893563889461,1.10482490283472e-07
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DNM1,Dynamin-1,37378,-0.0541620052508896,0.0102007404968053,-0.0741554566246279,-0.0341685538771513,1.11596013570594e-07
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DCTN6,Dynactin subunit 6,39485,-0.0335589108884976,0.00633824777338761,-0.0459818765243374,-0.0211359452526579,1.20847190480607e-07
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,C5,Complement C5,37449,-0.00716108243577141,0.00135341717204154,-0.00981378009297283,-0.00450838477856999,1.23463078876591e-07
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CASP8,Caspase-8,39980,-0.0290351644453111,0.00549654096097066,-0.0398083847288136,-0.0182619441618086,1.29129417854959e-07
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SEMA7A,Semaphorin-7A,39998,-0.0126717650747498,0.0024005238496413,-0.0173767918200468,-0.00796673832945288,1.31752360898807e-07
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SORCS2,VPS10 domain-containing receptor SorCS2,39473,-0.0160571339121718,0.0030511342469676,-0.0220373570362283,-0.0100769107881153,1.43850965630476e-07
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IL15RA,Interleukin-15 receptor subunit alpha,39583,-0.0160946123184679,0.00306133011197728,-0.0220948193379434,-0.0100944052989924,1.4802442156966e-07
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TNFSF14,Tumor necrosis factor ligand superfamily member 14,39745,-0.026919507932414,0.00512110322048979,-0.036956870244574,-0.016882145620254,1.48655302654526e-07
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TIGIT,T-cell immunoreceptor with Ig and ITIM domains,37165,-0.0167827044939203,0.0031940549792096,-0.0230430522531711,-0.0105223567346695,1.50836485432164e-07
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CD300LG,CMRF35-like molecule 9,39854,0.0171285697612643,0.00326446311717239,0.0107302220516064,0.0235269174709222,1.56586657533565e-07
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PGLYRP1,Peptidoglycan recognition protein 1,39958,-0.0196112951828355,0.00374062608231818,-0.0269429223041791,-0.0122796680614918,1.60170827183828e-07
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ADGRD1,Adhesion G-protein coupled receptor D1,37120,0.0181660469818498,0.00346487604142743,0.011374889940652,0.0249572040230475,1.60488669151418e-07
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SERPINI1,Neuroserpin,37084,-0.0143710475628362,0.00274307230648942,-0.0197474692835554,-0.00899462584211691,1.63899449329688e-07
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DNAJC9,DnaJ homolog subfamily C member 9,37378,-0.0353100823341861,0.00675180945300622,-0.0485436288620783,-0.0220765358062939,1.72298887510863e-07
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SEMA3F,Semaphorin-3F,39864,-0.0119016098001267,0.00227728679652601,-0.0163650919213177,-0.00743812767893574,1.75180041323708e-07
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,HGF,Hepatocyte growth factor,40054,-0.0158280066810408,0.00302872104700688,-0.0217642999331743,-0.00989171342890736,1.75393779207161e-07
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ST13,Hsc70-interacting protein,37120,-0.0256919953360294,0.00492393764381996,-0.0353429131179166,-0.0160410775541423,1.83816521721245e-07
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FBLN2,Fibulin-2,37433,-0.014042955870905,0.00269163645614297,-0.0193185633249452,-0.00876734841686478,1.8426710392686e-07
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CTSV,Cathepsin L2,39963,0.0189942983064525,0.00365030656504461,0.0118396974389651,0.02614889917394,1.9799073290797e-07
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,HBEGF,Proheparin-binding EGF-like growth factor,39980,-0.0335881488874552,0.00645532237438347,-0.0462405807412468,-0.0209357170336636,1.98317129764406e-07
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,STX4,Syntaxin-4,39784,-0.0275336158715916,0.0052933941841269,-0.0379086684724804,-0.0171585632707029,2.00130927923982e-07
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NXPH3,Neurexophilin-3,37052,-0.0137496115748148,0.00264377292732379,-0.0189314065123694,-0.00856781663726014,2.01452510161874e-07
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GLOD4,Glyoxalase domain-containing protein 4,39828,-0.0165912051044134,0.00319375545139476,-0.0228509657891472,-0.0103314444196797,2.07360910288406e-07
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CRADD,Death domain-containing protein CRADD,39709,-0.035298788170682,0.00679969135848063,-0.0486261832333041,-0.02197139310806,2.11486187350669e-07
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DKK1,Dickkopf-related protein 1,40005,-0.0275738437964245,0.00531913964998817,-0.0379993575104013,-0.0171483300824477,2.19924182915368e-07
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CD5L,CD5 antigen-like,37376,-0.0215491804655762,0.00415884775862871,-0.0297005220724885,-0.0133978388586639,2.2324534607122e-07
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ACRBP,Acrosin-binding protein,37364,-0.0177048238687833,0.00341840029865935,-0.0244048884541556,-0.0110047592834109,2.25958028004023e-07
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,OMD,Osteomodulin,39927,-0.0200469453997735,0.00387883874747901,-0.0276494693448324,-0.0124444214547147,2.39081556155919e-07
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TIGAR,"Fructose-2,6-bisphosphatase TIGAR",39449,-0.0216374660114894,0.00419014152421347,-0.0298501433989478,-0.013424788624031,2.44835465368004e-07
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,BPIFB2,BPI fold-containing family B member 2,37401,-0.0282129179829802,0.00546589970626031,-0.0389260814072505,-0.01749975455871,2.48282456784512e-07
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PSMG3,Proteasome assembly chaperone 3,39862,-0.0228510476341298,0.00442768891924078,-0.0315293179158417,-0.0141727773524178,2.48648887944341e-07
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CTF1,Cardiotrophin-1,39581,-0.0391019824743459,0.00757765035716164,-0.0539541771743827,-0.0242497877743091,2.49725037559549e-07
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DXO,Decapping and exoribonuclease protein,37384,-0.0208787971864966,0.00404610880410071,-0.028809170442534,-0.0129484239304593,2.50156909508472e-07
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CSF1R,Macrophage colony-stimulating factor 1 receptor,37441,-0.0181170202343814,0.00351279372298826,-0.0250020959314384,-0.0112319445373244,2.53872282326027e-07
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CPE,Carboxypeptidase E,39902,-0.0177106943176218,0.00343680897267765,-0.02444683990407,-0.0109745487311736,2.59064019385762e-07
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GRSF1,G-rich sequence factor 1,36870,-0.0370487543933374,0.00719660987824152,-0.0511541097546908,-0.022943399031984,2.66998965303314e-07
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,YARS1,"Tyrosine--tRNA ligase, cytoplasmic",37378,-0.0675174351436381,0.0131253029890831,-0.093243029002241,-0.0417918412850352,2.72616039074672e-07
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ADIPOQ,Adiponectin,37449,0.0302274274765191,0.00588047810300274,0.0187016903946337,0.0417531645584045,2.78106018320097e-07
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CCL5,C-C motif chemokine 5,39927,-0.0462723166751811,0.00900493455409754,-0.0639219884012122,-0.0286226449491499,2.80107995053344e-07
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CFD,Complement factor D,37449,-0.00833409473805323,0.00162415905352325,-0.0115174464829588,-0.00515074299314766,2.91669617053342e-07
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FXYD5,FXYD domain-containing ion transport regulator 5,39583,-0.0299476557720751,0.00584101008758278,-0.0413960355437373,-0.0184992760004128,2.97673767537389e-07
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TFF3,Trefoil factor 3,39835,-0.0221434352961485,0.00432285253618358,-0.0306162262670684,-0.0136706443252287,3.05161337240869e-07
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PSTPIP2,Proline-serine-threonine phosphatase-interacting protein 2,36705,-0.0499353678034519,0.00975421597558979,-0.0690536311156079,-0.0308171044912959,3.1100244013329e-07
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,RRM2,Ribonucleoside-diphosphate reductase subunit M2,39473,-0.0232141883416451,0.00453609776977031,-0.0321049399703949,-0.0143234367128953,3.13027108193836e-07
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ST3GAL1,"CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 1",39784,-0.019553595477729,0.00382363202573974,-0.0270479142481789,-0.0120592767072791,3.19269108559512e-07
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GLRX5,"Glutaredoxin-related protein 5, mitochondrial",37120,-0.0407988930886391,0.0079789453637907,-0.0564376260016689,-0.0251601601756094,3.20959231439263e-07
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,RNASE3,Eosinophil cationic protein,39787,-0.0489584141943752,0.00959256333689106,-0.0677598383346817,-0.0301569900540687,3.36752272444839e-07
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ABL1,Tyrosine-protein kinase ABL1,39784,-0.0311520788812884,0.00610566350919294,-0.0431191793593065,-0.0191849784032702,3.39657644610735e-07
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CRTAM,Cytotoxic and regulatory T-cell molecule,39745,-0.0224080712976802,0.00440497222556791,-0.0310418168597933,-0.0137743257355671,3.67926460331769e-07
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CETN3,Centrin-3,37378,-0.0357308270393874,0.0070291492844332,-0.0495079596368765,-0.0219536944418983,3.76015346578099e-07
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ELOA,Elongin-A,39784,-0.0231901901032297,0.00456399150501227,-0.0321356134530538,-0.0142447667534057,3.79460848442956e-07
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,STAB2,Stabilin-2,37433,-0.012667373304211,0.0024934583491416,-0.0175545516685285,-0.00778019493989345,3.81957791443972e-07
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PILRA,Paired immunoglobulin-like type 2 receptor alpha,39854,-0.018774391006685,0.00370145066946035,-0.0260292343188273,-0.0115195476945428,3.97703023412904e-07
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PRDX5,"Peroxiredoxin-5, mitochondrial",40054,-0.0312806296448348,0.00617153106779285,-0.0433768305377088,-0.0191844287519608,4.05303759563445e-07
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MPHOSPH8,M-phase phosphoprotein 8,39581,-0.0343419565982239,0.0067814257207517,-0.0476335510108973,-0.0210503621855506,4.14932118071848e-07
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FLT1,Vascular endothelial growth factor receptor 1,39751,-0.010447226897441,0.00206542000686697,-0.0144954501109002,-0.00639900368398169,4.2803526294766e-07
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CD80,T-lymphocyte activation antigen CD80,37433,-0.0150880361895577,0.00298489194395115,-0.020938424399702,-0.00923764797941349,4.36448318539997e-07
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DDX58,Antiviral innate immune response receptor RIG-I,39473,-0.0257436928974476,0.0050972487533028,-0.0357343004539211,-0.0157530853409741,4.4560564759183e-07
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SERPINA1,Alpha-1-antitrypsin,37243,-0.00362246318675632,0.000718825708278955,-0.00503136157498307,-0.00221356479852957,4.73043783253471e-07
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IL7R,Interleukin-7 receptor subunit alpha,39854,0.0233755217771778,0.00463903826241689,0.0142830067828406,0.0324680367715149,4.73389825974875e-07
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,LY75,Lymphocyte antigen 75,39862,-0.0173521166333475,0.00344397817484648,-0.0241023138560466,-0.0106019194106484,4.74571537470447e-07
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,RNASE6,Ribonuclease K6,37382,-0.0123772300088946,0.00246020599856462,-0.0171992337660813,-0.00755522625170796,4.94258866146868e-07
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,37120,-0.0124274716196729,0.00247100044179949,-0.0172706324855999,-0.00758431075374589,4.98635182083865e-07
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FAM172A,Cotranscriptional regulator FAM172A,37039,-0.0276453505068716,0.00549688693821047,-0.0384192489057641,-0.0168714521079791,4.98815038712238e-07
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,39473,-0.0350907113510811,0.00698287753962292,-0.0487771513287421,-0.0214042713734202,5.08334085898939e-07
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,LILRA5,Leukocyte immunoglobulin-like receptor subfamily A member 5,39842,-0.0141709328115295,0.0028212046168233,-0.0197004938605031,-0.00864137176255579,5.14169380959359e-07
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MENT,Protein MENT,37120,0.00993602847575884,0.00198002211600054,0.00605518512839779,0.0138168718231199,5.2850183323327e-07
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CLIP2,CAP-Gly domain-containing linker protein 2,39862,-0.0506222035629105,0.0100906175857111,-0.0703998140309043,-0.0308445930949167,5.31133897325766e-07
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ACYP1,Acylphosphatase-1,37069,-0.0293295325949007,0.00584866729502999,-0.0407929204931594,-0.0178661446966419,5.37948544343047e-07
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,LRPAP1,Alpha-2-macroglobulin receptor-associated protein,40005,-0.0249748357588551,0.00498424191057819,-0.0347439499035884,-0.0152057216141219,5.47889108690998e-07
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CTRC,Chymotrypsin-C,39852,-0.0275964121918001,0.00551226554005847,-0.0384004526503147,-0.0167923717332855,5.60576248423014e-07
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,VASH1,Tubulinyl-Tyr carboxypeptidase 1,39862,-0.0365639734702777,0.00730699553499824,-0.0508856847188743,-0.0222422622216812,5.67579608790621e-07
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CERT,Ceramide transfer protein,39485,-0.0274918979720048,0.00549946487507607,-0.0382708491271539,-0.0167129468168557,5.8248311317203e-07
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PAXX,Protein PAXX,37120,-0.0204717969413984,0.00409496600636635,-0.0284979303138765,-0.0124456635689204,5.82858841901778e-07
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,LY6D,Lymphocyte antigen 6D,39757,-0.0160912698459095,0.00322397686474278,-0.0224102645008053,-0.00977227519101361,6.06636413029821e-07
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CD7,T-cell antigen CD7,37033,-0.0189755158370119,0.0038075832497505,-0.0264383790065228,-0.0115126526675009,6.32008588281749e-07
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SUGT1,Protein SGT1 homolog,39473,-0.0360173434382812,0.0072346574800543,-0.0501972720991876,-0.0218374147773748,6.47806828994901e-07
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,VAMP5,Vesicle-associated membrane protein 5,39581,-0.0234676715539696,0.00471704136646412,-0.0327130726322392,-0.0142222704756999,6.59085997460775e-07
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ESAM,Endothelial cell-selective adhesion molecule,40048,-0.0138656612756061,0.00278743182785134,-0.0193290276581947,-0.00840229489301746,6.61380175033221e-07
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SCG3,Secretogranin-3,39881,-0.014386026904474,0.00289241965881837,-0.020055169435758,-0.00871688437318997,6.6367039703986e-07
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MGMT,Methylated-DNA--protein-cysteine methyltransferase,39862,-0.0543084761256036,0.0109239099199216,-0.0757193395686499,-0.0328976126825572,6.71161186404739e-07
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IL1B,Interleukin-1 beta,39474,-0.0247591917952623,0.0049828058125966,-0.0345254911879517,-0.014992892402573,6.80374233195222e-07
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GAST,Gastrin,37384,0.0513395230872342,0.0103327717224719,0.0310872905111894,0.0715917556632791,6.82585518628268e-07
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TMEM106A,Transmembrane protein 106A,37364,-0.0314487754164426,0.00634325907829855,-0.0438815632099078,-0.0190159876229775,7.2151747967992e-07
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IL1RN,Interleukin-1 receptor antagonist protein,39816,-0.0236489846687802,0.00477087866838153,-0.032999906858808,-0.0142980624787524,7.23448246589058e-07
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ACAA1,"3-ketoacyl-CoA thiolase, peroxisomal",39473,-0.036713776845659,0.00740787802241954,-0.0512332177696013,-0.0221943359217167,7.26964277602849e-07
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GGACT,Gamma-glutamylaminecyclotransferase,37433,-0.0314616616773286,0.00635246931044446,-0.0439125015257998,-0.0190108218288575,7.4083986018624e-07
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PDIA3,Protein disulfide-isomerase A3,37120,-0.0111688722440534,0.00225697828277912,-0.0155925496783005,-0.00674519480980635,7.56685829301364e-07
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PRKRA,Interferon-inducible double-stranded RNA-dependent protein kinase activator A,39473,-0.0298449411816784,0.00603209189205929,-0.0416678412901146,-0.0180220410732422,7.58798909993384e-07
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CHL1,Neural cell adhesion molecule L1-like protein,39896,-0.0137496446217371,0.00277940036583447,-0.0191972693387727,-0.00830201990470159,7.61362642763093e-07
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ANXA4,Annexin A4,39779,-0.0319712215938989,0.00646302555640567,-0.044638751684454,-0.0193036915033438,7.62175579427785e-07
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,LAT,Linker for activation of T-cells family member 1,40054,-0.0334589444589188,0.00676407346607982,-0.0467165284524352,-0.0202013604654023,7.62909846479844e-07
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ATOX1,Copper transport protein ATOX1,39909,-0.0321068523447025,0.00649466061784269,-0.0448363871556741,-0.0193773175337308,7.74764204053295e-07
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PAM,Peptidyl-glycine alpha-amidating monooxygenase,39952,-0.0122363219309053,0.00247617355408817,-0.0170896220969181,-0.00738302176489247,7.82527287069471e-07
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FCGR2A,Low affinity immunoglobulin gamma Fc region receptor II-a,39808,-0.0258086841332376,0.00522675846974113,-0.0360531307339303,-0.015564237532545,7.9808072919159e-07
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MESD,LRP chaperone MESD,39854,-0.0537256774890054,0.0108829084526395,-0.0750561780561787,-0.032395176921832,8.02551417953955e-07
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PRTG,Protogenin,40026,0.010942255664597,0.00221950673945535,0.00659202245526447,0.0152924888739294,8.30281713407389e-07
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CD74,HLA class II histocompatibility antigen gamma chain,40005,-0.0148717085427024,0.00301697995395322,-0.0207849892524508,-0.00895842783295414,8.33281653132717e-07
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SHBG,Sex hormone-binding globulin,37441,-0.0225682631874016,0.0045872477416902,-0.0315592687611144,-0.0135772576136888,8.76553298478547e-07
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SAMD9L,Sterile alpha motif domain-containing protein 9-like,39862,-0.0320339439257612,0.0065265650057907,-0.044826011337111,-0.0192418765144114,9.28024922646651e-07
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,INSR,Insulin receptor,37052,-0.00725693696935441,0.00148083449484097,-0.0101593725792427,-0.0043545013594661,9.66931436091565e-07
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CMC1,COX assembly mitochondrial protein homolog,37433,-0.0394940168828883,0.00806306448298163,-0.0552976232695323,-0.0236904104962443,9.78632008085337e-07
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GFRA2,GDNF family receptor alpha-2,39784,-0.00910233344181828,0.00185947917747354,-0.0127469126296664,-0.00545775425397015,9.92188107524115e-07
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ART3,Ecto-ADP-ribosyltransferase 3,39927,-0.0144128091023781,0.00294503159818832,-0.0201850710348272,-0.00864054716992903,9.97951724797022e-07
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ERP29,Endoplasmic reticulum resident protein 29,37120,-0.0520290210614234,0.0106410584376411,-0.0728854955992001,-0.0311725465236468,1.02298155938454e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CCL4,C-C motif chemokine 4,39878,-0.0271393581998784,0.00555861593187499,-0.0380342454263534,-0.0162444709734034,1.05815205831901e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,F2,Prothrombin,37449,-0.00637751060410002,0.00130639992698401,-0.00893805446098867,-0.00381696674721137,1.06346271288858e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,COL4A1,Collagen alpha-1(IV) chain,39864,0.0170117617362169,0.00348642121046005,0.0101783761637152,0.0238451473087186,1.0741468340303e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,EPO,Erythropoietin,39862,0.033543722300743,0.00688038534566964,0.0200581670232305,0.0470292775782555,1.09703274880898e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NUDT5,ADP-sugar pyrophosphatase,39854,-0.0223803943922932,0.00459903855834175,-0.031394509966643,-0.0133662788179433,1.14778791847256e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,STX7,Syntaxin-7,37052,-0.0213556795350551,0.00439381801003327,-0.0299675628347203,-0.0127437962353899,1.18501691497e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MTPN,Myotrophin,39581,-0.0140630020393832,0.00289748892618185,-0.0197420803346996,-0.00838392374406676,1.22457185304102e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,BSG,Basigin,40036,-0.00841865534171874,0.00173456836743637,-0.011818409341894,-0.00501890134154345,1.22458418611464e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MYDGF,Myeloid-derived growth factor,37433,-0.0436927477479522,0.00901273092108848,-0.0613577003532856,-0.0260277951426188,1.26162013582776e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ADAM22,Disintegrin and metalloproteinase domain-containing protein 22,39745,-0.0149634482148517,0.00308694076113199,-0.0210138521066704,-0.00891304432303298,1.26311262251648e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IGBP1,Immunoglobulin-binding protein 1,37408,-0.0260417240286208,0.00537453663092634,-0.0365758158252365,-0.0155076322320052,1.27762607821944e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SLAMF6,SLAM family member 6,39473,-0.0163055781107386,0.00336856288712799,-0.0229079613695094,-0.0097031948519677,1.30742014084485e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CLPP,"ATP-dependent Clp protease proteolytic subunit, mitochondrial",39709,-0.0416316932305482,0.00860406725901321,-0.0584956650582141,-0.0247677214028823,1.31982931343987e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,VEGFC,Vascular endothelial growth factor C,39909,-0.0239787966762725,0.00495720538481772,-0.0336949192305153,-0.0142626741220298,1.32929443154581e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PLAUR,Urokinase plasminogen activator surface receptor,39753,-0.0115563826270413,0.00238915643410001,-0.0162391292378773,-0.00687363601620528,1.33039270323494e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IL17D,Interleukin-17D,39583,-0.0146274250441062,0.00302481451067231,-0.0205560614850239,-0.00869878860318843,1.33860013708648e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,OSMR,Oncostatin-M-specific receptor subunit beta,39945,-0.00870686738158597,0.00180244966434967,-0.0122396687237113,-0.00517406603946061,1.37393521505059e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CD93,Complement component C1q receptor,39234,-0.0132208190636918,0.00274340063109998,-0.0185978843006477,-0.00784375382673579,1.4555859606076e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,QDPR,Dihydropteridine reductase,39786,-0.0186518358236422,0.00387848994586849,-0.0262536761175444,-0.01104999552974,1.53039056935518e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SUSD4,Sushi domain-containing protein 4,37364,-0.0178402708890936,0.0037158963884712,-0.0251234278104972,-0.0105571139676901,1.59513772250457e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CDKN2D,Cyclin-dependent kinase 4 inhibitor D,39784,-0.040573929378305,0.00847823681838045,-0.0571912735423307,-0.0239565852142794,1.71958729911242e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CCL19,C-C motif chemokine 19,40005,-0.0493214920064086,0.0103071394035867,-0.0695234852374386,-0.0291194987753786,1.72347691830885e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NACC1,Nucleus accumbens-associated protein 1,37364,-0.0234229289205191,0.00489958771920988,-0.0330261208501704,-0.0138197369908677,1.76623087707044e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IGF1R,Insulin-like growth factor 1 receptor,39784,-0.00926599318677186,0.00193899595753858,-0.0130664252635475,-0.00546556110999625,1.7795504923712e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NCS1,Neuronal calcium sensor 1,40026,-0.0119620993025004,0.00250651466945985,-0.0168748680546417,-0.00704933055035913,1.83632327870159e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SNCG,Gamma-synuclein,39745,-0.0276041674722882,0.00578893678378219,-0.0389504835685013,-0.0162578513760751,1.87309930076459e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NDUFS6,"NADH dehydrogenase [ubiquinone] iron-sulfur protein 6, mitochondrial",39473,-0.0344374237859862,0.00722279948514035,-0.0485941107768613,-0.0202807367951112,1.8785669124894e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ESYT2,Extended synaptotagmin-2,37384,-0.0348677087680743,0.00732861203066265,-0.0492317883481731,-0.0205036291879755,1.97785701700421e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DTD1,D-aminoacyl-tRNA deacylase 1,37120,-0.0373920438136057,0.00786108587547963,-0.0527997721295458,-0.0219843154976656,1.98954316571378e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DDT,D-dopachrome decarboxylase,37433,-0.0169774317503481,0.00357134839157871,-0.0239772745978423,-0.0099775889028538,2.01690384097913e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SCRG1,Scrapie-responsive protein 1,37433,-0.0111857890053734,0.00235331739268498,-0.0157982910950359,-0.00657328691571079,2.0227639366845e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CDC26,Anaphase-promoting complex subunit CDC26,37358,-0.0300161761188826,0.00632517149226818,-0.0424135122437282,-0.0176188399940369,2.10112522728722e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IL1R2,Interleukin-1 receptor type 2,39826,0.00829872220776695,0.00174913057405933,0.00487042628261066,0.0117270181329232,2.1084801474349e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CES1,Liver carboxylesterase 1,39850,0.0336211506384578,0.00708826913790705,0.0197281431281599,0.0475141581487556,2.12174192620837e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GGCT,Gamma-glutamylcyclotransferase,37426,-0.0203190269447173,0.00428588506291264,-0.0287193616680261,-0.0119186922214085,2.14915322501537e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PPP1R14A,Protein phosphatase 1 regulatory subunit 14A,37408,-0.032953303271248,0.0069508670712833,-0.0465770027309633,-0.0193296038115328,2.1494611938242e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CDHR2,Cadherin-related family member 2,39784,-0.030837783521126,0.00651546908952612,-0.0436081029365972,-0.0180674641056548,2.2311631092457e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SMAD1,Mothers against decapentaplegic homolog 1,39473,-0.0348924703331269,0.00737291209809977,-0.0493433780454025,-0.0204415626208514,2.23691198326671e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,JUN,Transcription factor AP-1,39583,-0.0219206631027956,0.00463434574570148,-0.0310039807643705,-0.0128373454412207,2.26420568601542e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SPP1,Osteopontin,40008,-0.0189546044938973,0.00401272301616615,-0.026819541605583,-0.0110896673822117,2.33625337027312e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GAS6,Growth arrest-specific protein 6,39943,0.0107428963553829,0.0022758035460006,0.00628232140522168,0.015203471305544,2.37265845256688e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CHCHD10,"Coiled-coil-helix-coiled-coil-helix domain-containing protein 10, mitochondrial",37384,-0.0161380644679822,0.00341923680360435,-0.0228397686030468,-0.00943636033291771,2.38459647546117e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,XCL1,Lymphotactin,40026,-0.0230681575135306,0.00488976339648224,-0.0326520937706358,-0.0134842212564254,2.40588530297213e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,STX8,Syntaxin-8,39862,-0.0204780889626342,0.00434764618940159,-0.0289994754938613,-0.0119567024314071,2.49607017903285e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IGFBP4,Insulin-like growth factor-binding protein 4,39581,-0.0166551116316481,0.00353659644553778,-0.0235868406649022,-0.00972338259839407,2.50616966540601e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PRG2,Bone marrow proteoglycan,37433,-0.0212098883475871,0.00450995484845372,-0.0300493998505564,-0.0123703768446179,2.59012182528594e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,AIF1,Allograft inflammatory factor 1,39473,-0.0221260555581246,0.00470576639707684,-0.0313493576963952,-0.012902753419854,2.59952357637866e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,RP2,Protein XRP2,39784,-0.0175359385294172,0.00373002744995163,-0.0248467923313224,-0.010225084727512,2.6069001578174e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,S100A11,Protein S100-A11,39699,-0.0190486819974269,0.00405328175885151,-0.0269931142447759,-0.011104249750078,2.62902845594155e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PLXNB3,Plexin-B3,39808,-0.0199746785861802,0.00425309322799012,-0.0283107413130409,-0.0116386158593196,2.6685477032792e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ADGRF5,Adhesion G protein-coupled receptor F5,37433,-0.0119306196092454,0.00254029537451372,-0.0169095985432923,-0.00695164067519853,2.6718732693468e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CXCL1,Growth-regulated alpha protein,39835,-0.0397213860244125,0.00846053041349733,-0.0563040256348673,-0.0231387464139577,2.68946924059867e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TREH,Trehalase,37433,0.0314726536140359,0.00670398865564027,0.018332835848981,0.0446124713790908,2.6972072052642e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SELP,P-selectin,39927,-0.0240168870647872,0.00511737142504352,-0.0340469350578724,-0.0139868390717019,2.71172889003018e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NRCAM,Neuronal cell adhesion molecule,39864,-0.011593675982201,0.0024707332056201,-0.0164363130652164,-0.00675103889918562,2.72249330259868e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FUT3_FUT5,3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase FUT3_4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase FUT5,40005,-0.0186278126707109,0.00397207278319915,-0.0264130753257812,-0.0108425500156406,2.75851383852648e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ACOX1,Peroxisomal acyl-coenzyme A oxidase 1,39864,-0.020398978388951,0.00435917383795557,-0.0289429591113439,-0.0118549976665581,2.89857710411038e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MLN,Promotilin,39862,-0.0370997003455585,0.00793968795445177,-0.052661488736284,-0.021537911954833,2.99701524756424e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CDCP1,CUB domain-containing protein 1,39745,-0.0207654979097817,0.00444580785510507,-0.0294792813057876,-0.0120517145137757,3.02480618529661e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,RAD23B,UV excision repair protein RAD23 homolog B,39473,-0.0196431863023108,0.00420774231385752,-0.0278903612374716,-0.0113960113671501,3.06163730495339e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SH3GLB2,Endophilin-B2,37384,-0.0274878628271327,0.00588879185943168,-0.0390298948716188,-0.0159458307826467,3.0732515790883e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,AFP,Alpha-fetoprotein,39695,-0.0279934224057359,0.00602120634456044,-0.0397949868410743,-0.0161918579703974,3.36014925328138e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NIT2,Omega-amidase NIT2,37373,-0.0311573454033816,0.00671555130493459,-0.0443198259610534,-0.0179948648457098,3.52394038592723e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TXN,Thioredoxin,37285,-0.017861154171933,0.00385023187814233,-0.025407608653092,-0.0103146996907741,3.53438071615508e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DSG4,Desmoglein-4,39721,-0.0203517882048681,0.00438798900491957,-0.0289522466545105,-0.0117513297552258,3.54490592173245e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ACE2,Angiotensin-converting enzyme 2,39581,0.0206529560367461,0.0044575093434126,0.0119162377236574,0.0293896743498348,3.6277903932985e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FKBP14,Peptidyl-prolyl cis-trans isomerase FKBP14,37408,-0.0410185504818113,0.00886545117021911,-0.0583948347754408,-0.0236422661881819,3.74824166827917e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TREML1,Trem-like transcript 1 protein,37441,-0.0218314543523925,0.00471969365921671,-0.0310820539244573,-0.0125808547803278,3.76949609985049e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TSPAN8,Tetraspanin-8,37378,0.0402925827067789,0.00871896268283402,0.0232034158484242,0.0573817495651336,3.84944580587829e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ADGRG2,Adhesion G-protein coupled receptor G2,39864,-0.0110537619269456,0.00239465710848462,-0.0157472898595755,-0.00636023399431578,3.94226975105634e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,AMIGO2,Amphoterin-induced protein 2,39784,-0.00925194142560753,0.0020069639990711,-0.0131855908637869,-0.00531829198742817,4.05955672330443e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TIMP1,Metalloproteinase inhibitor 1,39694,-0.0113465976005316,0.00246283772795558,-0.0161737595473246,-0.00651943565373866,4.11460259319531e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PTGES2,Prostaglandin E synthase 2,36957,-0.0227068028050723,0.00495129632840702,-0.0324113436087501,-0.0130022620013946,4.55935362456961e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,COL6A3,Collagen alpha-3(VI) chain,40048,-0.0130872954704705,0.00285501489480551,-0.0186831246642893,-0.0074914662766517,4.59647056532082e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PPL,Periplakin,37052,-0.0130901123300719,0.00285656568390252,-0.0186889810705209,-0.00749124358962301,4.6374095550223e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NSFL1C,NSFL1 cofactor p47,40005,-0.0265277501602506,0.00578961275340053,-0.0378753911569157,-0.0151801091635856,4.64095344356439e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,COCH,Cochlin,37433,-0.0186385549001201,0.00406818984567826,-0.0266122069976495,-0.0106649028025907,4.65685640645447e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IMPA1,Inositol monophosphatase 1,39745,-0.0250397902304656,0.00546605816096787,-0.0357532642259626,-0.0143263162349686,4.66366453913028e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ARHGEF1,Rho guanine nucleotide exchange factor 1,37384,-0.0369417439228322,0.00807313119396322,-0.0527650810630001,-0.0211184067826642,4.78422748332646e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TACSTD2,Tumor-associated calcium signal transducer 2,38019,0.0125136287847492,0.0027355322954253,0.00715198548571558,0.0178752720837828,4.81462814303277e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CLC,Galectin-10,39837,-0.0271876604601024,0.00594444777659949,-0.0388387781022374,-0.0155365428179674,4.82963951881325e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DAPP1,Dual adapter for phosphotyrosine and 3-phosphotyrosine and 3-phosphoinositide,39862,-0.0492216280320082,0.0107723595482801,-0.0703354527466372,-0.0281078033173792,4.93124976853938e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NCAM2,Neural cell adhesion molecule 2,39854,-0.0108778837828379,0.00238153028655239,-0.0155456831444806,-0.00621008442119519,4.97017566157365e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,AKT3,RAC-gamma serine/threonine-protein kinase,39387,-0.0237256415240389,0.00520523430082314,-0.0339279007536523,-0.0135233822944256,5.20283095108739e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NTproBNP,N-terminal prohormone of brain natriuretic peptide,39864,0.037700929522911,0.00827427211933006,0.0214833561690241,0.0539185028767979,5.24213326819691e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,OLR1,Oxidized low-density lipoprotein receptor 1,39717,-0.0238624380425388,0.00523712012844951,-0.0341271934942999,-0.0135976825907778,5.24248570754741e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,OTUD7B,OTU domain-containing protein 7B,37408,-0.0260102584334501,0.00571253551903364,-0.037206828050756,-0.0148136888161442,5.32988889080474e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SCG2,Secretogranin-2,39945,0.0126147260647797,0.00277293028042035,0.00717978271515578,0.0180496694144036,5.42334921216864e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CD84,SLAM family member 5,39862,-0.0126232988437337,0.00277704786857814,-0.0180663126661469,-0.00718028502132058,5.51849466510601e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ATP6V1G1,V-type proton ATPase subunit G 1,37039,-0.0293545809182949,0.00646172341677959,-0.0420195588151829,-0.0166896030214069,5.59939400062848e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,COL9A1,Collagen alpha-1(IX) chain,39862,-0.0176989754149776,0.00389697432609683,-0.0253370450941274,-0.0100609057358278,5.62038684697374e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,LIPF,Gastric triacylglycerol lipase,37039,0.02415801940993,0.005320962999902,0.0137289319301221,0.034587106889738,5.6709711192665e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CD164,Sialomucin core protein 24,39854,-0.0106038137466375,0.00233645573297586,-0.0151832669832702,-0.00602436051000486,5.70905737933428e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CHMP1A,Charged multivesicular body protein 1a,39745,-0.0322036449499185,0.00709689085334895,-0.0461135510224824,-0.0182937388773546,5.72847678375574e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PDCD1LG2,Programmed cell death 1 ligand 2,39784,-0.0124666271237355,0.00274822111686158,-0.0178531405127842,-0.00708011373468681,5.7680590862666e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CC2D1A,Coiled-coil and C2 domain-containing protein 1A,39745,-0.0299381138207963,0.00660242149406055,-0.0428788599491549,-0.0169973676924376,5.81858070697125e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ENO1,Alpha-enolase,39826,-0.0319269088377971,0.00704129503316677,-0.045727847102804,-0.0181259705727902,5.82321332016149e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,LACTB2,Endoribonuclease LACTB2,39864,-0.0269545575120721,0.00594482216098618,-0.038606408947605,-0.0153027060765392,5.82627534984701e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NUB1,NEDD8 ultimate buster 1,39862,-0.0340326830824716,0.00751103620609567,-0.0487543140464192,-0.0193110521185241,5.91232507388839e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,L3HYPDH,Trans-3-hydroxy-L-proline dehydratase,37433,-0.0358886693023867,0.00792873236457418,-0.0514289847369521,-0.0203483538678213,6.05050105635512e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PRELP,Prolargin,39858,-0.00895709467405585,0.00197912014618262,-0.0128361701605738,-0.00507801918753792,6.06020271494283e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,YWHAQ,14-3-3 protein theta,37120,-0.0299278296437148,0.00661687677273047,-0.0428969081182665,-0.0169587511691631,6.15116133940153e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FHIT,Bis(5'-adenosyl)-triphosphatase,39485,-0.0300255406774686,0.00664162910689875,-0.0430431337269902,-0.0170079476279471,6.20561394169709e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SLAMF8,SLAM family member 8,39473,-0.0209892096878892,0.00464325243523424,-0.0300899844609483,-0.0118884349148301,6.21859180112159e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ASPSCR1,Tether containing UBX domain for GLUT4,37408,-0.0272785718402173,0.00603693038552325,-0.0391109553958429,-0.0154461882845918,6.2771714924115e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,STC1,Stanniocalcin-1,40005,-0.0168790607185547,0.00373606695564014,-0.0242017519516094,-0.00955636948550001,6.29081026370817e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IL6,Interleukin-6,39784,-0.0285386833618594,0.00632588315748572,-0.0409374143505314,-0.0161399523731873,6.48571110512579e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ULBP2,UL16-binding protein 2,39745,-0.0146727824870221,0.00325410470460761,-0.021050827708053,-0.00829473726599117,6.55975403588645e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DRAXIN,Draxin,39745,-0.0168944573279548,0.00374684928830547,-0.0242382819330335,-0.00955063272287606,6.56069499443562e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,EIF4G1,Eukaryotic translation initiation factor 4 gamma 1,40054,-0.0400169779384152,0.00888420180130363,-0.0574300134689703,-0.0226039424078601,6.70621676162333e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SFTPA1,Pulmonary surfactant-associated protein A1,39473,-0.0232371957154004,0.00515938781854064,-0.0333495958397401,-0.0131247955910608,6.72115950644589e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ELAC1,Zinc phosphodiesterase ELAC protein 1,37408,-0.0342745064533053,0.00761281572437119,-0.0491956252730728,-0.0193533876335377,6.78110883488209e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MSRA,Mitochondrial peptide methionine sulfoxide reductase,39909,-0.0291161988771368,0.00648559561369185,-0.0418279662799728,-0.0164044314743008,7.1933561244491e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NT5C,"5'(3')-deoxyribonucleotidase, cytosolic type",37433,-0.0296015051228587,0.00659421248945934,-0.042526161602199,-0.0166768486435184,7.21431602843982e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IPCEF1,Interactor protein for cytohesin exchange factors 1,39716,-0.0358219101269981,0.00798128935831221,-0.0514652372692901,-0.0201785829847062,7.23209996064265e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,USP8,Ubiquitin carboxyl-terminal hydrolase 8,39581,-0.0388781469456132,0.00866525969034437,-0.0558620559386881,-0.0218942379525382,7.2858613520484e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,AP1G2,AP-1 complex subunit gamma-like 2,37364,-0.0319203038367756,0.00711902969420637,-0.0458736020374201,-0.0179670056361312,7.39296516826066e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DAG1,Dystroglycan,39927,-0.0194098119664795,0.00433036610634148,-0.0278973295349088,-0.0109222943980502,7.43684315948697e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,EPHA2,Ephrin type-A receptor 2,39244,-0.0117788458884966,0.00262830487230739,-0.0169303234382191,-0.00662736833877412,7.46421002010857e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NTF4,Neurotrophin-4,39473,-0.0158967239275919,0.00354899951130863,-0.0228527629697568,-0.00894068488542697,7.54504396389261e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MDH1,"Malate dehydrogenase, cytoplasmic",37393,-0.0160525694916653,0.00358439354210177,-0.0230779808341848,-0.00902715814914583,7.57981669880232e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MED18,Mediator of RNA polymerase II transcription subunit 18,39473,-0.0306947912249862,0.00686230427761438,-0.0441449076091104,-0.017244674840862,7.76898177040576e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PDGFC,Platelet-derived growth factor C,39473,-0.0116358870110063,0.00260305984252473,-0.0167378843023548,-0.00653388971965787,7.87406656018807e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CKMT1A_CKMT1B,"Creatine kinase U-type, mitochondrial",39805,0.0261486714483924,0.00585056065323746,0.014681572568047,0.0376157703287379,7.89686577631434e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,BCHE,Cholinesterase,37204,-0.0109805936045052,0.00245747035762104,-0.0157972355054424,-0.00616395170356794,7.95107694818694e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MANF,Mesencephalic astrocyte-derived neurotrophic factor,39927,-0.0480888123998248,0.0107634989858442,-0.0691852704120794,-0.0269923543875703,7.95797385076036e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,VGF,Neurosecretory protein VGF,37408,-0.0116161468725482,0.00260393147021231,-0.0167198525541643,-0.00651244119093207,8.22338461570818e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CD209,CD209 antigen,39881,-0.0154493739152629,0.00346486032070583,-0.0222405001438463,-0.00865824768667943,8.29513737013509e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PTPRZ1,Receptor-type tyrosine-protein phosphatase zeta,37433,-0.0128494118338271,0.00288276458038753,-0.0184996304113867,-0.00719919325626755,8.36546947175677e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,INSL3,Insulin-like 3,37384,-0.0287417897240717,0.00645013755583294,-0.0413840593335043,-0.0160995201146392,8.41752700866726e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MAPK9,Mitogen-activated protein kinase 9,39862,-0.0172519992586706,0.00387197508234755,-0.0248410704200718,-0.00966292809726939,8.42236867143132e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,RGS10,Regulator of G-protein signaling 10,37408,-0.0237472174669149,0.00533606696966722,-0.0342059087274626,-0.0132885262063671,8.6425774537055e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TBL1X,F-box-like/WD repeat-containing protein TBL1X,39473,-0.0337879593120211,0.00759499150660546,-0.0486741426649678,-0.0189017759590744,8.69823231131422e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,KITLG,Kit ligand,39864,0.0147115509368959,0.00330759614139716,0.00822866249975749,0.0211944393740344,8.73357286075454e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IDS,Iduronate 2-sulfatase,40054,-0.00356492902670737,0.000803270948580016,-0.0051393400859242,-0.00199051796749053,9.13914835485131e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GCC1,GRIP and coiled-coil domain-containing protein 1,37384,-0.0428550191415012,0.00965707952152616,-0.0617828950036924,-0.0239271432793099,9.16531612016218e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,UBE2Z,Ubiquitin-conjugating enzyme E2 Z,37052,-0.0238724249809532,0.00538006570106434,-0.0344173537550393,-0.0133274962068671,9.18753730402297e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,LGALS7_LGALS7B,Galectin-7,39818,-0.0160796995523057,0.00362477552142218,-0.0231842595742932,-0.00897513953031824,9.22357927925448e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MANSC1,MANSC domain-containing protein 1,39909,-0.0106885510213707,0.00241096359754225,-0.0154140396725535,-0.00596306237018785,9.34126673283146e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SCARF1,Scavenger receptor class F member 1,40048,-0.0169111702263585,0.00381482711342532,-0.0243882313686721,-0.00943410908404482,9.35372879125066e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CA13,Carbonic anhydrase 13,39653,-0.0417256718521056,0.00941373634683743,-0.060176595091907,-0.0232747486123043,9.38073492754749e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SERPINH1,Serpin H1,37165,-0.0507535592321261,0.0114644644664551,-0.073223909586378,-0.0282832088778741,9.62991638202035e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PDP1,"[Pyruvate dehydrogenase [acetyl-transferring]]-phosphatase 1, mitochondrial",39473,-0.0202122921462723,0.0045728789067083,-0.0291751348034205,-0.011249449489124,9.9349628114167e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TF,Serotransferrin,37449,0.00858317199540293,0.0019425986851481,0.00477567857251265,0.0123906654182932,1.00205273102651e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,LSP1,Lymphocyte-specific protein 1,39862,-0.0159206898349306,0.00360359388010444,-0.0229837338399353,-0.00885764582992586,1.00271085660597e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CX3CL1,Fractalkine,39745,-0.0130587656215412,0.00295686806108173,-0.0188542270212614,-0.00726330422182103,1.01012874270533e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,RGCC,Regulator of cell cycle RGCC,37408,-0.0297891774628521,0.00674610599981742,-0.0430115452224942,-0.0165668097032099,1.0143583651485e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TNFSF13,Tumor necrosis factor ligand superfamily member 13,39927,-0.0103417309304357,0.00234499847228838,-0.014937927936121,-0.00574553392475051,1.03983196154523e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GHRL,Appetite-regulating hormone,39864,-0.0301972111491235,0.00684824012431013,-0.0436197617927713,-0.0167746605054756,1.0429218236538e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,KYAT1,Kynurenine--oxoglutarate transaminase 1,39846,-0.0222917833523153,0.00505556842740009,-0.0322006974700194,-0.0123828692346111,1.04356618534241e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,EZR,Ezrin,40005,-0.0094320147299404,0.00214121187548496,-0.0136287900058909,-0.00523523945398988,1.06470091763276e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SLC9A3R1,Na(+)/H(+) exchange regulatory cofactor NHE-RF1,37120,-0.0337927719428576,0.0076715603458827,-0.0488290302207877,-0.0187565136649275,1.06642150803994e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NPY,Pro-neuropeptide Y,40026,-0.0260164483505798,0.00590757564628094,-0.0375952966172905,-0.0144376000838692,1.06998359996516e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,VEGFB,Vascular endothelial growth factor B,37052,-0.011114318628942,0.00252360909881837,-0.016060592462626,-0.00616804479525802,1.07042480426885e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CPA2,Carboxypeptidase A2,39929,0.0252884938165618,0.00574332493898381,0.0140315769361535,0.0365454106969701,1.07398718618883e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,INPP1,Inositol polyphosphate 1-phosphatase,39784,-0.0211706641722465,0.0048208156637974,-0.0306194628732894,-0.0117218654712036,1.13291692904078e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PPP1R2,Protein phosphatase inhibitor 2,39864,-0.0316312722730552,0.00720660012749687,-0.0457562085229491,-0.0175063360231614,1.14492381050546e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,AKR1B1,Aldo-keto reductase family 1 member B1,39473,-0.0301209411616769,0.00686290015850502,-0.0435722254723468,-0.0166696568510071,1.14645619985102e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,C8B,Complement component C8 beta chain,37449,-0.0118280527647054,0.00269762123091881,-0.0171153903773063,-0.00654071515210458,1.17059858156566e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TCOF1,Treacle protein,37433,-0.0118691385058823,0.00271057395710189,-0.017181863461802,-0.00655641354996264,1.20212215311876e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PVALB,Parvalbumin alpha,39967,-0.0444819265617483,0.0101768092321623,-0.0644284726567864,-0.0245353804667102,1.24504071504513e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,RPE,Ribulose-phosphate 3-epimerase,37165,-0.0277278429428582,0.00635232241259272,-0.04017839487154,-0.0152772910141765,1.28086041180445e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DNAJC6,Putative tyrosine-protein phosphatase auxilin,37039,-0.0328690197882024,0.00754414319686379,-0.0476555404540554,-0.0180824991223493,1.32919933703291e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,EIF4E,Eukaryotic translation initiation factor 4E,37052,-0.0353198464361079,0.00811460569639887,-0.0512244736010497,-0.0194152192711662,1.35528948446128e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SWAP70,Switch-associated protein 70,37378,-0.0138851532661199,0.00319397769200677,-0.0201453495424531,-0.00762495698978658,1.38836495518652e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,BAG4,BAG family molecular chaperone regulator 4,37052,-0.0193097506012645,0.00444413431741585,-0.0280202538633996,-0.0105992473391295,1.40318984948408e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CELA3A,Chymotrypsin-like elastase family member 3A,40030,-0.0215792189498058,0.00496993981623846,-0.0313203009896332,-0.0118381369099784,1.42083919328939e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ERBIN,Erbin,39784,-0.0397906088431165,0.00917746444813589,-0.0577784391614628,-0.0218027785247701,1.4619825396875e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CDH1,Cadherin-1,39311,0.0155835477304952,0.00360112372303393,0.0085253452333487,0.0226417502276417,1.51819273882718e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,STX6,Syntaxin-6,39473,-0.0263403880703575,0.0060872353751756,-0.0382713694057016,-0.0144094067350133,1.51989297763928e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PAEP,Glycodelin,39745,0.055816850695659,0.0129054435877581,0.0305221812636531,0.081111520127665,1.53418590508499e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CNTNAP2,Contactin-associated protein-like 2,39862,-0.0157896212605329,0.00365253446482782,-0.0229485888115954,-0.00863065370947037,1.54906674983118e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ABO,Histo-blood group ABO system transferase,37441,-0.0552046452188605,0.0127698739381642,-0.0802335981376623,-0.0301756923000587,1.54991758825565e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PIBF1,"Progesterone-induced-blocking factor 1, Isoform 4",37408,-0.029803771881631,0.0068992398642455,-0.0433262820155522,-0.0162812617477098,1.57237752613065e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GMPR,GMP reductase 1,40054,-0.0191106853342237,0.00442526601293614,-0.0277842067195785,-0.0104371639488688,1.5799942176931e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,AK2,"Adenylate kinase 2, mitochondrial",37384,-0.0409791253299228,0.00949068235902838,-0.0595808627536184,-0.0223773879062272,1.58694818304964e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MAP2,Microtubule-associated protein 2,37384,-0.0176833661086472,0.00409827580872948,-0.025715986693757,-0.00965074552353746,1.60859626074826e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ADAMTS16,A disintegrin and metalloproteinase with thrombospondin motifs 16,39581,-0.012294825781601,0.00284989470778621,-0.017880619408862,-0.00670903215434007,1.61208148511071e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,RBP5,Retinol-binding protein 5,39784,-0.0215377796509727,0.00499927069403338,-0.0313363502112781,-0.0117392090906673,1.65586735219978e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PDGFB,Platelet-derived growth factor subunit B,39927,-0.0329232465733533,0.00764265466835393,-0.047902849723327,-0.0179436434233796,1.65844052586776e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ATRN,"Attractin, Isoform 2",37449,-0.00623118240312483,0.00144959908026484,-0.00907239660044393,-0.00338996820580574,1.73112310480163e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,AK1,Adenylate kinase isoenzyme 1,39864,-0.024008929907378,0.00558981605116299,-0.0349649693676574,-0.0130528904470985,1.75628205258133e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GMPR2,GMP reductase 2,37120,-0.0256105458074267,0.00597316254946965,-0.0373179444043872,-0.0139031472104662,1.81889036244231e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CASC3,Protein CASC3,37035,-0.0160859455101468,0.00375332106643657,-0.0234424548003625,-0.00872943621993115,1.83384709032229e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,HSPA1A,Heat shock 70 kDa protein 1A,39900,-0.0272764849322048,0.0063757705132309,-0.0397729951381373,-0.0147799747262722,1.89547135713185e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SCGN,Secretagogin,39583,0.0164634040957143,0.0038482629684836,0.00892080867748645,0.0240059995139422,1.89576145244622e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DKKL1,Dickkopf-like protein 1,39784,0.0321552929484859,0.00751877627843188,0.0174184914427594,0.0468920944542123,1.90818942048062e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PMVK,Phosphomevalonate kinase,39476,-0.0423755773411374,0.00991378036677351,-0.0618065868600135,-0.0229445678222613,1.92779409669537e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CLUL1,Clusterin-like protein 1,39836,0.0172373364204611,0.00403442169437546,0.00932986989948519,0.025144802941437,1.94353958965178e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,EDA2R,Tumor necrosis factor receptor superfamily member 27,40026,-0.0135296409441758,0.00316804605632578,-0.0197390112145744,-0.00732027067377731,1.96009969072374e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ARL2BP,ADP-ribosylation factor-like protein 2-binding protein,37017,-0.0153972107337339,0.0036083503113575,-0.0224695773439946,-0.0083248441234732,1.99411211536494e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,RSPO1,R-spondin-1,39745,-0.0134122581003354,0.00314380778491838,-0.0195741213587754,-0.00725039484189541,1.99939975774218e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,HSDL2,Hydroxysteroid dehydrogenase-like protein 2,37039,-0.0178937872630983,0.00419412347121442,-0.0261142692666785,-0.009673305259518,2.00043671901826e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MBL2,Mannose-binding protein C,37253,-0.0406469382165311,0.0095574496038697,-0.0593795394401157,-0.0219143369929465,2.12445784546293e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IL20,Interleukin-20,39583,-0.0185394377091513,0.00435979737028391,-0.0270846405549078,-0.00999423486339489,2.12749011891222e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TGOLN2,Trans-Golgi network integral membrane protein 2,37441,-0.00938368372623043,0.00220737490526609,-0.013710138540552,-0.00505722891190889,2.14182332793449e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CPM,Carboxypeptidase M,39951,0.0130436324035442,0.00307040280409886,0.00702564290751041,0.0190616218995779,2.16723110898833e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PSME2,Proteasome activator complex subunit 2,39662,-0.0136759465308275,0.0032221894362216,-0.0199914378258218,-0.00736045523583311,2.20525418934392e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ADAM9,Disintegrin and metalloproteinase domain-containing protein 9,37378,0.0111401018640787,0.00262465253223475,0.00599578290089861,0.0162844208272588,2.2063146197452e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DNAJB8,DnaJ homolog subfamily B member 8,39581,-0.0215923787712528,0.00508872336938939,-0.031566276575256,-0.0116184809672496,2.21635156654875e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TACC3,Transforming acidic coiled-coil-containing protein 3,39784,-0.0443402895306269,0.0104508083255371,-0.0648238738486795,-0.0238567052125742,2.2203402469814e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,LAIR2,Leukocyte-associated immunoglobulin-like receptor 2,39745,-0.0386713284964749,0.00911567539649898,-0.056538052273613,-0.0208046047193369,2.2250500921149e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SUSD5,Sushi domain-containing protein 5,37060,-0.0128086197446457,0.00302055126920902,-0.0187289002322953,-0.00688833925699598,2.24550268811476e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ATP5IF1,"ATPase inhibitor, mitochondrial",39927,-0.0416241206680089,0.00982166803991761,-0.0608745900262474,-0.0223736513097704,2.26789105415721e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,STIP1,Stress-induced-phosphoprotein 1,39822,-0.0244453721689326,0.00577113292501565,-0.0357567927019633,-0.013133951635902,2.2901454809441e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GORASP2,Golgi reassembly-stacking protein 2,37378,-0.0178773032060948,0.00422120606438758,-0.0261508670922945,-0.00960373931989518,2.29943755782898e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ANXA3,Annexin A3,39981,-0.0263356668281678,0.00622236081444803,-0.0385314940244859,-0.0141398396318496,2.32465485960798e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GH1,Somatotropin,39842,-0.0680334448723048,0.0161089525990798,-0.0996069919665012,-0.0364598977781084,2.42049895034022e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ACY3,N-acyl-aromatic-L-amino acid amidohydrolase,37017,0.0211387747415287,0.00500705068239247,0.0113249554040394,0.0309525940790179,2.43985333099005e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MANSC4,MANSC domain-containing protein 4,37017,-0.0234400135575894,0.00555479007793851,-0.0343274021103489,-0.0125526250048299,2.46176262662548e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,HNRNPK,Heterogeneous nuclear ribonucleoprotein K,39502,-0.0297596194256846,0.00705457372294789,-0.0435865839226624,-0.0159326549287067,2.47333337160387e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,EREG,Proepiregulin,39709,-0.0299901466673612,0.00711272883856025,-0.0439310951909393,-0.0160491981437831,2.49604479871149e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NCK2,Cytoplasmic protein NCK2,39927,-0.0398788811155502,0.00947713794165812,-0.0584540714812001,-0.0213036907499003,2.5915044245935e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GRHPR,Glyoxylate reductase/hydroxypyruvate reductase,37433,-0.0239473959249285,0.00569371011570533,-0.035107067751711,-0.0127877240981461,2.61669366603965e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,LCAT,Phosphatidylcholine-sterol acyltransferase,37441,-0.00818489647030102,0.00194673218303889,-0.0120004915490572,-0.0043693013915448,2.63419135059813e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GSTP1,Glutathione S-transferase P,39389,-0.0260174402081142,0.00619248779806414,-0.0381547162923199,-0.0138801641239085,2.66689740237831e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SCAMP3,Secretory carrier-associated membrane protein 3,39784,-0.0317014518173458,0.00755023694914379,-0.0464999162376676,-0.0169029873970239,2.69867269542069e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PROK1,Prokineticin-1,39862,-0.0242347700164505,0.00577298661877195,-0.0355498237892435,-0.0129197162436575,2.70784644222871e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,VWC2L,von Willebrand factor C domain-containing protein 2-like,37408,-0.017777161451784,0.00423849821183703,-0.0260846179469845,-0.00946970495658338,2.75563417869057e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,STXBP3,Syntaxin-binding protein 3,39473,-0.0165353476150481,0.00394510022864124,-0.024267744063185,-0.00880295116691131,2.78809747167717e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NUMB,Protein numb homolog,37052,-0.0315614643092102,0.00753250823664832,-0.0463251804530409,-0.0167977481653795,2.80728361564101e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,HS1BP3,HCLS1-binding protein 3,37039,-0.0341093353500244,0.00814309517751222,-0.0500698018979483,-0.0181488688021004,2.82328979087939e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PMM2,Phosphomannomutase 2,37017,-0.0224803667639848,0.00536792032411156,-0.0330014905992434,-0.0119592429287261,2.83369110381414e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,RBM17,Splicing factor 45,37408,-0.0285638092400855,0.00682204126156275,-0.0419350101127485,-0.0151926083674225,2.84466562393176e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CEBPA,CCAAT/enhancer-binding protein alpha,37052,-0.0140675453274106,0.00336581185262456,-0.0206645365585547,-0.00747055409626644,2.93982553593156e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CLEC1A,C-type lectin domain family 1 member A,39581,-0.0119579475299522,0.00286138653122718,-0.0175662651311575,-0.00634962992874696,2.94280029718052e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NEDD9,Enhancer of filamentation 1,37052,-0.012414670684914,0.00297221075676008,-0.0182402037681638,-0.00658913760166429,2.97390359857204e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NEFL,Neurofilament light polypeptide,39434,-0.0162102728102245,0.00388245069693575,-0.0238198761762185,-0.00860066944423039,2.99253756745671e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SEC31A,Protein transport protein Sec31A,37039,-0.0284047028838085,0.00684899068398949,-0.0418287246244279,-0.0149806811431891,3.38552169853491e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,LAT2,Linker for activation of T-cells family member 2,39784,-0.0460962679332581,0.0111212359488232,-0.0678938903929516,-0.0242986454735645,3.41739611512765e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PDAP1,28 kDa heat- and acid-stable phosphoprotein,37433,-0.0364062534075828,0.00878838162299043,-0.0536314813886441,-0.0191810254265216,3.45555647500612e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SCARA5,Scavenger receptor class A member 5,40005,-0.0107732283654517,0.00260145020263745,-0.0158720707626211,-0.00567438596828226,3.47190332253735e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CD55,Complement decay-accelerating factor,39311,-0.00939131981775248,0.00227018553315938,-0.0138408834627449,-0.00494175617276008,3.54035338597158e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ACP6,Lysophosphatidic acid phosphatase type 6,40007,-0.0240847756826077,0.00582626586619626,-0.0355042567803524,-0.0126652945848631,3.58573339150486e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,RAB2B,Ras-related protein Rab-2B,37364,-0.023031836534819,0.00558635138176844,-0.0339810852430851,-0.0120825878265529,3.76407551545729e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,LRTM2,Leucine-rich repeat and transmembrane domain-containing protein 2,37408,-0.00941873451872955,0.00228545618877715,-0.0138982286487328,-0.00493924038872634,3.79209672586904e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TSPYL1,Testis-specific Y-encoded-like protein 1,37052,-0.0149101808979243,0.00362028034593186,-0.0220059303759507,-0.00781443141989782,3.83645387535718e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,HSPB1,Heat shock protein beta-1,39613,-0.0255970358035967,0.00621996638584187,-0.0377881699198468,-0.0134059016873467,3.88641371511219e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DCTD,Deoxycytidylate deaminase,37120,-0.0351057207446561,0.00853361391703069,-0.0518316040220363,-0.018379837467276,3.91521007454147e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,THTPA,Thiamine-triphosphatase,37341,-0.0323052677770877,0.00786551046163808,-0.0477216682818983,-0.0168888672722771,4.02838910202449e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,OTUD6B,Deubiquitinase OTUD6B,37378,-0.0213218233394154,0.00519247110058821,-0.0314990666965683,-0.0111445799822625,4.04419019482897e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DRG2,Developmentally-regulated GTP-binding protein 2,39784,-0.0207409527070468,0.00505466445402538,-0.0306480950369366,-0.0108338103771571,4.09274177876598e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,JAM2,Junctional adhesion molecule B,40005,-0.00916907841978811,0.00223465950360888,-0.0135490110468615,-0.00478914579271471,4.09614689672489e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,THY1,Thy-1 membrane glycoprotein,40005,-0.0098749576457332,0.00240699522706766,-0.0145926682907858,-0.0051572470006806,4.10523541652136e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,STK24,Serine/threonine-protein kinase 24,39485,-0.0227910615871983,0.00555626310015196,-0.0336813372634961,-0.0119007859109004,4.11903204670588e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ASAH1,Acid ceramidase,37336,-0.0172535367134089,0.00420804829411925,-0.0255013113698826,-0.00900576205693513,4.15344087289399e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CPVL,Probable serine carboxypeptidase CPVL,39986,-0.0146815775541165,0.00358662313811186,-0.0217113589048157,-0.00765179620341721,4.27115331638059e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GSN,Gelsolin,37379,-0.00679516029380881,0.0016601229425747,-0.0100490012612552,-0.0035413193263624,4.27993547521259e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,HIP1R,Huntingtin-interacting protein 1-related protein,37361,-0.0152595171681532,0.00372991476760057,-0.0225701501126503,-0.00794888422365604,4.31793640924525e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,C1R,Complement C1r subcomponent,37449,-0.00704021532381578,0.00172116633076793,-0.0104137013321209,-0.00366672931551063,4.33159665228339e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,VPS4B,Vacuolar protein sorting-associated protein 4B,37364,-0.0344849755734397,0.00843282472049479,-0.0510133120256095,-0.01795663912127,4.35045716928598e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,WARS,"Tryptophan--tRNA ligase, cytoplasmic",39854,-0.0136567752152159,0.00335300939474807,-0.0202286736289221,-0.00708487680150966,4.6636957252309e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,KLB,Beta-klotho,39485,-0.0267544093112472,0.00657349101036165,-0.039638451691556,-0.0138703669309384,4.72350959234111e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SRPK2,SRSF protein kinase 2,39862,-0.0304891740467404,0.00749657693564015,-0.0451824648405951,-0.0157958832528857,4.7834012319864e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PRKAB1,5'-AMP-activated protein kinase subunit beta-1,39583,-0.0202805946135089,0.00498937048126138,-0.0300597607567812,-0.0105014284702366,4.83157318616166e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IFNL1,Interferon lambda-1,39485,-0.0162816331590586,0.00400791334752119,-0.0241371433202001,-0.00842612299791706,4.88139019095795e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ROR1,Inactive tyrosine-protein kinase transmembrane receptor ROR1,39864,-0.0111413189857693,0.00274329872664073,-0.0165181844899851,-0.00576445348155348,4.90357129475405e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SERPINB6,Serpin B6,39966,-0.021762132860757,0.00536334773793791,-0.0322742944271153,-0.0112499712943987,4.98208465210759e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CR2,Complement receptor type 2,39927,-0.0164114840110414,0.00404593629994,-0.0243415191589238,-0.00848144886315899,5.00941459219253e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SNX9,Sorting nexin-9,39864,-0.0250770470155475,0.00618885162600148,-0.0372071962025104,-0.0129468978285846,5.10277647799822e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,BAMBI,BMP and activin membrane-bound inhibitor homolog,39473,-0.0108432668291746,0.00267786187062912,-0.0160918760956077,-0.00559465756274152,5.16354617090883e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ARHGAP45,Rho GTPase-activating protein 45,37120,-0.0298799461198516,0.00737891511021514,-0.0443426197358733,-0.0154172725038299,5.16480747519003e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SERPIND1,Heparin cofactor 2,37420,-0.0101513313543772,0.00250691483641037,-0.0150648844337416,-0.00523777827501289,5.16495587071388e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MCEE,"Methylmalonyl-CoA epimerase, mitochondrial",37408,-0.0156162252704995,0.00385808405174787,-0.0231780700119253,-0.00805438052907363,5.20189364738146e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,HARS1,"Histidine--tRNA ligase, cytoplasmic",39854,-0.0279546464744156,0.00692302991486241,-0.041523785107546,-0.0143855078412853,5.41784887015883e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,EBAG9,Receptor-binding cancer antigen expressed on SiSo cells,39745,-0.034039396371987,0.00843206176939457,-0.0505662374400003,-0.0175125553039736,5.44159945479332e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CEACAM21,Carcinoembryonic antigen-related cell adhesion molecule 21,39862,-0.0300312853165342,0.00744435051907032,-0.044622212333912,-0.0154403582991563,5.50655190097932e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NAA80,N-alpha-acetyltransferase 80,37035,-0.0436076369353247,0.0108141851907446,-0.0648034399091841,-0.0224118339614654,5.55098248965944e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GZMB,Granzyme B,39862,-0.0230151940691373,0.00571254669635336,-0.0342117855939899,-0.0118186025442847,5.6300962092304e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,APPL2,DCC-interacting protein 13-beta,37120,-0.0405785495107122,0.0100757111281164,-0.0603269433218203,-0.0208301556996041,5.67200233127183e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TRDMT1,tRNA (cytosine(38)-C(5))-methyltransferase,37165,-0.0301047460772252,0.00748272023233823,-0.0447708777326081,-0.0154386144218423,5.77214589213343e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TRIM58,E3 ubiquitin-protein ligase TRIM58,37364,-0.0305731451182684,0.00760869143886528,-0.0454861803384444,-0.0156601098980925,5.89656400683155e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ITGB1BP2,Integrin beta-1-binding protein 2,39581,-0.0402842768960266,0.0100394746723442,-0.0599616472538212,-0.0206069065382319,6.03348094147521e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DNAJB2,DnaJ homolog subfamily B member 2,37120,-0.0190454329318393,0.00474922417396246,-0.0283539123128057,-0.0097369535508729,6.0994714914593e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PDGFRB,Platelet-derived growth factor receptor beta,40048,-0.0124668164961608,0.00310969870066821,-0.0185618259494705,-0.00637180704285112,6.12468836636093e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CPPED1,Serine/threonine-protein phosphatase CPPED1,40005,-0.0234234421732037,0.00584516424779271,-0.0348799640988774,-0.01196692024753,6.16872758331026e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PLSCR3,Phospholipid scramblase 3,37369,-0.0212138652966383,0.00529740219855178,-0.0315967736057998,-0.0108309569874768,6.24604773673568e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FUOM,Fucose mutarotase,37120,-0.0226517372219903,0.00565943144400096,-0.0337442228522322,-0.0115592515917485,6.3024125069131e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PSIP1,PC4 and SFRS1-interacting protein,39862,-0.0225481775351099,0.00563442065603118,-0.033591642020931,-0.0115047130492888,6.31288543350459e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,RWDD1,RWD domain-containing protein 1,40005,-0.0227136292234161,0.00568877790598092,-0.0338636339191387,-0.0115636245276935,6.5612081233201e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DNM3,Dynamin-3,37408,-0.0195216694381361,0.00488920982133544,-0.0291045206879535,-0.00993881818831861,6.56403216747295e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,VCAN,Versican core protein,40005,-0.0105166383320433,0.00263484855395843,-0.0156809414978018,-0.00535233516628479,6.59848711300899e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CIAPIN1,Anamorsin,39909,-0.0224516946500014,0.00563507996485453,-0.0334964513811162,-0.0114069379188865,6.79860917033504e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CD40,Tumor necrosis factor receptor superfamily member 5,39855,-0.0178988616135338,0.00449620346531851,-0.0267114204055581,-0.00908630282150951,6.89629245061819e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SIAE,Sialate O-acetylesterase,39871,-0.0167637319791012,0.00421244878080507,-0.0250201315894791,-0.00850733236872326,6.93445108528287e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,VEGFA,Vascular endothelial growth factor A,39989,-0.0202161369099026,0.00508020501300781,-0.0301733387353979,-0.0102589350844073,6.93934114679426e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SLC51B,Organic solute transporter subunit beta,37017,0.0268836469851204,0.00675934372913061,0.0136353332760244,0.0401319606942164,7.0088027159616e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,BNIP2,BCL2/adenovirus E1B 19 kDa protein-interacting protein 2,37433,-0.01206411553441,0.00303383704702235,-0.0180104361465738,-0.0061177949222462,7.02935624801526e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TNFSF8,Tumor necrosis factor ligand superfamily member 8,37433,-0.0125797455318373,0.00316736164625451,-0.0187877743584961,-0.00637171670517843,7.17360411427497e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FUS,RNA-binding protein FUS,39451,-0.0139001631558104,0.00350351049879339,-0.0207670437334454,-0.00703328257817537,7.29567846410924e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,LETM1,Mitochondrial proton/calcium exchanger protein,37408,-0.0185001602143392,0.00466737442436915,-0.0276482140861028,-0.0093521063425757,7.41698257231709e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MFAP4,Microfibril-associated glycoprotein 4,37120,0.0112433725428367,0.00283803383899081,0.00568082621841474,0.0168059188672587,7.48147636077199e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GZMH,Granzyme H,39581,-0.0266124987212058,0.00672787021048925,-0.0397991243337647,-0.0134258731086469,7.66903472747545e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MTUS1,Microtubule-associated tumor suppressor 1,37165,-0.0197207716397313,0.00498717787744194,-0.0294956402795175,-0.00994590299994515,7.71582459645606e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PPM1F,Protein phosphatase 1F,37433,-0.0187351595926374,0.00474037790684424,-0.0280263002900521,-0.00944401889522268,7.78119727593921e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CCN2,CCN family member 2,39876,-0.0206220986649159,0.00522039299923283,-0.0308540689434122,-0.0103901283864195,7.83889575349045e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,AKT1S1,Proline-rich AKT1 substrate 1,39485,-0.0237191289782953,0.00601132916739173,-0.0355013341463831,-0.0119369238102076,7.99024872808408e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CTSB,Cathepsin B,39843,-0.0180384014086498,0.00457526615288698,-0.0270059230683083,-0.00907087974899132,8.09496997256479e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,RBPMS2,RNA-binding protein with multiple splicing 2,37039,-0.036066988927202,0.00916004562721695,-0.0540206783565472,-0.0181132994978568,8.27845053209464e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PRKAR1A,cAMP-dependent protein kinase type I-alpha regulatory subunit,39864,-0.0292731898767103,0.00744849648450634,-0.0438722429863427,-0.0146741367670779,8.52745666993317e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TXNDC9,Thioredoxin domain-containing protein 9,37384,-0.0188040806236904,0.00478487918036393,-0.0281824438172037,-0.00942571743017713,8.54053261899078e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TBC1D23,TBC1 domain family member 23,39784,-0.0315644346309273,0.00804382114564028,-0.0473303240763823,-0.0157985451854723,8.74349911409158e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CTHRC1,Collagen triple helix repeat-containing protein 1,37433,0.00937954452948484,0.0023916709317594,0.00469186950323642,0.0140672195557333,8.83392998973872e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,LIFR,Leukemia inhibitory factor receptor,39862,0.00852595444028472,0.00217494745494474,0.00426305742859304,0.0127888514519764,8.88905986293092e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,LHPP,Phospholysine phosphohistidine inorganic pyrophosphate phosphatase,39865,-0.0201465867024416,0.00514035438300337,-0.0302216812931282,-0.010071492111755,8.91763897415942e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PLPBP,Pyridoxal phosphate homeostasis protein,39864,-0.0237934962211876,0.00607681115262052,-0.0357040460803238,-0.0118829463620513,9.06070482560749e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FGFR2,Fibroblast growth factor receptor 2,39909,-0.00753327275638175,0.00192462671656035,-0.01130554112084,-0.00376100439192347,9.10988263859355e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,EIF4B,Eukaryotic translation initiation factor 4B,39745,-0.0202255113083938,0.00517311685703681,-0.0303648203481859,-0.0100862022686017,9.2781633277491e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,AP3B1,AP-3 complex subunit beta-1,37378,-0.0266947682115085,0.00683154207989173,-0.0400845906880963,-0.0133049457349207,9.36810959607923e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PIK3AP1,Phosphoinositide 3-kinase adapter protein 1,39862,-0.0211926826836364,0.00542856880279429,-0.0318326775371132,-0.0105526878301596,9.5036338112867e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IL7,Interleukin-7,39862,-0.0226869124342704,0.00581361091355931,-0.0340815898248467,-0.0112922350436942,9.56419325851315e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CD99L2,CD99 antigen-like protein 2,39854,-0.00838096939153011,0.00214790602506348,-0.0125908652006545,-0.0041710735824057,9.58212954925371e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MRPL46,"39S ribosomal protein L46, mitochondrial",39485,-0.00949463158564397,0.00243363529312117,-0.0142645567601615,-0.00472470641112649,9.60310271257672e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FKBP1B,Peptidyl-prolyl cis-trans isomerase FKBP1B,39928,-0.0389601788693246,0.0100076390527252,-0.0585751514126661,-0.0193452063259831,9.93942450718081e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,LTB,Lymphotoxin-beta,37364,-0.0118369537568453,0.00304251115257401,-0.0178002756158904,-0.00587363189780027,0.000100509115942892
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CEACAM3,Carcinoembryonic antigen-related cell adhesion molecule 3,39473,-0.0163543936445739,0.00420431937640381,-0.0245948596223254,-0.00811392766682244,0.000100700203093855
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SNX2,Sorting nexin-2,37364,-0.0279222653032809,0.0071797435410169,-0.041994562643674,-0.0138499679628878,0.000101126281921718
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NMI,N-myc-interactor,37307,-0.0249593107697824,0.0064234000864824,-0.0375491749392879,-0.0123694466002769,0.000102531012980611
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CSNK2A1,Casein kinase II subunit alpha,37408,0.0155477626828643,0.0040019553660673,0.00770393016537242,0.0233915952003562,0.000102799093698844
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CD200R1,Cell surface glycoprotein CD200 receptor 1,39805,-0.0119681817760846,0.00308474025440378,-0.018014272674716,-0.00592209087745322,0.000104961755192294
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,HMGCL,"Hydroxymethylglutaryl-CoA lyase, mitochondrial",37039,-0.017323699823585,0.00446889171605714,-0.026082727587057,-0.00856467206011298,0.000106479718143304
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,F11,Coagulation factor XI,37245,-0.0107993306390699,0.00278704276472924,-0.0162619344579392,-0.00533672682020058,0.000107205651665192
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MMUT,"Methylmalonyl-CoA mutase, mitochondrial",37017,-0.0173083880545836,0.00447198719510714,-0.0260734829569936,-0.00854329315217359,0.000109180746852747
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CNTN5,Contactin-5,39893,-0.0124022354251005,0.00320571231037988,-0.018685431553445,-0.00611903929675592,0.00010980834003637
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CXCL8,Interleukin-8,39746,-0.0227396982828203,0.00588902815033046,-0.034282193457468,-0.0111972031081726,0.000113201304711281
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ANXA5,Annexin A5,39411,-0.0104135123755671,0.0026997346467879,-0.0157049922832713,-0.00512203246786278,0.000115139069228867
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ITGA6,Integrin alpha-6,39862,-0.0182433390055739,0.004730382820054,-0.0275148893328797,-0.00897178867826806,0.000115410912181507
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PTGR1,Prostaglandin reductase 1,37433,0.0273188669763525,0.00708844573608773,0.0134255133336205,0.0412122206190844,0.000116739055028402
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GIPC3,PDZ domain-containing protein GIPC3,37378,-0.03392854372678,0.00881547308405552,-0.0512068709715288,-0.0166502164820312,0.000119268827533587
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MUC13,Mucin-13,39485,0.0173973427580648,0.00452209398776258,0.00853403854205018,0.0262606469740795,0.000119956410406411
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SH2D1A,SH2 domain-containing protein 1A,39862,-0.0193994624473051,0.00504320365139912,-0.0292841416040474,-0.00951478329056285,0.000120205962614111
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PPP1CC,Serine/threonine-protein phosphatase PP1-gamma catalytic subunit,37364,-0.0286666448664807,0.00746368553735168,-0.04329546851969,-0.0140378212132715,0.000123186309336187
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CCDC134,Coiled-coil domain-containing protein 134,37364,-0.0166203793746352,0.00433403490057599,-0.0251150877797641,-0.00812567096950623,0.000126211137665779
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FMNL1,Formin-like protein 1,39485,-0.0208631802260282,0.00544126495203583,-0.0315280595320185,-0.010198300920038,0.000126441219665554
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FDX2,"Ferredoxin-2, mitochondrial",37017,-0.0192642779484045,0.00502526948503736,-0.0291138061390777,-0.00941474975773124,0.000126930686998801
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,HMOX1,Heme oxygenase 1,39687,0.0162947973660152,0.0042512235139017,0.00796239927876789,0.0246271954532626,0.000127096989160692
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PNMA1,Paraneoplastic antigen Ma1,37039,-0.0194250967394467,0.00506945362981353,-0.0293612258538812,-0.00948896762501213,0.000127803269864592
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,APEX1,DNA-(apurinic or apyrimidinic site) endonuclease,39975,-0.0196461208529829,0.00513024735073834,-0.02970140566043,-0.00959083604553571,0.00012890653706831
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TNFRSF10B,Tumor necrosis factor receptor superfamily member 10B,39745,-0.0132414706926365,0.00345922949362856,-0.0200215605001485,-0.00646138088512455,0.000129754252770109
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CWC15,Spliceosome-associated protein CWC15 homolog,37320,-0.0208761112000753,0.00545389118198253,-0.0315657379167611,-0.0101864844833896,0.000129907403400513
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ARFIP1,Arfaptin-1,37408,-0.0235886093143315,0.00617010340144736,-0.0356820119811683,-0.0114952066474947,0.000132401469174459
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,KEL,Kell blood group glycoprotein,39485,0.012103164822073,0.00316767145283759,0.00589452877451131,0.0183118008696347,0.000133513067280569
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,BRDT,Bromodomain testis-specific protein,37017,-0.0124551832766463,0.00326145953300463,-0.0188476439613353,-0.0060627225919572,0.000134664230894986
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CHM,Rab proteins geranylgeranyltransferase component A 1,37035,-0.0209300475272586,0.00548338553974268,-0.0316774831851543,-0.010182611869363,0.000135705816661537
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,STAT2,Signal transducer and activator of transcription 2,37052,-0.0267519948595037,0.00701408392414563,-0.0404995993508292,-0.0130043903681783,0.000137336421767432
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SLC39A14,Zinc transporter ZIP14,39485,-0.0111131364692068,0.00291527103333085,-0.0168270676945353,-0.00539920524387831,0.00013835233536112
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SPARCL1,SPARC-like protein 1,39867,-0.00926607072508823,0.00243123319398205,-0.014031287785293,-0.00450085366488341,0.000138775839202998
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TXNDC15,Thioredoxin domain-containing protein 15,39909,-0.00922787693653316,0.00242229691408869,-0.013975578888147,-0.00448017498491934,0.000139735275665081
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GRAP2,GRB2-related adapter protein 2,39864,-0.0436806066144725,0.0114664332335919,-0.0661548157523127,-0.0212063974766324,0.000139806606475846
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DBN1,Drebrin,37052,-0.017765706224225,0.00466676633650336,-0.0269125682437716,-0.00861884420467841,0.000141381564854431
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,39751,-0.00817785613466706,0.00214906840714257,-0.0123900302126665,-0.00396568205666762,0.000142161784335964
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ADA,Adenosine deaminase,40054,-0.0117899370432311,0.00310168256128288,-0.0178692348633456,-0.0057106392231167,0.000144558198242926
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PTPN1,Tyrosine-protein phosphatase non-receptor type 1,39745,-0.0266268203958466,0.00700945876895039,-0.0403653595829893,-0.0128882812087038,0.000145999906261155
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ABRAXAS2,BRISC complex subunit Abraxas 2,37017,-0.0225970096403319,0.00595208292167234,-0.0342630921668097,-0.0109309271138541,0.00014741958909304
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,LRCH4,Leucine-rich repeat and calponin homology domain-containing protein 4,37017,-0.0231445649607803,0.00609731009730717,-0.0350952927515023,-0.0111938371700582,0.000147789851112959
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,UMOD,Uromodulin,40008,-0.0177982583014233,0.0046986947179247,-0.0270076999485557,-0.00858881665429093,0.000152467416186615
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,EDAR,Tumor necrosis factor receptor superfamily member EDAR,39862,-0.0312431269321519,0.00825827267955349,-0.0474293413840768,-0.0150569124802271,0.00015535635059592
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SPART,Spartin,37120,-0.0263113729061399,0.00695645256086936,-0.0399460199254439,-0.012676725886836,0.000156070064682334
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TRIM21,E3 ubiquitin-protein ligase TRIM21,39862,-0.0253001657355497,0.00669826393741165,-0.0384287630528765,-0.0121715684182228,0.00015922484534626
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GMFG,Glia maturation factor gamma,37433,-0.0242072586359502,0.00641187408026166,-0.036774531833263,-0.0116399854386373,0.000160445032896078
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,S100A13,Protein S100-A13,37052,-0.0116759183276815,0.00309426922342908,-0.0177406860056025,-0.00561115064976052,0.000161741930599899
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SNRPB2,U2 small nuclear ribonucleoprotein B'',37384,-0.0135761817352304,0.00360119047117655,-0.0206345150587364,-0.00651784841172436,0.000163997861423631
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CDKN1A,Cyclin-dependent kinase inhibitor 1,39784,-0.0358537204938839,0.00951718804330234,-0.0545074090587565,-0.0172000319290113,0.000165643740568688
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TBCB,Tubulin-folding cofactor B,39745,-0.0339862731651988,0.00903321078520584,-0.0516913663042023,-0.0162811800261954,0.000168916242521164
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GBA,Lysosomal acid glucosylceramidase,37035,-0.017724057723051,0.00471305731071134,-0.0269616500520452,-0.00848646539405676,0.000170220219359157
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CACYBP,Calcyclin-binding protein,37084,-0.0347505716410629,0.00924811997899985,-0.0528768867999026,-0.0166242564822232,0.0001723001934362
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GALNT2,Polypeptide N-acetylgalactosaminyltransferase 2,40026,-0.00843528004506242,0.00224715381398233,-0.0128397015204678,-0.00403085856965705,0.000174810267969383
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DIABLO,"Diablo homolog, mitochondrial",39814,-0.0368036461866061,0.00980562856255376,-0.0560226781692115,-0.0175846142040007,0.000175127720013935
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,LBR,Delta(14)-sterol reductase LBR,40005,-0.022333280084779,0.00595263085350353,-0.034000436557646,-0.0106661236119121,0.000176160157096528
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,OCLN,Occludin,37408,-0.0143342270308817,0.00382305377361028,-0.0218274124271579,-0.00684104163460558,0.000177982700842184
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GP6,Platelet glycoprotein VI,39832,-0.0296268459828541,0.00790559405852737,-0.0451218103375678,-0.0141318816281405,0.000179177652879461
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SLC4A1,Band 3 anion transport protein,37433,0.0155444902322876,0.00414949942987752,0.00741147134972765,0.0236775091148475,0.000180339588284266
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NUDC,Nuclear migration protein nudC,40054,-0.0215011419156926,0.00574112355608689,-0.0327537440856229,-0.0102485397457623,0.000180939105736738
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NRP1,Neuropilin-1,39945,-0.00924254461417493,0.00247135850136456,-0.0140864072768495,-0.00439868195150041,0.000184758687044668
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TBCC,Tubulin-specific chaperone C,39745,-0.0270995948949237,0.00724651782324862,-0.041302769828491,-0.0128964199613564,0.000184908269253744
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ANK2,Ankyrin-2,37017,-0.0236732101292021,0.00633489447465259,-0.0360896032995211,-0.011256816958883,0.000187050846367051
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TSHB,Thyrotropin subunit beta,39864,-0.0249726413011715,0.00668466614576107,-0.0380745869468632,-0.0118706956554798,0.000187761892227947
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MIF,Macrophage migration inhibitory factor,39822,-0.0227071855973798,0.00607825677393602,-0.0346205688742944,-0.0107938023204652,0.000187766747959105
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,APOL1,Apolipoprotein L1,37441,-0.0204057501723393,0.00546405520990372,-0.0311152983837506,-0.00969620196092806,0.000188825029657814
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TP53,Cellular tumor antigen p53,39473,-0.0147194310794108,0.00394262974495076,-0.0224469853795143,-0.00699187677930733,0.000189579840537793
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CFHR2,Complement factor H-related protein 2,37360,-0.0187149206184466,0.00501522102390561,-0.0285447538253016,-0.00888508741159164,0.000191029249874825
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SPRR3,Small proline-rich protein 3,37384,-0.0217517663673952,0.00583132051330721,-0.0331811545734773,-0.010322378161313,0.000192139336410223
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GP1BB,Platelet glycoprotein Ib beta chain,37017,-0.0225325377497411,0.00604322939270285,-0.0343772673594387,-0.0106878081400435,0.000193385586856875
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IFNAR1,Interferon alpha/beta receptor 1,37378,-0.00845878639122206,0.00227055093839191,-0.0129090662304702,-0.00400850655197392,0.000195773408824512
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,HDGFL2,Hepatoma-derived growth factor-related protein 2,37384,-0.0207728664020913,0.00557643752280001,-0.0317026839467793,-0.00984304885740325,0.000196020754375611
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CETN2,Centrin-2,39485,-0.022496320146363,0.00604796518907292,-0.0343503319169459,-0.0106423083757801,0.000200196394416731
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SMOC2,SPARC-related modular calcium-binding protein 2,39927,-0.0125881904161358,0.00338676486229221,-0.0192262495462285,-0.00595013128604305,0.000202384643643519
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SUSD1,Sushi domain-containing protein 1,39581,-0.0161333281966854,0.004345557006134,-0.024650619928708,-0.00761603646466272,0.000205846966523122
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SUMF2,Inactive C-alpha-formylglycine-generating enzyme 2,40005,-0.0172995822429922,0.0046611089827305,-0.026435355849144,-0.00816380863684043,0.00020674842367352
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DNAJB14,DnaJ homolog subfamily B member 14,37378,-0.0214330809682112,0.00578448924988235,-0.0327706798979806,-0.0100954820384418,0.000212009639725092
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,LRP1,Prolow-density lipoprotein receptor-related protein 1,39784,-0.00876771084838132,0.00236702882929382,-0.0134070873537972,-0.00412833434296543,0.000212859895470046
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,AAMDC,Mth938 domain-containing protein,37039,-0.0175982026107934,0.00475230026665064,-0.0269127111334287,-0.00828369408815818,0.000213857272618945
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IL22,Interleukin-22,37364,0.021574387387073,0.00582893485932708,0.010149675062792,0.0329990997113541,0.000215386693535825
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DNPEP,Aspartyl aminopeptidase,37384,-0.019420253645783,0.00525923946451975,-0.0297283629962417,-0.00911214429532425,0.000222848740992834
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PAPPA,Pappalysin-1,39583,-0.0156367552766104,0.00423687078136757,-0.0239410220080908,-0.00733248854512996,0.000224447920427988
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,EHBP1,EH domain-binding protein 1,37433,-0.0246573936569457,0.00668196522791819,-0.0377540455036653,-0.0115607418102261,0.0002250063106543
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ARHGAP1,Rho GTPase-activating protein 1,39473,-0.0154442786852695,0.00418792814014169,-0.0236526178399472,-0.00723593953059176,0.000226960451412575
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,HPSE,Heparanase,37302,-0.0308915803042469,0.00837667032699005,-0.0473098541451474,-0.0144733064633463,0.000227082274586896
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DECR1,"2,4-dienoyl-CoA reductase, mitochondrial",39862,-0.0317037625882461,0.00859838277151364,-0.0485565928204128,-0.0148509323560793,0.000227505032921041
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FABP9,Fatty acid-binding protein 9,39862,-0.0181389078672582,0.00493265170456789,-0.0278069052082113,-0.00847091052630517,0.00023647459856349
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,RNASET2,Ribonuclease T2,39970,-0.00835345869341627,0.00227220354076605,-0.0128069776333177,-0.00389993975351481,0.000237345688886861
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,XRCC4,DNA repair protein XRCC4,39485,-0.0121988263802314,0.00331844485001325,-0.0187029782862574,-0.00569467447420545,0.000237650145408264
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TWF2,Twinfilin-2,37433,-0.027647618905926,0.00752471782374979,-0.0423960658404756,-0.0128991719713764,0.000239476369522317
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FCGR2B,Low affinity immunoglobulin gamma Fc region receptor II-b,39473,-0.0189158310424091,0.00515373597121556,-0.0290171535459916,-0.00881450853882659,0.000243059322102395
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CAMKK1,Calcium/calmodulin-dependent protein kinase kinase 1,39473,-0.0148471517862539,0.00404563096213886,-0.022776588472046,-0.00691771510046171,0.000243431951855341
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,EFCAB2,Dynein regulatory complex protein 8,37165,-0.0114750125356568,0.00312773988998929,-0.0176053827200358,-0.00534464235127777,0.00024465497572389
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MYOM2,Myomesin-2,37017,0.016848398918693,0.0045944514698745,0.00784327403773898,0.025853523799647,0.000246265595273012
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,OMG,Oligodendrocyte-myelin glycoprotein,39784,-0.0212388233257812,0.00580052607737296,-0.0326078544374322,-0.00986979221413018,0.000251521064172616
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PON3,Serum paraoxonase/lactonase 3,39927,-0.00919300899103265,0.00251257633762652,-0.0141176586127806,-0.00426835936928467,0.00025421167108763
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,LHB,Lutropin subunit beta,39473,-0.0288857181902689,0.00789756873212101,-0.044364952905226,-0.0134064834753117,0.000255479107230239
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ATP6AP2,Renin receptor,39473,-0.0132798854606051,0.00363730478760232,-0.0204090028443057,-0.00615076807690459,0.000262050291590426
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NEK7,Serine/threonine-protein kinase Nek7,37165,-0.024135361439337,0.00661066730867785,-0.0370922693643456,-0.0111784535143284,0.000262251011551637
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PINLYP,phospholipase A2 inhibitor and Ly6/PLAUR domain-containing protein,37120,-0.0217473595157678,0.00595899666257825,-0.0334269929744211,-0.0100677260571144,0.000263760000853819
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,HLA_DRA,,39795,-0.0115428651041632,0.00316305896959463,-0.0177424606845686,-0.00534326952375768,0.000263823661642619
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TNFAIP8,Tumor necrosis factor alpha-induced protein 8,39583,-0.011666718453993,0.00320125967587329,-0.0179411874187046,-0.00539224948928132,0.000268864006171938
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,BCAM,Basal cell adhesion molecule,39854,-0.00764469361311947,0.00209891452225608,-0.0117585660767414,-0.00353082114949756,0.000271158265270697
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PDLIM7,PDZ and LIM domain protein 7,39927,-0.0410362630187364,0.0112709671308224,-0.0631273585951483,-0.0189451674423245,0.000272558773220395
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CSF2RB,Cytokine receptor common subunit beta,37052,-0.0140464848613542,0.00385945361693472,-0.0216110139505463,-0.00648195577216216,0.000274210573508114
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,RILP,Rab-interacting lysosomal protein,39980,-0.0192586430009953,0.00529209732589926,-0.0296311537597578,-0.00888613224223272,0.000274412827880932
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,AFM,Afamin,37449,0.00613935051862231,0.001689079722202,0.00282875426310639,0.00944994677413823,0.000279297686168825
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,VCAM1,Vascular cell adhesion protein 1,39904,-0.00865074982969822,0.002380269189198,-0.0133160774405263,-0.00398542221887014,0.000279544476141578
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NARS1,"Asparagine--tRNA ligase, cytoplasmic",37408,-0.0152084193032124,0.00419276238077123,-0.023426233569524,-0.00699060503690082,0.000287449205794599
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TGFBR2,TGF-beta receptor type-2,39909,-0.00963919392173663,0.00265942989292413,-0.0148516765118679,-0.00442671133160534,0.000290377895409568
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SLA2,Src-like-adapter 2,37408,-0.0340174868441237,0.00938737872022297,-0.0524167491357607,-0.0156182245524867,0.000291428144725499
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TIMM8A,Mitochondrial import inner membrane translocase subunit Tim8 A,37384,0.0280675554364728,0.00774689260015685,0.0128836459401654,0.0432514649327802,0.000292190490136309
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TEK,Angiopoietin-1 receptor,39909,-0.00700423108308173,0.00193340387173001,-0.0107937026716725,-0.00321475949449092,0.000292391499841648
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,AMY2A,Pancreatic alpha-amylase,39242,-0.0151981806890973,0.00419973739555131,-0.0234296659843779,-0.00696669539381672,0.000296874616023177
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,BOLA1,BolA-like protein 1,36987,-0.0177260227104623,0.00490326273765816,-0.0273364176762723,-0.00811562774465229,0.000301299342993893
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,AMY2B,Alpha-amylase 2B,38828,-0.0155159455896545,0.00429681758883004,-0.0239377080637614,-0.00709418311554763,0.000305978010903485
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MCTS1,Malignant T-cell-amplified sequence 1,37378,-0.00801516104363958,0.0022204269258679,-0.0123671978183407,-0.00366312426893849,0.000307613603006454
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PTEN,"Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN",39485,-0.00976331736503484,0.00270494780021429,-0.0150650150534548,-0.00446161967661483,0.000307830890093748
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,AHCY,Adenosylhomocysteinase,39864,-0.021835030098987,0.00605059216961054,-0.0336941907514236,-0.00997586944655032,0.000308622986490539
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,RTN4R,Reticulon-4 receptor,40026,-0.0106425524555856,0.00295539893397301,-0.0164351343661727,-0.00484997054499849,0.000317878438061798
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DCTPP1,dCTP pyrophosphatase 1,39864,-0.010189027345014,0.00283002614784715,-0.0157358785947944,-0.00464217609523361,0.000318774675476918
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TMCO5A,Transmembrane and coiled-coil domain-containing protein 5A,37035,-0.0169521345153445,0.00471008745291367,-0.0261839059230553,-0.00772036310763373,0.000320476431498697
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ENO2,Gamma-enolase,40005,-0.0212127978649517,0.00589961792699667,-0.0327760490018651,-0.00964954672803819,0.000324582089841898
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,METAP2,Methionine aminopeptidase 2,40007,-0.0185033384791005,0.00514986421313659,-0.0285970723368483,-0.00840960462135283,0.00032789483230014
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DNPH1,2'-deoxynucleoside 5'-phosphate N-hydrolase 1,39900,-0.016251726601617,0.00453091033541742,-0.0251323108590352,-0.00737114234419888,0.000335683458451538
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FUT8,"Alpha-(1,6)-fucosyltransferase",39745,-0.0184485155066333,0.00514423073775299,-0.0285312077526292,-0.00836582326063745,0.000336469750850503
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,RRM2B,Ribonucleoside-diphosphate reductase subunit M2 B,39473,-0.0218113451696329,0.00609127825488232,-0.0337502505492022,-0.00987243979006355,0.000343649504566887
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PSME1,Proteasome activator complex subunit 1,39734,-0.0117724197971957,0.00329345891664015,-0.0182275992738104,-0.00531724032058103,0.000351958923131473
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ITGB1,Integrin beta-1,39858,-0.00691374987398272,0.00193839450307282,-0.0107130031000054,-0.00311449664796,0.000362504746274398
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PPP1R12A,Protein phosphatase 1 regulatory subunit 12A,39909,-0.0301284992574312,0.00844829375376253,-0.0466871550148057,-0.0135698435000566,0.000363216856113325
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GPR37,Prosaposin receptor GPR37,39581,-0.020491743012411,0.00574692107371875,-0.0317557083168997,-0.00922777770792224,0.000363976346233343
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CLEC3B,Tetranectin,37134,-0.00670290505150303,0.0018805232955543,-0.0103887307107895,-0.0030170793922166,0.000365993839315623
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,STAMBP,STAM-binding protein,39709,-0.0204438037574274,0.00573801207458735,-0.0316903074236186,-0.0091973000912362,0.000367896090107452
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,VTI1A,Vesicle transport through interaction with t-SNAREs homolog 1A,37120,-0.0185275021141333,0.00520024567087007,-0.0287199836290386,-0.00833502059922795,0.000368189767314643
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ENAH,Protein enabled homolog,39583,-0.0152584544272562,0.00428657222100812,-0.0236601359804321,-0.00685677287408026,0.000372524658637566
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SUGP1,SURP and G-patch domain-containing protein 1,37378,-0.0127185595526356,0.00357368170625293,-0.0197229756968913,-0.00571414340837983,0.000373614837768619
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SERPINA6,Corticosteroid-binding globulin,37449,-0.00556842179678799,0.00156464590501396,-0.00863512777061535,-0.00250171582296064,0.000373678057720537
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,STAT5B,Signal transducer and activator of transcription 5B,39784,-0.043750764545926,0.012296910438754,-0.0678527090058838,-0.0196488200859682,0.000374966010820437
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,AP2B1,AP-2 complex subunit beta,37035,-0.0156284177452778,0.00439298815823083,-0.0242386745354102,-0.00701816095514534,0.000375598239778005
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PSMD9,26S proteasome non-ATPase regulatory subunit 9,39784,-0.0170849368391813,0.00480807329656939,-0.0265087605004573,-0.00766111317790527,0.000381407164406899
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GBP2,Guanylate-binding protein 2,39583,-0.0187882402499363,0.00529468021628693,-0.0291658134738587,-0.00841066702601394,0.000388542452392983
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,LYPD8,Ly6/PLAUR domain-containing protein 8,39473,0.0165966890975697,0.00468622749385438,0.00741168320961512,0.0257816949855243,0.000398884456693795
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CCS,Copper chaperone for superoxide dismutase,39745,-0.0149010073206461,0.00420909162496242,-0.0231508269055724,-0.00665118773571978,0.000400974127809981
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,S100A12,Protein S100-A12,39611,-0.0236384900809542,0.00667717346685261,-0.0367257500759853,-0.0105512300859231,0.000400986029813328
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CLSTN2,Calsyntenin-2,40054,0.0124385818000951,0.00351472173971094,0.00554972719026163,0.0193274364099285,0.000402779113022862
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GBP4,Guanylate-binding protein 4,39485,-0.0154452258334837,0.00436430099403247,-0.0239992557817874,-0.00689119588518007,0.00040282449333618
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,AKT2,RAC-beta serine/threonine-protein kinase,37408,-0.039971475364748,0.0113237472090807,-0.062166019894546,-0.0177769308349499,0.000417126411579093
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,B4GALT1,"Beta-1,4-galactosyltransferase 1",39927,-0.00846462174415768,0.00239835880741081,-0.0131654050066829,-0.0037638384816325,0.000417763227640525
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PPP1R9B,Neurabin-2,40054,-0.029808098708955,0.00844871446077641,-0.0463675790520768,-0.0132486183658333,0.000419677711170914
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GIGYF2,GRB10-interacting GYF protein 2,37408,-0.0240699003114019,0.00682487275262121,-0.0374466509065395,-0.0106931497162643,0.000422019300478089
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DFFA,DNA fragmentation factor subunit alpha,40054,-0.0213116506798467,0.00604732672337439,-0.0331644110576605,-0.00945889030203287,0.000426024875865176
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ANKRD54,Ankyrin repeat domain-containing protein 54,39473,-0.0177668562982401,0.00504298102161142,-0.0276510991005985,-0.00788261349588171,0.000427771629740821
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DDR1,Epithelial discoidin domain-containing receptor 1,40005,-0.0073089132679884,0.0020760637702715,-0.0113779982577205,-0.00323982827825625,0.000431818445477552
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,EGLN1,Egl nine homolog 1,39862,-0.0167371007725399,0.00475669441989999,-0.0260602218355439,-0.00741397970953596,0.000434966590583102
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,BIRC2,Baculoviral IAP repeat-containing protein 2,39473,-0.0200224292090546,0.00569252206300998,-0.0311797724525541,-0.00886508596555501,0.000437163770255556
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TNFRSF11B,Tumor necrosis factor receptor superfamily member 11B,39858,-0.00930143103549469,0.00264851941678343,-0.0144925290923902,-0.00411033297859918,0.000446080820351303
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,VAT1,Synaptic vesicle membrane protein VAT-1 homolog,39784,-0.00620120606187454,0.00176872479954151,-0.0096679066689759,-0.00273450545477318,0.000456091617081014
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,APOB,Apolipoprotein B-100,37441,-0.00707215136458717,0.00201753843910186,-0.0110265267052268,-0.00311777602394753,0.000457500555923534
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GRK5,G protein-coupled receptor kinase 5,39581,-0.0165480928160385,0.00473467938001711,-0.025828064400872,-0.00726812123120496,0.000475221469129748
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MRI1,Methylthioribose-1-phosphate isomerase,37035,-0.0210780648408871,0.0060321347071848,-0.0329010488669693,-0.00925508081480495,0.000476874708468102
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,BTC,Probetacellulin,39473,-0.0230741700469343,0.0066081977848529,-0.036026237705246,-0.0101221023886226,0.0004811946087022
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,HAVCR1,Hepatitis A virus cellular receptor 1,39999,-0.0186552490927546,0.00534791001552524,-0.029137152723184,-0.00817334546232508,0.000487351321083706
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SNAP29,Synaptosomal-associated protein 29,39909,-0.0283944042873405,0.00814772401419882,-0.0443639433551702,-0.0124248652195108,0.00049354427425223
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FKBP5,Peptidyl-prolyl cis-trans isomerase FKBP5,39745,-0.0294810128734482,0.00846075707827472,-0.0460640967468666,-0.0128979290000297,0.000494494467590075
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PLG,Plasminogen,37158,-0.00700039870160569,0.00201108781511488,-0.0109421308192309,-0.00305866658398052,0.000501332177276691
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SMNDC1,Survival of motor neuron-related-splicing factor 30,37378,-0.0184666741059792,0.00531190957669735,-0.028878016876306,-0.00805533133565241,0.000509663904487409
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MYO9B,Unconventional myosin-IXb,39583,-0.0205149022710775,0.00590397534311441,-0.0320866939435817,-0.00894311059857322,0.000512686908549343
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PACS2,Phosphofurin acidic cluster sorting protein 2,37017,-0.0193710350342773,0.00557506100006568,-0.030298154594406,-0.00844391547414858,0.000513287895534784
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SOD2,"Superoxide dismutase [Mn], mitochondrial",39854,-0.0115518558004243,0.00332655829175464,-0.0180719100522634,-0.00503180154858525,0.000516776656574139
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,BRSK2,Serine/threonine-protein kinase BRSK2,37408,-0.0119262708608497,0.00343449962101596,-0.018657890118041,-0.00519465160365842,0.000517260259737169
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IL2RB,Interleukin-2 receptor subunit beta,39583,-0.0112358888493573,0.00324200180626673,-0.0175902123896401,-0.00488156530907452,0.000530213833511252
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NPPB,Natriuretic peptides B,39581,0.0391234542326556,0.0113127169604833,0.0169505289901084,0.0612963794752028,0.000544912662550562
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FKBP4,Peptidyl-prolyl cis-trans isomerase FKBP4,39745,-0.0136793799956643,0.0039605194448883,-0.0214419981076454,-0.00591676188368327,0.000553909795015217
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NOTCH3,Neurogenic locus notch homolog protein 3,40048,0.0104321236259078,0.0030300261585188,0.00449327235521097,0.0163709748966047,0.00057693481075263
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GPC1,Glypican-1,40026,-0.00890359819501465,0.00258607749306955,-0.013972310081431,-0.00383488630859832,0.000576976152986574
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TEF,Thyrotroph embryonic factor,37017,-0.0130218354938035,0.00378288092600238,-0.0204362821087681,-0.00560738887883882,0.000578570304562729
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PALM2,Paralemmin-2,37384,-0.0115848730475705,0.00336656907425239,-0.0181833484331052,-0.00498639766203581,0.000580995312947693
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SERPINB1,Leukocyte elastase inhibitor,39807,-0.0274223583895489,0.00798126387613388,-0.0430656355867713,-0.0117790811923265,0.000592221245968514
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TP53I3,Quinone oxidoreductase PIG3,36870,-0.0163970915717631,0.00477284196215381,-0.0257518618175846,-0.00704232132594165,0.000593311386089173
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ELN,Elastin,37433,-0.0102647863789823,0.00298998893594296,-0.0161251646934305,-0.00440440806453412,0.0005986098160786
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TARBP2,RISC-loading complex subunit TARBP2,39485,-0.0243672554312549,0.00710904278711942,-0.038300979294009,-0.0104335315685009,0.000610416379592852
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,KIF22,Kinesin-like protein KIF22,37017,-0.0370016858984769,0.0108185617682528,-0.0582060669642523,-0.0157973048327014,0.000627642485375985
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SULT2A1,Bile salt sulfotransferase,39862,-0.0170318657044383,0.00498010292827665,-0.0267928674438605,-0.00727086396501602,0.000627814141229935
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NUDT2,Bis(5'-nucleosyl)-tetraphosphatase [asymmetrical],39784,-0.0175806596784401,0.00514515474197994,-0.0276651629727208,-0.00749615638415948,0.000634886795315554
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,RNASEH2A,Ribonuclease H2 subunit A,37408,-0.0150056927096718,0.00439290098882711,-0.0236157786477729,-0.00639560677157063,0.000637591169240093
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,APRT,Adenine phosphoribosyltransferase,39734,-0.0146517575522307,0.00428969520235433,-0.0230595601488452,-0.00624395495561617,0.000638078447038627
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CRNN,Cornulin,39393,-0.0197109711740516,0.00577160371317126,-0.0310233144518673,-0.00839862789623596,0.000639067321117002
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,COMMD9,COMM domain-containing protein 9,37364,0.011925623077719,0.00349550728983603,0.00507442878964037,0.0187768173657976,0.000647482943216125
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GPI,Glucose-6-phosphate isomerase,37441,-0.014372865066078,0.00422762436614013,-0.0226590088237127,-0.0060867213084434,0.000676415668448737
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,BOLA2_BOLA2B,BolA-like protein 2,37039,-0.0165830352606363,0.00487843683954763,-0.0261447714661496,-0.0070212990551229,0.000677706792213741
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,BHMT2,S-methylmethionine--homocysteine S-methyltransferase BHMT2,37017,-0.00785574537306618,0.00231171345305717,-0.0123867037410582,-0.00332478700507413,0.000680232176441393
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PAFAH2,"Platelet-activating factor acetylhydrolase 2, cytoplasmic",37165,-0.0150935840979841,0.00444720737792694,-0.0238101105587209,-0.00637705763724731,0.000690941574520636
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PIGR,Polymeric immunoglobulin receptor,39673,-0.010968365487062,0.00324166283250069,-0.0173220246387633,-0.00461470633536063,0.000717258351925727
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TREM2,Triggering receptor expressed on myeloid cells 2,39858,-0.0155949513643195,0.00460916145600777,-0.0246289078180948,-0.00656099491054431,0.000717481678340869
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,LPO,Lactoperoxidase,39340,0.018023011848195,0.00533185948236832,0.0075725672627531,0.0284734564336369,0.000725991165166873
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IL20RA,Interleukin-20 receptor subunit alpha,39583,-0.0137377602352403,0.00407085845765205,-0.0217166428122383,-0.00575887765824226,0.000740857695719302
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PROS1,Vitamin K-dependent protein S,37449,-0.00735498899447913,0.00218044370703321,-0.0116286586602642,-0.00308131932869404,0.000745178210269245
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IFIT3,Interferon-induced protein with tetratricopeptide repeats 3,37165,-0.0114471681611259,0.00339561097879943,-0.0181025656795728,-0.00479177064267905,0.000750637517222519
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,LPCAT2,Lysophosphatidylcholine acyltransferase 2,39784,-0.0115348356739809,0.00342180491634928,-0.0182415733100255,-0.00482809803793633,0.000750793439958024
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MZB1,Marginal zone B- and B1-cell-specific protein,39904,-0.0147863273292086,0.00438740742008829,-0.0233856458725817,-0.00618700878583555,0.000752977316247096
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TLR1,Toll-like receptor 1,37052,-0.00781086349229774,0.00232243982679256,-0.0123628455528112,-0.00325888143178433,0.000772596360335871
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,KLRB1,Killer cell lectin-like receptor subfamily B member 1,40054,-0.0108171547836101,0.00322050896039016,-0.0171293523459749,-0.00450495722124542,0.000784525882412405
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PCBP2,Poly(rC)-binding protein 2,37408,-0.021695455377479,0.00646070227405549,-0.0343584318346278,-0.00903247892033028,0.000787064763941194
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DKK3,Dickkopf-related protein 3,40048,-0.00859073084024053,0.00256231198921081,-0.0136128623390937,-0.00356859934138735,0.000802031452403219
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,KCTD5,BTB/POZ domain-containing protein KCTD5,37161,-0.0130252694944764,0.00389135291031999,-0.0206523211987036,-0.00539821779024922,0.000818484993814208
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,WASHC3,WASH complex subunit 3,37384,-0.0225701498463649,0.00674878865619093,-0.0357977756124991,-0.0093425240802307,0.000827068933902091
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CLEC12A,C-type lectin domain family 12 member A,37052,-0.00599425744169673,0.00179302219824189,-0.00950858095025083,-0.00247993393314262,0.000830777287985087
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SIGLEC6,Sialic acid-binding Ig-like lectin 6,40026,-0.0098616479160232,0.00295051082390446,-0.0156446491308759,-0.00407864670117046,0.000832598503027911
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DBNL,Drebrin-like protein,39927,-0.0277463663809872,0.00830407848954585,-0.0440223602204971,-0.0114703725414774,0.000835790069746519
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TGFB1,Transforming growth factor beta-1 proprotein,40036,-0.0114668318841468,0.0034331519248576,-0.0181958096568677,-0.00473785411142591,0.000839586157510062
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FCRL3,Fc receptor-like protein 3,39583,-0.0155262069404414,0.00465629455674383,-0.0246525442716593,-0.00639986960922351,0.000856641629018726
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GPIHBP1,Glycosylphosphatidylinositol-anchored high density lipoprotein-binding protein 1,37378,-0.0208382722832712,0.0062669697645324,-0.0331215330217547,-0.00855501154478773,0.00088623520165765
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TMPRSS11D,Transmembrane protease serine 11D,37353,-0.0107049071682983,0.00322015174803388,-0.0170164045944447,-0.00439340974215191,0.000888614220234825
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ZNRF4,E3 ubiquitin-protein ligase ZNRF4,37364,-0.0158319996261004,0.00476416452512747,-0.0251697620953502,-0.00649423715685055,0.000892459120902627
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IL10RA,Interleukin-10 receptor subunit alpha,39583,-0.0173181516590005,0.0052180933703451,-0.0275456146648769,-0.00709068865312409,0.000905892065836072
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NGRN,Neugrin,37384,-0.00630071828226734,0.00189869182970253,-0.0100221542684843,-0.00257928229605038,0.000907567926268852
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PLXDC2,Plexin domain-containing protein 2,37384,0.00791737583554167,0.0023860757365968,0.00324066739181195,0.0125940842792714,0.000908524616790241
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,RAB11FIP3,Rab11 family-interacting protein 3,37433,-0.031789121724887,0.00958541802424976,-0.0505765410524165,-0.0130017023973574,0.000914231590839763
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,THOP1,Thimet oligopeptidase,39794,-0.00900205105526987,0.0027177812915736,-0.0143289023867541,-0.00367519972378562,0.00092745009264536
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ANGPTL1,Angiopoietin-related protein 1,39613,0.00864051707342474,0.00261148441142427,0.00352200762703318,0.0137590265198163,0.000939533788051043
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DPP10,Inactive dipeptidyl peptidase 10,39862,-0.0102182933451362,0.00308904490194093,-0.0162728213529404,-0.00416376533733197,0.000942011103141677
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NMT1,Glycylpeptide N-tetradecanoyltransferase 1,37408,-0.0194965660283849,0.0058976888302253,-0.0310560361356265,-0.00793709592114334,0.000949525668659496
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ENTPD5,Ectonucleoside triphosphate diphosphohydrolase 5,39581,-0.00633854116448779,0.00191807075981754,-0.0100979598537302,-0.00257912247524541,0.000953097631291976
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NADK,NAD kinase,39864,-0.0157367612942333,0.00476612580645673,-0.0250783678748885,-0.00639515471357812,0.00096279281708584
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PTPN6,Tyrosine-protein phosphatase non-receptor type 6,39904,-0.0264025552554988,0.00800336673090357,-0.0420891540480698,-0.0107159564629278,0.000972650588088465
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NAP1L4,Nucleosome assembly protein 1-like 4,37358,-0.011910691467362,0.00361255182937015,-0.0189912930529275,-0.00483008988179647,0.000979654719301659
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CASP2,Caspase-2,39862,-0.0200450527277302,0.00609367393431723,-0.031988653638992,-0.00810145181646845,0.0010058749293788
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DOK2,Docking protein 2,39864,-0.0360267755554589,0.0109522737547104,-0.0574932321146913,-0.0145603189962266,0.00100606101486139
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,KRT8,"Keratin, type II cytoskeletal 8",36987,0.019112250058161,0.00581369399702289,0.00771740982399615,0.0305070902923259,0.00101363430119148
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CES2,Cocaine esterase,39784,-0.0158884320062503,0.00483714609795626,-0.0253692383582446,-0.00640762565425601,0.0010232205826798
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TOP1,DNA topoisomerase 1,37378,0.0332486580261562,0.0101307694651522,0.0133923498744578,0.0531049661778546,0.00103354040145141
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PXN,Paxillin,39485,-0.0151424695625895,0.00461694781369909,-0.0241916872774398,-0.00609325184773934,0.00104123654253355
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NAA10,N-alpha-acetyltransferase 10,37017,-0.0147937895788774,0.00451171045048406,-0.0236367420618261,-0.00595083709592861,0.00104455073081223
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TOMM20,Mitochondrial import receptor subunit TOM20 homolog,37433,-0.0222608392338683,0.00679500507118826,-0.0355790491733973,-0.00894262929433935,0.00105530547516544
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ERP44,Endoplasmic reticulum resident protein 44,39754,-0.00760294633046568,0.00232242104354615,-0.0121548915758161,-0.00305100108511522,0.00106370092866324
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,UROD,Uroporphyrinogen decarboxylase,37120,-0.0202422638027449,0.00618367813911791,-0.032362272955416,-0.00812225465007382,0.00106496775858041
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TIMM10,Mitochondrial import inner membrane translocase subunit Tim10,37433,-0.0116388723276752,0.00355657333520064,-0.0186097560646684,-0.00466798859068194,0.00106868698058745
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TYMP,Thymidine phosphorylase,39760,-0.0197388392201572,0.00604229722530269,-0.0315817417817505,-0.00789593665856391,0.00109009718919679
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CCL14,C-C motif chemokine 14,39839,-0.0113233309609345,0.0034683624290637,-0.0181213213218993,-0.00452534059996964,0.00109791788961489
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MTHFSD,Methenyltetrahydrofolate synthase domain-containing protein,37165,-0.0329789821149287,0.0101172828671625,-0.0528088565345671,-0.0131491076952903,0.0011182295231418
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DKK4,Dickkopf-related protein 4,39714,-0.0131682033417309,0.00404192634524229,-0.0210903789784058,-0.005246027705056,0.0011247495066434
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CTSD,Cathepsin D,38717,0.0114465433102081,0.00351370705847107,0.00455967747560484,0.0183334091448114,0.00112577970418106
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ARTN,Artemin,39583,-0.0130340658724458,0.00400215079921524,-0.0208782814389076,-0.00518985030598389,0.00112928306472469
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,LRIG3,Leucine-rich repeats and immunoglobulin-like domains protein 3,37027,-0.00810840899946465,0.002492051962125,-0.0129928308452297,-0.00322398715369964,0.00114196573754177
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MOCS2,Molybdopterin synthase catalytic subunit,37120,-0.0196865155315892,0.00606696895329328,-0.0315777746800441,-0.00779525638313439,0.00117796185955665
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,STAM,Signal transducing adapter molecule 1,37364,-0.0104689084621497,0.00324290711585949,-0.0168250064092343,-0.00411281051506513,0.00124848373628085
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CCN3,CCN family member 3,40038,-0.00931251749036113,0.00288728216642276,-0.0149715905365497,-0.00365344444417252,0.00126065344923946
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SAA4,Serum amyloid A-4 protein,37449,0.00947356447045886,0.00293757129063871,0.003715924740807,0.0152312042001107,0.00126285954032806
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NPHS1,Nephrin,37052,-0.00982482496494845,0.00305001601428256,-0.0158028563529423,-0.00384679357695463,0.00127948002887184
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NFIC,Nuclear factor 1 C-type,37408,-0.0120270093708908,0.00373647641768775,-0.0193505031495588,-0.00470351559222284,0.00129026649891541
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,LAMTOR5,Ragulator complex protein LAMTOR5,37364,-0.0118562398919184,0.00368568710372641,-0.0190801866152222,-0.00463229316861467,0.00129919528611061
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CEP43,Centrosomal protein 43,39472,-0.0200911955613022,0.00625174319809043,-0.0323446122295595,-0.00783777889304501,0.00131304982976229
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PDCD6,Programmed cell death protein 6,39864,-0.0199907213720282,0.006221200114934,-0.0321842735972988,-0.00779716914675753,0.00131468817215641
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,APLP1,Amyloid-like protein 1,39864,-0.0146754756735094,0.00457118335913518,-0.0236349950574143,-0.00571595628960445,0.00132797021845111
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ITGB2,Integrin beta-2,39727,-0.00820461931564154,0.00255970713781564,-0.0132216453057602,-0.0031875933255229,0.00135190670594512
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,AGXT,Serine--pyruvate aminotransferase,39864,-0.0222717409720727,0.00695232877103174,-0.0358983053632949,-0.00864517658085046,0.00136036933019347
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FKBP7,Peptidyl-prolyl cis-trans isomerase FKBP7,39449,-0.0135907407727837,0.0042430005941143,-0.0219070219372478,-0.00527445960831971,0.00136231594656176
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NECAP2,Adaptin ear-binding coat-associated protein 2,37017,-0.0185494923650885,0.00579327851220566,-0.0299043182490115,-0.00719466648116537,0.00136849548930967
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TMED8,Protein TMED8,37378,-0.029482110793892,0.00921707583508397,-0.0475475794306566,-0.0114166421571274,0.00138395684412254
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MYL1,"Myosin light chain 1/3, skeletal muscle isoform",37017,0.0116450378723677,0.0036411142974424,0.00450845384938064,0.0187816218953548,0.00138612350119999
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,S100A4,Protein S100-A4,39909,-0.0162194071140279,0.00507341020090815,-0.0261632911078079,-0.00627552312024796,0.00139161202589399
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,VPS53,Vacuolar protein sorting-associated protein 53 homolog,39784,-0.0219046780370183,0.00685764585057674,-0.0353456639041487,-0.00846369216988787,0.00140492997369944
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,OGN,Mimecan,39854,-0.011233798792159,0.00352024525889679,-0.0181334794995967,-0.00433411808472125,0.00141958000267432
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,RNF41,E3 ubiquitin-protein ligase NRDP1,39473,-0.0191298341386543,0.00600271860921831,-0.0308951626127222,-0.00736450566458639,0.00144108756232331
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CEACAM16,Carcinoembryonic antigen-related cell adhesion molecule 16,37378,-0.023854701937645,0.00748553366910671,-0.0385263479290941,-0.00918305594619579,0.00144196512209058
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CLIC5,Chloride intracellular channel protein 5,37035,-0.0091369801018306,0.00286891532085219,-0.0147600541307009,-0.00351390607296031,0.00145181122712998
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TLR4,Toll-like receptor 4,37052,-0.00781242673719854,0.00245403835472655,-0.0126223419124626,-0.0030025115619345,0.00145844859568209
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",37384,-0.0276800946333002,0.00872618678555723,-0.0447834207329923,-0.010576768533608,0.00151693653289524
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,LUZP2,Leucine zipper protein 2,37364,-0.0123436069943787,0.00389319543158833,-0.0199742700402918,-0.00471294394846557,0.00152485733344397
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NBL1,Neuroblastoma suppressor of tumorigenicity 1,39909,-0.00721925745973492,0.00227860893435507,-0.0116853309710709,-0.00275318394839898,0.00153634433215173
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MAGED1,Melanoma-associated antigen D1,39473,-0.0136910946718289,0.00432247248285081,-0.0221631407382164,-0.00521904860544129,0.00154093055082814
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2,39473,-0.0176527579815973,0.00557335482667511,-0.0285765334418805,-0.00672898252131411,0.00154131925701356
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SH3BGRL2,SH3 domain-binding glutamic acid-rich-like protein 2,36987,-0.0174377362658254,0.00550578320016659,-0.0282290713381519,-0.00664640119349891,0.0015428420086528
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TMPRSS5,Transmembrane protease serine 5,39663,-0.010734702634642,0.00339149529050545,-0.0173820334040326,-0.00408737186525129,0.00155279589739093
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DCXR,L-xylulose reductase,39909,-0.0152137301303255,0.00480912605006644,-0.0246396171884557,-0.00578784307219531,0.00156168331074016
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DLK1,Protein delta homolog 1,40048,-0.015720873954681,0.00497427069971662,-0.0254704445261256,-0.00597130338323643,0.00157822315651915
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DNER,Delta and Notch-like epidermal growth factor-related receptor,39817,-0.0071571175543541,0.00226507685819013,-0.0115966681964068,-0.00271756691230145,0.00158189586231537
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,HYAL1,Hyaluronidase-1,39743,-0.00642595722965585,0.00203401956851988,-0.0104126355839548,-0.00243927887535689,0.00158477382899409
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PPIF,"Peptidyl-prolyl cis-trans isomerase F, mitochondrial",37433,-0.0173426147389412,0.00549327349219354,-0.0281094307836406,-0.0065757986942419,0.00159715250624644
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FARSA,Phenylalanine--tRNA ligase alpha subunit,37035,-0.0193850669720959,0.00614022167496151,-0.0314199014550205,-0.00735023248917136,0.00159726188644739
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ITGB5,Integrin beta-5,39909,0.0106853066768061,0.00338728423761509,0.00404622957108054,0.0173243837825317,0.00161050715994931
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ECI2,Enoyl-CoA delta isomerase 2,37017,-0.0174155095686529,0.00552195202091811,-0.0282385355296523,-0.00659248360765336,0.00161484172368062
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PCDH1,Protocadherin-1,40014,-0.00584948182013989,0.00185566646040339,-0.00948658808253054,-0.00221237555774924,0.00162326517308026
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,REPS1,RalBP1-associated Eps domain-containing protein 1,37052,-0.0107737124660813,0.00341923401797161,-0.0174754111413057,-0.00407201379085698,0.00163124248840604
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ICA1,Islet cell autoantigen 1,39583,-0.0225767137528375,0.00716648222333722,-0.0366230189105784,-0.00853040859509653,0.00163397273774068
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MAPKAPK2,MAP kinase-activated protein kinase 2,37165,-0.0206490371262692,0.00655686150921391,-0.0335004856843284,-0.0077975885682099,0.00164065826530235
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FAM13A,Protein FAM13A,37378,-0.0190000444212653,0.00603399783932523,-0.0308266801863428,-0.00717340865618785,0.00164281255968677
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ADAM15,Disintegrin and metalloproteinase domain-containing protein 15,39581,0.00860166910038812,0.00273434424953407,0.00324235437130134,0.0139609838294749,0.00165948500353828
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PPCDC,Phosphopantothenoylcysteine decarboxylase,40005,-0.0132400603997461,0.0042090209945711,-0.0214897415491054,-0.00499037925038674,0.0016602527969828
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FSTL1,Follistatin-related protein 1,37039,0.00640807080113656,0.00203812980444295,0.00241333638442837,0.0104028052178447,0.00166972021295561
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CALCB,Calcitonin gene-related peptide 2,37384,-0.0110137343268044,0.00350319470508627,-0.0178799959487735,-0.00414747270483526,0.00167066379671278
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FABP2,"Fatty acid-binding protein, intestinal",39864,-0.0218373037013608,0.00694877865042478,-0.0354569098561934,-0.00821769754652827,0.0016775413755221
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DNMBP,Dynamin-binding protein,39745,-0.0173742051028758,0.00552878335421797,-0.028210620477143,-0.00653778972860855,0.00167819280883785
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NEXN,Nexilin,37441,-0.0192589349820534,0.00612934579243584,-0.0312724527352276,-0.00724541722887916,0.00168108966516173
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TYRO3,Tyrosine-protein kinase receptor TYRO3,39864,-0.00789704652908498,0.00251422085420012,-0.0128249194033172,-0.00296917365485275,0.00168706436432584
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CASP9,Caspase-9,37052,-0.0177038962770061,0.0056390586414152,-0.0287564512141799,-0.00665134133983235,0.00169602386187606
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MME,Neprilysin,39784,0.0220539187891719,0.00702942018131768,0.00827625523378926,0.0358315823445546,0.00170779353450097
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SEMA6C,Semaphorin-6C,37052,-0.00730675258902818,0.00233031314743091,-0.0118741663579928,-0.0027393388200636,0.00171924106481391
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,BAG3,BAG family molecular chaperone regulator 3,39716,-0.0110540018635599,0.0035257634630581,-0.0179644982511538,-0.00414350547596602,0.00172045858840162
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CALB1,Calbindin,39784,-0.0117416379343148,0.00374515680110596,-0.0190821452644825,-0.0044011306041471,0.00172077025372342
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DLG4,Disks large homolog 4,37384,-0.020009112276236,0.00638332390213013,-0.0325204271244111,-0.00749779742806097,0.00172461803545674
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NFYA,Nuclear transcription factor Y subunit alpha,37017,-0.0105738683459473,0.00337639582886941,-0.0171916041705313,-0.00395613252136322,0.00174176598444856
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,EIF2S2,Eukaryotic translation initiation factor 2 subunit 2,37039,-0.011875122680109,0.0037925488749023,-0.0193085184749175,-0.00444172688530049,0.00174490898514192
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PSAPL1,Proactivator polypeptide-like 1,37378,-0.0138596887013551,0.00442740504364134,-0.0225374025868922,-0.00518197481581812,0.00174921414292452
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,EVPL,Envoplakin,37165,-0.00920028895378466,0.00293955279504129,-0.0149618124320656,-0.00343876547550374,0.00175288079419003
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,C7orf50,Uncharacterized protein C7orf50,37384,-0.00610632596868856,0.00195128408926782,-0.0099308427836535,-0.00228180915372363,0.00175543022785789
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,COL5A1,Collagen alpha-1(V) chain,37120,0.0110236725549722,0.00352599116048121,0.00411272988042905,0.0179346152295154,0.0017734075426758
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PTH,Parathyroid hormone,37035,-0.0223340029803778,0.00714430794104235,-0.0363368465448208,-0.00833115941593477,0.00177511105208732
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PPP1R12B,Protein phosphatase 1 regulatory subunit 12B,37165,-0.0200320959257266,0.00640924416695562,-0.0325942144929596,-0.00746997735849356,0.00177884665302294
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,AIF1L,Allograft inflammatory factor 1-like,37039,-0.0162878625908214,0.00521182888637666,-0.0265030472081197,-0.00607267797352316,0.00178086858777241
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,RALB,Ras-related protein Ral-B,37052,-0.00813266342651817,0.00260372237028345,-0.0132359592722737,-0.00302936758076261,0.00179115567695464
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,WWP2,NEDD4-like E3 ubiquitin-protein ligase WWP2,39745,-0.0148695373361807,0.00476379367889179,-0.0242065729468086,-0.00553250172555276,0.00180337755837169
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FES,Tyrosine-protein kinase Fes/Fps,39473,-0.0131905997657128,0.00422820191650706,-0.0214778755220667,-0.00490332400935898,0.00181382671591603
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CRTAC1,Cartilage acidic protein 1,40048,-0.0083729234716016,0.00268523811338929,-0.0136359901738446,-0.00310985676935859,0.0018232108788184
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GPKOW,G-patch domain and KOW motifs-containing protein,39485,-0.00757443595894426,0.00242990396636664,-0.0123370477330229,-0.00281182418486566,0.00182924365661243
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ENPP2,Ectonucleotide pyrophosphatase/phosphodiesterase family member 2,40048,-0.00748288281038831,0.00240309996953243,-0.0121929587506719,-0.00277280687010476,0.00184988027314698
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PLA2G4A,Cytosolic phospholipase A2,39927,-0.024501163525985,0.00787296032943927,-0.039932165771686,-0.00907016128028403,0.0018610942530096
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MITD1,MIT domain-containing protein 1,39745,-0.0269151281165673,0.00866424911192792,-0.043897056375946,-0.00993319985718858,0.00189676652121466
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,LAMP1,Lysosome-associated membrane glycoprotein 1,37093,0.00782677035355249,0.00251955428902992,0.00288844394705385,0.0127650967600511,0.00189774055490333
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SMPD1,Sphingomyelin phosphodiesterase,39908,0.0135553036887542,0.00436954049980042,0.00499100430914534,0.022119603068363,0.00192404336330259
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MXRA8,Matrix remodeling-associated protein 8,37120,0.00831678392447543,0.00268155393114726,0.00306093821942681,0.0135726296295241,0.0019296043993978
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PRCP,Lysosomal Pro-X carboxypeptidase,39944,-0.00859043926269758,0.00277094699007877,-0.014021495363252,-0.0031593831621432,0.00193735984840627
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ATG16L1,Autophagy-related protein 16-1,37378,-0.0236801959110405,0.00765628165202781,-0.038686507949015,-0.00867388387306599,0.00198607597967429
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,APOD,Apolipoprotein D,36777,0.0119076902410655,0.00385631078130851,0.00434932110970078,0.0194660593724301,0.00202040916838305
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,APP,Amyloid-beta precursor protein,39825,-0.0183182853870076,0.00593407430660864,-0.0299490710279605,-0.00668749974605462,0.00202557150119907
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TPR,Nucleoprotein TPR,37017,-0.0129599358516205,0.00419989928129041,-0.0211917384429497,-0.00472813326029129,0.00203445208548064
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ACTN2,Alpha-actinin-2,37017,0.0162531380754689,0.00526862605740753,0.00592663100295019,0.0265796451479877,0.00204048909287047
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GALNT10,Polypeptide N-acetylgalactosaminyltransferase 10,39784,-0.00772079422046269,0.00250313553811935,-0.0126269398751766,-0.00281464856574876,0.00204278681500798
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SMAD5,Mothers against decapentaplegic homolog 5,39784,-0.0056491784932499,0.00183191778295835,-0.00923973734784827,-0.00205861963865153,0.00204758252090742
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TNC,Tenascin,39927,-0.0129505865822056,0.00420041132933239,-0.021183392787697,-0.00471778037671408,0.00205154451455196
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CRYZL1,Quinone oxidoreductase-like protein 1,37039,-0.0252271899719702,0.00822402903892725,-0.0413462868882676,-0.00910809305567275,0.00216296860759816
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DNLZ,DNL-type zinc finger protein,36987,-0.0245197393206698,0.00801445493647916,-0.040228070996169,-0.00881140764517067,0.00222198757833759
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SMAD3,Mothers against decapentaplegic homolog 3,37364,-0.0139024890791219,0.00454545819824705,-0.0228115871476861,-0.00499339101055762,0.00222850035590148
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CORO1A,Coronin-1A,39516,-0.0243854369883259,0.00797633382880203,-0.0400190512927779,-0.00875182268387395,0.00223774118434256
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ANG,Angiogenin,39839,-0.00920491101001031,0.00301209566711927,-0.0151086185175641,-0.00330120350245654,0.00224694515555701
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CD3E,T-cell surface glycoprotein CD3 epsilon chain,37165,-0.00934985475834494,0.0030603239517564,-0.0153480897037875,-0.0033516198129024,0.0022536716876342
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TXNRD1,"Thioredoxin reductase 1, cytoplasmic",39854,-0.0126818023862824,0.00415111991378642,-0.0208179974173038,-0.00454560735526099,0.00225407246287137
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,EEF1D,Elongation factor 1-delta,37433,-0.024813525427633,0.00812415264492865,-0.0407368646116931,-0.0088901862435728,0.00226030430946819
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CRKL,Crk-like protein,39877,-0.0291974398127452,0.00956008382387783,-0.0479352041075457,-0.0104596755179446,0.00226108399978855
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PDGFA,Platelet-derived growth factor subunit A,40048,-0.0195657917305093,0.00640713798417125,-0.0321237821794849,-0.0070078012815336,0.00226367997387422
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,STK4,Serine/threonine-protein kinase 4,39864,-0.0237824470232429,0.0077890339486786,-0.039048953562653,-0.00851594048383284,0.00226692705136956
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ASRGL1,Isoaspartyl peptidase/L-asparaginase,37039,-0.0277980647461225,0.00910537429861097,-0.0456445983714,-0.00995153112084502,0.00227070857175851
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CASP7,Caspase-7,37384,-0.022924053257755,0.00751107586139559,-0.0376457619460903,-0.00820234456941961,0.00227737835269046
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DAAM1,Disheveled-associated activator of morphogenesis 1,37120,-0.0224650141128385,0.00736861603617687,-0.0369075015437452,-0.00802252668193185,0.00230254090480274
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CAPS,Calcyphosin,37384,-0.0235868704356924,0.00774433503235298,-0.0387657670991042,-0.00840797377228051,0.00232591292417851
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,REN,Renin,39864,0.0178835514209604,0.00588542438301608,0.00634811963024889,0.0294189832116719,0.00238050007767864
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TGFBR1,TGF-beta receptor type-1,37052,-0.0058757640720373,0.00193840046054693,-0.00967502897470928,-0.00207649916936533,0.00244021004982041
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ALDH5A1,"Succinate-semialdehyde dehydrogenase, mitochondrial",37408,-0.012661090067858,0.00418984950829698,-0.0208731951041201,-0.00444898503159595,0.00251705443657004
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ARHGAP25,Rho GTPase-activating protein 25,39473,-0.0162814641843657,0.00539040959391724,-0.0268466669884434,-0.00571626138028785,0.00252807374407503
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SH3BP1,SH3 domain-binding protein 1,37378,-0.0128916587480498,0.00427094605057095,-0.0212627130071689,-0.00452060448893072,0.00254540577549951
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,AGT,Angiotensinogen,37441,0.00601299842906713,0.00199653789281532,0.00209978415914909,0.00992621269898517,0.00260256355557721
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ACADSB,"Short/branched chain specific acyl-CoA dehydrogenase, mitochondrial",37433,-0.0235467652684999,0.00782079078448199,-0.0388755152060846,-0.00821801533091515,0.00261047449138138
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PCYT2,Ethanolamine-phosphate cytidylyltransferase,37378,-0.020544591339488,0.00683474454550385,-0.0339406906486756,-0.00714849203030045,0.00265277931691702
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,EIF2AK2,"Interferon-induced, double-stranded RNA-activated protein kinase",37354,-0.0292038192815398,0.00972166142486167,-0.0482582756742687,-0.0101493628888109,0.00266948806949399
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PSMG4,Proteasome assembly chaperone 4,37052,-0.0148120695794437,0.00493456229344444,-0.0244838116745948,-0.00514032748429262,0.00268980104477808
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,BCL2L1,Bcl-2-like protein 1,37384,-0.0267273734550866,0.00891092791484353,-0.0441927921681799,-0.00926195474199326,0.0027101066691973
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IL10,Interleukin-10,39583,-0.0211958679713713,0.00707025990286941,-0.0350535773809953,-0.00733815856174723,0.00272279782937713
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FOLH1,Glutamate carboxypeptidase 2,37052,-0.0291782629388997,0.0097568800210885,-0.0483017477802331,-0.0100547780975662,0.00279005956993922
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FCRL5,Fc receptor-like protein 5,39854,-0.0148909254967437,0.00498130679238819,-0.0246542868098246,-0.00512756418366286,0.00279986408663222
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CDC37,Hsp90 co-chaperone Cdc37,39909,-0.0223368186380036,0.00747343048368779,-0.0369847423860317,-0.00768889488997555,0.00280471263323457
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CD8A,T-cell surface glycoprotein CD8 alpha chain,40005,-0.0125444756582094,0.00419951516039414,-0.0207755253725819,-0.00431342594383685,0.00282037765655309
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PTPN9,Tyrosine-protein phosphatase non-receptor type 9,37018,-0.0103516451348668,0.00346540480934709,-0.0171438385611871,-0.00355945170854649,0.00282120880140789
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,BAX,Apoptosis regulator BAX,39452,-0.0243618738177481,0.00817540534569166,-0.0403856682953038,-0.00833807934019245,0.00288788914524756
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,LRRC59,Leucine-rich repeat-containing protein 59,37433,-0.012389182010081,0.00415826608118746,-0.0205393835292084,-0.00423898049095358,0.00289314668010265
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,BNIP3L,BCL2/adenovirus E1B 19 kDa protein-interacting protein 3-like,37052,-0.0119932442512089,0.00403263009863353,-0.0198971992445306,-0.00408928925788715,0.0029442872582735
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,S100A16,Protein S100-A16,39452,0.0164966620101976,0.00554854563019647,0.00562151257501251,0.0273718114453827,0.00295210403933028
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CNPY2,Protein canopy homolog 2,39581,-0.0159981828306333,0.00538434751374774,-0.0265515039575789,-0.00544486170368775,0.00297049647869732
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ARL13B,ADP-ribosylation factor-like protein 13B,37017,-0.0183980097880254,0.00619614865828187,-0.0305424611582579,-0.00625355841779296,0.0029905098867725
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CLEC4D,C-type lectin domain family 4 member D,39862,-0.0160160556377566,0.00540299767671815,-0.0266059310841242,-0.00542618019138903,0.00303828627090653
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DGKA,Diacylglycerol kinase alpha,37052,-0.0144584474495849,0.00487853466083041,-0.0240203753848125,-0.00489651951435729,0.00304520766709264
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ENSA,Alpha-endosulfine,37364,-0.013862602257144,0.00467990338001353,-0.0230352128819705,-0.00468999163231751,0.00306025390832403
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DDAH1,"N(G),N(G)-dimethylarginine dimethylaminohydrolase 1",39784,-0.0116512142462828,0.00393552150513111,-0.0193648363963398,-0.00393759209622581,0.00307566747998585
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,VAV3,Guanine nucleotide exchange factor VAV3,36987,-0.0262882702778645,0.00888208470838893,-0.0436971563063068,-0.00887938424942214,0.00308492877539518
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TPPP3,Tubulin polymerization-promoting protein family member 3,39485,-0.010267156519452,0.00347132182852946,-0.0170709473033698,-0.0034633657355343,0.0031039948545208
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MRPL52,"39S ribosomal protein L52, mitochondrial",36938,-0.00666564988929682,0.00225362372960964,-0.0110827523993317,-0.00224854737926192,0.00310450213050033
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,C1GALT1C1,C1GALT1-specific chaperone 1,37017,-0.00860189746548122,0.00291795456646895,-0.0143210884157604,-0.00288270651520208,0.00320481512365862
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,HPGDS,Hematopoietic prostaglandin D synthase,39473,-0.00977097837744394,0.00331793604003318,-0.016274133015909,-0.0032678237389789,0.00323539068315795
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MAP2K1,Dual specificity mitogen-activated protein kinase kinase 1,37378,-0.0170210228256408,0.00579615172100763,-0.0283814801988157,-0.00566056545246579,0.00332383171005572
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CCL21,C-C motif chemokine 21,39927,-0.0102524669081916,0.00349329033664078,-0.0170993159680075,-0.00340561784837571,0.00334124628359839
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FASLG,Tumor necrosis factor ligand superfamily member 6,40054,-0.00960065821632853,0.00327394398338901,-0.016017588423771,-0.00318372800888607,0.0033677610837804
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,HSBP1,Heat shock factor-binding protein 1,37039,-0.0251880060703365,0.00858921314743393,-0.042022863839307,-0.00835314830136602,0.00336805949258059
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PLAT,Tissue-type plasminogen activator,39998,-0.0129681467243144,0.00442338346845709,-0.0216379783224903,-0.00429831512613852,0.00337557516981237
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,RRAS,Ras-related protein R-Ras,37035,-0.0345667886339092,0.0117932840009373,-0.0576816252757463,-0.0114519519920721,0.00338391036800166
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DUSP3,Dual specificity protein phosphatase 3,39485,-0.0221553428552595,0.00757593592225705,-0.0370041772628834,-0.00730650844763572,0.00345576319907716
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CSNK1D,Casein kinase I isoform delta,37052,-0.0168301584511356,0.00575834105966442,-0.0281165069280778,-0.0055438099741933,0.00347550501462858
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ASGR1,Asialoglycoprotein receptor 1,39745,-0.00757708696624494,0.00259342736030188,-0.0126602045924366,-0.00249396934005326,0.00348672911490577
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SNED1,"Sushi, nidogen and EGF-like domain-containing protein 1",37039,-0.00843154673344595,0.00288603395906846,-0.0140881732932201,-0.00277492017367177,0.00348942047226802
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,C1QL2,Complement C1q-like protein 2,37052,-0.0108995417972158,0.00373633424500473,-0.0182227569174251,-0.00357632667700657,0.00353812899266352
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PRTN3,Myeloblastin,39417,-0.012019209964778,0.00412539988240482,-0.0201049937342914,-0.00393342619526454,0.00357950152488712
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,HDGF,Hepatoma-derived growth factor,40010,-0.0243854497410711,0.00837051519468216,-0.0407916595226482,-0.00797923995949408,0.00358172033713877
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GOPC,Golgi-associated PDZ and coiled-coil motif-containing protein,39862,-0.0262942597240352,0.00904778767552607,-0.0440279235680663,-0.00856059588000407,0.00366403614583966
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CPXM1,Probable carboxypeptidase X1,39909,-0.0175544780739435,0.00606026468648228,-0.0294325968594488,-0.00567635928843823,0.00377677367869388
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FZD8,Frizzled-8,36987,-0.0110032677080032,0.00379854406556146,-0.0184484140765036,-0.00355812133950272,0.00377725175175251
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CARHSP1,Calcium-regulated heat-stable protein 1,39485,-0.0130725266493079,0.00451536805676479,-0.0219226480405668,-0.00422240525804889,0.00379540063413925
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IMPACT,Protein IMPACT,37384,-0.0142622643337972,0.00492976901622274,-0.0239246116055937,-0.00459991706200059,0.00382081127861166
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,F13B,Coagulation factor XIII B chain,37376,-0.00657046642391212,0.00227130365195399,-0.0110222215817419,-0.00211871126608229,0.00382412920240813
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TOP2B,DNA topoisomerase 2-beta,37052,-0.0204519754914247,0.00708581940307657,-0.0343401815214548,-0.00656376946139462,0.00390402217830593
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ITGBL1,Integrin beta-like protein 1,37433,0.00917483635152604,0.0031788752270004,0.00294424090660526,0.0154054317964468,0.00390552072017404
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CDH5,Cadherin-5,40048,-0.0078480501176783,0.00272040559296022,-0.0131800450798803,-0.00251605515547626,0.00392076687226028
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GNE,Bifunctional UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase,39473,-0.0168899341096643,0.00586019261791979,-0.0283759116407871,-0.00540395657854153,0.00395514545615847
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,COPB2,Coatomer subunit beta',37017,-0.0109877227472657,0.00381445200376931,-0.0184640486746535,-0.00351139681987782,0.00397622114718868
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,KCNC4,Potassium voltage-gated channel subfamily C member 4,36987,-0.014410155404667,0.00500414094474922,-0.0242182716563754,-0.00460203915295848,0.00398765387847439
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,37165,-0.027315349782901,0.00948889487433631,-0.0459135837366002,-0.00871711582920186,0.00399998567772504
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ISM1,Isthmin-1,39862,0.0102100690633584,0.00355529093058714,0.00324169883940757,0.0171784392873092,0.00408682772973536
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PLA2G2A,"Phospholipase A2, membrane associated",39822,-0.0139497459128403,0.00486278557327345,-0.0234808056364563,-0.00441868618922437,0.00412737099557822
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,AKR1B10,Aldo-keto reductase family 1 member B10,37035,0.0156063007071492,0.00544641272968405,0.00493133175696851,0.02628126965733,0.00417105600140728
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,HMCN2,Hemicentin-2,37096,0.014463647181876,0.00506412266833011,0.00453796675194894,0.024389327611803,0.00429545881418717
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TFRC,Transferrin receptor protein 1,39914,-0.00996402321435869,0.0034894766372604,-0.0168033974233891,-0.00312464900532831,0.00430311020629197
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GLRX,Glutaredoxin-1,39767,-0.0142705764752761,0.00500817691831428,-0.0240866032351721,-0.0044545497153801,0.00438503942753249
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PILRB,Paired immunoglobulin-like type 2 receptor beta,39864,-0.01443635622306,0.00506887991586089,-0.0243713608581474,-0.00450135158797267,0.0044045894699795
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PARD3,Partitioning defective 3 homolog,37165,-0.0187368188301923,0.00660690295299602,-0.0316863486180645,-0.00578728904232008,0.00457591548099743
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PAK4,Serine/threonine-protein kinase PAK 4,39485,-0.0155492462954191,0.00549582818684945,-0.026321069541644,-0.00477742304919421,0.00467120557103608
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,C2CD2L,Phospholipid transfer protein C2CD2L,39449,-0.0105587418591753,0.00373508226640414,-0.0178795031013274,-0.00323798061702321,0.00470593616088744
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SLC27A4,Long-chain fatty acid transport protein 4,39485,-0.0170259996076794,0.00604354726062846,-0.0288713522385112,-0.00518064697684763,0.00485021756669014
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SMPD3,Sphingomyelin phosphodiesterase 3,37052,-0.0150601603117917,0.00535180556016723,-0.0255496992097195,-0.00457062141386392,0.00489965376065961
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NPPC,C-type natriuretic peptide,39862,-0.0114598555525007,0.00407525878667552,-0.0194473627743847,-0.00347234833061668,0.00492858554573395
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DMP1,Dentin matrix acidic phosphoprotein 1,37039,-0.0151248928037877,0.00538239479671688,-0.0256743866053528,-0.00457539900222266,0.00496041183555018
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,COL9A2,Collagen alpha-2(IX) chain,37165,-0.0115753924565095,0.00412007373292466,-0.0196507369730418,-0.00350004793997714,0.00496892167989893
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SLIRP,"SRA stem-loop-interacting RNA-binding protein, mitochondrial",36958,-0.0141858594903804,0.00505820835603615,-0.0240999478682112,-0.00427177111254951,0.00504653666908395
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PPBP,Platelet basic protein,37367,-0.0212089260566985,0.007566666790608,-0.0360395929662901,-0.0063782591471068,0.00507109843232159
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,JPT2,Jupiter microtubule associated homolog 2,37378,-0.0220187671358605,0.00786244117329964,-0.0374291518355278,-0.00660838243619321,0.00510959213930951
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PALLD,Palladin,37052,-0.0101473377767968,0.00362624864204729,-0.0172547851152095,-0.0030398904383841,0.00514466139014188
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,EP300,Histone acetyltransferase p300,37052,-0.00735730354679125,0.00263456846325967,-0.0125210577347802,-0.00219354935880231,0.00523611158108399
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CD40LG,CD40 ligand,40054,-0.019348248346164,0.00694115703030416,-0.0329529161255601,-0.00574358056676779,0.00531837035847922
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FYB1,FYN-binding protein 1,39832,-0.0227968180749099,0.00818034152913792,-0.0388302874720203,-0.00676334867779962,0.00532973159401902
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,RAPGEF2,Rap guanine nucleotide exchange factor 2,37165,-0.0133404737164625,0.00478928779407026,-0.0227274777928402,-0.00395346964008478,0.0053523852007676
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,RPA2,Replication protein A 32 kDa subunit,37052,-0.0079186015791365,0.00284290778978658,-0.0134907008471182,-0.0023465023111548,0.00535399496900815
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ZNF830,Zinc finger protein 830,37364,0.019971957190128,0.00717795343578818,0.00590316845598317,0.0340407459242728,0.00540329371960837
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CD101,Immunoglobulin superfamily member 2,37378,-0.0104394915131005,0.00375198490366183,-0.0177933819242777,-0.00308560110192327,0.00540347003767346
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,RIDA,2-iminobutanoate/2-iminopropanoate deaminase,37120,-0.0121391890166759,0.00436590817473276,-0.0206963690391521,-0.00358200899419973,0.00543601764885722
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,BDNF,Brain-derived neurotrophic factor,37433,-0.0204051693288194,0.00734345136327699,-0.0347983340008423,-0.00601200465679651,0.00546537241067696
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GALNT3,Polypeptide N-acetylgalactosaminyltransferase 3,39583,-0.0104558165004702,0.00376793702271572,-0.017840973064993,-0.00307065993594734,0.00552762972437799
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,LEP,Leptin,39864,-0.0167547523985139,0.00604997776251058,-0.0286127088130346,-0.00489679598399316,0.00562259114809947
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,INHBC,Inhibin beta C chain,39854,0.010230792520252,0.00369650734088984,0.00298563813210787,0.0174759469083961,0.00565197500474226
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PPM1A,Protein phosphatase 1A,39473,-0.00753291534882106,0.00272628254966787,-0.0128764291461701,-0.00218940155147203,0.00573271478531812
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TNR,Tenascin-R,39745,-0.010320872673818,0.00374055204154809,-0.0176523546752523,-0.00298939067238379,0.00580121768649247
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FOLR1,Folate receptor alpha,39805,-0.00674749879816511,0.00244563682072531,-0.0115409469667867,-0.00195405062954349,0.0058045605724542
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,COX6B1,Cytochrome c oxidase subunit 6B1,37433,-0.00786088509646921,0.00284947297261776,-0.0134458521228,-0.0022759180701384,0.00581067496833587
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,KLRK1,NKG2-D type II integral membrane protein,37384,-0.0109025636670875,0.00395222157851651,-0.0186489179609799,-0.00315620937319514,0.00581291125193099
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,LPL,Lipoprotein lipase,39864,0.01163421330873,0.00421945749694818,0.00336407661471157,0.0199043500027484,0.00583510141543182
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,COL24A1,Collagen alpha-1(XXIV) chain,37378,-0.0135899001155997,0.00493112464230878,-0.0232549044145249,-0.00392489581667445,0.00586015397024431
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,KIRREL1,Kin of IRRE-like protein 1,36987,-0.0148079272171537,0.00537499780614552,-0.0253429229171989,-0.00427293151710844,0.00587794153989956
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PCDHB15,Protocadherin beta-15,37364,0.00973949079982958,0.00353962563088667,0.0028018245632917,0.0166771570363675,0.00593913212247748
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IRAK4,Interleukin-1 receptor-associated kinase 4,39862,-0.0257089051679074,0.0093453650482192,-0.0440258206624171,-0.00739198967339779,0.00594842189791928
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SEL1L,Protein sel-1 homolog 1,37039,-0.00765859206962096,0.00278508584942359,-0.0131173603344912,-0.00219982380475072,0.00597022826159213
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SPARC,SPARC,39909,-0.0173043992893941,0.0062949172496743,-0.0296424370987557,-0.00496636148003249,0.00598537457042317
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ELOB,Elongin-B,37017,-0.00961687401980937,0.00350332163619598,-0.0164833844267535,-0.00275036361286525,0.00605795181752776
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,S100G,Protein S100-G,37408,-0.0109812393154776,0.00400171649611478,-0.0188246036478625,-0.00313787498309259,0.00607509489899632
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PPP1R14D,Protein phosphatase 1 regulatory subunit 14D,37408,-0.00896931482583753,0.00327609749614489,-0.0153904659182815,-0.00254816373339354,0.00619315510019488
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,STX1B,Syntaxin-1B,37035,-0.0104104139617861,0.00380277770991421,-0.017863858273218,-0.00295696965035429,0.00619758376599017
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,37017,-0.00894578555719649,0.00327186624687152,-0.0153586434010647,-0.0025329277133283,0.00626244879321213
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MARS1,"Methionine--tRNA ligase, cytoplasmic",37084,-0.0210541166152091,0.00770081377559954,-0.0361477116153842,-0.00596052161503398,0.00626510417873641
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TDRKH,Tudor and KH domain-containing protein,39485,-0.0208205686175541,0.0076173269148216,-0.0357505293706045,-0.00589060786450376,0.00627705163054064
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SYTL4,Synaptotagmin-like protein 4,37433,-0.0175729499228736,0.00643308280499251,-0.0301817922206589,-0.00496410762508826,0.0063098924032567
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,HTR1A,5-hydroxytryptamine receptor 1A,36987,-0.0184894499274215,0.0067694331170727,-0.031757538836884,-0.00522136101795899,0.00631665344281371
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NID2,Nidogen-2,39854,-0.0176895202541308,0.00648035899219363,-0.0303910238788303,-0.0049880166294313,0.00634588309581301
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ARAF,Serine/threonine-protein kinase A-Raf,37165,-0.0163113741168593,0.00597785713366726,-0.0280279740988471,-0.00459477413487148,0.00636810949326501
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PRSS27,Serine protease 27,39814,-0.00978055643465835,0.00358535986962509,-0.0168078617791235,-0.00275325109019318,0.00638057952326569
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,WIF1,Wnt inhibitory factor 1,40026,-0.00814892139350642,0.00298914129383073,-0.0140076383294147,-0.00229020445759819,0.00641421020461803
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CDH3,Cadherin-3,40005,-0.00840496248672735,0.00308829922758831,-0.0144580289728004,-0.00235189600065426,0.00650461113867333
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CPQ,Carboxypeptidase Q,37426,0.00914333989962437,0.00336001048267133,0.00255771935358856,0.0157289604456602,0.00651237069742497
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PCDH7,Protocadherin-7,37378,-0.00812219871676757,0.0029905700886439,-0.0139837160905096,-0.00226068134302554,0.00661725831581197
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,JAM3,Junctional adhesion molecule C,37120,-0.0122513478253785,0.00451172211057065,-0.021094323162097,-0.00340837248866004,0.00662718370997048
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FOXJ3,Forkhead box protein J3,37052,-0.0108483091165257,0.00399597892693636,-0.018680427813321,-0.00301619041973046,0.00664007768045702
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,LSM1,U6 snRNA-associated Sm-like protein LSm1,39473,-0.0132397837139352,0.00488179463010765,-0.0228081011889462,-0.00367146623892421,0.0066937063942569
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PLIN1,Perilipin-1,39485,-0.00838053903178383,0.00309164247109731,-0.0144401582751345,-0.00232091978843311,0.00672131092727223
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NAPRT,Nicotinate phosphoribosyltransferase,37384,-0.00788699703847156,0.00290979659810253,-0.0135901983707525,-0.0021837957061906,0.00672670591273447
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CEP170,Centrosomal protein of 170 kDa,37039,-0.0185949851572571,0.00686141353381184,-0.0320433556835283,-0.00514661463098585,0.00673538455737003
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SV2A,Synaptic vesicle glycoprotein 2A,37035,-0.0148853656599767,0.00549631977726932,-0.0256581524234245,-0.0041125788965288,0.00677279475673584
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SIRPA,Tyrosine-protein phosphatase non-receptor type substrate 1,39873,-0.0137901491712008,0.00509237967938189,-0.0237712133427893,-0.00380908499961225,0.00677624984433645
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,F7,Coagulation factor VII,39895,-0.007228137473483,0.00267024408072439,-0.0124618158717028,-0.00199445907526319,0.00679824991666474
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SLITRK2,SLIT and NTRK-like protein 2,40026,-0.00931193323870966,0.00344325635773271,-0.0160607156998658,-0.00256315077755356,0.00685000442596608
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CDC42BPB,Serine/threonine-protein kinase MRCK beta,37378,-0.0246507786002881,0.0091197528149578,-0.0425254941176054,-0.00677606308297078,0.00688006435065148
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,LEO1,RNA polymerase-associated protein LEO1,37408,-0.00672101598809335,0.00249195966197866,-0.0116052569255715,-0.00183677505061518,0.00700368729212422
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MYO6,Unconventional myosin-VI,37408,-0.00916638767740736,0.00339913463449611,-0.0158286915610197,-0.00250408379379498,0.00701205480126841
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,EBI3_IL27,Interleukin-27,40007,-0.00740040570597097,0.0027458513690844,-0.0127822743893764,-0.00201853702256554,0.00704356020286918
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NFKBIE,NF-kappa-B inhibitor epsilon,39473,-0.0118430564124091,0.00440239189529429,-0.020471744527186,-0.00321436829763233,0.00714977204186962
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PRTFDC1,Phosphoribosyltransferase domain-containing protein 1,39485,-0.02708065396063,0.0100691631976422,-0.0468162138280088,-0.00734509409325115,0.00716428070487986
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IL1RL1,Interleukin-1 receptor-like 1,39998,0.0112161883012355,0.00417780541703062,0.00302768968385549,0.0194046869186155,0.00726673142734972
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,LAMP2,Lysosome-associated membrane glycoprotein 2,39379,-0.00461249096002087,0.00171980186688582,-0.00798330261911708,-0.00124167930092465,0.00732631626296491
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GFOD2,Glucose-fructose oxidoreductase domain-containing protein 2,39473,-0.030356563225074,0.0113306895919203,-0.0525647148252377,-0.00814841162491019,0.0073887722069461
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,EVI5,Ecotropic viral integration site 5 protein homolog,37052,-0.0217372026084354,0.00811505849283297,-0.037642717254388,-0.00583168796248279,0.00740166562822411
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PTP4A3,Protein tyrosine phosphatase type IVA 3,37052,-0.0123317974030114,0.00460421698462533,-0.021356062692877,-0.00330753211314571,0.00740730793737408
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,BRD3,Bromodomain-containing protein 3,37017,-0.0110774958755299,0.00413855671705303,-0.0191890670409538,-0.00296592471010598,0.0074452942661949
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SSNA1,Sjoegren syndrome nuclear autoantigen 1,37378,-0.0120078032145226,0.0044988009436821,-0.0208254530641395,-0.00319015336490565,0.00761429353045399
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,RASSF2,Ras association domain-containing protein 2,39473,-0.0131206267422821,0.00491905589812595,-0.022761976302609,-0.00347927718195528,0.00765409182795653
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,LDLRAP1,Low density lipoprotein receptor adapter protein 1,37408,-0.0231769633111267,0.00870787697707925,-0.040244402186202,-0.00610952443605131,0.00778599147348485
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GNPDA2,Glucosamine-6-phosphate isomerase 2,37120,-0.00876036295332761,0.00329830682472044,-0.0152250443297797,-0.00229568157687554,0.00791639413491143
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TPSG1,Tryptase gamma,37052,-0.00635384877001602,0.00239486353084959,-0.0110477812904812,-0.00165991624955082,0.00798481826691896
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GART,Trifunctional purine biosynthetic protein adenosine-3,37408,-0.00631585845144693,0.0023819869364152,-0.0109845528468207,-0.00164716405607314,0.00802263719520882
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,RANGAP1,Ran GTPase-activating protein 1,39473,-0.0117143154585021,0.00441997234105105,-0.0203774612469622,-0.00305116967004205,0.00804980243541194
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SRP14,Signal recognition particle 14 kDa protein,39784,-0.0141167813431631,0.00533101039160668,-0.0245655617107122,-0.00366800097561403,0.00810373684583652
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,WAS,Wiskott-Aldrich syndrome protein,39583,-0.0159048815447666,0.00602341622529922,-0.0277107773463531,-0.00409898574318016,0.00828635130351328
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,HDDC2,5'-deoxynucleotidase HDDC2,37378,-0.0101577406431799,0.00384956490723341,-0.0177028878613573,-0.00261259342500239,0.00833267831200526
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ATP6V1F,V-type proton ATPase subunit F,39449,-0.0155486022507429,0.00590848392423947,-0.0271292307422522,-0.00396797375923351,0.00850744722661278
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,OTOA,Otoancorin,36987,-0.0124382050065769,0.00472810939368417,-0.0217052994181979,-0.00317111059495591,0.0085310443910245
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,LAYN,Layilin,39709,-0.00755003744978224,0.00287484602726287,-0.0131847356632175,-0.00191533923634702,0.00864167598192691
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CHP1,Calcineurin B homologous protein 1,36987,-0.0170026724081121,0.00647695202675921,-0.0296974983805602,-0.00430784643566406,0.0086722909662763
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FCAR,Immunoglobulin alpha Fc receptor,39862,-0.0109408936879522,0.00417187910292233,-0.01911777672968,-0.00276401064622444,0.00873613145857675
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PIKFYVE,1-phosphatidylinositol 3-phosphate 5-kinase,37052,-0.013385412158702,0.00511212126623856,-0.0234051698405296,-0.00336565447687445,0.00884525618790948
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PTK7,Inactive tyrosine-protein kinase 7,39485,-0.00899074821869067,0.00343499223889063,-0.0157233330069163,-0.00225816343046503,0.0088687850166215
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MEPE,Matrix extracellular phosphoglycoprotein,39858,-0.00576310767878474,0.00220273246488158,-0.0100804633099526,-0.00144575204761685,0.00889602690798548
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,HIF1A,Hypoxia-inducible factor 1-alpha,37052,-0.015890569419501,0.00608812987953673,-0.027823303983393,-0.00395783485560898,0.00906205760505207
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CEACAM20,Carcinoembryonic antigen-related cell adhesion molecule 20,37165,0.0100716101409806,0.00386220262166915,0.0025016930025091,0.0176415272794522,0.0091244634266919
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FABP1,"Fatty acid-binding protein, liver",39858,-0.0217976293505417,0.00835914572528497,-0.0381815549721003,-0.00541370372898321,0.00912538671172749
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,A1BG,Alpha-1B-glycoprotein,37449,-0.00396474150439871,0.00152075455685367,-0.0069454204358319,-0.000984062572965517,0.00914155487547629
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NFE2,Transcription factor NF-E2 45 kDa subunit,37039,-0.0172758850113708,0.00662931151428644,-0.0302693355793722,-0.00428243444336935,0.00917135649999943
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,RCOR1,REST corepressor 1,39581,-0.010466304394186,0.00401636878599853,-0.0183383872147431,-0.00259422157362889,0.00917163308772345
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MAP2K6,Dual specificity mitogen-activated protein kinase kinase 6,39862,-0.0234030216316538,0.00898149892801579,-0.0410067595305647,-0.00579928373274284,0.00917737123163659
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IL33,Interleukin-33,39583,-0.00910658735735789,0.00349577709157551,-0.0159583104568459,-0.0022548642578699,0.00919539982730842
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ANXA2,Annexin A2,36875,-0.0161353397628152,0.00619677154292022,-0.0282810119869388,-0.00398966753869154,0.00922931506675365
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GUK1,Guanylate kinase,37017,-0.00962219983925197,0.00369609763627383,-0.0168665512063487,-0.00237784847215528,0.00924239072681693
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,EDF1,Endothelial differentiation-related factor 1,37408,-0.0159653966581932,0.00613680782665374,-0.0279935399984345,-0.00393725331795185,0.00928963289610602
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,BAG6,Large proline-rich protein BAG6,39581,-0.00857884371267962,0.00330359088455064,-0.0150538818463989,-0.00210380557896037,0.00941777587077958
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,RANBP1,Ran-specific GTPase-activating protein,37039,-0.0120538961179385,0.00465004895056263,-0.0211679920610412,-0.0029398001748357,0.00954672267058981
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,RBP1,Retinol-binding protein 1,37035,-0.0162935791403921,0.00628563420646447,-0.0286134221850625,-0.00397373609572173,0.00954714454237403
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PDZD2,PDZ domain-containing protein 2,37017,-0.0138589089784957,0.00535220917024219,-0.0243492389521704,-0.00336857900482097,0.0096254520708577
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FOXO1,Forkhead box protein O1,39862,-0.0198484459888932,0.00766733392290402,-0.0348764204777851,-0.00482047150000135,0.00964254501375377
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SHMT1,"Serine hydroxymethyltransferase, cytosolic",39904,-0.0200873117435402,0.00776170314503292,-0.0353002499078047,-0.00487437357927563,0.00966211255728956
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,YJU2,Splicing factor YJU2,37364,-0.00748500051250132,0.00289316772411755,-0.0131556092517717,-0.00181439177323091,0.00968826397907967
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ZHX2,Zinc fingers and homeoboxes protein 2,37384,-0.00717334033507047,0.00277306816845163,-0.0126085539452357,-0.00173812672490527,0.00969785068541124
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FOXO3,Forkhead box protein O3,39473,-0.0225520507772207,0.00872040255341959,-0.0396440397819231,-0.00546006177251833,0.00971514032852002
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,KLK4,Kallikrein-4,40026,-0.0138772983923129,0.00536732432264458,-0.0243972540646963,-0.00335734271992951,0.00973202809766403
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CASP3,Caspase-3,40048,-0.0205198594230225,0.00793694435326641,-0.0360762703554246,-0.0049634484906203,0.00973639210327565
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SUMF1,Formylglycine-generating enzyme,37052,-0.0157332288681222,0.00608641623731425,-0.0276626046932581,-0.00380385304298625,0.00974926054290984
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,YOD1,Ubiquitin thioesterase OTU1,37017,-0.0141305719244797,0.00547197114549637,-0.0248556353696526,-0.00340550847930679,0.00982356207385159
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,RBKS,Ribokinase,39500,-0.0113973705852608,0.00441598777920022,-0.0200527066324932,-0.00274203453802837,0.00986238002850137
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PF4,Platelet factor 4,37381,-0.0221755313096751,0.00859705687114728,-0.0390257627771238,-0.00532529984222645,0.00990672912545164
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ITGB1BP1,Integrin beta-1-binding protein 1,39473,-0.00934549535082428,0.00362341994469357,-0.0164473984424237,-0.00224359225922488,0.00991223790360054
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DGKZ,Diacylglycerol kinase zeta,39583,-0.00828698174048865,0.00321470886526535,-0.0145878111164087,-0.00198615236456856,0.00995122846170219
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,LYSMD3,LysM and putative peptidoglycan-binding domain-containing protein 3,37035,-0.023135664394936,0.00897626096812315,-0.0407291358924574,-0.00554219289741466,0.00996463614296042
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NELL1,Protein kinase C-binding protein NELL1,39909,-0.0093935584719474,0.00364564128182512,-0.0165390153843246,-0.00224810155957016,0.00998500738091209
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SCPEP1,Retinoid-inducible serine carboxypeptidase,36991,-0.0116535661528882,0.00452593472423213,-0.0205243982123832,-0.00278273409339324,0.0100394395905085
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,C2orf69,UPF0565 protein C2orf69,37035,-0.0134499031138911,0.00522985603062157,-0.0237004209339093,-0.00319938529387278,0.0101293373479416
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,VSNL1,Visinin-like protein 1,37384,-0.00864083732675886,0.0033632163294338,-0.0152327413324491,-0.00204893332106861,0.0102034402271863
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ITPA,Inosine triphosphate pyrophosphatase,37017,-0.0155384785285551,0.00604907356002103,-0.0273946627061964,-0.00368229435091393,0.0102179169196622
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SSBP1,"Single-stranded DNA-binding protein, mitochondrial",37052,-0.00809308434905277,0.00315308278576909,-0.0142731266091602,-0.00191304208894536,0.0102774422080548
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,RABGAP1L,Rab GTPase-activating protein 1-like,39583,-0.0136539980151039,0.00532171945779555,-0.0240845681523832,-0.00322342787782462,0.0103056196416644
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CIT,Citron Rho-interacting kinase,37035,-0.0103998558302175,0.00405557192129533,-0.0183487767959564,-0.0024509348644787,0.0103482748998905
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FCRLB,Fc receptor-like B,39473,-0.0132486320645631,0.00516676413156769,-0.0233754897624358,-0.00312177436669046,0.0103505734957037
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TNN,Tenascin-N,37433,-0.00979919567078413,0.00382363334062833,-0.0172935170184157,-0.00230487432315261,0.0103939619196171
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IQGAP2,Ras GTPase-activating-like protein IQGAP2,39784,-0.0125154902735203,0.00488905821283886,-0.0220980443706845,-0.00293293617635613,0.0104794360838525
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NPTX1,Neuronal pentraxin-1,39854,-0.00932268968674823,0.00364221699709543,-0.0164614350010553,-0.00218394437244119,0.0104877924867091
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IRAK1,Interleukin-1 receptor-associated kinase 1,39583,-0.0160733444888205,0.00628989888404459,-0.0284015463015479,-0.00374514267609311,0.0106152457353116
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PLXNB2,Plexin-B2,39980,-0.00537836912499678,0.00210484884572239,-0.00950387286261267,-0.00125286538738089,0.0106209187398547
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,BGLAP,Osteocalcin,37433,-0.0196191745477896,0.0076959241242721,-0.0347031858313629,-0.00453516326421629,0.0108050222060169
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,RBP2,Retinol-binding protein 2,39784,-0.0173950408170238,0.00682845107203415,-0.0307788049182108,-0.00401127671583689,0.0108610987580594
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,HSPB6,Heat shock protein beta-6,40026,-0.00850884204700432,0.00334395712998574,-0.0150629980217764,-0.00195468607223227,0.0109513070731878
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ADGRB3,Adhesion G protein-coupled receptor B3,39716,-0.00748924191747099,0.00294434718327125,-0.0132601623966826,-0.00171832143825935,0.0109810704356632
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,B3GAT3,Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase 3,37017,-0.00457461749773999,0.0017992870851663,-0.00810122018466593,-0.00104801481081405,0.0110188440555778
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,EGFL7,Epidermal growth factor-like protein 7,39473,-0.00894942811140761,0.00352012649057255,-0.0158488760329298,-0.00204998018988541,0.0110202503436951
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,LRRN1,Leucine-rich repeat neuronal protein 1,39583,-0.00887499136312729,0.00349261066801987,-0.0157205082724462,-0.00202947445380834,0.0110606945024265
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,KLHL41,Kelch-like protein 41,37408,0.0115692074440025,0.00455287427534014,0.00264557386433577,0.0204928410236691,0.0110621892273975
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GC,Vitamin D-binding protein,37449,-0.00583574616293109,0.00230061462188933,-0.0103449508218342,-0.001326541504028,0.0112044715928978
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,UNC79,Protein unc-79 homolog,36958,-0.0127580554060485,0.00503424973904361,-0.0226251848945739,-0.00289092591752299,0.0112803282813073
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CNP,"2',3'-cyclic-nucleotide 3'-phosphodiesterase",37022,-0.0179567920595783,0.00709835720086798,-0.0318695721732795,-0.00404401194587707,0.0114272211915672
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,RAB6A,Ras-related protein Rab-6A,39862,0.0104375434048859,0.00412663610750612,0.00234933663417393,0.0185257501755979,0.0114382130071349
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MYLPF,"Myosin regulatory light chain 2, skeletal muscle isoform",37035,0.010926583348933,0.00432109896583359,0.00245722937589912,0.0193959373219668,0.0114615147274751
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MTR,Methionine synthase,37017,-0.0145113801087282,0.00574556450651824,-0.025772686541504,-0.00325007367595249,0.0115595441626373
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PTTG1,Securin,37165,-0.00941297289240404,0.00372731244164532,-0.0167185052780289,-0.00210744050677921,0.0115680234837465
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PPME1,Protein phosphatase methylesterase 1,39784,-0.0135119273451502,0.00535104721295884,-0.0239999798825495,-0.00302387480775088,0.0115761752640216
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TG,Thyroglobulin,37364,-0.0244392237242957,0.00967857377505276,-0.0434092283233991,-0.00546921912519225,0.0115783747632315
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CNTN2,Contactin-2,40026,-0.00996215440716591,0.0039527055908988,-0.0177094573653276,-0.00221485144900427,0.0117337638558044
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SMARCA2,Probable global transcription activator SNF2L2,39485,-0.0165775259513479,0.00657859873713786,-0.0294715794761381,-0.0036834724265577,0.0117481187141042
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SUSD2,Sushi domain-containing protein 2,39854,-0.00632992396147331,0.00251264095281687,-0.0112547002289944,-0.00140514769395225,0.0117707990735593
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ENOPH1,Enolase-phosphatase E1,37364,-0.012510296697021,0.00497044500103664,-0.0222523688990528,-0.00276822449498919,0.0118494864815902
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FAM3B,Protein FAM3B,39784,0.00804840365317118,0.00320840771769665,0.00175992452648575,0.0143368827798566,0.0121331465373923
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TNFAIP2,Tumor necrosis factor alpha-induced protein 2,37378,-0.0106932671640385,0.00426458086365191,-0.0190518456567963,-0.00233468867128076,0.0121718541882923
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CNTN1,Contactin-1,40048,-0.00595972702806087,0.00237699462519723,-0.0106186364934474,-0.0013008175626743,0.0121770710197763
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DNAJC21,DnaJ homolog subfamily C member 21,37384,-0.00858475053330747,0.00342399365101178,-0.0152957780892906,-0.00187372297732439,0.0121796688968721
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,HBZ,Hemoglobin subunit zeta,37433,-0.023492930418887,0.00939008973756893,-0.0418975063045221,-0.00508835453325192,0.0123650574668299
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SNX5,Sorting nexin-5,37039,-0.00677556992187222,0.00270899341267765,-0.0120851970107204,-0.00146594283302402,0.0123914832171992
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,KLF4,Krueppel-like factor 4,36987,-0.00876862659947806,0.00352082767008209,-0.015669448832839,-0.00186780436611717,0.0127685613785623
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DAPK2,Death-associated protein kinase 2,37052,-0.0117520486115655,0.00474242975655609,-0.0210472109344154,-0.00245688628871556,0.0132221301926063
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PCDH12,Protocadherin-12,37408,0.00558164325015604,0.00225399288138614,0.00116381720263921,0.00999946929767287,0.0132859872724065
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PBLD,Phenazine biosynthesis-like domain-containing protein,39485,-0.0113862645632822,0.0046056422582163,-0.0204133233893862,-0.00235920573717829,0.0134374083343891
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PRKAR2A,cAMP-dependent protein kinase type II-alpha regulatory subunit,37362,-0.0180333150404104,0.00730258289321269,-0.0323463775111072,-0.0037202525697135,0.0135446201773684
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,COMMD1,COMM domain-containing protein 1,37039,-0.0136114562203591,0.00551330461853738,-0.0244175332726923,-0.0028053791680258,0.0135678437271329
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PGR,Progesterone receptor,37052,-0.0230827485926014,0.0093515816009948,-0.0414118485305512,-0.00475364865465156,0.0135872619001864
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SPINT2,Kunitz-type protease inhibitor 2,39927,-0.00905261877365674,0.00366789783440433,-0.0162416985290892,-0.00186353901822425,0.0135948134143881
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SPINK6,Serine protease inhibitor Kazal-type 6,40026,-0.0118863802329872,0.00482197450908598,-0.0213374502707957,-0.00243531019517868,0.0137099511961808
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PCNA,Proliferating cell nuclear antigen,36958,-0.0140309706196219,0.00569687930493866,-0.0251968540573017,-0.00286508718194215,0.0137937499217204
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GABARAP,Gamma-aminobutyric acid receptor-associated protein,37364,-0.0106854264052908,0.00435126704713782,-0.019213909817681,-0.0021569429929007,0.0140733763008773
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SEPTIN7,Septin-7,37165,-0.0112521738839342,0.00458340093516117,-0.0202356397168501,-0.00226870805101834,0.0141018099243496
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,VTA1,Vacuolar protein sorting-associated protein VTA1 homolog,40005,-0.015511798041651,0.00632373133732,-0.0279063114627982,-0.00311728462050376,0.0141794949183203
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,HJV,Hemojuvelin,37408,0.00967621882203461,0.00395339908453383,0.0019275566163483,0.0174248810277209,0.0143949436582545
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PHYKPL,5-phosphohydroxy-L-lysine phospho-lyase,37120,-0.00918804523729242,0.00375838907720026,-0.0165544878286049,-0.00182160264597992,0.0145111413427681
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CDH2,Cadherin-2,39864,-0.00765836866942996,0.00313292755271491,-0.0137989066727512,-0.00151783066610874,0.0145169546987383
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,VSTM2B,V-set and transmembrane domain-containing protein 2B,37165,-0.00905669829885696,0.00370676014051415,-0.0163219481742647,-0.00179144842344923,0.0145668535069253
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CA2,Carbonic anhydrase 2,39817,-0.0147833073041943,0.00605261933863187,-0.0266464412079127,-0.00292017340047579,0.0145981414139342
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,POMC,Pro-opiomelanocortin,37039,-0.0154073500465286,0.00631203664551936,-0.0277789418717466,-0.0030357582213107,0.0146618554273635
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PDLIM5,PDZ and LIM domain protein 5,37408,-0.025994095300441,0.0106680929993735,-0.0469035575792131,-0.00508463302166895,0.01483801265304
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MKI67,Proliferation marker protein Ki-67,37052,-0.00852123128190788,0.0034982506741703,-0.0153778026032817,-0.00166465996053409,0.014869786590364
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,KIAA2013,Uncharacterized protein KIAA2013,37364,-0.0124340889078433,0.00510548694273282,-0.0224408433155997,-0.00242733450008699,0.0148866877354045
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IKZF2,Zinc finger protein Helios,39473,-0.0204420402133574,0.0083953127608588,-0.0368968532246407,-0.00398722720207421,0.014905589616754
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,RYR1,Ryanodine receptor 1,37017,-0.00734349804779978,0.0030194739114152,-0.0132616669141736,-0.00142532918142599,0.0150270677256205
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,POLR2A,DNA-directed RNA polymerase II subunit RPB1,37052,-0.00643974452899997,0.00265132471644652,-0.0116363409732352,-0.00124314808476479,0.0151588919056475
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,L1CAM,Neural cell adhesion molecule L1,39909,0.0061973085480126,0.00255203882954938,0.00119531244209581,0.0111993046539294,0.0151775447264122
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SOX9,Transcription factor SOX-9,37035,-0.00586811303080823,0.00241789745132703,-0.0106071920354092,-0.00112903402620726,0.0152397283614474
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CRISP3,Cysteine-rich secretory protein 3,37321,-0.00580084076131524,0.00239383178267371,-0.0104927510553557,-0.00110893046727476,0.0153956500387722
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,BRD1,Bromodomain-containing protein 1,37165,0.00666036604029493,0.00274857804056099,0.00127315308079539,0.0120475789997945,0.015397526884467
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,LYAR,Cell growth-regulating nucleolar protein,39473,-0.0111450555321934,0.00460300115157787,-0.0201669377892861,-0.00212317327510082,0.01547819812969
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CCER2,Coiled-coil domain-containing glutamate-rich protein 2,37039,-0.0131318944010922,0.00542432507922208,-0.0237635715563674,-0.00250021724581689,0.0154944107262685
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ACE,Angiotensin-converting enzyme,37441,0.00552688195514691,0.0022838523163674,0.00105053141506681,0.010003232495227,0.0155343054668731
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DYNLT1,Dynein light chain Tctex-type 1,37035,-0.0172778061230185,0.00715028398694455,-0.0312923627374299,-0.00326324950860723,0.0156891783108539
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CMIP,C-Maf-inducing protein,37364,-0.0178488260213882,0.00738969773446132,-0.0323326335809324,-0.00336501846184402,0.0157325891169562
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,RABEP1,Rab GTPase-binding effector protein 1,37120,-0.0167752447727603,0.00694819202293229,-0.0303937011377076,-0.00315678840781304,0.015777528295638
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CHCHD6,MICOS complex subunit MIC25,37364,-0.00623350277691582,0.00258849779779358,-0.0113069584605912,-0.00116004709324041,0.0160467065145967
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TPMT,Thiopurine S-methyltransferase,39473,-0.0156239930462423,0.00649716652866979,-0.0283584394424351,-0.00288954665004951,0.0161955639464224
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GOT1,"Aspartate aminotransferase, cytoplasmic",37433,-0.00901618504095812,0.00375150013270896,-0.0163691253010677,-0.00166324478084855,0.0162587556560175
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IGHMBP2,DNA-binding protein SMUBP-2,37017,-0.0120792525809474,0.00502802478501771,-0.0219341811595821,-0.00222432400231268,0.0163023115592725
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PSMD1,26S proteasome non-ATPase regulatory subunit 1,37408,-0.0103264388414165,0.00429925655987269,-0.018752981698767,-0.00189989598406602,0.0163229793191567
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,LGALS3BP,Galectin-3-binding protein,37449,-0.00644208652609864,0.00268275676764546,-0.0117002897906837,-0.00118388326151354,0.0163505731077372
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,RBFOX3,RNA binding protein fox-1 homolog 3,37408,-0.00791035850706629,0.00329630919234493,-0.0143711245240624,-0.00144959249007022,0.0164191364358453
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PNMA2,Paraneoplastic antigen Ma2,36987,0.00927458199965447,0.00387534009711292,0.00167891540931314,0.0168702485899958,0.0167147071883517
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PRG3,Proteoglycan 3,37433,-0.0106207137360368,0.00444561652140385,-0.0193341221179884,-0.00190730535408526,0.0169064702660485
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DDX39A,ATP-dependent RNA helicase DDX39A,37052,-0.00478704859646579,0.00200572640500222,-0.00871827235027014,-0.000855824842661441,0.0170147931353356
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SLC9A3R2,Na(+)/H(+) exchange regulatory cofactor NHE-RF2,37378,-0.0106931179640358,0.00448112867065274,-0.0194761301585152,-0.00191010576955646,0.017034596934596
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,KLRF1,Killer cell lectin-like receptor subfamily F member 1,37052,-0.00901656789856064,0.00378016648914941,-0.0164256942172935,-0.0016074415798278,0.0170824614631713
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,LACRT,Extracellular glycoprotein lacritin,37335,0.0102397068076432,0.00429740963032822,0.00181678393219992,0.0186626296830865,0.0171970528483371
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MTSS1,Protein MTSS 1,37378,0.0234162227698666,0.00982926197140517,0.00415086930591244,0.0426815762338207,0.0172187519844765
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,WDR46,WD repeat-containing protein 46,37364,-0.00765401581754977,0.00321342561832292,-0.0139523300294627,-0.00135570160563685,0.0172379600653673
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IGLON5,IgLON family member 5,36958,-0.0195724320653883,0.00821808827551744,-0.0356798850854025,-0.00346497904537415,0.017250479334725
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ACADM,"Medium-chain specific acyl-CoA dehydrogenase, mitochondrial",37165,-0.0149316774476731,0.00627518980593136,-0.0272310494672986,-0.00263230542804764,0.0173511808356295
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GAD2,Glutamate decarboxylase 2,37052,-0.00986863983313012,0.00414755184499767,-0.0179978414493255,-0.00173943821693469,0.0173554929098083
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,BGN,Biglycan,39444,0.0253327645795119,0.010647010675043,0.00446462365642759,0.0462009055025962,0.0173560508964283
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CD82,CD82 antigen,37165,-0.00893647793462292,0.00376420877406875,-0.0163143271317977,-0.00155862873744818,0.0176075399511202
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,BLOC1S3,Biogenesis of lysosome-related organelles complex 1 subunit 3,37384,-0.00871044806440371,0.00366912603406802,-0.015901935091177,-0.0015189610376304,0.0176111731568034
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NTRK2,BDNF/NT-3 growth factors receptor,39864,-0.00540925888912023,0.00228119836758351,-0.00988040768958392,-0.000938110088656548,0.0177404929897969
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,BOC,Brother of CDO,39581,-0.00496058003314516,0.00209330746491913,-0.00906346266438666,-0.000857697401903662,0.0178129324291977
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CST7,Cystatin-F,39878,-0.0195054276460753,0.00823325336793643,-0.0356426042472307,-0.00336825104491994,0.0178430626769276
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,XIAP,E3 ubiquitin-protein ligase XIAP,37052,-0.0123217098494293,0.00521843327926563,-0.0225498390767899,-0.00209358062206866,0.0182308748093554
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NRGN,Neurogranin,37441,-0.0192225925809439,0.0081679843312586,-0.0352318418702108,-0.00321334329167707,0.0186164282682079
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IFNG,Interferon gamma,39583,-0.0240172672556023,0.0102160186139487,-0.0440406637389418,-0.00399387077226285,0.018738231988963
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NECTIN2,Nectin-2,39842,-0.00591682750678041,0.00251888269508898,-0.0108538375891548,-0.000979817424406018,0.0188365766799211
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SEPTIN8,Septin-8,37353,-0.00665603272581111,0.0028374471743775,-0.012217429187591,-0.00109463626403122,0.0190016035760787
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DDX1,ATP-dependent RNA helicase DDX1,37378,0.0104374268376237,0.00445087242835299,0.00171371687805185,0.0191611367971956,0.0190399623475439
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SMAD2,Mothers against decapentaplegic homolog 2,37364,-0.0144791100350169,0.00617778923138104,-0.0265875769285238,-0.00237064314151011,0.0191060764703942
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IFIT1,Interferon-induced protein with tetratricopeptide repeats 1,37165,-0.0108945119106337,0.00465109852306836,-0.0200106650158476,-0.00177835880541968,0.0191772722554966
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",37120,-0.0218511375761218,0.00932931716529365,-0.0401365992200974,-0.00356567593214625,0.0191850930168043
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,HSP90B1,Endoplasmin,39401,-0.0140999057576279,0.00602223335962944,-0.0259034831425016,-0.00229632837275416,0.01922885230552
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SPINK8,Serine protease inhibitor Kazal-type 8,37017,-0.0077846872588039,0.00332906567860539,-0.0143096559888705,-0.00125971852873734,0.0193814031547864
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ENOX2,Ecto-NOX disulfide-thiol exchanger 2,37017,-0.0057637920976199,0.00246600562278524,-0.010597163118279,-0.000930421076960817,0.0194385665602624
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GLO1,Lactoylglutathione lyase,39581,-0.0120822613513574,0.00517023345940026,-0.0222159189317819,-0.00194860377093291,0.019457449123856
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SKIV2L,Helicase SKI2W,37017,-0.00839136284565252,0.0035915938202017,-0.0154308867332478,-0.00135183895805719,0.0194858718895714
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SIGLEC7,Sialic acid-binding Ig-like lectin 7,39864,-0.00585408691098414,0.00250680978280211,-0.0107674340852763,-0.000940739736692001,0.0195414199170938
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,WFDC1,WAP four-disulfide core domain protein 1,37119,-0.0109144314010842,0.00468120844295632,-0.0200895999492785,-0.00173926285288978,0.0197397307791471
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SIRT1,NAD-dependent protein deacetylase sirtuin-1,37052,-0.0186545390464732,0.00800288615538477,-0.0343401959110273,-0.00296888218191902,0.0197695902836275
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NEDD4L,E3 ubiquitin-protein ligase NEDD4-like,37052,-0.00995262199581884,0.00426985190828255,-0.0183215317360526,-0.00158371225558505,0.0197733238571928
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PODXL,Podocalyxin,39784,-0.00312886957703869,0.00134398913853033,-0.00576308828855813,-0.000494650865519247,0.0199220793310009
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PTPRM,Receptor-type tyrosine-protein phosphatase mu,39841,-0.00503818054089706,0.00216625033475099,-0.009284031197009,-0.000792329884785115,0.0200437523688588
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,VIPR1,Vasoactive intestinal polypeptide receptor 1,37039,0.00536929486182266,0.00231134394200856,0.000839060735485881,0.00989952898815945,0.0201932990540879
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,BCR,Breakpoint cluster region protein,39862,-0.0190385914794456,0.00819697727261792,-0.0351046669337768,-0.00297251602511452,0.0202112120240059
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,BMP4,Bone morphogenetic protein 4,39716,0.00951305808666644,0.00409747540453188,0.00148200629378396,0.0175441098795489,0.0202623657765142
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,F11R,Junctional adhesion molecule A,39854,-0.011704536112308,0.00504509013691178,-0.0215929127806551,-0.00181615944396089,0.0203541820651086
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,BECN1,Beclin-1,37039,-0.012486176747717,0.00538262987166513,-0.0230361312961807,-0.00193622219925335,0.0203714059785638
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GPHA2,Glycoprotein hormone alpha-2,37378,-0.0095214909596217,0.00414250021707518,-0.0176407913850891,-0.00140219053415434,0.0215491617112079
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NENF,Neudesin,37364,-0.0224794144416179,0.00978041108715316,-0.0416490201724381,-0.0033098087107977,0.0215535523076641
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DCTN1,Dynactin subunit 1,40026,-0.0133288249420459,0.00579994719615802,-0.0246967214465156,-0.00196092843757616,0.0215691324766668
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,KIRREL2,Kin of IRRE-like protein 2,39485,-0.00810368964573263,0.00353644064902085,-0.0150351133178135,-0.00117226597365177,0.0219488006712504
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ROBO4,Roundabout homolog 4,37039,0.00363371798013564,0.00158600255120463,0.000525152979774565,0.00674228298049672,0.0219723327202533
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,STX5,Syntaxin-5,37052,-0.00830135876423,0.00362538849749801,-0.0154071202193261,-0.00119559730913391,0.0220495200010706
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SPRED2,"Sprouty-related, EVH1 domain-containing protein 2",37052,-0.00928738519023288,0.00405894970553595,-0.0172429266130833,-0.00133184376738242,0.0221459729839679
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,VSIG2,V-set and immunoglobulin domain-containing protein 2,37364,0.010874359777628,0.00475358221415855,0.00155733863787727,0.0201913809173788,0.0221754156995867
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,AMOTL2,Angiomotin-like protein 2,37329,-0.00985766465901665,0.004312319678229,-0.0183098112283455,-0.00140551808968781,0.0222737604036674
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,RNASE1,Ribonuclease pancreatic,37441,-0.00454429110485065,0.00199453914854044,-0.00845358783598991,-0.000634994373711393,0.0227202114639946
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PI3,Elafin,39590,-0.010747161458934,0.00471944491235332,-0.0199972734871465,-0.00149704943072144,0.0227871238106116
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PPM1B,Protein phosphatase 1B,37052,-0.0129238796940536,0.00567622056196667,-0.0240492719955083,-0.00179848739259896,0.0228113687984005
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,EIF4G3,Eukaryotic translation initiation factor 4 gamma 3,37408,-0.0133368352990658,0.00585956986860728,-0.024821592241536,-0.00185207835659548,0.0228569052703339
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NBN,Nibrin,39583,-0.0104704529519517,0.00460331113126364,-0.0194929427692284,-0.00144796313467492,0.0229464564862544
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,AKAP12,A-kinase anchor protein 12,37120,-0.00427384164540436,0.00187974560610444,-0.00795814303336907,-0.000589540257439655,0.0230042972654859
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,EVI2B,Protein EVI2B,36958,-0.00832398757092789,0.00367464452527885,-0.0155262908404744,-0.00112168430138135,0.023513618514483
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CASP10,Caspase-10,39485,-0.0144502598904596,0.00638282575684858,-0.0269605983738828,-0.00193992140703634,0.0235921747370143
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CAT,Catalase,37248,-0.0106516915509065,0.00470669442589709,-0.0198768126256648,-0.00142657047614824,0.0236458454475476
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,WASF1,Wiskott-Aldrich syndrome protein family member 1,39581,-0.0190226984276275,0.00841594905059269,-0.0355179585667892,-0.0025274382884658,0.0238153085319872
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CD34,Hematopoietic progenitor cell antigen CD34,39941,-0.00483525787550499,0.00214238352457727,-0.00903432958367643,-0.000636186167333548,0.0240244052613512
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,LILRB5,Leukocyte immunoglobulin-like receptor subfamily B member 5,40048,-0.0140467170491412,0.00622427528324454,-0.0262462966043005,-0.00184713749398191,0.0240361361659265
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SERPINE2,Glia-derived nexin,37433,-0.0129678894412173,0.00574945229177617,-0.0242368159330986,-0.00169896294933604,0.0241178215314369
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SLIT2,Slit homolog 2 protein,39485,-0.0103944280528203,0.00460889561032502,-0.0194278634490573,-0.00136099265658322,0.0241284755207583
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,LGALS8,Galectin-8,40005,-0.0122908409786025,0.00545395890110006,-0.0229806004247586,-0.00160108153244636,0.0242370200706723
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CEND1,Cell cycle exit and neuronal differentiation protein 1,36987,-0.0118078357479372,0.00524052502269222,-0.0220792647924139,-0.00153640670346041,0.0242643638631621
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GIMAP8,GTPase IMAP family member 8,36958,-0.00994348504452354,0.00441660591770913,-0.0186000326432334,-0.00128693744581365,0.0243776000683422
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,EGF,Pro-epidermal growth factor,39804,-0.0207652655952555,0.00925679888511168,-0.0389085914100744,-0.00262193978043663,0.0248947110115348
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TMEM25,Transmembrane protein 25,37408,0.00894257283963412,0.00398657637692199,0.00112888314086702,0.0167562625384012,0.0249018800935802
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,HTRA2,"Serine protease HTRA2, mitochondrial",39909,-0.0122858654705384,0.00549103363868571,-0.0230482914023624,-0.00152343953871444,0.0252711806243136
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ERC2,ERC protein 2,37035,-0.015004834569086,0.00670897835458697,-0.0281544321440765,-0.00185523699409555,0.0253337102076217
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CAMSAP1,Calmodulin-regulated spectrin-associated protein 1,37408,-0.0212329409673744,0.00950489458256782,-0.0398625343492073,-0.00260334758554145,0.0255062043096747
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,INPP5J,"Phosphatidylinositol 4,5-bisphosphate 5-phosphatase A",37408,0.00828714309296637,0.0037147869757485,0.00100616062049931,0.0155681255654334,0.0257071822883487
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NLGN2,Neuroligin-2,36987,-0.00937055242966536,0.00420669440255318,-0.0176156734586696,-0.00112543140066113,0.0259285287494194
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CA5A,"Carbonic anhydrase 5A, mitochondrial",39581,-0.0181423286612978,0.00814639928207892,-0.0341092712541725,-0.00217538606842312,0.0259589393888417
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NDRG1,Protein NDRG1,39485,-0.0137524307633689,0.00618634067336492,-0.0258776584831641,-0.00162720304357364,0.0262279207607937
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ATXN3,Ataxin-3,37384,-0.0121310911092549,0.00545883843802237,-0.0228304144477787,-0.00143176777073104,0.0262805744114881
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,VWF,von Willebrand factor,40048,-0.0144792552708568,0.00651858204983579,-0.0272556760885349,-0.00170283445317867,0.0263493210930687
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CA9,Carbonic anhydrase 9,40026,0.00856855391918645,0.00386095541308803,0.00100108130953391,0.016136026528839,0.0264812831464219
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,RNF149,E3 ubiquitin-protein ligase RNF149,37039,-0.00581212960914375,0.00261942156021281,-0.0109461958671609,-0.000678063351126643,0.0265132219387307
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ADAMTSL4,ADAMTS-like protein 4,37039,0.00476774058846255,0.00215236733956103,0.000549100602922923,0.00898638057400218,0.0267692240836638
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MICALL2,MICAL-like protein 2,37035,-0.013486305991813,0.00609180223759658,-0.0254262383775023,-0.00154637360612368,0.0268565027530292
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TBC1D5,TBC1 domain family member 5,39862,-0.0153758136992665,0.00695002075744662,-0.0289978543838619,-0.0017537730146711,0.0269572012140935
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IGLC2,Immunoglobulin lambda constant 2,37418,-0.00480234549269751,0.00217091371899086,-0.00905733638191959,-0.000547354603475434,0.0269742230726506
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CTRB1,Chymotrypsinogen B,39854,-0.010528270734983,0.00476599634624944,-0.0198696235736319,-0.00118691789633413,0.0271860652855257
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SCRIB,Protein scribble homolog,37039,-0.0177085088266307,0.00802615795861943,-0.0334397784255248,-0.00197723922773667,0.0273767288932918
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ATP6V1D,V-type proton ATPase subunit D,39784,-0.00513055344306145,0.00232702200081392,-0.00969151656465673,-0.000569590321466166,0.0274843271204534
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SART1,U4/U6.U5 tri-snRNP-associated protein 1,37017,-0.00704075128944169,0.00319338459799589,-0.0132997851015136,-0.000781717477369749,0.0274858789774842
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SIGLEC9,Sialic acid-binding Ig-like lectin 9,39999,-0.00594983724600113,0.00269888788385883,-0.0112396574983644,-0.000660016993637815,0.0274996420586899
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,HSD11B1,Corticosteroid 11-beta-dehydrogenase isozyme 1,39862,-0.00763020093880963,0.00346194916458425,-0.0144156213013947,-0.000844780576224505,0.0275372094870842
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CD207,C-type lectin domain family 4 member K,39492,-0.00740989126704239,0.0033645265176895,-0.0140043632417138,-0.000815419292370963,0.0276545885404748
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TGFB2,Transforming growth factor beta-2 proprotein,37364,-0.0103118824482637,0.00468641880544166,-0.0194972633069294,-0.00112650158959805,0.0277971152389553
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SRC,Proto-oncogene tyrosine-protein kinase Src,39883,-0.0235703339808629,0.0107127947065715,-0.0445674116057431,-0.00257325635598277,0.0278066438778153
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CRYGD,Gamma-crystallin D,37384,-0.0188608227496475,0.00857442476920709,-0.0356666952972934,-0.00205495020200163,0.027847854972505
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FGFR4,Fibroblast growth factor receptor 4,37120,-0.0103279601164848,0.00470319846972505,-0.0195462291171459,-0.00110969111582373,0.028113213741817
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SORD,Sorbitol dehydrogenase,39959,-0.0134050785958054,0.00611191621145384,-0.0253844343702549,-0.00142572282135583,0.0283022281398437
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,S100P,Protein S100-P,39581,-0.0103197484094607,0.00470762844714286,-0.0195467001658607,-0.00109279665306073,0.0283845029267204
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TNXB,Tenascin-X,39854,0.00502521724113214,0.00229311711013585,0.000530707705265879,0.00951972677699841,0.0284346941659941
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DAND5,DAN domain family member 5,37052,-0.0104488371280265,0.00478046992765565,-0.0198185581862316,-0.00107911606982147,0.0288525691237664
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,YY1,Transcriptional repressor protein YY1,37052,-0.0053977610569628,0.00247195958335508,-0.0102428018403388,-0.000552720273586844,0.0290095039355434
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,XPNPEP2,Xaa-Pro aminopeptidase 2,39909,-0.0192905528194921,0.00883641187510214,-0.0366099200946923,-0.00197118554429188,0.0290447005082245
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ATXN2L,Ataxin-2-like protein,37408,-0.00933611425341186,0.00428105870127913,-0.017726989307919,-0.000945239198904761,0.0292156745294714
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ATP5PO,"ATP synthase subunit O, mitochondrial",39485,-0.00845950963668569,0.00389036815793755,-0.0160846312262433,-0.000834388047128084,0.0296844080010201
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,KLKB1,Plasma kallikrein,37183,-0.00484254149472244,0.00222719256047143,-0.00920783891324645,-0.000477244076198434,0.0297016111304944
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,HBQ1,Hemoglobin subunit theta-1,40026,-0.0116297150068429,0.00534989849528121,-0.022115516057594,-0.0011439139560917,0.029733136206329
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FLT3,Receptor-type tyrosine-protein kinase FLT3,39473,-0.00590918977016072,0.00272018071658882,-0.0112407439746748,-0.000577635565646641,0.0298441241857361
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CCNE1,G1/S-specific cyclin-E1,37052,-0.018501105509878,0.00851762279360676,-0.0351956461853472,-0.00180656483440871,0.0298660752738077
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,RNF5,E3 ubiquitin-protein ligase RNF5,37039,-0.0141720729446228,0.00654061389359599,-0.0269916761760709,-0.00135246971317467,0.03026947311567
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DARS1,"Aspartate--tRNA ligase, cytoplasmic",39709,-0.0141655395444622,0.00654095482152351,-0.0269858109946483,-0.0013452680942761,0.0303513961722812
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SPON1,Spondin-1,39881,-0.00615162189610086,0.00284372974871467,-0.0117253322035816,-0.000577911588620101,0.0305387634950174
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CTSC,Dipeptidyl peptidase 1,39852,0.00825998808979391,0.00381950501194488,0.000773758266381949,0.0157462179132059,0.0305882137278937
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CAPN3,Calpain-3,37364,0.00724952982152079,0.00335332441658447,0.000677013965015223,0.0138220456780264,0.03064390498019
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MAMDC2,MAM domain-containing protein 2,37433,-0.00634306059957959,0.00294305742632565,-0.0121114531551779,-0.00057466804398131,0.0311588450801602
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GLI2,Zinc finger protein GLI2,37052,-0.00659858675860701,0.0030628019682332,-0.0126016786163441,-0.000595494900869939,0.0312246594475851
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FGF19,Fibroblast growth factor 19,39927,-0.0146976187567999,0.00683015664413815,-0.0280847257793107,-0.00131051173428912,0.0314223375633502
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,HRG,Histidine-rich glycoprotein,37376,-0.00606501812477916,0.00281930972340645,-0.0115908651826558,-0.000539171066902515,0.0314747529756855
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CA1,Carbonic anhydrase 1,39527,-0.01137803203719,0.00529326974914633,-0.0217528407455168,-0.00100322332886322,0.0316078270365273
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IL22RA1,Interleukin-22 receptor subunit alpha-1,39583,0.00825152323109256,0.00384758849299255,0.000710249784827167,0.015792796677358,0.032000435362904
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NRN1,Neuritin,37408,0.00671492730821894,0.00313630630989937,0.000567766940816168,0.0128620876756217,0.0322893734633459
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,AFAP1,Actin filament-associated protein 1,37120,-0.0161768311636322,0.00756444615693421,-0.0310031456312233,-0.00135051669604114,0.0324915831936556
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CLEC1B,C-type lectin domain family 1 member B,40005,-0.0183425148466881,0.00858598144485833,-0.0351710384786105,-0.00151399121476583,0.0326672795241334
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,APOC1,Apolipoprotein C-I,37420,0.00711800892380172,0.00333470213488161,0.000581992739433757,0.0136540251081697,0.0328176147560769
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,VWA1,von Willebrand factor A domain-containing protein 1,40007,0.00812959336589292,0.00380893432655146,0.000664082085852064,0.0155951046459338,0.0328292791188027
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TSC1,Hamartin,37052,-0.0145142728039303,0.00680415647934235,-0.0278504195034412,-0.00117812610441925,0.0329309882575923
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ACP1,Low molecular weight phosphotyrosine protein phosphatase,37052,-0.00824218220683442,0.00386502544136696,-0.0158176320719137,-0.000666732341755189,0.0329838479861755
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ITM2A,Integral membrane protein 2A,39862,-0.0112407857134831,0.00527138783588576,-0.0215727058718191,-0.00090886555514697,0.0329879371788709
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ERCC1,DNA excision repair protein ERCC-1,36958,-0.00623643165054349,0.00293067827756134,-0.0119805610745637,-0.000492302226523264,0.0333571657802413
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IL3,Interleukin-3,36958,-0.0113017442443959,0.00531208750984889,-0.0217134357636997,-0.000890052725092034,0.033392842810912
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PMCH,Pro-MCH,37017,-0.0157145526831437,0.0073941221265182,-0.0302070320511194,-0.00122207331516802,0.0335821425983295
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DEFB4A_DEFB4B,Beta-defensin 4A,39581,-0.0274208901484987,0.0129325148018087,-0.0527686191600438,-0.00207316113695356,0.033995856385023
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PHOSPHO1,Phosphoethanolamine/phosphocholine phosphatase,39745,-0.005515217259788,0.00260122874887486,-0.0106136256075827,-0.000416808911993266,0.0340016563353312
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,AMFR,E3 ubiquitin-protein ligase AMFR,39485,-0.0122513933422545,0.00577851747936186,-0.0235772876018037,-0.000925499082705269,0.0340080989691879
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IVD,"Isovaleryl-CoA dehydrogenase, mitochondrial",39485,-0.00936060555305406,0.00441963611447803,-0.018023092337431,-0.000698118768677111,0.0341943345742823
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CSPG5,Chondroitin sulfate proteoglycan 5,36987,-0.00923825654069319,0.00436367748923013,-0.0177910644195843,-0.000685448661802134,0.034271772776267
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TPSAB1,Tryptase alpha/beta-1,40034,-0.00987072808178238,0.00466479597182528,-0.0190137281865599,-0.000727727977004837,0.0343596838288804
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PER3,Period circadian protein homolog 3,37052,-0.0220830530047294,0.0104648741347112,-0.0425942063087635,-0.0015718997006954,0.034859286474104
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SLITRK6,SLIT and NTRK-like protein 6,39581,-0.00625671978376203,0.00296872301725278,-0.0120754168975775,-0.000438022669946587,0.0350860858633858
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SERPINA4,Kallistatin,37237,-0.00437713514613342,0.00208099627317301,-0.00845588784155252,-0.000298382450714311,0.0354508038383467
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CASP1,Caspase-1,39485,-0.0125445796956482,0.00597004340808035,-0.0242458647754857,-0.000843294615810675,0.0356346185678687
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TLR3,Toll-like receptor 3,40054,-0.0114131660283459,0.0054382183738705,-0.0220720740411321,-0.000754258015559698,0.0358591719074941
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,REEP4,Receptor expression-enhancing protein 4,37408,-0.0116600794571269,0.00555736732727208,-0.0225525194185802,-0.000767639495673607,0.0359121295359421
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SH2B3,SH2B adapter protein 3,39473,-0.0184586206917478,0.00879953116010457,-0.0357057017655528,-0.00121153961794288,0.0359492549540741
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ING1,Inhibitor of growth protein 1,39449,-0.00841992005577753,0.00401880205364319,-0.0162967720809182,-0.000543068030636888,0.036175370105515
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FGF6,Fibroblast growth factor 6,37052,-0.00764256492777028,0.00364888819530618,-0.0147943857905704,-0.000490744064970172,0.036235257444733
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ICAM4,Intercellular adhesion molecule 4,39862,-0.00976198938255124,0.00467654990628804,-0.0189280271988758,-0.000595951566226686,0.0368646988516311
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DDX4,Probable ATP-dependent RNA helicase DDX4,37052,-0.0102440904137702,0.00490774034090927,-0.0198632614819523,-0.000624919345588022,0.0368771487179752
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SAFB2,Scaffold attachment factor B2,37408,-0.00509192752574387,0.00244138236028967,-0.00987703695191162,-0.000306818099576111,0.0370268352703911
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IL13RA2,Interleukin-13 receptor subunit alpha-2,36987,-0.00535456782000629,0.00256995554236871,-0.010391680683049,-0.000317454956963629,0.0372226508743328
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,YES1,Tyrosine-protein kinase Yes,39784,-0.0211796335084014,0.0101875751132487,-0.0411472807303687,-0.00121198628643403,0.0376363421110781
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SKAP2,Src kinase-associated phosphoprotein 2,39927,-0.0192781873369636,0.00929051241817609,-0.0374875916765887,-0.00106878299733846,0.0379986796017104
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ACTA2,"Actin, aortic smooth muscle",39581,-0.00800867116807882,0.00385979636204436,-0.0155738720376858,-0.000443470298471861,0.0380125189900783
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PFDN2,Prefoldin subunit 2,39485,-0.0103341406127423,0.00498498930371435,-0.0201047196480224,-0.000563561577462148,0.0381838189160463
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,RTKN2,Rhotekin-2,37017,-0.00961001424199071,0.00463652525127332,-0.0186976037344864,-0.000522424749495006,0.0382218752540171
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GIMAP7,GTPase IMAP family member 7,37120,0.00601640683063764,0.00290808640209737,0.000316557482526803,0.0117162561787485,0.0385791019615585
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,POSTN,Periostin,37433,-0.00683506178021411,0.0033087917465253,-0.0133202936034037,-0.000349829957024524,0.0388731612297092
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,EFHD1,EF-hand domain-containing protein D1,37408,-0.00633169665374781,0.00307439441329857,-0.012357509703813,-0.000305883603682605,0.0394660090260468
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SYNGAP1,Ras/Rap GTPase-activating protein SynGAP,36987,-0.0103449687951809,0.00503441141459348,-0.0202124151677841,-0.000477522422577707,0.0399130789662733
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,AMOT,Angiomotin,37120,0.00756037473471808,0.00368349670241078,0.000340721197992949,0.0147800282714432,0.0401407390618578
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MAP4K5,Mitogen-activated protein kinase kinase kinase kinase 5,39709,-0.0204698772955289,0.00998291444939303,-0.0400363896163393,-0.000903364974718594,0.0403329417411636
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TNFRSF6B,Tumor necrosis factor receptor superfamily member 6B,39745,-0.00987976025906953,0.0048185096355792,-0.0193240391448048,-0.000435481373334292,0.0403440527604086
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PREB,Prolactin regulatory element-binding protein,39583,-0.00523723675724085,0.00255604549015915,-0.0102470859179528,-0.000227387596528916,0.0404825200617325
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IL10RB,Interleukin-10 receptor subunit beta,39927,-0.00512318822894981,0.0025019721510137,-0.0100270536449367,-0.000219322812962954,0.0406095521334196
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,KIF20B,Kinesin-like protein KIF20B,36987,-0.013713452516266,0.00670231827829826,-0.0268499963417306,-0.00057690869080144,0.0407687763854055
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ATXN2,Ataxin-2,36987,-0.020324503904877,0.00993476209731359,-0.0397966376156117,-0.000852370194142374,0.0407962589275815
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ADAM12,Disintegrin and metalloproteinase domain-containing protein 12,37052,0.00659985096056104,0.00322755653740535,0.000273840147246559,0.0129258617738755,0.0408900017752501
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,LRRC37A2,Leucine-rich repeat-containing protein 37A2,37378,-0.00769226826552009,0.0037690409807578,-0.0150795885878054,-0.000304947943234797,0.0412792928237989
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ENO3,Beta-enolase,37039,0.0109577886309813,0.0053695170649635,0.000433535183652842,0.0214820420783098,0.041296554397221
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TSPAN15,Tetraspanin-15,37017,-0.00898299852573521,0.00440514209538298,-0.0176170770326859,-0.000348920018784577,0.0414492694834677
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,VSTM1,V-set and transmembrane domain-containing protein 1,39485,-0.00879072812006446,0.00431181128691105,-0.0172418782424101,-0.000339577997718813,0.041491251985406
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,VPS28,Vacuolar protein sorting-associated protein 28 homolog,37165,-0.0122249278003422,0.00599639865581826,-0.023977869165746,-0.000471986434938419,0.0414985404813001
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,LYPD3,Ly6/PLAUR domain-containing protein 3,39790,-0.00626555284513182,0.00307397880733938,-0.012290551307517,-0.000240554382746644,0.0415409133031461
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CD276,CD276 antigen,39858,0.00639875147190939,0.00314142710179766,0.000241554352385977,0.0125559485914328,0.0416771747202803
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SPINT3,Kunitz-type protease inhibitor 3,37378,-0.0264042074363972,0.0129741885011568,-0.0518336168986645,-0.00097479797412986,0.0418568960373296
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,AMN,Protein amnionless,39583,-0.00865915229200686,0.00425859422410979,-0.017005996971262,-0.000312307612751682,0.0420353640929131
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,APOH,Beta-2-glycoprotein 1,39854,-0.0064312463195799,0.00316604794025502,-0.0126367002824797,-0.000225792356680051,0.0422393709317651
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TNFRSF12A,Tumor necrosis factor receptor superfamily member 12A,39909,-0.00631312657164265,0.00310937213057072,-0.0124074959475613,-0.000218757195724039,0.0423370111989737
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,LXN,Latexin,39678,-0.0120875409726995,0.00595757530179237,-0.0237643885642126,-0.000410693381186459,0.0424814899921065
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MAVS,Mitochondrial antiviral-signaling protein,39473,-0.0167643429423396,0.00826637343695109,-0.0329664348787638,-0.000562251005915483,0.0425754942948434
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DEFB118,Beta-defensin 118,36987,-0.010486405037272,0.00518476023601096,-0.0206485350998534,-0.000324274974690468,0.0431404321737724
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GIT1,ARF GTPase-activating protein GIT1,37052,-0.0175909229361172,0.00869859642782657,-0.0346401719346572,-0.000541673937577085,0.0431684600126375
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,POF1B,Protein POF1B,37052,0.00811882990512313,0.00402826419365347,0.000223432085562327,0.0160142277246839,0.0438760754613664
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ANKMY2,Ankyrin repeat and MYND domain-containing protein 2,37052,-0.0144138664007973,0.00715520355010268,-0.0284380653589985,-0.00038966744259601,0.0439815879550092
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,KIR2DS4,Killer cell immunoglobulin-like receptor 2DS4,37378,0.030487564668195,0.0151607065534969,0.000772579823340998,0.060202549513049,0.0443495664602455
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DCBLD2,"Discoidin, CUB and LCCL domain-containing protein 2",39909,0.00618430113777881,0.00308618402435274,0.000135380450047451,0.0122332218255102,0.0451011260131335
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CA3,Carbonic anhydrase 3,40013,-0.0107505506414407,0.00537427780511432,-0.0212841351394648,-0.000216966143416616,0.0454769023985861
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MATN2,Matrilin-2,39881,-0.00530921095606458,0.00265707038200888,-0.010517068904802,-0.000101353007327181,0.0457178531478259
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ODAM,Odontogenic ameloblast-associated protein,39452,-0.00911508634823308,0.00457282735208103,-0.0180778279583119,-0.000152344738154257,0.0462443359006524
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GPR158,Probable G-protein coupled receptor 158,37408,-0.00633466424513388,0.00317809924763178,-0.0125637387704922,-0.000105589719775578,0.0462569257716579
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CEACAM18,Carcinoembryonic antigen-related cell adhesion molecule 18,37165,-0.0120841146943495,0.0060684682590046,-0.0239783124819985,-0.000189916906700473,0.046468802205234
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,RAP1A,Ras-related protein Rap-1A,37052,-0.0120475125193353,0.00605417723575192,-0.0239136999014091,-0.000181325137261542,0.046617004784568
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,USP25,Ubiquitin carboxyl-terminal hydrolase 25,37364,-0.0128855565997327,0.00648318289874563,-0.0255925950812741,-0.000178518118191246,0.0468832427596268
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CEACAM19,Carcinoembryonic antigen-related cell adhesion molecule 19,37378,-0.00684115951864646,0.00344204989663623,-0.0135875773160535,-9.47417212394455e-05,0.0468844143941109
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FAM171B,Protein FAM171B,37364,-0.00490539295907637,0.00246891905613359,-0.0097444743090982,-6.63116090545363e-05,0.0469582466021882
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MZT1,Mitotic-spindle organizing protein 1,39473,-0.00945677752606792,0.0047651089105351,-0.0187963909907167,-0.000117164061419124,0.047207814052624
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ZPR1,Zinc finger protein ZPR1,36987,-0.0169937944989179,0.008571241837427,-0.0337934285002748,-0.000194160497560953,0.04742706512463
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ARNTL,Aryl hydrocarbon receptor nuclear translocator-like protein 1,37017,-0.00915477884170078,0.00462430287489168,-0.0182184124764885,-9.11452069130986e-05,0.0477569252091623
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NCLN,Nicalin,39583,-0.00931958422688416,0.00470868825642729,-0.0185486132094817,-9.05552442866733e-05,0.0478073610814096
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ATF2,Cyclic AMP-dependent transcription factor ATF-2,39485,-0.0121847858727356,0.00616044486588778,-0.0242592578098757,-0.000110313935595571,0.047956760672364
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ITPR1,"Inositol 1,4,5-trisphosphate receptor type 1",37039,-0.0123039558589028,0.00622558807361465,-0.0245061084831875,-0.000101803234618097,0.0481356975636582
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NHLRC3,NHL repeat-containing protein 3,36834,0.00561646020465198,0.00284616033646242,3.79859451856302e-05,0.0111949344641183,0.0484773005015321
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CCL13,C-C motif chemokine 13,40020,-0.0120461204295098,0.00613534066369373,-0.0240713881303495,-2.08527286701104e-05,0.049616976357907
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,RET,Proto-oncogene tyrosine-protein kinase receptor Ret,39784,-0.00684447818111404,0.00349759968392055,-0.0136997735615983,1.08171993702492e-05,0.0503758220090071
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,LILRA3,Leukocyte immunoglobulin-like receptor subfamily A member 3,37433,-0.0234174909945451,0.0119701593679035,-0.046879003355636,4.40213665458787e-05,0.0504476641109501
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CCL16,C-C motif chemokine 16,40048,-0.0090852178003595,0.00465072270434951,-0.0182006343008845,3.01987001655422e-05,0.0507767887632499
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CRELD1,Protein disulfide isomerase CRELD1,37120,0.00647803315241203,0.00331803598365714,-2.53173755559531e-05,0.01298138368038,0.0509153330662501
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,RAD51,DNA repair protein RAD51 homolog 1,37165,-0.00919275738911434,0.00470907523051497,-0.0184225448409237,3.70300626950128e-05,0.0509429527860392
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PITHD1,PITH domain-containing protein 1,36927,-0.0137455801287515,0.00704899594881945,-0.0275616121884376,7.04519309346462e-05,0.0511968317590112
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,EPHA10,Ephrin type-A receptor 10,39485,-0.011158085461146,0.0057291220035014,-0.0223871645880087,7.09936657167284e-05,0.0514797382091073
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CEACAM8,Carcinoembryonic antigen-related cell adhesion molecule 8,39581,-0.00839326445840119,0.00431065398880724,-0.0168421462764634,5.5617359661005e-05,0.051540805520179
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SLC13A1,Solute carrier family 13 member 1,37364,-0.0103620601272949,0.00532692001432489,-0.0208028233553716,7.87031007819239e-05,0.0517685819060182
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CTSH,Pro-cathepsin H,39542,-0.0125614195859647,0.00646283368237678,-0.0252285736034232,0.000105734431493811,0.0519567897706679
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SAG,S-arrestin,36987,0.00921914194485045,0.00474325047103475,-7.76289783776616e-05,0.0185159128680786,0.0519609689454571
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IGF2R,Cation-independent mannose-6-phosphate receptor,39854,-0.00406459761495972,0.00209431176256055,-0.0081694486695784,4.0253439658966e-05,0.0523025595603154
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,EDN1,Endothelin-1,37039,0.00484654948833626,0.00249757986395755,-4.87070450205318e-05,0.00974180602169306,0.0523404591402767
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PSMC3,26S proteasome regulatory subunit 6A,36958,-0.00518187220800184,0.00267096379863067,-0.010416961253318,5.32168373142848e-05,0.0523919156946168
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TTF2,Transcription termination factor 2,37035,-0.00854400232324192,0.00440594305218779,-0.01717965070553,9.1646059046149e-05,0.0524983794376005
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TCN1,Transcobalamin-1,37231,-0.00590959564017817,0.00305002599450635,-0.0118876465894106,6.84553090542868e-05,0.0526984667562678
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ESR1,Estrogen receptor,37052,-0.0102118705606792,0.00529305507575579,-0.0205862585091606,0.000162517387802139,0.0537155345521878
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MAPRE3,Microtubule-associated protein RP/EB family member 3,36958,-0.0247502664513475,0.0128311004044386,-0.0498992232440472,0.000398690341352117,0.0537614047977584
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SFRP4,Secreted frizzled-related protein 4,37120,0.00713657090190092,0.00370089369640397,-0.000117180743050858,0.0143903225468527,0.0538345247350756
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,RAB27B,Ras-related protein Rab-27B,37433,-0.0140789556700689,0.00730319516977967,-0.0283932182028371,0.00023530686269924,0.053903300238
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TDGF1,Teratocarcinoma-derived growth factor 1,39485,-0.024341902364035,0.0126319949334705,-0.0491006124336371,0.000416807705567211,0.0539972659471465
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CHIT1,Chitotriosidase-1,39902,-0.0258685706387743,0.0134388833374425,-0.0522087819801616,0.000471640702612897,0.0542589349134955
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,BCL2,Apoptosis regulator Bcl-2,37378,-0.00867106346102613,0.00450488422688048,-0.0175006365457119,0.000158509623659611,0.0542736139604491
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ATG4A,Cysteine protease ATG4A,39473,-0.0101131488564862,0.00525576261652645,-0.020414443584878,0.000188145871905666,0.0543474251268116
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PDE4D,"cAMP-specific 3',5'-cyclic phosphodiesterase 4D",37017,-0.0105874858070843,0.00551916181070037,-0.0214050429560571,0.000230071341888384,0.0550928157606806
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CD58,Lymphocyte function-associated antigen 3,39831,0.00298264838216348,0.0015548568464904,-6.4871036957701e-05,0.00603016780128467,0.0550935222967171
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NAAA,N-acylethanolamine-hydrolyzing acid amidase,39670,-0.0100823355371862,0.00526673531916895,-0.0204051367627574,0.000240465688384909,0.0555944315680678
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TP53INP1,Tumor protein p53-inducible nuclear protein 1,39581,-0.00543993786256061,0.00284371706398911,-0.0110136233079793,0.000133747582858046,0.0557703811825765
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ECM1,Extracellular matrix protein 1,37102,-0.00616564820427171,0.00322348974068438,-0.0124836880960131,0.000152391687469671,0.0558048626625197
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SPTBN2,"Spectrin beta chain, non-erythrocytic 2",36987,-0.00544147434092125,0.00284802125328459,-0.011023595997359,0.000140647315516541,0.0560757377066763
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,RPL14,60S ribosomal protein L14,37039,-0.00686874432131134,0.00359868970364359,-0.0139221761404528,0.000184687497830103,0.0563251833063992
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PEAR1,Platelet endothelial aggregation receptor 1,40048,-0.00385239170058474,0.00201988969702368,-0.00781137550675116,0.000106592105581673,0.0565086530800033
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NFX1,Transcriptional repressor NF-X1,37017,-0.0114516149422049,0.00600655265923753,-0.0232244581543105,0.000321228269900622,0.0566044894563771
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GPRC5C,G-protein coupled receptor family C group 5 member C,37364,-0.00968972595595458,0.00508301824637605,-0.0196524417188516,0.000272989806942486,0.0566333099054112
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TXK,Tyrosine-protein kinase TXK,37165,-0.0126290159347249,0.00662815562432149,-0.025620200958395,0.000362169088945178,0.0567549563709384
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CNTNAP4,Contactin-associated protein-like 4,37035,-0.0175979312886982,0.00925667961211078,-0.0357410233284354,0.00054516075103889,0.0573098981332433
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FGD3,"FYVE, RhoGEF and PH domain-containing protein 3",37408,-0.0135940986640997,0.00716027802877519,-0.0276282436004991,0.000440046272299646,0.0576457632069917
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,KRT18,"Keratin, type I cytoskeletal 18",39784,-0.0137952317950184,0.00726783479963191,-0.028040188002297,0.000449724412260122,0.0576981741783354
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CPLX2,Complexin-2,36958,-0.00506718225709878,0.00267323133373682,-0.0103067156712229,0.000172351157025383,0.0580446075287872
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IL32,Interleukin-32,39862,0.0072349669532109,0.00381930235946561,-0.000250865671341691,0.0147207995777635,0.0582010444614057
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IL4,Interleukin-4,39583,-0.0152631420739845,0.0080641073665693,-0.0310687925124603,0.000542508364491368,0.058412725841466
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,EFNB2,Ephrin-B2,37035,-0.0102008754718398,0.0053915094865158,-0.0207682340654107,0.000366483121731214,0.0585094393824689
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SPINK4,Serine protease inhibitor Kazal-type 4,39862,0.0104743172624175,0.00553658115261965,-0.000377381796716991,0.021326016321552,0.0585305429182249
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GOLGA3,Golgin subfamily A member 3,37408,-0.0130872323537256,0.00692114493998336,-0.026652676436093,0.000478211728641759,0.0586582507709464
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GGT5,Glutathione hydrolase 5 proenzyme,39745,0.00387176377378289,0.0020481439442801,-0.000142598357006111,0.00788612590457189,0.0587257705660909
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ZNF75D,Zinc finger protein 75D,37165,-0.00998148369791063,0.00528165328844536,-0.0203335241432635,0.000370556747442271,0.0588009773516726
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,KAZN,Kazrin,37378,-0.0175281874403364,0.00927551765485809,-0.0357082020438582,0.000651827163185497,0.0588159836870404
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PRR4,Proline-rich protein 4,37027,-0.0117494244992168,0.00621929011372554,-0.0239392331221188,0.000440384123685284,0.0588882451938658
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,C7,Complement component C7,37145,0.00538375744064148,0.0028549855013173,-0.00021201414194043,0.0109795290232234,0.0593519355340004
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FNTA,Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha,37364,-0.00600912605854157,0.00319336533391235,-0.0122681221130098,0.000249869995926633,0.0598909955477997
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,HLA_A,,37408,-0.00541161422303275,0.00287609175660224,-0.0110487540659731,0.000225525619907648,0.0599136585788968
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,LY96,Lymphocyte antigen 96,39745,-0.00592232905124682,0.00314973243189036,-0.0120958046177519,0.000251146515258282,0.0600903656085187
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,EHD3,EH domain-containing protein 3,37039,-0.0196244320207504,0.0104572364789251,-0.0401206155194435,0.000871751477942797,0.0605900041252116
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TRIM25,E3 ubiquitin/ISG15 ligase TRIM25,37378,-0.0180560875967411,0.00964109971389242,-0.0369526430359703,0.000840467842487994,0.0611141916878804
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DTNB,Dystrobrevin beta,37344,-0.00732858699281329,0.00391558904495517,-0.0150031415209254,0.000345967535298835,0.0612775668384482
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ATP1B1,Sodium/potassium-transporting ATPase subunit beta-1,37017,-0.00815782028679302,0.00436928136474111,-0.0167216117616856,0.000405971188099555,0.061911921618463
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,WASF3,Wiskott-Aldrich syndrome protein family member 3,39485,-0.0140218378237578,0.00751104190204027,-0.0287434799517567,0.000699804304241117,0.0619440555757705
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GPR15L,Protein GPR15L,37378,-0.010199147527003,0.00546630180635889,-0.0209130990674664,0.000514804013460412,0.0620878803615571
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GDNF,Glial cell line-derived neurotrophic factor,39485,-0.00636523304143508,0.00342350249928165,-0.0130752979400271,0.000344831857156962,0.0630069347011672
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GET3,ATPase GET3,37433,-0.00927078957133747,0.00498718963546457,-0.019045681256848,0.000504102114173077,0.0630600205050719
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GNGT1,Guanine nucleotide-binding protein G(T) subunit gamma-T1,37035,0.00857891911689882,0.00462048505684623,-0.000477231594519789,0.0176350698283174,0.0633741646389263
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IL36A,Interleukin-36 alpha,37052,-0.00968108437620263,0.00523963195140218,-0.0199507630009509,0.000588594248545645,0.0646731975735406
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GCLM,Glutamate--cysteine ligase regulatory subunit,37017,-0.00728370258303003,0.00394480817135057,-0.0150155265988771,0.00044812143281709,0.0648562692911274
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,C1QTNF5,Complement C1q tumor necrosis factor-related protein 5,37120,-0.0061722690382796,0.00334501946062825,-0.012728507181111,0.000383969104551778,0.0650290323516142
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GPNMB,Transmembrane glycoprotein NMB,39440,-0.00464220831833605,0.00252079252142657,-0.00958296166033213,0.000298545023660038,0.0655575086687998
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PKD1,Polycystin-1,37433,0.00429534620614489,0.00233306587976195,-0.000277462918188534,0.00886815533047832,0.0656325714202481
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CGB3_CGB5_CGB8,Choriogonadotropin subunit beta 3,37441,-0.00762781051594483,0.00416445179799555,-0.0157901360400161,0.000534515008126455,0.0670257459915917
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TXLNA,Alpha-taxilin,39745,-0.014558821871009,0.00795270248887878,-0.0301461187492114,0.00102847500719338,0.0671676356738209
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NPTN,Neuroplastin,39473,-0.0137211599477916,0.00749597651419555,-0.0284132739156149,0.000970954020031662,0.0671987440866945
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ADH4,All-trans-retinol dehydrogenase [NAD(+)] ADH4,39581,-0.0138185933915054,0.00755503040504541,-0.0286264529853944,0.000989266202383607,0.0674097615520931
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NIT1,Deaminated glutathione amidase,37039,-0.00763999905132134,0.00419130649569441,-0.0158549597828824,0.000574961680239714,0.0683532403401128
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MCEMP1,Mast cell-expressed membrane protein 1,37052,-0.0146274773998599,0.00803155229029967,-0.0303693198888472,0.00111436508912748,0.0685912599268455
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ENPP7,Ectonucleotide pyrophosphatase/phosphodiesterase family member 7,39425,0.0141476664466439,0.00777325940823753,-0.00108792199350169,0.0293832548867894,0.0687716526047387
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DHRS4L2,Dehydrogenase/reductase SDR family member 4-like 2,37384,-0.00783356764250637,0.00430624656276613,-0.016273810905528,0.000606675620515243,0.0689156385980387
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TARS1,"Threonine--tRNA ligase 1, cytoplasmic",37364,-0.00593018196382347,0.00325999947769833,-0.0123197809401122,0.000459417012465262,0.0689221990595557
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,UPK3A,Uroplakin-3a,36987,-0.0077368773157848,0.00425908258040804,-0.0160846791733846,0.000610924541814948,0.069307371651609
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NUDT15,Nucleotide triphosphate diphosphatase NUDT15,37017,-0.00818523867349412,0.00451082828114538,-0.0170264621045391,0.000655984757550838,0.0696119271508277
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IL17RA,Interleukin-17 receptor A,39854,-0.00712727059197499,0.00392955922855678,-0.0148292066799463,0.000574665495996305,0.0697336798201646
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,LRP11,Low-density lipoprotein receptor-related protein 11,39864,-0.00562807773854237,0.00310851997963099,-0.0117207768986191,0.000464621421534377,0.0702319300597495
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TSPAN7,Tetraspanin-7,36987,-0.0152260127611852,0.00840972813363519,-0.0317090799031101,0.00125705438073982,0.0702374538332987
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FTCD,Formimidoyltransferase-cyclodeaminase,37364,0.013601767724229,0.00751469256269299,-0.00112702969864924,0.0283305651471073,0.0703144128519897
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,HAO1,Hydroxyacid oxidase 1,40026,-0.0208009040059615,0.0115038414695172,-0.0433484332862153,0.00174662527429224,0.0705985812691827
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,OGA,Protein O-GlcNAcase,37378,-0.011457366641262,0.00634063511303323,-0.0238850114628072,0.000970278180283083,0.0707884633733853
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TDP1,Tyrosyl-DNA phosphodiesterase 1,37364,-0.0111112073951014,0.00615314984393005,-0.0231713810892043,0.000948966299001448,0.070975668507854
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IL2RG,Cytokine receptor common subunit gamma,37364,-0.00605842331532228,0.00335726405042775,-0.0126386608541607,0.000521814223516108,0.0711640170654264
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GIPC2,PDZ domain-containing protein GIPC2,37384,-0.00460982878458214,0.0025555304284044,-0.00961866842425476,0.000399010855090492,0.0712749067724904
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NOP56,Nucleolar protein 56,37017,-0.0177430931281614,0.00984490006573123,-0.0370390972569946,0.00155291100067185,0.0715270106891622
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IL13,Interleukin-13,39583,-0.00783964293660403,0.00435434475012831,-0.0163741586468555,0.000694872773647458,0.0718137367382765
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SEZ6,Seizure protein 6 homolog,37035,-0.00500666313372914,0.00278265812799358,-0.0104606730645966,0.000447346797138264,0.0720039780709001
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ANGPTL3,Angiopoietin-related protein 3,39888,-0.00565120061933761,0.00314306134902791,-0.0118116008634323,0.000509199624757098,0.0721970137007611
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MTHFD2,"Bifunctional methylenetetrahydrofolate dehydrogenase/cyclohydrolase, mitochondrial",37384,0.00405465692063442,0.00225662297550077,-0.000368324111347093,0.00847763795261593,0.0723927249155147
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DHPS,Deoxyhypusine synthase,37364,-0.00655955763975132,0.00365101204806997,-0.0137155412539685,0.000596425974465823,0.0724149835386405
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SCN3B,Sodium channel subunit beta-3,36987,-0.00713006709889856,0.00396945331260525,-0.0149101955916048,0.000650061393807726,0.072480290376683
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SAP18,Histone deacetylase complex subunit SAP18,37165,-0.0117119347026091,0.00652451292103852,-0.0244999800278446,0.00107611062262643,0.0726657898244592
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DDX25,ATP-dependent RNA helicase DDX25,37035,0.0060214293281301,0.00335494880430373,-0.000554270328305211,0.0125971289845654,0.0727100422861354
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,HDAC8,Histone deacetylase 8,37052,-0.0100900358308252,0.0056264729738371,-0.0211179228595459,0.000937851197895558,0.0729455400984217
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DMD,Dystrophin,37039,-0.00825699884235393,0.00460716379976032,-0.0172870398898842,0.000773042205176289,0.0731224783125075
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SERPINF1,Pigment epithelium-derived factor,37250,0.00408218411747846,0.00227809936842821,-0.000382890644640827,0.00854725887959775,0.0731674878056514
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TP53BP1,TP53-binding protein 1,37052,-0.0140149148580923,0.00783196568674009,-0.0293655676041029,0.00133573788791829,0.073565224958278
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IMMT,MICOS complex subunit MIC60,37364,-0.00699505844262433,0.00391031044158079,-0.0146592669081227,0.000669150022874022,0.0736572788338556
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ECSCR,Endothelial cell-specific chemotaxis regulator,36987,-0.00784011113897464,0.00438527431529125,-0.0164352487969455,0.00075502651899621,0.0738270074282468
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TOR1AIP1,Torsin-1A-interacting protein 1,37039,-0.00802445717012149,0.00448867485314151,-0.0168222598822788,0.000773345542035859,0.0738454798077635
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,KLK11,Kallikrein-11,39775,-0.00464503174741237,0.00259843250506426,-0.00973795945733832,0.000447895962513577,0.0738550008297068
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PM20D1,N-fatty-acyl-amino acid synthase/hydrolase PM20D1,39797,0.0298154780673266,0.0166848502666057,-0.00288682845522065,0.0625177845898739,0.0739598720505723
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TNIP1,TNFAIP3-interacting protein 1,37384,-0.0140300840536887,0.00785322056789579,-0.0294223963667644,0.00136222825938707,0.0740344370347656
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CCL11,Eotaxin,40054,-0.00603384766455487,0.00340492822466863,-0.0127075069849054,0.000639811655795648,0.0763980079495588
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ITPRIP,"Inositol 1,4,5-trisphosphate receptor-interacting protein",36987,0.00733000337209033,0.00413779136468057,-0.000780067702683579,0.0154400744468642,0.0765045647006743
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TSC22D1,TSC22 domain family protein 1,37408,-0.0106826379267114,0.00604004918122425,-0.022521134321911,0.0011558584684881,0.07697742698721
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CCND2,G1/S-specific cyclin-D2,37165,-0.00580990766952023,0.00328627434474338,-0.0122510053852173,0.000631190046176795,0.0770952835661118
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IFT20,Intraflagellar transport protein 20 homolog,37035,-0.00686807812717918,0.00390042906495873,-0.0145129190944983,0.000776762840139934,0.0782866603525975
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ATRAID,All-trans retinoic acid-induced differentiation factor,37378,-0.00424394838322118,0.00241406978305303,-0.00897552515800513,0.000487628391562761,0.0787691722365359
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PTH1R,Parathyroid hormone/parathyroid hormone-related peptide receptor,39862,-0.00579336549721132,0.00329672061840186,-0.012254937909279,0.000668206914856325,0.0788838263584655
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ADAMTSL5,ADAMTS-like protein 5,37433,0.00613306558562483,0.00349152889443413,-0.000710331047466073,0.0129764622187157,0.079016087864556
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CALCOCO2,Calcium-binding and coiled-coil domain-containing protein 2,37039,-0.0120092776073134,0.00684208502884507,-0.0254197642638498,0.00140120904922288,0.0792470874647004
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,STEAP4,Metalloreductase STEAP4,36987,-0.0117614023811453,0.0067074276880513,-0.0249079606497259,0.00138515588743523,0.0795413994772434
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TPP1,Tripeptidyl-peptidase 1,39763,-0.00728865441575128,0.0041568727823389,-0.0154361250691355,0.000858816237632965,0.0795528959038015
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CLSPN,Claspin,39449,-0.00539045888734125,0.00307473141068604,-0.0114169324522859,0.000636014677603387,0.0795962785453695
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IL17F,Interleukin-17F,39583,-0.0120998793784805,0.00691454594056544,-0.0256523894219887,0.00145263066502777,0.0801521957638702
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CREG1,Protein CREG1,39656,-0.00587179785542465,0.00335999134876296,-0.0124573808990001,0.00071378518815076,0.0805590907394931
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TDO2,"Tryptophan 2,3-dioxygenase",37035,-0.00612578572420305,0.00350545674829405,-0.0129964809508594,0.000744909502453287,0.0805739385822672
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MAPT,Microtubule-associated protein tau,39485,-0.00821473424175754,0.00470258696250712,-0.0174318046882715,0.00100233620475642,0.0806822628536614
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PRUNE2,Protein prune homolog 2,37165,-0.00444291775043357,0.0025459842211835,-0.00943304682395323,0.000547211323086088,0.0809959717846432
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GALNT7,N-acetylgalactosaminyltransferase 7,39784,0.00322690451559042,0.00185078333856743,-0.000400630828001739,0.00685443985918258,0.0812596000261957
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TGM2,Protein-glutamine gamma-glutamyltransferase 2,39831,0.0112834588156778,0.0065001844492713,-0.00145690270489392,0.0240238203362496,0.0826065546799257
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GTPBP2,GTP-binding protein 2,37035,-0.0125693804191694,0.00724572824880475,-0.0267710077868267,0.0016322469484879,0.0828120694206664
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,C1QBP,"Complement component 1 Q subcomponent-binding protein, mitochondrial",37408,-0.00999439913706281,0.00577596502729913,-0.0213152905905691,0.00132649231644348,0.0835918298714019
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MEGF10,Multiple epidermal growth factor-like domains protein 10,39858,-0.00619108348239279,0.00358050625862242,-0.0132088757492927,0.000826708784507149,0.0838089855354392
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,AMY1A_AMY1B_AMY1C,Alpha-amylase 1A_Alpha-amylase 1B_Alpha-amylase 1C,36671,-0.00752231424367209,0.00435621896280796,-0.0160605034107757,0.00101587492343151,0.0842278867183563
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,EIF1AX,"Eukaryotic translation initiation factor 1A, X-chromosomal",37384,-0.0085008283677237,0.00492322844828721,-0.0181503561263666,0.00114869939091922,0.0842484134486738
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MEP1B,Meprin A subunit beta,39864,-0.0177370947916417,0.0102857593895934,-0.0378971831952448,0.00242299361196135,0.0846491563171239
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ISLR2,Immunoglobulin superfamily containing leucine-rich repeat protein 2,39210,0.00580561674490705,0.00337157515642324,-0.000802670561682512,0.0124139040514966,0.0851023274377223
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ANGPT1,Angiopoietin-1,39790,-0.0129454931615914,0.00753634687943042,-0.027716733045275,0.00182574672209222,0.0858632740404619
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SERPINE1,Plasminogen activator inhibitor 1,40048,-0.0103299646090231,0.00603652572525254,-0.0221615550305181,0.00150162581247185,0.0870553529012695
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SFTPD,Pulmonary surfactant-associated protein D,39864,-0.0100576825615935,0.00588478246131302,-0.0215918561857671,0.00147649106257998,0.0874517882944695
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,KIR2DL3,Killer cell immunoglobulin-like receptor 2DL3,39473,-0.0113705700034685,0.00666340749110605,-0.0244308486860364,0.00168970867909934,0.0879498464905332
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FRMD4B,FERM domain-containing protein 4B,37017,-0.0107043921061151,0.00627772369750462,-0.0230087305532241,0.00159994634099399,0.0881920918640466
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CD69,Early activation antigen CD69,39781,-0.0133002652765152,0.00784677306133412,-0.0286799404767301,0.00207940992369963,0.0900953399946298
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SLURP1,Secreted Ly-6/uPAR-related protein 1,37366,-0.00555192400447347,0.00327772342198258,-0.0119762619115593,0.000872413902612387,0.0903196206614181
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,LYPLA2,Acyl-protein thioesterase 2,36987,-0.0158783838207084,0.00938575142138676,-0.0342744566066265,0.00251768896520961,0.0907165957003392
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SNU13,NHP2-like protein 1,37017,0.00931456395450212,0.00552337770175678,-0.00151125634094116,0.0201403842499454,0.0917445879665721
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SOX2,Transcription factor SOX-2,37388,-0.00356395407265631,0.00211508806653171,-0.00770952668305846,0.00058161853774585,0.0920088380968751
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CABP2,Calcium-binding protein 2,37035,-0.00990875324174895,0.0058894627292475,-0.0214521001910741,0.00163459370757616,0.0925044312194236
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TNFRSF10C,Tumor necrosis factor receptor superfamily member 10C,39877,-0.00731365223944467,0.0043518982599339,-0.0158433728289151,0.00121606835002578,0.0928667442150707
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PNLIPRP1,Inactive pancreatic lipase-related protein 1,37384,-0.0115626435034689,0.00688797284346973,-0.0250630702766696,0.00193778326973178,0.0932391915702651
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SORBS1,Sorbin and SH3 domain-containing protein 1,37408,-0.00566092633817604,0.00337540473697013,-0.0122767196226375,0.000954866946285403,0.093543967321614
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,UNG,Uracil-DNA glycosylase,37364,-0.00518126832089649,0.0030898988156193,-0.0112374699995103,0.000874933357717337,0.0935967675063097
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,EIF4EBP1,Eukaryotic translation initiation factor 4E-binding protein 1,39864,-0.00950201058337777,0.0056748736535612,-0.0206247629443577,0.00162074177760217,0.0940714780919715
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MYH4,Myosin-4,37017,-0.00711971691735544,0.00426333850301681,-0.0154758603832684,0.00123642654855751,0.0949458605814687
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PLXNA4,Plexin-A4,39862,-0.0120894172333638,0.00724182433635227,-0.0262833929326142,0.00210455846588666,0.0950600000748478
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PDE1C,"Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1C",36958,-0.00813424022762847,0.00487479936335364,-0.0176888469798016,0.00142036652454466,0.0952144772307586
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PQBP1,Polyglutamine-binding protein 1,39473,-0.00813756456145415,0.00488472345758388,-0.0177116225383186,0.00143649341541026,0.0957491632993861
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,B3GNT7,"UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7",37039,0.00550832103425159,0.00330905708355479,-0.000977430849515801,0.011994072918019,0.0960124587004068
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NMRK2,Nicotinamide riboside kinase 2,36958,0.00605691934027046,0.00363868185842033,-0.00107489710223339,0.0131887357827743,0.0960181763589252
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MMP15,Matrix metalloproteinase-15,37433,-0.00734146772499292,0.00441057516126072,-0.0159861950410639,0.00130325959107809,0.0960326736019118
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PRDX6,Peroxiredoxin-6,40026,0.00877403766828564,0.0052746820418868,-0.00156433913381249,0.0191124144703838,0.0962467872837154
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CRTAP,Cartilage-associated protein,37035,-0.00734489407186948,0.0044230119201749,-0.0160139974354123,0.00132420929167333,0.0968157654361486
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,VSIR,V-type immunoglobulin domain-containing suppressor of T-cell activation,39837,-0.00909041894423393,0.00548324587234132,-0.0198375808540229,0.00165674296555505,0.0973666500001581
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DEFB104A_DEFB104B,Beta-defensin 104,36987,-0.00863591882243182,0.00521174378548484,-0.0188509366419821,0.00157909899711846,0.0975410694054336
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MYCBP2,E3 ubiquitin-protein ligase MYCBP2,37408,-0.00992151122753404,0.00599387168765426,-0.0216694997353364,0.0018264772802683,0.097891710963632
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MMP8,Neutrophil collagenase,39981,-0.0105721315644008,0.00638904910539395,-0.0230946678109729,0.00195040468217138,0.0979993699272281
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TPM3,Tropomyosin alpha-3 chain,37017,0.00652882242301546,0.00395988955547202,-0.00123256110570969,0.0142902059517406,0.0992250910365285
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TBR1,T-box brain protein 1,37035,0.00711290913598323,0.00431451008273324,-0.00134353062617393,0.0155693488981404,0.0992530802497972
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,BCL2L11,"Bcl-2-like protein 11, Isoform BimL ",39862,-0.00646269635150065,0.00392295936528887,-0.0141516967074668,0.00122630400446553,0.0994948040339975
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PCBD1,Pterin-4-alpha-carbinolamine dehydratase,37110,-0.00696207756833452,0.0042286693013539,-0.0152502693989882,0.00132611426231912,0.0997053225847052
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CSDE1,Cold shock domain-containing protein E1,37017,-0.0175983425578565,0.0106914715636223,-0.0385536268225562,0.00335694170684329,0.0997841706752742
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MYOC,Myocilin,39854,-0.00673364656413494,0.00409694228716398,-0.0147636534469763,0.00129636031870646,0.100282937949651
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,LARP1,La-related protein 1,37364,-0.00937271816691325,0.00571235887816583,-0.0205689415681183,0.00182350523429179,0.10086659963848
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GAMT,Guanidinoacetate N-methyltransferase,37017,-0.00538401271878399,0.00328656985401444,-0.0118256896326523,0.00105766419508431,0.101406811336324
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,EIF5A,Eukaryotic translation initiation factor 5A-1,39583,-0.00440886704279449,0.00269224495035168,-0.00968566714548378,0.000867933059894799,0.101521552384246
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MRPL24,"39S ribosomal protein L24, mitochondrial",37017,-0.0057954444460827,0.00354181177260541,-0.0127373955203893,0.0011465066282239,0.101802042857447
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GTF2IRD1,General transcription factor II-I repeat domain-containing protein 1,37165,-0.0105751910162674,0.00646304899560445,-0.0232427670476521,0.00209238501511737,0.101810050892979
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NGF,Beta-nerve growth factor,39745,-0.00179269746506781,0.00109616872928293,-0.00394118817446236,0.000355793244326742,0.10198061579632
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MRPS16,"28S ribosomal protein S16, mitochondrial",37052,-0.00432062064524992,0.00264728437325997,-0.00950929801683947,0.000868056726339628,0.102683258708583
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PPIE,Peptidyl-prolyl cis-trans isomerase E,37165,-0.00910178648824707,0.00558133427112146,-0.0200412016596451,0.001837628683151,0.102965781570974
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,OPHN1,Oligophrenin-1,37384,-0.0156709563638198,0.00961613327999419,-0.0345185775926084,0.00317666486496883,0.103198234960909
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,RNASE10,Inactive ribonuclease-like protein 10,37039,-0.00677818103546385,0.00416796704397494,-0.0149473964416547,0.00139103437072703,0.103919135580783
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GAPDH,Glyceraldehyde-3-phosphate dehydrogenase,36842,-0.00475352574611037,0.00292912604195674,-0.0104946127883456,0.000987561296124845,0.104646226185143
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MVK,Mevalonate kinase,39583,0.0114675769330615,0.00707044429475047,-0.00239049388464943,0.0253256477507724,0.104844105159584
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PROCR,Endothelial protein C receptor,37017,0.0052721847855163,0.00326078628417879,-0.00111895633147413,0.0116633259025067,0.105935797121451
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,HEBP1,Heme-binding protein 1,39581,-0.00776081230213593,0.00480052840734334,-0.0171698479805289,0.00164822337625702,0.105972204624802
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ARMCX2,Armadillo repeat-containing X-linked protein 2,36987,-0.00902385822565335,0.00558597319072533,-0.019972365679475,0.0019246492281683,0.106237395644706
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CRISP2,Cysteine-rich secretory protein 2,40026,-0.00805213041405524,0.00500054337030093,-0.0178531954198451,0.00174893459173459,0.107362576069954
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,RGMA,Repulsive guidance molecule A,40005,0.00443750930729018,0.00276063064094531,-0.00097332674896264,0.00984834536354299,0.107980517680999
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IL12RB2,Interleukin-12 receptor subunit beta-2,37052,-0.0059538042579314,0.003709203632255,-0.0132238433771512,0.0013162348612884,0.108486155140512
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NXPE4,NXPE family member 4,37017,-0.00500044312089611,0.00311804088251798,-0.0111118032506313,0.00111091700883912,0.108801302050156
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ARG2,"Arginase-2, mitochondrial",37364,-0.00625064953173404,0.00390722830694248,-0.0139088170133413,0.00140751794987323,0.109673980888178
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NFAT5,Nuclear factor of activated T-cells 5,37052,-0.0122902908412084,0.00769315221986904,-0.0273688691921517,0.00278828750973494,0.110164347226641
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,RARRES1,Retinoic acid receptor responder protein 1,39473,-0.00482450486948136,0.00302510019480116,-0.0107537012512916,0.00110469151232892,0.110771656098304
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MUC16,Mucin-16,39784,-0.0265160430578397,0.0166265364738243,-0.0591040545465353,0.00607196843085593,0.110776238106391
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PAIP2B,Polyadenylate-binding protein-interacting protein 2B,36927,-0.00747407577720663,0.00469688840529689,-0.0166799770515885,0.00173182549717528,0.11157022943719
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,EDDM3B,Epididymal secretory protein E3-beta,37364,-0.00729838777720338,0.00458679258804275,-0.0162885012497672,0.00169172569536041,0.111593698843371
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,RNF168,E3 ubiquitin-protein ligase RNF168,37052,-0.00586615874512377,0.00368960335036314,-0.0130977813118355,0.00136546382158798,0.111877743309116
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,VIT,Vitrin,37433,0.00520488949164077,0.00327525079061739,-0.00121460205796932,0.0116243810412508,0.112048120735116
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,BTLA,B- and T-lymphocyte attenuator,36958,-0.0122527259613256,0.00772998618637799,-0.0274034988866264,0.00289804696397531,0.112969965012115
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,STX16,Syntaxin-16,39473,-0.00823660112458384,0.00520400372185871,-0.0184364484194269,0.00196324617025924,0.113500278960256
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CILP,Cartilage intermediate layer protein 1,37433,0.0075700264276212,0.004784815053104,-0.00180821107646264,0.016948263931705,0.113651449053099
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SLK,STE20-like serine/threonine-protein kinase,37165,-0.0108364562218246,0.00685351466565776,-0.0242693449665138,0.00259643252286463,0.113866797270562
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SLC28A1,Sodium/nucleoside cotransporter 1,36958,-0.0083935293576251,0.00531158179880786,-0.0188042296832885,0.00201717096803831,0.114077986265264
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CAMLG,Guided entry of tail-anchored proteins factor CAMLG,37035,-0.0076914942079028,0.00486838506795994,-0.0172335289411043,0.00185054052529868,0.114156944379813
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,EDNRB,Endothelin receptor type B,37052,-0.00655964457912596,0.00415309110990427,-0.0146997031545383,0.0015804139962864,0.114254378024111
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FBN2,Fibrillin-2,37035,-0.00847191180883176,0.0053794683135301,-0.0190156697033508,0.00207184608568724,0.115312673516276
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,LILRA6,Leukocyte immunoglobulin-like receptor subfamily A member 6,37433,-0.0102795440354822,0.00653286151661614,-0.0230839526080498,0.00252486453708545,0.115623334640282
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SDK2,Protein sidekick-2,37120,-0.00521054165994039,0.00331232060463121,-0.0117026900450176,0.00128160672513679,0.115724407642426
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MUC2,Mucin-2,37433,-0.0126270332672984,0.00802898837808264,-0.0283638504883403,0.00310978395374362,0.115816131015567
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PAGR1,PAXIP1-associated glutamate-rich protein 1,37039,-0.00608484032232559,0.00386951581777537,-0.0136690913251653,0.00149941068051415,0.115857045456364
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ARF6,ADP-ribosylation factor 6,37378,-0.0148700462643312,0.00947407360969058,-0.0334392305393248,0.00369913801066232,0.116542898945376
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PALM3,Paralemmin-3,37017,-0.0105888889601065,0.00675072525467468,-0.0238203104592689,0.00264253253905588,0.116775536400394
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TTN,Titin,37017,0.00957040340323771,0.00610292695600414,-0.0023913334305304,0.0215321402370058,0.11686641260983
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CLMP,CXADR-like membrane protein,40026,-0.00285613487535769,0.00182708654208476,-0.00643722449784382,0.000724954747128441,0.118020862475244
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FGF3,Fibroblast growth factor 3,37052,-0.00427759417653287,0.00274077236092061,-0.00964950800393728,0.00109431965087153,0.118612445138931
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PRND,Prion-like protein doppel,37384,-0.00703553767220799,0.00452153226668186,-0.0158977409149044,0.00182666557048847,0.119729731903655
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,STC2,Stanniocalcin-2,39827,0.00366934809781236,0.00235955751811584,-0.000955384637694691,0.00829408083331942,0.119942054038584
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ARG1,Arginase-1,39750,-0.00716085208695731,0.00460865645198043,-0.0161938187328389,0.00187211455892433,0.120256100366389
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,37433,0.00369190737644464,0.00238205758694212,-0.000976925493961909,0.00836074024685119,0.121193236214118
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,AXIN1,Axin-1,39862,-0.0131887445038807,0.00851023951028552,-0.0298688139440404,0.00349132493627888,0.121221284717389
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NUBP1,Cytosolic Fe-S cluster assembly factor NUBP1,37364,-0.0134550608632522,0.00869436583157276,-0.0304960178931348,0.00358589616663038,0.121751477866924
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MED21,Mediator of RNA polymerase II transcription subunit 21,37017,-0.00677478329688811,0.0043813539984796,-0.0153622371339081,0.00181267054013191,0.122061934810469
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PRAME,Melanoma antigen preferentially expressed in tumors,36958,0.00351813382810049,0.00228394848544978,-0.000958405203381087,0.00799467285958206,0.123493482820869
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PLEKHO1,Pleckstrin homology domain-containing family O member 1,37384,-0.00950226619498983,0.00618091770783534,-0.0216168649023471,0.00261233251236744,0.124229736552892
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,COMT,Catechol O-methyltransferase,39399,-0.0116884657148124,0.00761682287196504,-0.0266174385438639,0.00324050711423906,0.124912496863994
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IL3RA,Interleukin-3 receptor subunit alpha,39583,0.00419367269236235,0.00273952335898046,-0.00117579309123935,0.00956313847596404,0.125838015171947
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,KLK13,Kallikrein-13,39486,-0.00576237907960235,0.00377451650450339,-0.013160431428429,0.00163567326922429,0.126867419215579
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,EIF5,Eukaryotic translation initiation factor 5,37017,-0.00599509203558435,0.00393358072724796,-0.0137049102609903,0.00171472618982164,0.127512742378787
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,HEXIM1,Protein HEXIM1,39862,-0.0110763089975677,0.00728025754115751,-0.0253456137782364,0.003192995783101,0.128174935705045
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TEX101,Testis-expressed protein 101,37035,-0.00660311103164069,0.00435202203841344,-0.015133074226931,0.00192685216364964,0.129227245171457
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,RELB,Transcription factor RelB,37052,-0.00663252084802152,0.00437974010384755,-0.0152168114515627,0.00195176975551968,0.12995749596071
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TRAF3,"TNF receptor-associated factor 3, Isoform 2",37052,-0.00483322796156903,0.00319721214546725,-0.0110997637666848,0.00143330784354677,0.130633963815322
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TEX33,Testis-expressed protein 33,37165,-0.00535571617015767,0.00354733034404529,-0.0123084836444864,0.00159705130417111,0.131121318735514
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,EXOSC10,Exosome component 10,37017,-0.00819407724809725,0.0054389718945246,-0.0188544621613655,0.00246630766517096,0.131950325775179
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,COPE,Coatomer subunit epsilon,39485,-0.00635745014660477,0.00422542353667124,-0.0146392802784804,0.00192437998527086,0.132454592946298
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SLC44A4,Choline transporter-like protein 4,37035,-0.00911933634443118,0.00606912673173605,-0.0210148247386338,0.00277615204977147,0.132971865481387
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PAFAH1B3,Platelet-activating factor acetylhydrolase IB subunit alpha1,37408,-0.0154682976893322,0.0103040926300539,-0.0356643192442379,0.00472772386557347,0.133332317936361
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GLT8D2,Glycosyltransferase 8 domain-containing protein 2,39485,-0.00656052763049095,0.0043758295575569,-0.0151371535633025,0.00201609830232057,0.133825129442409
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GFER,FAD-linked sulfhydryl oxidase ALR,39473,-0.00866488280532442,0.00578936678308345,-0.020012041700168,0.00268227608951914,0.134494358589021
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CXADR,Coxsackievirus and adenovirus receptor,39862,0.00676488318772842,0.00452037233332541,-0.00209504658558939,0.0156248129610462,0.134534720412545
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,AGR3,Anterior gradient protein 3,39460,-0.00786956567071432,0.00526634115431089,-0.0181915943331637,0.00245246299173503,0.135113875204708
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ZCCHC8,Zinc finger CCHC domain-containing protein 8,37017,-0.00784538896397148,0.00525088854918567,-0.0181371305203754,0.00244635259243243,0.13517165427696
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,HRC,Sarcoplasmic reticulum histidine-rich calcium-binding protein,37039,0.00463014796203592,0.00310361962197078,-0.00145294649702681,0.0107132424210987,0.135761307566182
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FGL1,Fibrinogen-like protein 1,37441,-0.0082192997738891,0.0055169641743626,-0.0190325495556398,0.00259395000786159,0.136294020311995
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CTSO,Cathepsin O,40054,-0.00397926855879967,0.0026714121401218,-0.00921523635343839,0.00125669923583906,0.136355511760011
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ALDH3A1,"Aldehyde dehydrogenase, dimeric NADP-preferring",39838,-0.00841144986127223,0.00565008043206223,-0.0194856075081142,0.00266270778556975,0.136577955816991
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SLC12A2,Solute carrier family 12 member 2,37017,-0.00369900210456066,0.00248532261800337,-0.00857023443584726,0.00117223022672594,0.136685531713785
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,HCG22,Protein PBMUCL2,37017,-0.00719362517405323,0.0048345378175247,-0.0166693192964017,0.00228206894829519,0.136783974553121
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CSH1,Chorionic somatomammotropin hormone 1,37441,-0.00461088137998646,0.00310035589080275,-0.0106875789259599,0.00146581616598692,0.136982477873243
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,AARSD1,Alanyl-tRNA editing protein Aarsd1,39784,-0.00725174303720689,0.00487780783185994,-0.0168122463876524,0.00230876031323859,0.137118946010185
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,KIAA1549,UPF0606 protein KIAA1549,37165,-0.00911499597108937,0.0061402008228634,-0.0211497895839016,0.00291979764172289,0.13770571835477
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CCDC50,Coiled-coil domain-containing protein 50,37408,-0.0102142126308862,0.00688459156498208,-0.023708012098251,0.0032795868364787,0.137929364256377
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PECR,Peroxisomal trans-2-enoyl-CoA reductase,37039,-0.00369128698663576,0.00248874302477563,-0.008569223315196,0.00118664934192448,0.138046972619655
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,THSD1,Thrombospondin type-1 domain-containing protein 1,36971,-0.00454843058020974,0.00307349991475532,-0.0105724904131302,0.00147562925271069,0.138927605181661
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PON1,Serum paraoxonase/arylesterase 1,37441,0.00336778374834419,0.00227840268084608,-0.00109788550611413,0.0078334530028025,0.139395190128604
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FGF16,Fibroblast growth factor 16,37052,-0.0063545296322641,0.00430023749107148,-0.0147829951147642,0.002073935850236,0.139507689879576
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TMOD4,Tropomodulin-4,36958,0.00537143898926853,0.00363527519783926,-0.00175370039849641,0.0124965783770335,0.139542133543532
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FAP,Prolyl endopeptidase FAP,40048,-0.00359385283874415,0.00243473830893457,-0.00836593992425592,0.00117823424676761,0.139943596985999
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SNAP23,Synaptosomal-associated protein 23,39864,-0.0114320215603704,0.00776674209324598,-0.0266548360631325,0.00379079294239176,0.141062196193126
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IL34,Interleukin-34,39452,-0.00468172131528622,0.00319554209045914,-0.0109449838125861,0.0015815411820137,0.142919553693225
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CCT5,T-complex protein 1 subunit epsilon,39473,-0.00585186350516464,0.00399921246961892,-0.0136903199456177,0.00198659293528845,0.143418029574378
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DCUN1D1,DCN1-like protein 1,36987,-0.00977607902653889,0.00669216552567661,-0.0228927234568651,0.00334056540378727,0.144087557805051
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FGF20,Fibroblast growth factor 20,37052,-0.00557920413777817,0.00382652280614848,-0.0130791888378292,0.00192078056227285,0.14485470436182
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CEBPB,CCAAT/enhancer-binding protein beta,39581,-0.00486725328111338,0.00333890009290454,-0.0114114974632063,0.00167699090097952,0.144931779115422
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MEGF11,Multiple epidermal growth factor-like domains protein 11,37017,-0.00411725647707849,0.00282501116064115,-0.00965427835193514,0.00141976539777817,0.145021542260611
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CORO6,Coronin-6,36987,0.00493026732916918,0.00338297642770744,-0.0017003664691374,0.0115609011274758,0.145036647012276
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,HSD17B3,Testosterone 17-beta-dehydrogenase 3,37017,-0.00619380458311506,0.00425374007698435,-0.0145311351340044,0.00214352596777427,0.14539314957577
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ICOSLG,ICOS ligand,39784,-0.00244934123204579,0.0016849928668194,-0.00575192725101181,0.000853244786920227,0.1460710828315
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,LCN15,Lipocalin-15,37408,0.00802812018925707,0.00552282449059124,-0.00279661581230176,0.0188528561908159,0.146073241923938
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CD36,Platelet glycoprotein 4,37052,-0.00591423650141008,0.0040723945855323,-0.0138961298890534,0.00206765688623323,0.146448962131943
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,BRD2,Bromodomain-containing protein 2,36987,-0.0043864649792955,0.00302159204104337,-0.0103087853797405,0.0015358554211495,0.146607113364856
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DDA1,DET1- and DDB1-associated protein 1,37017,-0.00514320786962733,0.00354508426278906,-0.0120915730246939,0.00180515728543922,0.146859429314835
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CSRP3,Cysteine and glycine-rich protein 3,37017,0.0125896461199937,0.00868934199141549,-0.00444146418318061,0.0296207564231681,0.147400320010964
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,OGT,UDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunit,37165,-0.00817734262761512,0.0056485924387249,-0.0192485838075159,0.00289389855228569,0.147730705901736
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DPP7,Dipeptidyl peptidase 2,39750,0.00776140188099463,0.00536717088908155,-0.00275825306160521,0.0182810568235945,0.148172219926097
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CST6,Cystatin-M,39520,-0.00604161160636524,0.00418079920283956,-0.0142359780439308,0.00215275483120029,0.148453927485687
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TMPRSS11B,Transmembrane protease serine 11B,36987,-0.00985098891409236,0.00685000067107971,-0.0232769902294086,0.00357501240122387,0.150429399134145
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TPRKB,EKC/KEOPS complex subunit TPRKB,36958,-0.00843714840570331,0.00587252930632996,-0.01994730584611,0.0030730090347034,0.150822998729787
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CBLN1,Cerebellin-1,36987,-0.0123201732802865,0.00858245985720099,-0.0291417946004005,0.00450144803982742,0.151166764330926
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PSG1,Pregnancy-specific beta-1-glycoprotein 1,39745,0.014141371954486,0.00985554358682241,-0.00517549347568592,0.0334582373846579,0.151345333210616
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NAMPT,Nicotinamide phosphoribosyltransferase,39473,-0.00653799268167693,0.00455942160617326,-0.0154744590297765,0.00239847366642265,0.151605928028653
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CCAR2,Cell cycle and apoptosis regulator protein 2,37384,0.00731968891554643,0.00511624432641938,-0.00270814996423555,0.0173475277953284,0.152546145900028
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TCTN3,Tectonic-3,37433,0.00375607705843762,0.00262625460682692,-0.00139138197094314,0.00890353608781839,0.152681800706806
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CDON,Cell adhesion molecule-related/down-regulated by oncogenes,39881,-0.00340681594707333,0.00238309371678484,-0.00807767963197163,0.00126404773782497,0.152857961886584
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IL19,Interleukin-19,39415,-0.00875061398088298,0.00613072998732995,-0.0207668447560497,0.00326561679428373,0.153503031107707
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ASAH2,Neutral ceramidase,39745,-0.00666305936987102,0.00467088412867042,-0.015817992262065,0.00249187352232299,0.153741054660845
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PLXDC1,Plexin domain-containing protein 1,39473,0.00438270975657176,0.00307253260849175,-0.00163945415607207,0.0104048736692156,0.153768285173192
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GH2,Growth hormone variant,39473,-0.0209199303111843,0.0146750100323934,-0.0496829499746753,0.00784308935230672,0.154018864187237
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,LRRC38,Leucine-rich repeat-containing protein 38,37035,0.00613496320701066,0.00432181438023354,-0.00233579297824707,0.0146057193922684,0.155767000048079
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CALCA,Calcitonin,39709,-0.00770741014699045,0.00543358062668668,-0.0183572281752963,0.00294240788131544,0.156071158001888
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,RANBP2,E3 SUMO-protein ligase RanBP2,36987,-0.00427186221180305,0.0030139748721846,-0.0101792529612849,0.00163552853767877,0.156403879477566
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FCRL6,Fc receptor-like protein 6,39862,-0.00833115081835149,0.00588318294003328,-0.0198621893808167,0.00319988774411374,0.156766913378177
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SERPINA5,Plasma serine protease inhibitor,37279,-0.00400823871129727,0.0028318025377061,-0.00955857168520123,0.00154209426260669,0.156963550248571
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,BMP6,Bone morphogenetic protein 6,39564,-0.00528809908064311,0.00373668172810345,-0.0126119952677259,0.00203579710643964,0.157033843438721
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CD226,CD226 antigen,37052,-0.00528088821382696,0.00373419773934576,-0.0125999157829446,0.00203813935529072,0.157327905928013
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SPINK1,Serine protease inhibitor Kazal-type 1,39854,-0.00505468388652604,0.0035785785303402,-0.0120686978059928,0.00195933003294075,0.157827040443887
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,VWA5A,von Willebrand factor A domain-containing protein 5A,36958,0.0102468895597876,0.00725611358887633,-0.00397509307441005,0.0244688721939852,0.157922710170067
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IFNW1,Interferon omega-1,37017,-0.00446174003983646,0.00315959078185364,-0.0106545379722696,0.00173105789259667,0.157936538538936
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,BATF,Basic leucine zipper transcriptional factor ATF-like,37035,-0.010604672567027,0.00751303628695798,-0.0253302236894646,0.00412087855541068,0.15811999350258
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CRACR2A,EF-hand calcium-binding domain-containing protein 4B,39473,-0.0107489230934745,0.00761827629503034,-0.025680744631734,0.00418289844478492,0.15828252760837
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TRIM26,Tripartite motif-containing protein 26,36958,-0.00702245264643328,0.00497736695273875,-0.0167780918738012,0.00273318658093468,0.158304629563341
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MAEA,E3 ubiquitin-protein transferase MAEA,39473,-0.0050409936305894,0.00357810352459304,-0.0120540765387918,0.00197208927761295,0.15890088946736
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SELPLG,P-selectin glycoprotein ligand 1,39862,0.00349268277398962,0.00248070098639926,-0.00136949115935292,0.00835485670733216,0.159167711030764
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ANKRA2,Ankyrin repeat family A protein 2,36958,-0.00681209663266803,0.00484441260760215,-0.0163071453435682,0.00268295207823219,0.159695598310251
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ILKAP,Integrin-linked kinase-associated serine/threonine phosphatase 2C,39465,-0.00739350170955669,0.00526277964529111,-0.0177085498143273,0.00292154639521389,0.160080947641199
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MYH9,Myosin-9,37433,-0.0139319228366923,0.00991713262094306,-0.0333695027737407,0.00550565710035611,0.160093598412904
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,UROS,Uroporphyrinogen-III synthase,37035,0.00861590891302562,0.0061353697900031,-0.00340941587538046,0.0206412337014317,0.160252664829246
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",36987,-0.00702164276351577,0.00501045591611817,-0.0168421363591074,0.00279885083207585,0.161118739660324
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CEP85,Centrosomal protein of 85 kDa,39473,-0.00799193914289168,0.00570357082300991,-0.0191709379559911,0.00318705967020775,0.161169134254766
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CPXM2,Inactive carboxypeptidase-like protein X2,37433,-0.00299391815007166,0.00213693514766366,-0.00718231103949243,0.00119447473934911,0.161226859269671
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,KDM3A,Lysine-specific demethylase 3A,37052,-0.0115871822425072,0.00829114751623138,-0.0278378313743207,0.00466346688930632,0.162275764995238
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CDH23,Cadherin-23,37384,0.00333221104528672,0.0023908605595978,-0.00135387565152498,0.00801829774209841,0.163422438810573
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DUSP29,Dual specificity phosphatase 29,37035,0.0082724721252437,0.0059478505362641,-0.00338531492583394,0.0199302591763213,0.164299291375303
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,AOC1,Amiloride-sensitive amine oxidase [copper-containing],39583,-0.00677647786120934,0.00488646206685411,-0.0163539435122434,0.00280098778982471,0.165526645366354
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,KRT14,"Keratin, type I cytoskeletal 14",39060,-0.00357746622336607,0.00258928880965104,-0.00865247229028212,0.00149753984354997,0.16710242610813
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GSTM4,Glutathione S-transferase Mu 4,37017,-0.0088263273738119,0.00638992828878028,-0.0213505868198212,0.00369793207219745,0.167214070989988
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ARID4B,AT-rich interactive domain-containing protein 4B,39485,-0.0050040995175488,0.00362336184200546,-0.0121058887278795,0.0020976896927819,0.167278617007762
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,RBPMS,RNA-binding protein with multiple splicing,37052,-0.00797963301406439,0.00578106274607187,-0.0193105159963653,0.00335124996823648,0.167515974170908
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,RGS8,Regulator of G-protein signaling 8,39583,-0.0081065132281364,0.00587598300579325,-0.0196234399194912,0.00341041346321837,0.167729086070855
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SPAG1,Sperm-associated antigen 1,37408,-0.00716168188921981,0.00519715724061999,-0.017348110080835,0.00302474630239538,0.16822609326347
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,KIF1C,Kinesin-like protein KIF1C,37017,-0.00449488628911242,0.0032648847208121,-0.0108940603419041,0.0019042877636793,0.168617124467231
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CDC25A,M-phase inducer phosphatase 1,36958,-0.00511079711871465,0.0037139137229608,-0.0123900680157178,0.00216847377828852,0.168807497484984
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SPRR1B,Cornifin-B,37165,-0.0107699832019179,0.00783085966347248,-0.026118468142324,0.00457850173848815,0.169053621758098
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FGF12,Fibroblast growth factor 12,37052,-0.00573607403599278,0.00417260831663871,-0.0139143863366047,0.0024422382646191,0.169248609595137
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,C1QTNF1,Complement C1q tumor necrosis factor-related protein 1,39927,0.00508769004478859,0.00370258861145734,-0.00216938363366779,0.012344763723245,0.169432906203639
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TRIM24,Transcription intermediary factor 1-alpha,37131,-0.00799923337435693,0.00582344436003022,-0.0194131843200162,0.0034147175713023,0.169581087961418
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SMS,Spermine synthase,36987,-0.00785241121579711,0.00572639979725261,-0.0190761548184122,0.00337133238681801,0.170315824057969
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CFC1,Cryptic protein,39473,-0.00570848147979743,0.0041685344793934,-0.0138788090594085,0.00246184609981364,0.170887198482613
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GAS2,Growth arrest-specific protein 2,37165,-0.00647800898946735,0.00473172793517092,-0.0157521957424023,0.00279617776346765,0.171004321799185
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,AOC3,Membrane primary amine oxidase,39927,-0.00366510162653346,0.00268221698623029,-0.00892224691954484,0.00159204366647791,0.171818497175053
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CDHR1,Cadherin-related family member 1,39485,0.00520672329115239,0.00381403373067749,-0.00226878282097549,0.0126822294032803,0.172225964550287
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,BLVRB,Flavin reductase,39854,-0.00783691224775737,0.00574902092877985,-0.0191049932681659,0.00343116877265113,0.172847066142732
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,C1QTNF6,Complement C1q tumor necrosis factor-related protein 6,37408,0.0038690630527683,0.00283953976918684,-0.0016964348948379,0.00943456100037449,0.173041678688341
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,EIF2AK3,Eukaryotic translation initiation factor 2-alpha kinase 3,37017,-0.00796470710981249,0.00585412148905397,-0.0194387852283583,0.0035093710087333,0.173685615800199
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,EPHX2,Bifunctional epoxide hydrolase 2,39581,-0.00745046485014003,0.00548342315579383,-0.0181979742354959,0.00329704453521588,0.174253199051038
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GGT1,Glutathione hydrolase 1 proenzyme,39822,0.00601114374938697,0.00443290586511185,-0.00267735174623225,0.0146996392450062,0.175109493601201
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NFKB1,Nuclear factor NF-kappa-B p105 subunit,37017,-0.00904723127277951,0.00667997385794708,-0.0221399800343558,0.00404551748879676,0.175638038470531
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FDX1,"Adrenodoxin, mitochondrial",37017,-0.00766913470093225,0.00566440952424954,-0.0187713773684614,0.00343310796659685,0.175786432457565
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ERVV_1,,37017,-0.00580378447910151,0.00429251714797332,-0.0142171180891292,0.00260954913092619,0.176376102579605
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,LAMA1,Laminin subunit alpha-1,37017,-0.00653343840828657,0.00483781868074187,-0.0160155630225406,0.00294868620596749,0.176881248150562
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,JCHAIN,Immunoglobulin J chain,39583,-0.00730421711098959,0.00540870400312616,-0.0179052769571169,0.00329684273513769,0.176889175011484
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,HMMR,Hyaluronan mediated motility receptor,36938,-0.00568657232550274,0.00423100575907597,-0.0139793436132916,0.00260619896228617,0.178964014254817
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DDHD2,Phospholipase DDHD2,37408,-0.00798557414084387,0.00594591525927292,-0.0196395680490188,0.00366841976733104,0.179283038757228
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PSMA1,Proteasome subunit alpha type-1,39473,-0.00557245965695771,0.00414968550988227,-0.013705843256327,0.00256092394241155,0.179335819460132
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SHPK,Sedoheptulokinase,37165,-0.00501729385367745,0.00373905626421963,-0.0123458441315479,0.00231125642419303,0.179663961765284
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,RICTOR,Rapamycin-insensitive companion of mTOR,37052,-0.00572288797062261,0.00426548379230097,-0.0140832362035325,0.0026374602622873,0.179724870192441
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,HGFAC,Hepatocyte growth factor activator,37314,-0.00337860145771818,0.00252397025451724,-0.00832558315657196,0.00156838024113561,0.180721625278477
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NTF3,Neurotrophin-3,39862,-0.00400431839147318,0.0030026746572525,-0.00988956071968808,0.00188092393674171,0.182359264596808
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,LTO1,Protein LTO1 homolog,39583,-0.00479918277233447,0.00360456036923753,-0.01186412109604,0.00226575555137108,0.183070245695636
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,HIP1,Huntingtin-interacting protein 1,37017,-0.00398172010881449,0.00299276202234574,-0.00984753367261215,0.00188409345498316,0.183393122334587
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,BCL7B,B-cell CLL/lymphoma 7 protein family member B,37364,-0.00535784554963553,0.00403732154740372,-0.0132709957825468,0.00255530468327576,0.18450491400427
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NECTIN1,Nectin-1,37052,-0.00377522781131,0.00285688244747016,-0.00937471740835152,0.00182426178573152,0.186374222383254
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PCDH17,Protocadherin-17,39864,-0.00411867958013415,0.00312250712781586,-0.0102387935506532,0.00200143439038493,0.18717806213777
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,LIF,Leukemia inhibitory factor,39485,-0.00602146238176998,0.00458676915960497,-0.0150115299345957,0.00296860517105577,0.189273170739024
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,RAB39B,Ras-related protein Rab-39B,37017,-0.0103619427469762,0.00791637454620711,-0.0258780368575421,0.00515415136358978,0.190582524059185
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MATN3,Matrilin-3,39716,-0.00365454937769016,0.00279376698053673,-0.00913033265954215,0.00182123390416184,0.190855589864482
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,OSBPL2,Oxysterol-binding protein-related protein 2,37384,-0.00447389055635829,0.00342646367256312,-0.011189759354582,0.00224197824186541,0.191681083319085
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DGCR6,Protein DGCR6,36987,-0.00504925171957576,0.00386823764633483,-0.012630997506392,0.0025324940672405,0.191809973768526
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CRX,Cone-rod homeobox protein,39581,-0.0125948272101423,0.00966123622871918,-0.0315308502184319,0.00634119579814734,0.19237356631247
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,HRAS,GTPase Hras,37157,-0.0113808011036165,0.00873190290810783,-0.0284953308035078,0.00573372859627486,0.192474916315627
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ABCA2,ATP-binding cassette sub-family A member 2,37017,0.00426872933467411,0.00327999535361296,-0.00216006155840729,0.0106975202277555,0.193129406817553
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GFRAL,GDNF family receptor alpha-like,36938,-0.0072082518917062,0.00554476502888734,-0.0180759913483254,0.00365948756491299,0.193620335226028
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SMTN,Smoothelin,37338,-0.0111482896974791,0.00857952253864731,-0.0279641538732278,0.00566757447826966,0.193826593913575
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ESM1,Endothelial cell-specific molecule 1,39858,-0.00394931700852179,0.0030427091211259,-0.00991302688592856,0.00201439286888497,0.194319535938447
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PGM2,Phosphoglucomutase-2,37035,-0.00703013068906515,0.00541949724739139,-0.0176523452939523,0.00359208391582197,0.194587706500312
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PCARE,Photoreceptor cilium actin regulator,36987,0.00986868327020093,0.00761156476455583,-0.0050499836683285,0.0247873502087304,0.194812973833783
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,LAMB1,Laminin subunit beta-1,37039,0.00349954509413198,0.00270471463439423,-0.00180169558928071,0.00880078577754468,0.195733517376736
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NPTX2,Neuronal pentraxin-2,37433,-0.00387847489675034,0.00300033010763437,-0.00975912190771371,0.00200217211421303,0.196142819511108
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IRAG2,"Inositol 1,4,5-triphosphate receptor associated 2",39581,-0.0102324329268813,0.00792510902701703,-0.0257656466198347,0.00530078076607205,0.196673785604612
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CYP24A1,"1,25-dihydroxyvitamin D(3) 24-hydroxylase, mitochondrial",37017,-0.00979262703764886,0.00758482214912041,-0.0246588784499249,0.00507362437462715,0.196697942880628
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,RNF31,E3 ubiquitin-protein ligase RNF31,37052,-0.00430579376062859,0.00333741301632011,-0.010847123272616,0.00223553575135882,0.197018038878046
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ST8SIA1,"Alpha-N-acetylneuraminide alpha-2,8-sialyltransferase",37052,-0.00577425415130087,0.00448370108884768,-0.0145623082854423,0.00301379998284058,0.197827008602384
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SERPINB9,Serpin B9,39745,-0.00383568791226408,0.00298108858288237,-0.00967862153471353,0.00200724571018537,0.198226836729152
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FGF2,Fibroblast growth factor 2,39862,-0.00762782322324307,0.00594607642688113,-0.0192821330199301,0.00402648657344395,0.199569160733937
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ARHGEF12,Rho guanine nucleotide exchange factor 12,39862,-0.0118705744102522,0.0092664716578888,-0.0300328588597142,0.00629171003920985,0.200203731874057
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CEACAM6,Carcinoembryonic antigen-related cell adhesion molecule 6,37433,-0.00452253350965848,0.0035331368531556,-0.0114474817418435,0.00240241472252649,0.200555233186474
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,HEG1,Protein HEG homolog 1,37120,-0.00309148454532914,0.0024170390321244,-0.00782888104829296,0.00164591195763469,0.200906089790296
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MYL4,Myosin light chain 4,37039,0.00589873621035859,0.00461581202934252,-0.00314825536715275,0.0149457277878699,0.201292679662005
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CD33,Myeloid cell surface antigen CD33,39909,-0.00895434576855915,0.00700715621832631,-0.0226883719564787,0.00477968041936042,0.201308161338359
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CDC123,Cell division cycle protein 123 homolog,36958,0.00723830626785772,0.0056706305419217,-0.00387612959430883,0.0183527421300243,0.201817258772377
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DCN,Decorin,39581,-0.00247699953915506,0.00194207451511956,-0.0062834655887894,0.00132946651047928,0.202172391111504
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IGDCC3,Immunoglobulin superfamily DCC subclass member 3,36987,-0.005475044886154,0.00430075202309787,-0.0139045188514258,0.00295442907911781,0.203025111216816
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MYBPC2,"Myosin-binding protein C, fast-type",37039,0.00963095534837223,0.00757188096906994,-0.00520993135100485,0.0244718420477493,0.203417957815554
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DHODH,Dihydroorotate dehydrogenase,37017,-0.00520973603615938,0.00414173707010937,-0.0133275406935737,0.002908068621255,0.20846378597777
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,KRT5,"Keratin, type II cytoskeletal 5",39485,-0.00566335602121177,0.00451090925428845,-0.0145047381596171,0.00317802611719359,0.209323365169588
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MDM1,Nuclear protein MDM1,37035,-0.00351629035547123,0.00280087800677301,-0.00900601124874633,0.00197343053780387,0.209347032135236
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CREB3,Cyclic AMP-responsive element-binding protein 3,36958,-0.00628323438137424,0.00500648488533613,-0.0160959447566331,0.00352947599388458,0.209494201503926
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TYRP1,"5,6-dihydroxyindole-2-carboxylic acid oxidase",37052,-0.00668584703938567,0.00533319500853264,-0.0171389092561096,0.0037672151773383,0.20999916178037
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ATP2B4,Plasma membrane calcium-transporting ATPase 4,37017,-0.00711165097085307,0.00568036606466068,-0.018245168457588,0.00402186651588187,0.210602854697355
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CPA4,Carboxypeptidase A4,36864,-0.00485488922769578,0.00388083869706535,-0.0124613330739439,0.0027515546185523,0.210960742385305
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MRPL28,"39S ribosomal protein L28, mitochondrial",37408,-0.00401360742770723,0.00321180462099908,-0.0103087444848654,0.00228152962945096,0.211451772402356
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DOK1,Docking protein 1,37384,-0.015252525455015,0.0122221536869276,-0.0392079466813931,0.00870289577136301,0.212074307698155
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NOS1,"Nitric oxide synthase, brain",39485,0.00599682733383845,0.00482109121814435,-0.00345251145372448,0.0154461661214014,0.213564805120951
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TARM1,"T-cell-interacting, activating receptor on myeloid cells protein 1",37035,-0.00855638596470981,0.00688203605352152,-0.022045176629612,0.00493240470019237,0.213782075086795
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GATA3,Trans-acting T-cell-specific transcription factor GATA-3,36958,-0.00290503101175138,0.0023388562430794,-0.00748918924818701,0.00167912722468425,0.214231738707366
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TPT1,Translationally-controlled tumor protein,39583,-0.00723477681667116,0.00582825217873233,-0.0186581510869865,0.00418859745364421,0.214502857884286
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ADGRV1,Adhesion G-protein coupled receptor V1,36987,-0.00767953504400717,0.00618799426040041,-0.019808003794392,0.00444893370637763,0.214613947066431
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,RNF4,E3 ubiquitin-protein ligase RNF4,37165,-0.00726207979203118,0.00586152805252035,-0.0187506747749711,0.0042265151909087,0.215389686647255
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,COL1A1,Collagen alpha-1(I) chain,40048,0.00272914313207945,0.00220881890373012,-0.00160014191923158,0.00705842818339047,0.216637591085773
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,UGDH,UDP-glucose 6-dehydrogenase,37017,-0.0110350675590922,0.0089357957468076,-0.0285492272228351,0.00647909210465071,0.216879221657638
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SHD,SH2 domain-containing adapter protein D,36998,-0.00914744489433097,0.00742161958208856,-0.0236938192752245,0.00539892948656262,0.217769394439172
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CA7,Carbonic anhydrase 7,37165,0.00369209737449475,0.00300829919740781,-0.00220416905242456,0.00958836380141406,0.219730100395268
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ATXN10,Ataxin-10,39485,-0.00801728607594218,0.00653360313101934,-0.0208231482127401,0.00478857606085573,0.219809151823571
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TUBB3,Tubulin beta-3 chain,36987,-0.0030819691947584,0.00251239935995048,-0.00800627194026135,0.00184233355074454,0.219956037456286
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MGLL,Monoglyceride lipase,39904,-0.0095678434227064,0.00780110856676468,-0.0248580162135652,0.00572232936815238,0.220038999123563
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,HAGH,"Hydroxyacylglutathione hydrolase, mitochondrial",39980,-0.00771350670515485,0.00630353789649262,-0.0200684409822804,0.00464142757197068,0.221091245078213
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IL1A,Interleukin-1 alpha,39583,-0.00579836698912646,0.00477023024353535,-0.0151480182664557,0.00355128428820282,0.224181543870945
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MYOM1,Myomesin-1,36987,-0.00512960399198541,0.00423011542247949,-0.0134206302200452,0.00316142223607438,0.225289598360073
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SUOX,"Sulfite oxidase, mitochondrial",37408,-0.00677505205421888,0.00559149921540696,-0.0177343905164165,0.00418428640797875,0.225659845933343
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,HMGCS1,"Hydroxymethylglutaryl-CoA synthase, cytoplasmic",37017,-0.00467981802974812,0.00387456880468996,-0.0122739728869404,0.00291433682744421,0.22713460904149
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GPD1,Glycerol-3-phosphate dehydrogenase,37364,-0.00562215567890274,0.00466469742165722,-0.0147649626253509,0.00352065126754541,0.228125516517955
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CCL15,C-C motif chemokine 15,40048,-0.00465980164709509,0.00386664234843873,-0.012238420650035,0.00291881735584481,0.228171240453013
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MUCL3,Mucin-like protein 3,36958,-0.00481275278996271,0.00400054309393825,-0.0126538172540817,0.00302831167415626,0.228988445669087
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,VSIG10,V-set and immunoglobulin domain-containing protein 10,37364,-0.0038943485971978,0.0032432905394481,-0.0102511980545161,0.00246250086012048,0.229873144203862
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,LPP,Lipoma-preferred partner,37017,-0.00719260100575888,0.00599208726941662,-0.0189370920538154,0.00455189004229769,0.230025111778755
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SARG,Specifically androgen-regulated gene protein,37386,-0.0116381100638031,0.0097542176069492,-0.0307563765734235,0.00748015644581737,0.232836966627776
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NAGA,Alpha-N-acetylgalactosaminidase,37033,-0.00641091469203249,0.0053734987011858,-0.0169429721463567,0.00412114276229169,0.232866755951326
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PDXDC1,Pyridoxal-dependent decarboxylase domain-containing protein 1,36958,0.00610811671287899,0.00513323586306679,-0.00395302557873191,0.0161692590044899,0.234101189068362
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SLMAP,Sarcolemmal membrane-associated protein,37378,-0.00887252721503472,0.00746084115896547,-0.023495775886607,0.00575072145653759,0.234376858167318
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NUDT10,Diphosphoinositol polyphosphate phosphohydrolase 3-alpha,37039,0.00280913394940819,0.00236266298819158,-0.0018216855074473,0.00743995340626368,0.234473138367213
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FGF23,Fibroblast growth factor 23,40004,0.00619180331216895,0.0052098638092035,-0.00401952975386991,0.0164031363782078,0.234663018253008
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IL31RA,Interleukin-31 receptor subunit alpha,37011,-0.00422756862651729,0.00355711936439664,-0.0111995225807347,0.00274438532770013,0.234665439028546
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SCN2B,Sodium channel subunit beta-2,37035,0.00306613569425555,0.00258025134184207,-0.0019911569357549,0.008123428324266,0.234733143022601
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SPON2,Spondin-2,39771,0.0035594503181601,0.00299678081346932,-0.00231424007623977,0.00943314071255998,0.23494650485046
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,RAB10,Ras-related protein Rab-10,37433,-0.00566068841442715,0.0047678706381877,-0.015005714865275,0.00368433803642074,0.235146989612835
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TJAP1,Tight junction-associated protein 1,39909,-0.00878175707899517,0.00741430218318448,-0.0233137893580367,0.00575027520004641,0.236258555430223
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GAGE2A,G antigen 2A,36958,-0.00642828785504961,0.00543653785224177,-0.0170839020454435,0.00422732633534425,0.237059332164095
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,EPHA1,Ephrin type-A receptor 1,39900,-0.00350847488733001,0.00298090453134326,-0.0093510477687628,0.00233409799410278,0.239219632155999
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CNTN3,Contactin-3,39854,-0.00339470314849821,0.00291240578595706,-0.00910301848897406,0.00231361219197763,0.243793178245203
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,KCNH2,Potassium voltage-gated channel subfamily H member 2,37035,-0.00812955600972634,0.00697498983529909,-0.0218005360869126,0.00554142406745988,0.243825849996564
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,HNF1A,Hepatocyte nuclear factor 1-alpha,37035,-0.00739368588501386,0.00635710087170135,-0.0198536035935485,0.00506623182352079,0.244826470311857
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NEO1,Neogenin,37408,-0.0022373119705765,0.00192481649629429,-0.00600995230331332,0.00153532836216031,0.245113479287928
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CRYM,Ketimine reductase mu-crystallin,36987,-0.00794743012692425,0.00684769461336781,-0.0213689115691252,0.00547405131527665,0.245825963355932
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MMP9,Matrix metalloproteinase-9,39839,-0.00625773162199439,0.00540312590199088,-0.0168478583898965,0.00433239514590774,0.246812484329108
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SCT,Secretin,37035,0.0045798455349432,0.00395445811320073,-0.00317089236693023,0.0123305834368166,0.24682486702333
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CCDC28A,Coiled-coil domain-containing protein 28A,37035,0.00304823764820189,0.00263627090661385,-0.00211885332876125,0.00821532862516504,0.24759221507467
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,RAB33A,Ras-related protein Rab-33A,37017,-0.00687919936946712,0.00599418561543402,-0.0186278031757178,0.00486940443678356,0.251135859081223
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CDK5RAP3,CDK5 regulatory subunit-associated protein 3,37408,-0.00606538236171743,0.00528613434363898,-0.0164262056752498,0.00429544095181497,0.251230990482766
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IL6ST,Interleukin-6 receptor subunit beta,39864,-0.00179711049776498,0.00156973353212418,-0.00487378822072838,0.00127956722519842,0.252288139107323
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PLB1,"Phospholipase B1, membrane-associated",37384,-0.00608088373756425,0.00532931741371234,-0.0165263458684404,0.00436457839331195,0.253879775760449
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PDRG1,p53 and DNA damage-regulated protein 1,37035,-0.00542040461109612,0.00475125559697652,-0.0147328655811701,0.00389205635897786,0.25395880961207
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MST1,Hepatocyte growth factor-like protein,37267,-0.00640545632900815,0.00562163310436574,-0.017423857213565,0.0046129445555487,0.25454428609673
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ICAM2,Intercellular adhesion molecule 2,40048,0.00316125973612245,0.00279433776153433,-0.00231564227648483,0.00863816174872973,0.257941774937059
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ADAMTS1,A disintegrin and metalloproteinase with thrombospondin motifs 1,37052,-0.00315513149195434,0.00279010706579622,-0.00862374134091493,0.00231347835700624,0.258148005093261
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DPEP1,Dipeptidase 1,39709,-0.00477428909156071,0.00422263185144659,-0.013050647520396,0.0035020693372746,0.258222495634111
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,COL4A4,Collagen alpha-4(IV) chain,37143,-0.00528263914273382,0.00467980590791757,-0.0144550587222522,0.00388978043678461,0.258995905866946
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SMC3,Structural maintenance of chromosomes protein 3,36958,-0.00531495957440033,0.0047145775557047,-0.0145555315835815,0.00392561243478087,0.259616923567328
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CA11,Carbonic anhydrase-related protein 11,39473,-0.00315748806918067,0.00280126295754395,-0.00864796346596681,0.00233298732760546,0.259689669524084
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,AMPD3,AMP deaminase 3,37384,0.00709263551936824,0.00630298518735108,-0.00526121544783987,0.0194464864865764,0.260489541904455
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ADAM23,Disintegrin and metalloproteinase domain-containing protein 23,40054,-0.00344275882918566,0.00306462051683023,-0.00944941504217292,0.00256389738380159,0.261289270503188
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,EPPK1,Epiplakin,37039,-0.0074444605538239,0.00663578879382255,-0.0204506065897161,0.0055616854820683,0.2619401964017
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MFAP3,Microfibril-associated glycoprotein 3,39581,-0.00489097192908159,0.00438333507279131,-0.0134823086717526,0.00370036481358938,0.26452025175257
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SIL1,Nucleotide exchange factor SIL1,37039,0.00330681650412057,0.00296786053752711,-0.00251019014943257,0.00912382315767372,0.265209914834029
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SDCCAG8,Serologically defined colon cancer antigen 8,37364,-0.0113425417756667,0.0101982590975373,-0.0313311296068398,0.00864604605550634,0.266070365120073
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CEP164,Centrosomal protein of 164 kDa,39583,0.00601077444432136,0.00540967130123419,-0.00459218130609766,0.0166137301947404,0.266535244635197
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CD2,T-cell surface antigen CD2,37017,-0.00380133742899445,0.00342474589442803,-0.0105138393820734,0.00291116452408449,0.267035734390977
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SORT1,Sortilin,39842,-0.00368693200905701,0.00333011189451236,-0.0102139513223012,0.00284008730418721,0.268245922528696
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,RGL2,Ral guanine nucleotide dissociation stimulator-like 2,37165,-0.00636229052168763,0.00577215105366325,-0.0176757065868676,0.00495112554349234,0.270377679752108
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ASS1,Argininosuccinate synthase,37017,-0.00786096673376716,0.00713413086826707,-0.0218438632355706,0.00612192976803629,0.270533353906411
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IDUA,Alpha-L-iduronidase,40026,0.00450645106430937,0.00409366137410893,-0.00351712522894413,0.0125300273575629,0.27098429816721
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PGLYRP2,N-acetylmuramoyl-L-alanine amidase,37302,0.0029806652168869,0.00270995836023323,-0.00233085316917023,0.00829218360294403,0.271398283749833
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TP73,Tumor protein p73,37035,-0.00340325204262238,0.00309845539682488,-0.00947622462039915,0.00266972053515439,0.272062804820716
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PMS1,PMS1 protein homolog 1,37035,-0.00489043084396538,0.00445246590873399,-0.013617264025084,0.00383640233715325,0.272065394623745
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,METAP1,Methionine aminopeptidase 1,39485,-0.00298722631914397,0.00272256918003084,-0.00832346191200441,0.00234900927371647,0.272567123201918
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GABARAPL1,Gamma-aminobutyric acid receptor-associated protein-like 1,37165,-0.00642045206421454,0.00585177386339088,-0.0178899288364607,0.00504902470803158,0.272582360424747
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NMNAT1,Nicotinamide/nicotinic acid mononucleotide adenylyltransferase 1,39745,0.00689887801640069,0.00629472880278924,-0.00543879043706622,0.0192365464698676,0.273105453382654
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MINDY1,Ubiquitin carboxyl-terminal hydrolase MINDY-1,37364,-0.0105478393614329,0.00962578850403224,-0.0294143848293361,0.00831870610647024,0.273190383311834
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,AZI2,5-azacytidine-induced protein 2,37408,-0.00540877674410005,0.00494080532695441,-0.0150927551849307,0.00427520169673061,0.273660706747688
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DCUN1D2,DCN1-like protein 2,36958,0.00782527587765028,0.00716653376185591,-0.0062211302955873,0.0218716820508879,0.274888697769484
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CA12,Carbonic anhydrase 12,39784,0.00309223918036598,0.0028475558364933,-0.00248897025916088,0.00867344861989285,0.277527509094597
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CDC27,Cell division cycle protein 27 homolog,39473,-0.0059372272726582,0.00547679104073587,-0.0166717377125005,0.0047972831671841,0.278350307974796
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,KAZALD1,Kazal-type serine protease inhibitor domain-containing protein 1,39784,-0.00429202982490639,0.0039604536337939,-0.0120545189471424,0.00347045929732965,0.278504587955381
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ECHDC3,"Enoyl-CoA hydratase domain-containing protein 3, mitochondrial",37433,-0.00723126201751516,0.00673816067311489,-0.0204380569368203,0.00597553290179002,0.28320925880676
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ZBTB16,Zinc finger and BTB domain-containing protein 16,39473,-0.00678251659366047,0.00633701158731685,-0.0192030593048015,0.00563802611748056,0.284499910258752
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CEP350,Centrosome-associated protein 350,36958,-0.00344891206983168,0.00322585146928219,-0.00977158094962478,0.00287375680996141,0.285022768930558
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ADM,Pro-adrenomedullin,40026,0.00250543641862485,0.00234859612546233,-0.00209781198728131,0.00710868482453102,0.286086922019595
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ALDH1A1,Retinal dehydrogenase 1,39854,-0.0049940703059941,0.00468780900091363,-0.0141821759477848,0.00419403533579662,0.28674205269045
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SPINK5,Serine protease inhibitor Kazal-type 5,39854,-0.00315938273395343,0.00296637233819929,-0.00897347251682404,0.00265470704891719,0.286862079054368
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,AP3S2,AP-3 complex subunit sigma-2,37384,-0.00445149632799028,0.00419199051040174,-0.0126677977283777,0.00376480507239713,0.288297707226431
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,OSM,Oncostatin-M,39781,-0.00676641049038004,0.00637512694330297,-0.0192616592992539,0.00572883831849379,0.288534891588437
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GDF15,Growth/differentiation factor 15,40048,-0.00401127854598572,0.00378351776928226,-0.0114269733737789,0.00340441628180752,0.289070279658012
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PFDN6,Prefoldin subunit 6,37035,-0.00622142865830379,0.00590724299714709,-0.0177996249327121,0.00535676761610449,0.292274832706612
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TSPAN1,Tetraspanin-1,39581,0.00379802016743317,0.00360782250205708,-0.00327331193659871,0.0108693522714651,0.292486375446772
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ENTR1,Endosome-associated-trafficking regulator 1,37039,0.00558000460353452,0.00532600241727431,-0.00485896013432314,0.0160189693413922,0.29480022571536
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PKN3,Serine/threonine-protein kinase N3,37165,-0.00711474625010533,0.00679104397562382,-0.020425192442328,0.00619569994211735,0.294811523318676
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,HSPA2,Heat shock-related 70 kDa protein 2,37364,-0.00315530827935072,0.00301340990915032,-0.00906159170128534,0.0027509751425839,0.295077286539142
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,WASL,Neural Wiskott-Aldrich syndrome protein,37052,-0.00559220684935525,0.00535648169049382,-0.0160909109627231,0.00490649726401263,0.296501068004705
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ENDOU,Poly(U)-specific endoribonuclease,36426,-0.00479062064896515,0.00460715053700028,-0.0138206357014857,0.0042393944035554,0.29844219247227
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ERI1,3'-5' exoribonuclease 1,37165,-0.00310090363704773,0.00299098028825966,-0.00896322500203666,0.0027614177279412,0.299870473050024
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,LYVE1,Lymphatic vessel endothelial hyaluronic acid receptor 1,37449,0.00176836853219785,0.00170582810519183,-0.00157505455397813,0.00511179161837383,0.299911482965103
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,OBP2B,Odorant-binding protein 2b,39697,-0.00580721611606902,0.00561490690556016,-0.0168124336509669,0.00519800141882891,0.301035209858841
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IGSF21,Immunoglobulin superfamily member 21,37039,0.00363716512757335,0.00351928769584857,-0.00326063875628985,0.0105349690114366,0.301391420857332
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PEPD,Xaa-Pro dipeptidase,37441,-0.00236477721652137,0.00228908567934735,-0.00685138514804218,0.00212183071499945,0.301591279892268
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,LEPR,Leptin receptor,39864,0.00284120579062122,0.00276008154061697,-0.00256855402898803,0.00825096561023047,0.303311074969481
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IGDCC4,Immunoglobulin superfamily DCC subclass member 4,37433,-0.00236758935459649,0.00230174993293669,-0.00687901922315239,0.00214384051395942,0.303684092911932
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PTS,6-pyruvoyl tetrahydrobiopterin synthase,39415,-0.00500632423442057,0.00487352951401376,-0.0145584420818876,0.0045457936130464,0.304319598465863
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IL17C,Interleukin-17C,39583,0.00606565335073923,0.00593444039370616,-0.00556584982092484,0.0176971565224033,0.306744368712051
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SERPINA11,Serpin A11,40048,-0.00372194224255562,0.00365002274476077,-0.0108759868222867,0.00343210233717549,0.307884174431345
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PGA4,Pepsin A-4,37441,0.00563953069188087,0.00554071564399295,-0.00522027197034531,0.016499333354107,0.308774817386751
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PSCA,Prostate stem cell antigen,37378,-0.0229592327668031,0.0225961700833787,-0.0672477261302254,0.0213292605966191,0.309615455973075
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SSB,Lupus La protein,39485,-0.00550093210071055,0.00542119023844748,-0.0161264649680676,0.00512460076664652,0.310260136126193
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ITIH1,Inter-alpha-trypsin inhibitor heavy chain H1,37449,-0.00168134962225499,0.00165849326836777,-0.00493199642825582,0.00156929718374584,0.310705123712026
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,RBP7,Retinoid-binding protein 7,37378,-0.00543568450462502,0.00536819942381484,-0.0159573553753021,0.00508598636605207,0.311283111980412
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DCDC2C,Doublecortin domain-containing protein 2C,36958,-0.00568560188662666,0.00565690018273182,-0.016773126244781,0.00540192247152771,0.314879905390578
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CDH22,Cadherin-22,37165,-0.0025983464978147,0.00258936215560359,-0.00767349632279774,0.00247680332716834,0.315652532328294
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,KRT17,"Keratin, type I cytoskeletal 17",37017,0.00348593428628278,0.00347950777596204,-0.00333390095460282,0.0103057695271684,0.316435937589205
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PBK,Lymphokine-activated killer T-cell-originated protein kinase,36958,0.0027154648485534,0.00271413240529756,-0.00260423466582981,0.00803516436293661,0.317091468415145
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,BTN1A1,Butyrophilin subfamily 1 member A1,37344,-0.00365244721174084,0.00365363236038834,-0.010813566638102,0.00350867221462031,0.317485450920245
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,UBE2B,Ubiquitin-conjugating enzyme E2 B,37364,-0.00252783336368809,0.00253277495338751,-0.00749207227232761,0.00243640554495143,0.31827350969659
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CBS,Cystathionine beta-synthase,37039,-0.00452024640568345,0.00453482363185956,-0.0134085007241282,0.00436800791276129,0.318886942609891
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,BTD,Biotinidase,37449,0.00182021667662963,0.00182821317949096,-0.00176308115517265,0.0054035145084319,0.319449598080667
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FGR,Tyrosine-protein kinase Fgr,39485,-0.00500949191526543,0.00503775130761648,-0.0148834844781937,0.00486450064766288,0.320048202329637
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IL5RA,Interleukin-5 receptor subunit alpha,39862,0.00478694750418819,0.00484105718790949,-0.0047015245841144,0.0142754195924908,0.322764820223711
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,JMJD1C,Probable JmjC domain-containing histone demethylation protein 2C,36958,0.00496938266515489,0.00502569861405193,-0.00488098661838688,0.0148197519486967,0.322782008165962
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SCLY,Selenocysteine lyase,39980,-0.00433898236977225,0.00438840016202757,-0.0129402466873463,0.00426228194780179,0.322805698608878
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PKLR,Pyruvate kinase PKLR,39877,0.00564188182425306,0.00571070742139579,-0.00555110472168269,0.0168348683701888,0.323193052485066
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MDGA1,MAM domain-containing glycosylphosphatidylinositol anchor protein 1,39745,-0.0061675104928437,0.00624991431594282,-0.0184173425520916,0.00608232156640422,0.32374826837477
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,KLK7,Kallikrein-7,36814,-0.00343161475548286,0.00348099654026751,-0.0102543679744072,0.00339113846344147,0.324242858352273
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MILR1,Allergin-1,39583,0.00435448471940258,0.00442225366210608,-0.00431313245832534,0.0130221018971305,0.324798655541079
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MFAP5,Microfibrillar-associated protein 5,40048,-0.00353267190220855,0.00359022903895162,-0.0105695208185537,0.00350417701413662,0.325145759012115
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CNTF,Ciliary neurotrophic factor,36987,-0.00297617768470289,0.00302903411571344,-0.00891308455150123,0.00296072918209545,0.325847036568509
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TMEM132A,Transmembrane protein 132A,37039,0.00546790030785783,0.00557610496660345,-0.00546126542668493,0.0163970660424006,0.326810531575148
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,HMBS,Porphobilinogen deaminase,40026,0.00375862667711036,0.00383369392654151,-0.00375541341891099,0.0112726667731317,0.326893966469927
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TJP3,Tight junction protein ZO-3,36987,-0.00379098448275728,0.0038786103437529,-0.011393060756513,0.00381109179099841,0.32838525350875
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IL1R1,Interleukin-1 receptor type 1,39822,0.00195552314347607,0.00200421625045172,-0.0019727407074093,0.00588378699436144,0.329225626563107
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CACNA1C,Voltage-dependent L-type calcium channel subunit alpha-1C,36987,-0.00281191299411392,0.00289244203825773,-0.00848109938909906,0.00285727340087123,0.330989463909693
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CASP4,Caspase-4,37165,-0.0143079828666555,0.0147270222192392,-0.0431729464163643,0.0145569806830534,0.331294006828806
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,VEGFD,Vascular endothelial growth factor D,40020,-0.00307494916195406,0.00316858149872447,-0.00928536889945402,0.00313547057554591,0.331836879143028
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SCN3A,Sodium channel protein type 3 subunit alpha,37035,0.00333107210336154,0.00343441955896578,-0.00340039023221138,0.0100625344389345,0.33210999765016
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FH,"Fumarate hydratase, mitochondrial",36987,-0.00714808496137024,0.00738228724685633,-0.0216173679652086,0.00732119804246817,0.332924833337249
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CSF2,Granulocyte-macrophage colony-stimulating factor,37017,0.00302747061592558,0.00313196015635382,-0.00311117129052791,0.00916611252237906,0.333742971893399
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ADH1B,All-trans-retinol dehydrogenase,37120,-0.00653151059671658,0.00675832257984578,-0.0197778228532143,0.00671480165978115,0.333841880399696
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ADRA2A,Alpha-2A adrenergic receptor,37017,-0.00617800622641275,0.00639339572042468,-0.0187090618384451,0.00635304938561961,0.333906531215848
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IGFBP3,Insulin-like growth factor-binding protein 3,39927,-0.00238398839087729,0.00247101470229783,-0.00722717720738103,0.00245920042562645,0.334668962970308
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CLSTN1,Calsyntenin-1,39485,0.00433896879781003,0.00449749694437671,-0.00447612521316833,0.0131540628087884,0.334684015569825
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FMR1,Synaptic functional regulator FMR1,39473,-0.003051789063758,0.00317888655195853,-0.00928240670559672,0.00317882857808072,0.337060902890462
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ELAVL4,ELAV-like protein 4,36987,-0.0072339173334543,0.00754110058648374,-0.0220144744829624,0.00754663981605384,0.337442697653179
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DNAJA4,DnaJ homolog subfamily A member 4,37384,-0.00594329190196569,0.00620321751522176,-0.0181015982318003,0.00621501442786895,0.338030340384924
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NFKB2,Nuclear factor NF-kappa-B p100 subunit,37165,-0.0049898302204951,0.0052143330233727,-0.0152099229463056,0.00523026250531539,0.338612373990432
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,STAU1,Double-stranded RNA-binding protein Staufen homolog 1,36958,-0.00578624536762439,0.00604982224593709,-0.0176438969696611,0.00607140623441231,0.33887152789887
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,EDIL3,EGF-like repeat and discoidin I-like domain-containing protein 3,39581,0.00312381874198441,0.00327333131841557,-0.0032919106421101,0.00953954812607893,0.339934320204087
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ATP1B4,Protein ATP1B4,36958,-0.00356039277361474,0.00373283291343228,-0.010876745283942,0.00375595973671253,0.34020022051114
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CALY,Neuron-specific vesicular protein calcyon,37017,-0.00320639353236282,0.00337971640120156,-0.00983063767871788,0.00341785061399224,0.342782121820285
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,AKR1C4,Aldo-keto reductase family 1 member C4,39581,0.00446758318719823,0.00471818104751755,-0.00478005166593617,0.0137152180403326,0.34371103658441
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PCSK7,Proprotein convertase subtilisin/kexin type 7,37364,0.00374378071964065,0.0039538137011038,-0.00400569413452281,0.0114932555738041,0.343717697761632
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,RRP15,RRP15-like protein,36987,-0.0076312119351471,0.00806852296568765,-0.0234455169478949,0.0081830930776007,0.344267829898361
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,BEX3,Protein BEX3,36958,-0.00394239387128134,0.0041714558589579,-0.0121184473548388,0.00423365961227614,0.34463126253487
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CINP,Cyclin-dependent kinase 2-interacting protein,37165,-0.0036580315738435,0.0038849648290725,-0.0112725626388256,0.00395649949113861,0.346421329314054
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FNDC1,Fibronectin type III domain-containing protein 1,37384,-0.00385418159319745,0.00410034428342887,-0.011890856388718,0.00418249320232314,0.347252116829378
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FGF9,Fibroblast growth factor 9,36927,-0.00338186667207858,0.00361153780501545,-0.0104604807699089,0.00369674742575169,0.34908135259587
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,BANK1,B-cell scaffold protein with ankyrin repeats,39862,-0.00886646774493242,0.00948127834133419,-0.0274497732939474,0.0097168378040826,0.349722379585947
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MYL6B,Myosin light chain 6B,37035,0.0077203399721534,0.00827597085914057,-0.00850056291176212,0.0239412428560689,0.350908241804793
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,BMP10,Bone morphogenetic protein 10,37120,0.00234860382992125,0.0025207524637598,-0.00259207099904796,0.00728927865889046,0.351504702408123
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PTPRH,Receptor-type tyrosine-protein phosphatase H,37378,-0.00404506260163459,0.0043448044301745,-0.0125608792847766,0.00447075408150744,0.35186427584415
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GNAS,Neuroendocrine secretory protein 55,37408,-0.007483416751212,0.00805248898727831,-0.0232662951662775,0.00829946166385349,0.352734832579284
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NGFR,Tumor necrosis factor receptor superfamily member 16,37433,0.00246745007770512,0.00265714714255546,-0.00274055832170359,0.00767545847711382,0.353108400600816
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SNX18,Sorting nexin-18,37378,0.00371929687800679,0.00402696397085794,-0.00417355250487477,0.0116121462608883,0.355712010234075
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TAGLN3,Transgelin-3,36958,-0.00488576023128356,0.00532668581684787,-0.0153260644323054,0.00555454396973827,0.359042538748384
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PLIN3,Perilipin-3,39864,-0.0035060311203803,0.00383493909563656,-0.011022511747828,0.00401044950706735,0.360607756123055
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CXCL14,C-X-C motif chemokine 14,39583,0.00504197780512846,0.00552018556358943,-0.00577758589950682,0.0158615415097637,0.361061419750737
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DYNC1H1,Cytoplasmic dynein 1 heavy chain 1,37364,0.00388050955418558,0.00427741800430974,-0.00450322973426151,0.0122642488426327,0.364312789199053
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CES3,Carboxylesterase 3,39784,0.00557634450526718,0.00615243386622231,-0.00648242587252855,0.0176351148830629,0.364756940372945
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PRSS53,Serine protease 53,37384,-0.00300285604550062,0.0033207227806546,-0.00951147269558364,0.00350576060458241,0.365864198204753
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FCN1,Ficolin-1,37426,0.00452609289640193,0.00501280805578927,-0.00529901089294504,0.0143511966857489,0.366591983988467
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CCL2,C-C motif chemokine 2,39716,0.0041490747577236,0.00460777436809233,-0.00488216300373737,0.0131803125191846,0.3678939984598
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SCARB1,Scavenger receptor class B member 1,39485,-0.00457413404502308,0.00509003426353881,-0.0145506012015591,0.00540233311151299,0.368855607602614
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TANK,TRAF family member-associated NF-kappa-B activator,39583,-0.0056811113851129,0.00632982278798703,-0.0180875640495675,0.00672534127934167,0.369457874548953
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SLC16A1,Monocarboxylate transporter 1,39485,-0.00463985920873044,0.00518095996580677,-0.0147945407417117,0.00551482232425082,0.370501737001352
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TPSD1,Tryptase delta,37408,0.00291560764012301,0.00325907707255201,-0.00347218342207894,0.00930339870232495,0.37101072568301
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,OSTN,Osteocrin,37035,0.00334098980132991,0.00374356403677842,-0.00399639571075578,0.0106783753134156,0.372161486573043
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NOS2,"Nitric oxide synthase, inducible",37017,-0.00314220550498687,0.00353081386226763,-0.0100626006750314,0.00377818966505769,0.373515438008437
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SLC34A3,Sodium-dependent phosphate transport protein 2C,36958,0.00384260639180657,0.00432692755649567,-0.00463817161892494,0.0123233844025381,0.374520420990814
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CD248,Endosialin,37433,-0.00312445686127767,0.00353095619806514,-0.0100451310094853,0.00379621728693001,0.376239422984984
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GFRA3,GDNF family receptor alpha-3,39705,0.00217795215801564,0.00246447526027899,-0.00265241935213118,0.00700832366816245,0.376850693552126
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PRR5,Proline-rich protein 5,37052,-0.00374493595981501,0.00423912247397763,-0.0120536160088112,0.00456374408918115,0.377024164336354
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,LRTM1,Leucine-rich repeat and transmembrane domain-containing protein 1,37035,-0.00330115115108362,0.00374586526888469,-0.0106430470780976,0.00404074477593038,0.378183086079511
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SCN2A,Sodium channel protein type 2 subunit alpha,36987,-0.00381252832623546,0.00433222108988539,-0.0123036816624108,0.0046786250099399,0.378853691331233
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,KCNIP4,Kv channel-interacting protein 4,39485,-0.00411962692577755,0.00468539753573201,-0.0133030060958123,0.00506375224425718,0.379280285753991
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,KLRC1,NKG2-A/NKG2-B type II integral membrane protein,36987,-0.00479961216022195,0.00546593785348114,-0.015512850353045,0.0059136260326011,0.379908290881188
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ANXA1,Annexin A1,37068,-0.00342211186038214,0.00389966387019177,-0.011065453045958,0.00422122932519372,0.380209248750624
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,LELP1,Late cornified envelope-like proline-rich protein 1,36987,-0.00572914451870605,0.00654145706604643,-0.0185504003681571,0.00709211133074496,0.381143456250668
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MORN4,MORN repeat-containing protein 4,36958,0.00621261056596611,0.00710817628498397,-0.00771941495260248,0.0201446360845347,0.382129336966259
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GP2,Pancreatic secretory granule membrane major glycoprotein GP2,39347,0.00664999081982673,0.00762005639734126,-0.00828531971896215,0.0215853013586156,0.382842465740466
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MAP3K5,Mitogen-activated protein kinase kinase kinase 5,39473,-0.00764731632555102,0.00878537798195902,-0.0248666571701907,0.00957202451908866,0.384062688300146
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CLEC10A,C-type lectin domain family 10 member A,39745,0.00278475813099754,0.00321207363378552,-0.00351090619122208,0.00908042245321716,0.385973819523394
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,REXO2,"Oligoribonuclease, mitochondrial",37017,-0.00368124544243012,0.00426255954317468,-0.0120358621470525,0.00467337126219224,0.387810641521507
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MTSS2,Protein MTSS 2,37364,-0.00766201660915972,0.0088854897489676,-0.0250775765171362,0.00975354329881678,0.388534124791513
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,VPS37A,Vacuolar protein sorting-associated protein 37A,39784,-0.00611063601530786,0.007098152860661,-0.0200230156222034,0.0078017435915877,0.38931879276975
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,OLFM4,Olfactomedin-4,36650,0.00941943205873343,0.0109752366713231,-0.0120920318170598,0.0309308959345266,0.390773775180424
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CUZD1,CUB and zona pellucida-like domain-containing protein 1,37035,-0.00279950117824013,0.00326365656892582,-0.00919626805333474,0.00359726569685448,0.391029246415697
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NRXN3,Neurexin-3,37035,-0.00269240438442038,0.00313960553441148,-0.00884603123186687,0.00346122246302611,0.391150319480194
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GSTT2B,Glutathione S-transferase theta-2B,37384,-0.0182299795650852,0.0212819348086124,-0.0599425717899655,0.0234826126597952,0.391684430879141
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GBP6,Guanylate-binding protein 6,37017,-0.00352363252082284,0.00412045266922097,-0.0115997197524959,0.00455245471085026,0.392480000306314
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GLB1,Beta-galactosidase,39745,0.00321122659622937,0.00375995747527357,-0.00415829005530683,0.0105807432477656,0.393085020250615
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PRSS2,Trypsin-2,39927,-0.00391269982202003,0.00458289861936891,-0.0128951811159831,0.00506978147194303,0.393250190406853
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CDA,Cytidine deaminase,37418,0.00350994973048951,0.00413198504616007,-0.00458874095998424,0.0116086404209633,0.395641223955304
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TK1,"Thymidine kinase, cytosolic",37165,-0.00349470906460789,0.00411637616446746,-0.0115628063469641,0.00457338821774832,0.395909313897803
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CA8,Carbonic anhydrase-related protein,37052,-0.00197117363872437,0.00232271361134757,-0.00652369231696559,0.00258134503951686,0.396090819810011
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NPR1,Atrial natriuretic peptide receptor 1,37017,-0.00313919745607765,0.00370464686596579,-0.0104003053133706,0.00412191040121529,0.396805711674527
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,KLK3,Prostate-specific antigen,37433,-0.00592753590510401,0.00700517901066008,-0.0196576867659978,0.00780261495578975,0.397475732217343
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DENND2B,DENN domain-containing protein 2B,37017,0.0038928041834735,0.00460068935458153,-0.00512454695150629,0.0129101553184533,0.397492838586596
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ZNRD2,Protein ZNRD2,37378,-0.0050541192811309,0.00605026384414327,-0.0169126364156517,0.00680439785338991,0.403532517401577
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GHRHR,Growth hormone-releasing hormone receptor,39485,-0.00401090456703162,0.00482104014427694,-0.0134601432498144,0.00543833411575119,0.405445172964039
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PNLIPRP2,Pancreatic lipase-related protein 2,39858,-0.0218276718921851,0.026253712483613,-0.0732849483600665,0.0296296045756963,0.405752894709965
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,AHNAK2,Protein AHNAK2,37039,-0.00216789928902488,0.00260963900945713,-0.00728279174756085,0.0029469931695111,0.406142550061927
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DUOX2,Dual oxidase 2,39581,-0.00528025596571517,0.00637100088403107,-0.0177674176984161,0.00720690576698573,0.407232797404237
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FOLR3,Folate receptor gamma,39854,-0.0139710719499203,0.0168866419752861,-0.0470688902214811,0.0191267463216405,0.408054118256909
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SPRING1,SREBP regulating gene protein,36958,-0.0044124091287132,0.00533683356766025,-0.0148726029213273,0.00604778466390088,0.408374505729008
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ENTPD6,Ectonucleoside triphosphate diphosphohydrolase 6,39581,-0.00198232022826789,0.00240377033938645,-0.00669371009346533,0.00272906963692955,0.409570784981836
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GADD45B,Growth arrest and DNA damage-inducible protein GADD45 beta,37165,-0.00374378020126448,0.00454692098120257,-0.0126557453244215,0.00516818492189255,0.410314641706051
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,VSTM2L,V-set and transmembrane domain-containing protein 2-like protein,39581,0.00417024483959405,0.00506547895051955,-0.00575809390342428,0.0140985835826124,0.410368306342649
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CLINT1,Clathrin interactor 1,36958,-0.00357965798825035,0.00435967115812351,-0.0121246134581724,0.00496529748167172,0.411613137561949
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CLEC2L,C-type lectin domain family 2 member L,37035,-0.00373226574157799,0.00457029469107324,-0.0126900433360815,0.00522551185292556,0.41415142031237
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,RLN1,Prorelaxin H1,37408,0.0058569992507531,0.00718617590052311,-0.00822790551427219,0.0199419040157784,0.415065458059626
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CLASP1,CLIP-associating protein 1,36958,-0.00531157873146894,0.00652766206399941,-0.0181057963769078,0.00748263891396991,0.415829860582688
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ATP5F1D,"ATP synthase subunit delta, mitochondrial",37017,-0.00367091872761384,0.00453318741720879,-0.0125559660653431,0.00521412861011538,0.418076934837656
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IZUMO1,Izumo sperm-egg fusion protein 1,36958,-0.00361082907080844,0.0044671418848776,-0.0123664271651685,0.00514476902355166,0.418927650413333
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TRPV3,Transient receptor potential cation channel subfamily V member 3,37017,0.00373145417310966,0.00461718966675214,-0.00531823757372454,0.0127811459199438,0.419009830074648
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TRIM5,Tripartite motif-containing protein 5,39862,0.00621642520551782,0.0076985827709003,-0.00887279702544677,0.0213056474364824,0.41940397051877
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,AIDA,"Axin interactor, dorsalization-associated protein",37035,-0.00611553163673819,0.00757878604624191,-0.0209699522873723,0.00873888901389595,0.419722762554935
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CEP152,Centrosomal protein of 152 kDa,36958,-0.00299903976238008,0.00371860884235577,-0.0102875130933974,0.00428943356863722,0.419972082558877
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PRC1,Protein regulator of cytokinesis 1,37364,-0.00331019841159019,0.00411140201395442,-0.0113685463589409,0.00474814953576048,0.420760902688196
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,RAB6B,Ras-related protein Rab-6B,39485,-0.00337928840731415,0.00420078147340598,-0.0116128200951899,0.00485424328056156,0.421153531095589
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,BLOC1S2,Biogenesis of lysosome-related organelles complex 1 subunit 2,36987,-0.00514927858064433,0.00644255153479072,-0.0177766795888341,0.00747812242754548,0.424153693315751
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,AMBN,Ameloblastin,39583,0.00203569922435787,0.00254944232571856,-0.00296120773405052,0.00703260618276625,0.424599387073468
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GUCA2A,Guanylin,39792,-0.00228980802775438,0.00287495552754559,-0.00792472086174373,0.00334510480623498,0.425772350256523
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,BRAP,BRCA1-associated protein,37245,-0.00777558517868449,0.00981367585002196,-0.0270103898447275,0.0114592194873586,0.428187351298988
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PRKAG3,5'-AMP-activated protein kinase subunit gamma-3,37035,-0.00225150221422892,0.00284255576722953,-0.0078229115179988,0.00331990708954096,0.42833431338947
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CASQ2,Calsequestrin-2,37017,-0.00344037430360839,0.00435120014009653,-0.0119687265781976,0.00508797797098081,0.429149377526508
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,HTR1B,5-hydroxytryptamine receptor 1B,36987,-0.00301813552466959,0.00382241963049927,-0.0105100780004482,0.00447380695110898,0.429782855368319
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IL4R,Interleukin-4 receptor subunit alpha,39862,-0.00251481657723872,0.00318854868407843,-0.00876437199803245,0.00373473884355501,0.430297543236107
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,RLN2,Prorelaxin H2,37091,-0.00998165855034823,0.0126616257831406,-0.0347984450853038,0.0148351279846074,0.430512327501741
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,THRAP3,Thyroid hormone receptor-associated protein 3,37017,0.00813580241343755,0.0103366053433329,-0.0121239440594949,0.02839554888637,0.431245415137033
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ARHGAP30,Rho GTPase-activating protein 30,37165,-0.00276154368764107,0.00351420587934639,-0.00964938721116,0.00412629983587786,0.431985203815444
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,M6PR,Cation-dependent mannose-6-phosphate receptor,37039,0.00287725750154916,0.00366553720157886,-0.00430719541354541,0.0100617104166437,0.43249794218647
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,APOM,Apolipoprotein M,39904,-0.00186010539378216,0.00237708255322125,-0.0065191871980958,0.00279897641053148,0.433922870116122
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DYNLT3,Dynein light chain Tctex-type 3,37364,-0.00304553138635072,0.00389854758612369,-0.0106866846551532,0.00459562188245171,0.434700678343255
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PSMD5,26S proteasome non-ATPase regulatory subunit 5,37035,-0.0038701488290599,0.00495854825644816,-0.0135889034116983,0.00584860575357849,0.435110422595642
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IL18RAP,Interleukin-18 receptor accessory protein,39635,-0.0119202320838952,0.0152892589541168,-0.0418871796339641,0.0180467154661737,0.435610102049364
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ARHGEF5,Rho guanine nucleotide exchange factor 5,36987,-0.00518309791712255,0.00667041289813079,-0.0182571071974589,0.00789091136321379,0.437156223926809
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CPOX,"Oxygen-dependent coproporphyrinogen-III oxidase, mitochondrial",37052,-0.00191900605477746,0.00247355826175368,-0.00676718024781468,0.00292916813825976,0.437876322885579
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CTAG1A_CTAG1B,Cancer/testis antigen 1,37131,-0.00350828557154084,0.00452774330116369,-0.0123826624418217,0.00536609129873999,0.438446846392101
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DDI2,Protein DDI1 homolog 2,37120,-0.00518968577104342,0.00670002939762327,-0.018321743390385,0.00794237184829818,0.43860371919759
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TAX1BP1,Tax1-binding protein 1,37384,-0.00434027713976702,0.00561929651552073,-0.0153540983101876,0.00667354403065361,0.439898162416736
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GSAP,Gamma-secretase-activating protein,39473,-0.0060542224772316,0.00785659233758324,-0.0214531434588948,0.00934469850443155,0.440960821317299
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ICAM5,Intercellular adhesion molecule 5,39864,-0.00302013897856326,0.00394026060200915,-0.0107430497585012,0.00470277180137468,0.443400840623688
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,AZU1,Azurocidin,39340,0.00522928251905855,0.00683724498317697,-0.0081717176479683,0.0186302826860854,0.444388582887496
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SAT1,Diamine acetyltransferase 1,37017,0.00337698725319862,0.00443238389228743,-0.00531048517568475,0.012064459682082,0.446139545946794
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DPP6,Dipeptidyl aminopeptidase-like protein 6,39784,-0.00225236162747541,0.00295766857535118,-0.00804939203516373,0.0035446687802129,0.446350173945095
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,REG1A,Lithostathine-1-alpha,39800,-0.003151364638857,0.00414458844517459,-0.0112747579913992,0.0049720287136852,0.447052782027198
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,WFDC12,WAP four-disulfide core domain protein 12,39986,0.00421052861270261,0.00554986643780606,-0.00666720960539728,0.0150882668308025,0.448059841634982
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FAM171A2,Protein FAM171A2,37408,0.0106157718990409,0.013998077137227,-0.016820459289924,0.0380520030880059,0.448240560473689
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IL1RAP,Interleukin-1 receptor accessory protein,39854,-0.00289860056073014,0.0038222666072919,-0.0103902431110223,0.00459304198956199,0.448255055047355
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SEPTIN3,Neuronal-specific septin-3,37408,-0.00515154522671599,0.00679967500358902,-0.0184789082337505,0.00817581778031849,0.448693842355147
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,RALY,RNA-binding protein Raly,37364,-0.00324359977638412,0.00433772724679515,-0.0117455451801026,0.00525834562733437,0.454615054424442
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TRAF2,TNF receptor-associated factor 2,39862,-0.00473553837747921,0.00633654846573679,-0.0171551733703233,0.0076840966153649,0.454871025000522
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NPHS2,Podocin,37052,-0.00678344846828455,0.0090868261592821,-0.0245936277404775,0.0110267308039084,0.455369913739637
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,COL28A1,Collagen alpha-1(XXVIII) chain,37035,-0.00514396470962867,0.00694323284192219,-0.0187527010797962,0.00846477166053882,0.458791427222574
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,COL2A1,Collagen alpha-1(II) chain,37039,-0.00530060513121199,0.0071558346782419,-0.0193260411005661,0.00872483083814213,0.458864963262417
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ENG,Endoglin,40048,0.00111612879913748,0.00151188108197768,-0.00184715812153877,0.00407941571981373,0.460380242299556
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DDX53,Probable ATP-dependent RNA helicase DDX53,37035,-0.00231503740593617,0.00314998667647611,-0.00848901129182933,0.003858936479957,0.462391785790691
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PDZK1,Na(+)/H(+) exchange regulatory cofactor NHE-RF3,37052,0.0029214490437911,0.0039907342117159,-0.00490039001117207,0.0107432880987543,0.464146151172814
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TSNAX,Translin-associated protein X,37017,-0.00255913430559707,0.00350054643492037,-0.009420205318041,0.00430193670684686,0.464751191916117
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SLAMF1,Signaling lymphocytic activation molecule,39583,0.00381787996751312,0.00523126564895522,-0.0064354007044391,0.0140711606394654,0.46551136239876
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,REST,RE1-silencing transcription factor,36958,-0.0023179202690937,0.00318109245139952,-0.00855286147383676,0.00391702093564937,0.466225493743961
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NFATC3,"Nuclear factor of activated T-cells, cytoplasmic 3",39583,0.00388728427828811,0.00533960486778939,-0.00657834126257909,0.0143529098191553,0.466618473657259
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,UHRF2,E3 ubiquitin-protein ligase UHRF2,37017,-0.0022432164353218,0.00308381749278638,-0.0082874987211831,0.0038010658505395,0.466984446760972
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,LYZL2,Lysozyme-like protein 2,36958,-0.00233697988761066,0.00321296960996863,-0.00863440032314918,0.00396044054792787,0.467019536012576
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IL17A,Interleukin-17A,39554,-0.00274488669441864,0.00378232034528654,-0.0101582345711803,0.00466846118234299,0.468024311981679
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CDAN1,Codanin-1,37384,-0.00145601776831988,0.00200662539909252,-0.00538900355054122,0.00247696801390146,0.468093405037484
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,BCAT2,"Branched-chain-amino-acid aminotransferase, mitochondrial",36987,0.00349119184251761,0.0048125419512082,-0.00594139038185045,0.0129237740668857,0.468197442185303
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TFAP2A,Transcription factor AP-2-alpha,36987,-0.00383178922447351,0.00529281852851335,-0.0142057135403597,0.00654213509141266,0.469103156302846
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MAPK13,Mitogen-activated protein kinase 13,36958,-0.00275087355452708,0.0038015764177697,-0.0102019633333557,0.00470021622430153,0.469315725274205
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,AKR7L,Aflatoxin B1 aldehyde reductase member 4,37052,0.00453410847850368,0.00628768973003268,-0.00778976339236038,0.0168579803493677,0.470855347925446
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,C1QTNF9,Complement C1q and tumor necrosis factor-related protein 9A,37089,0.00314870926802815,0.00437370917732768,-0.00542376071953411,0.0117211792555904,0.471588582700863
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GLYR1,Putative oxidoreductase GLYR1,37364,0.00382041854789215,0.00531607533490251,-0.00659908910851678,0.0142399262043011,0.472366596369005
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,AGBL2,Cytosolic carboxypeptidase 2,36987,-0.00585677700015681,0.00818061902845252,-0.0218907902959238,0.0101772362956101,0.47404531372643
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,KLK8,Kallikrein-8,39312,0.00221522795806246,0.00310538790800679,-0.00387133234163085,0.00830178825775577,0.475640078765951
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,VTCN1,V-set domain-containing T-cell activation inhibitor 1,39473,-0.0020585753571336,0.00288602583924075,-0.00771518600204546,0.00359803528777826,0.475676559456332
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,LMOD1,Leiomodin-1,37408,0.00222817143555981,0.00313828786769336,-0.00392287278511917,0.00837921565623879,0.477718915061694
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TOP1MT,"DNA topoisomerase I, mitochondrial",36958,0.00308562189813778,0.00434836343423882,-0.00543717043297029,0.0116084142292459,0.477961540994431
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FUT1,"Galactoside alpha-(1,2)-fucosyltransferase 1",37135,0.00401844555748794,0.00575955610580804,-0.00727028440989581,0.0153071755248717,0.485376693329362
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TERF1,Telomeric repeat-binding factor 1,37052,-0.00181400658536766,0.0026017719740372,-0.00691347965448058,0.00328546648374526,0.485677620210616
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CRYBB2,Beta-crystallin B2,37384,0.0035023219680443,0.00505532971766699,-0.006406124278583,0.0134107682146716,0.488448267019817
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ITGA2,Integrin alpha-2,37120,-0.00207549043356576,0.00299872842492084,-0.00795299814641059,0.00380201727927908,0.488871889764609
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MICB_MICA,MHC class I polypeptide-related sequence A_MHC class I polypeptide-related sequence B,39862,-0.00921427800385686,0.0133161221171331,-0.0353138773534377,0.016885321345724,0.488969935412547
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TXNL1,Thioredoxin-like protein 1,36967,0.00601864287803747,0.0087288913807643,-0.0110899842282606,0.0231272699843355,0.490515671232008
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,UBQLN3,Ubiquilin-3,37017,-0.00288010309797974,0.00419243967060983,-0.011097284852375,0.00533707865641553,0.492110311644603
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GHR,Growth hormone receptor,37120,-0.00176157615273122,0.00256692043907435,-0.00679274021331695,0.00326958790785449,0.492560839960618
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CLEC14A,C-type lectin domain family 14 member A,39854,-0.00184770417230196,0.00269496790657519,-0.00712984126918934,0.00343443292458542,0.492967319739328
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PRDX2,Peroxiredoxin-2,37245,-0.00371095567286275,0.00541857242684452,-0.014331357629478,0.0069094462837525,0.493445041015071
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MORC3,MORC family CW-type zinc finger protein 3,37384,0.00169432624668422,0.00249126854830997,-0.00318856010800333,0.00657721260137176,0.496449099255284
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TBC1D17,TBC1 domain family member 17,39485,-0.00266419061642352,0.00392768994261188,-0.0103624629039428,0.00503408167109577,0.497585325495482
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,INSL4,Early placenta insulin-like peptide,37364,0.00320245424025538,0.00476271756199162,-0.0061324721812482,0.012537380661759,0.5013401928338
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,LSM8,U6 snRNA-associated Sm-like protein LSm8,37165,-0.00519109296895474,0.00772998010470228,-0.0203418539741712,0.00995966803626172,0.501879832121925
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FURIN,Furin,39909,-0.0020257249016999,0.00302327782049693,-0.00795134942987387,0.00389989962647408,0.502840280834138
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PRSS22,Brain-specific serine protease 4,37052,-0.00200181332484592,0.00299646066152345,-0.00787487622143189,0.00387124957174005,0.504107446541531
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PLCB1,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-1",37052,-0.00272874577734341,0.00408672085507965,-0.0107387186532995,0.00528122709861271,0.50433018793532
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CTBS,Di-N-acetylchitobiase,37292,-0.00164170631545883,0.0024624458175285,-0.00646810011781469,0.00318468748689702,0.504976867559201
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CYB5A,Cytochrome b5,36958,-0.0042328399423651,0.00638726923104759,-0.0167518876352184,0.00828620775048818,0.507534709410407
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,C1QA,Complement C1q subcomponent subunit A,39967,0.00135486652275278,0.0020458817637717,-0.00265506173423976,0.00536479477974532,0.507826339010087
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ADGRE5,Adhesion G protein-coupled receptor E5,39958,-0.00175694824782745,0.00265432105718827,-0.00695941751991646,0.00344552102426156,0.508031955251155
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PFKFB2,"6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 2",39754,-0.00442139699812827,0.00668502104845905,-0.017524038253108,0.00868124425685147,0.508372694823998
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ADAMTS8,A disintegrin and metalloproteinase with thrombospondin motifs 8,39909,0.00266895996597176,0.00405276299704576,-0.00527445550823792,0.0106123754401814,0.510192182873957
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IGSF3,Immunoglobulin superfamily member 3,39784,-0.00208398545149639,0.00316659741993963,-0.00829051639457806,0.00412254549158528,0.510473713143003
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,LRP2BP,LRP2-binding protein,37035,-0.00468536951713011,0.0071379417885648,-0.0186757354227171,0.00930499638845689,0.51157604402512
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MORF4L2,Mortality factor 4-like protein 2,36958,0.00216290215283634,0.0033105476743323,-0.00432577128885497,0.00865157559452764,0.513550732895973
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ITGAM,Integrin alpha-M,39854,0.0018348719106582,0.00281272744161067,-0.00367807387489872,0.00734781769621513,0.514187271358785
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CALCOCO1,Calcium-binding and coiled-coil domain-containing protein 1,39973,0.00600026172858315,0.00919900434046593,-0.0120297867787301,0.0240303102358964,0.514234409292003
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DOC2B,Double C2-like domain-containing protein beta,37035,-0.00211540609201629,0.00325277073570403,-0.00849083673399619,0.00426002454996361,0.515484129044272
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CDH4,Cadherin-4,36987,-0.00271457548805029,0.00417780874427866,-0.0109030806268365,0.00547392965073588,0.515858246707384
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IL20RB,Interleukin-20 receptor subunit beta,37052,-0.00249528219511434,0.00384631172992732,-0.0100340531857719,0.0050434887955432,0.516513380840197
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PADI2,Protein-arginine deiminase type-2,39583,-0.00328957066525526,0.00509203790390578,-0.0132699649569106,0.00669082362640008,0.518274262225026
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ART5,Ecto-ADP-ribosyltransferase 5,36987,-0.00354114623037771,0.00549827223171679,-0.0143177598045426,0.0072354673437872,0.519556151149845
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FIS1,Mitochondrial fission 1 protein,39851,0.00447571368328953,0.00698452419830523,-0.00921395374538873,0.0181653811119678,0.521658970986432
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CLEC5A,C-type lectin domain family 5 member A,39814,0.00161625475431909,0.00253267224628799,-0.00334778284840537,0.00658029235704354,0.523377501188939
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NDST1,Bifunctional heparan sulfate N-deacetylase/N-sulfotransferase 1,37364,-0.00346736166195709,0.00545412707163025,-0.0141574507223524,0.0072227273984382,0.524962061831747
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PRDX1,Peroxiredoxin-1,39430,-0.00509930733577633,0.00807690214941335,-0.0209300355486265,0.0107314208770738,0.527824597927206
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,RAC3,Ras-related C3 botulinum toxin substrate 3,37035,0.00384342179497194,0.00609801982669815,-0.00810869706535643,0.0157955406553003,0.52852642858176
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,THBS4,Thrombospondin-4,39888,0.00250340562678933,0.00398934002673495,-0.00531570082561117,0.0103225120791898,0.530324910351653
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,F9,Coagulation factor IX,39904,-0.00101692610178532,0.00162323061341469,-0.0041984581040781,0.00216460590050747,0.531007211340842
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ATP6V1G2,V-type proton ATPase subunit G 2,37017,-0.00550991013080059,0.00879642142105586,-0.0227508961160701,0.0117310758544689,0.531076018914229
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IL5,Interleukin-5,39583,-0.00803951415917852,0.0128902615641267,-0.0333044268248669,0.0172253985065098,0.532840905680485
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ACSL1,Long-chain-fatty-acid--CoA ligase 1,37017,-0.00203047368608887,0.00326085596829697,-0.00842175138395094,0.0043608040117732,0.533504835452066
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TCL1B,T-cell leukemia/lymphoma protein 1B,39581,-0.00436247022487619,0.00700836951916128,-0.0180988744824323,0.00937393403267992,0.533644664082698
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,STOML2,"Stomatin-like protein 2, mitochondrial",36958,-0.00513895334200799,0.00826254615201532,-0.021333543799958,0.011055637115942,0.53398057678247
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CEACAM5,Carcinoembryonic antigen-related cell adhesion molecule 5,39243,0.00340883347813215,0.00549668138767717,-0.00736466204171509,0.0141823289979794,0.535160256651811
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,S100A3,Protein S100-A3,37364,-0.00248946127770276,0.0040208234521278,-0.0103702752438732,0.00539135268846772,0.535833162435369
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SHH,Sonic hedgehog protein,37052,0.00239656370064771,0.00388598887463411,-0.00521997449363516,0.0100131018949306,0.537430639746258
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ARSA,Arylsulfatase A,39854,0.0024685203206233,0.00401090150694803,-0.00539284663299484,0.0103298872742414,0.538264528167708
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MELTF,Melanotransferrin,37433,0.00158944162893203,0.0025865496108465,-0.0034801956083271,0.00665907886619117,0.538893512932454
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PNPT1,"Polyribonucleotide nucleotidyltransferase 1, mitochondrial",39583,-0.00652476534512109,0.0108253471977823,-0.0277424458527744,0.0146929151625322,0.546696778259915
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CCN4,CCN family member 4,40026,-0.00214840042748905,0.0035741664236634,-0.00915376661786932,0.00485696576289122,0.547787589533122
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,RAB37,Ras-related protein Rab-37,39583,-0.00444754934288594,0.00744661903930063,-0.0190429226599152,0.0101478239741433,0.550344051002469
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TADA3,Transcriptional adapter 3,37364,-0.00210186243508809,0.00353091291549478,-0.00902245174945786,0.00481872687928167,0.551669970550804
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TLR2,Toll-like receptor 2,37165,-0.00120637703010833,0.0020274007476032,-0.00518008249541061,0.00276732843519395,0.551829329337466
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CPB1,Carboxypeptidase B,40048,0.00303788118269839,0.00512451500547483,-0.00700616822803228,0.0130819305934291,0.553314317436512
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CACNA1H,Voltage-dependent T-type calcium channel subunit alpha-1H,37017,-0.00303452473477907,0.00514190647302054,-0.0131126614218993,0.00704361195234118,0.55509649275183
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PTX3,Pentraxin-related protein PTX3,39862,0.00261110002925383,0.00443366141868828,-0.00607887635137519,0.0113010764098829,0.555918994874659
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PECAM1,Platelet endothelial cell adhesion molecule,39854,0.00155968408756685,0.00267791857351027,-0.00368903631651328,0.00680840449164699,0.560289319551126
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,REG4,Regenerating islet-derived protein 4,39881,0.00243245980820289,0.00419651466935173,-0.0057927089437265,0.0106576285601323,0.562166841782077
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GDF2,Growth/differentiation factor 2,39864,-0.00182424290743693,0.0031516593432742,-0.00800149522025435,0.00435300940538049,0.562718898933892
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,LEG1,Protein LEG1 homolog,36699,-0.00359257782830979,0.00624504137781944,-0.0158328589288359,0.00864770327221632,0.565119560121769
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ANP32C,Acidic leucine-rich nuclear phosphoprotein 32 family member C,37039,0.00208551037917171,0.00362783668573407,-0.00502504952486706,0.00919607028321049,0.565393525994703
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MNAT1,CDK-activating kinase assembly factor MAT1,37165,-0.00224487056713439,0.00391028250572074,-0.00990902427834705,0.00541928314407826,0.565913752455071
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DEFB103A_DEFB103B,Beta-defensin 103,36996,-0.00205408966621228,0.00358105616728581,-0.00907295975409247,0.00496478042166791,0.566249116266139
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SCARF2,Scavenger receptor class F member 2,40005,-0.00143905235765592,0.00250909022802463,-0.00635686920458419,0.00347876448927234,0.566290147766831
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ADD1,Alpha-adducin,37120,-0.00352221473093185,0.00615146379863313,-0.0155790837762528,0.0085346543143891,0.566937756823367
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ENTPD2,Ectonucleoside triphosphate diphosphohydrolase 2,39473,-0.00221247183054531,0.0038836301561078,-0.0098243869365166,0.00539944327542598,0.568895023053359
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CELA2A,Chymotrypsin-like elastase family member 2A,37433,0.00297748855769005,0.00528150100532644,-0.00737425341274977,0.0133292305281299,0.572928138168549
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GUSB,Beta-glucuronidase,39915,-0.00294579122707618,0.00523433684648317,-0.0132050914461832,0.00731350899203082,0.573591110069106
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,EPHB4,Ephrin type-B receptor 4,40048,-0.00117944207688093,0.00209638958335595,-0.00528836566025859,0.00292948150649673,0.573710762707827
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MMP10,Stromelysin-2,39853,0.00294602422470148,0.00524434472249891,-0.00733289143139638,0.0132249398807993,0.57429247053969
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,HSD17B14,17-beta-hydroxysteroid dehydrogenase 14,37384,0.00309286640703857,0.00551136492750796,-0.00770940885087703,0.0138951416649542,0.574684302216815
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,OFD1,Oral-facial-digital syndrome 1 protein,37165,-0.00339239789343925,0.00607346712083918,-0.015296393450284,0.00851159766340554,0.576471209178299
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GLP1R,Glucagon-like peptide 1 receptor,36987,0.00188706603960304,0.00338298577681145,-0.00474358608294741,0.00851771816215348,0.576983091851154
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ECE1,Endothelin-converting enzyme 1,39485,-0.00172599341763494,0.00312359903515955,-0.00784824752654765,0.00439626069127778,0.580568797818248
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,KIR2DL2,Killer cell immunoglobulin-like receptor 2DL2,37364,-0.00411717002496562,0.00745896655129514,-0.0187367444655041,0.0105024044155729,0.580973976439835
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CD109,CD109 antigen,39854,0.00165896220839947,0.00300855089460748,-0.00423779754503118,0.00755572196183013,0.581356441297023
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,KLK1,Kallikrein-1,39716,0.00616243403706324,0.0112116898100935,-0.01581247799072,0.0281373460648465,0.582571559266724
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,39927,-0.00208178343735944,0.00380736248204754,-0.00954421390217263,0.00538064702745374,0.584538600916264
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GASK1A,Golgi-associated kinase 1A,37017,0.00206539885863114,0.00381972112778606,-0.00542125455182955,0.00955205226909183,0.588709879921491
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TTR,Transthyretin,37305,-0.0012117192563603,0.0022434244532984,-0.00560883118482516,0.00318539267210456,0.589122966374292
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,REG3G,Regenerating islet-derived protein 3-gamma,37364,-0.00188102718177168,0.0034861472901998,-0.00871387587056328,0.00495182150701993,0.58950118332434
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,THAP12,52 kDa repressor of the inhibitor of the protein kinase,36927,0.00420951560052482,0.00782719695889313,-0.0111317904389057,0.0195508216399553,0.59071996193661
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MFAP3L,Microfibrillar-associated protein 3-like,37035,0.00308437406507921,0.00576899832693848,-0.0082228626557202,0.0143916107858786,0.592903428703296
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GABRA4,Gamma-aminobutyric acid receptor subunit alpha-4,36987,0.00312546698801101,0.00589115149789865,-0.00842118994787035,0.0146721239238924,0.595749443637377
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MSLNL,Mesothelin-like protein,37035,-0.00172059145246332,0.00324786546362721,-0.00808640776117266,0.00464522485624602,0.596286789397496
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,RUVBL1,RuvB-like 1,39473,-0.00480160738182266,0.00906835044537764,-0.0225755742547628,0.0129723594911175,0.596472610557462
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,INPP5D,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 1",37039,-0.00269914298299634,0.00510229038814384,-0.0126996321437583,0.00730134617776558,0.59681009446335
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TRAF3IP2,E3 ubiquitin ligase TRAF3IP2,37017,-0.00223286100425899,0.00422122141420317,-0.0105064549760972,0.00604073296757922,0.596841509420488
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,RCC1,Regulator of chromosome condensation,37364,-0.00237647036258,0.00451236873508561,-0.0112207130833478,0.00646777235818781,0.598440485227036
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,RIPK4,Receptor-interacting serine/threonine-protein kinase 4,37017,0.00315110590251658,0.00602708853012805,-0.00866198761653441,0.0149641994215676,0.601105613025284
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GSTA1,Glutathione S-transferase A1,39837,-0.00393181453946267,0.00758246422523562,-0.0187934444209245,0.0109298153419992,0.604088414803506
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IDI2,Isopentenyl-diphosphate delta-isomerase 2,39485,0.00216536716479789,0.00418650231773729,-0.00604017737796719,0.010370911707563,0.605005839581852
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IL21R,Interleukin-21 receptor,37052,-0.00250108282883926,0.00484080005437417,-0.0119890509354126,0.00698688527773411,0.605397125898969
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,RAB3GAP1,Rab3 GTPase-activating protein catalytic subunit,36987,-0.0026586471320047,0.00514988119166536,-0.0127524142676688,0.00743512000365941,0.605685665471367
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FCER1A,High affinity immunoglobulin epsilon receptor subunit alpha,37408,0.00109089355840267,0.00212791054966525,-0.00307981111894123,0.00526159823574657,0.608197882447453
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,LMOD2,Leiomodin-2,36987,0.00291963597905252,0.00572472282264562,-0.00830082075333289,0.0141400927114379,0.610056690537795
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ENPEP,Glutamyl aminopeptidase,37017,-0.00190056561956573,0.00373790637031276,-0.00922686210537875,0.00542573086624729,0.611141232483521
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ACRV1,Acrosomal protein SP-10,37052,-0.00329709613151261,0.0064977607383186,-0.0160327071786171,0.00943851491559184,0.611868381321651
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ESPL1,Separin,36958,-0.00242093147467776,0.00479553643653836,-0.0118201828902929,0.00697831994093743,0.613686616626312
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SSH3,Protein phosphatase Slingshot homolog 3,36958,-0.00132768248333929,0.00264187565003113,-0.0065057587574003,0.00385039379072173,0.615287043112899
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PTPRB,Receptor-type tyrosine-protein phosphatase beta,37433,-0.00130567802012375,0.00260721301659773,-0.0064158155326553,0.0038044594924078,0.616523855471722
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ARHGAP5,Rho GTPase-activating protein 5,36958,-0.00330183231531408,0.00659649541387269,-0.0162309633265046,0.00962729869587639,0.616700907270894
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TFF2,Trefoil factor 2,39904,0.00252882491749096,0.00509130780993461,-0.00745013838998088,0.0125077882249628,0.619411261018312
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SERPINA12,Serpin A12,39401,0.00523981111597634,0.0105511910321685,-0.0154405233070738,0.0259201455390265,0.619472184412355
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,VNN1,Pantetheinase,37441,0.00319952260129448,0.00645379475845683,-0.00944991512528091,0.0158489603278699,0.620072939946333
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,INPPL1,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 2",39784,-0.00431847938452313,0.00872493382634847,-0.0214193496841661,0.0127823909151199,0.620636306716606
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CHAC2,Glutathione-specific gamma-glutamylcyclotransferase 2,39473,-0.00260036799234117,0.00529123485901226,-0.0129711883160052,0.00777045233132286,0.623116369539268
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PGLYRP4,Peptidoglycan recognition protein 4,37017,-0.00272170256744719,0.00557112835376494,-0.0136411141408265,0.00819770900593209,0.625177637017814
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GAD1,Glutamate decarboxylase 1,36958,0.00112919415752455,0.00231150963555285,-0.00340136472815903,0.00565975304320813,0.625197256043963
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ATP1B2,Sodium/potassium-transporting ATPase subunit beta-2,37017,-0.0013396490151561,0.00274411642137571,-0.00671811720105249,0.00403881917074029,0.625423707376346
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ADAMTS13,A disintegrin and metalloproteinase with thrombospondin motifs 13,40048,-0.000986519248166539,0.00202476181059125,-0.00495505239692539,0.00298201390059231,0.626103851950071
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,HADH,"Hydroxyacyl-coenzyme A dehydrogenase, mitochondrial",37017,0.00280577871347071,0.00576520810871834,-0.00849402917961724,0.0141055866065587,0.626497255895179
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CPTP,Ceramide-1-phosphate transfer protein,37017,0.00171636549222025,0.00354349970079656,-0.00522889392134101,0.00866162490578152,0.628131259471055
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MLLT1,Protein ENL,36958,-0.00305025546192021,0.00636175383801797,-0.0155192929844354,0.00941878206059501,0.631613948662871
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ITGB7,Integrin beta-7,40026,-0.00194028509955439,0.0040588010766262,-0.00989553520974175,0.00601496501063297,0.632625423073366
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FAM20A,Pseudokinase FAM20A,37433,0.0012009384291647,0.00251528648183675,-0.00372902307523532,0.00613089993356472,0.63304518827676
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CENPJ,Centromere protein J,37165,-0.00307990936610989,0.00648799292878984,-0.015796375506538,0.0096365567743182,0.635002113221004
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TRIM40,E3 ubiquitin ligase TRIM40,37035,-0.00308963533022281,0.00650917596796271,-0.0158476202274297,0.00966834956698411,0.635038310097642
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,RNF43,E3 ubiquitin-protein ligase RNF43,37165,0.00247236718704919,0.00526378738357933,-0.00784465608476629,0.0127893904588647,0.638581646440011
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CHRM1,Muscarinic acetylcholine receptor M1,37035,-0.00154145712080767,0.00328722629570006,-0.0079844206603798,0.00490150641876445,0.639132194229407
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IL2,Interleukin-2,39583,0.00130350421194864,0.0027839796273709,-0.00415309585769832,0.0067601042815956,0.639636517215407
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SERPINA9,Serpin A9,39711,0.00303569060164704,0.00649969264972379,-0.00970370699181159,0.0157750881951057,0.640469518256641
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IGF2BP3,Insulin-like growth factor 2 mRNA-binding protein 3,37017,0.001943735602826,0.00416670039585942,-0.00622299717305846,0.0101104683787105,0.64087054625703
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TSLP,Thymic stromal lymphopoietin,39581,0.00249734750162467,0.00536665530593816,-0.00802129689801412,0.0130159919012635,0.64169068803349
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SELENOP,Selenoprotein P,37449,-0.000920189229364865,0.00197860776875041,-0.00479826045611568,0.00295788199738594,0.641889463326124
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,VNN2,Vascular non-inflammatory molecule 2,39784,-0.00191460810551142,0.00413258268811491,-0.0100144701742166,0.00618525396319381,0.643158704431444
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ACTN4,Alpha-actinin-4,39583,-0.00129943820633994,0.00280523126546997,-0.00679769148666108,0.00419881507398119,0.643213354064952
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CADPS,Calcium-dependent secretion activator 1,37035,-0.0017968322403246,0.00387929009658844,-0.00940024082963794,0.00580657634898874,0.643238816121119
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TCP11,T-complex protein 11 homolog,37165,0.00246399134541566,0.00531994322840031,-0.00796309738224894,0.0128910800730803,0.64325639330614
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GJA8,Gap junction alpha-8 protein,36958,0.00245113704965851,0.00532412243279365,-0.00798414291861704,0.0128864170179341,0.64524876297609
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IKBKG,NF-kappa-B essential modulator,39862,0.00377885083771981,0.00821765131120977,-0.0123277457322514,0.019885447407691,0.645633293746705
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TNFRSF10A,Tumor necrosis factor receptor superfamily member 10A,39745,-0.00129445321467461,0.00282671921754294,-0.00683482288105876,0.00424591645170954,0.647005518737634
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,BSND,Barttin,36958,-0.00137589330727973,0.00300543454365003,-0.00726654501283378,0.00451475839827433,0.647102445285838
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,KIAA1549L,UPF0606 protein KIAA1549L,37165,-0.00112224413716576,0.00246998695778312,-0.00596341857442068,0.00371893030008915,0.649582724959185
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,EPHA4,Ephrin type-A receptor 4,37120,0.00113751149009171,0.00251016470506997,-0.00378241133184543,0.00605743431202885,0.650439441573959
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NUP50,Nuclear pore complex protein Nup50,37017,0.00133424031167392,0.00295029404287745,-0.00444833601236587,0.00711681663571372,0.651103713306393
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TET2,Methylcytosine dioxygenase TET2,37157,-0.00393281257429559,0.00883522697492529,-0.0212498574451492,0.013384232296558,0.656234037919235
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GID8,Glucose-induced degradation protein 8 homolog,37408,-0.0013185076767622,0.00298321400273845,-0.00716560712212957,0.00452859176860517,0.65851394682919
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IGFL4,Insulin growth factor-like family member 4,37052,0.00301077953253293,0.00684104322321137,-0.0103976651849614,0.0164192242500272,0.659868037650141
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CREBZF,CREB/ATF bZIP transcription factor,36958,0.0010228035063908,0.00234009309465743,-0.00356377895913777,0.00560938597191937,0.6620618952492
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,39994,-0.00117230405014815,0.0026918834905239,-0.006448395691575,0.0041037875912787,0.663208386879758
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CTSZ,Cathepsin Z,39861,0.001204278748466,0.00276792841565408,-0.004220860946216,0.00662941844314799,0.663508011209193
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CGN,Cingulin,37035,0.00150989679349568,0.00347870152062765,-0.00530835818693451,0.00832815177392588,0.66426625430438
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NEB,Nebulin,37017,0.00144798887159466,0.0033499624817378,-0.00511793759261143,0.00801391533580076,0.665573837719482
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CD177,CD177 antigen,39840,-0.00477084683794275,0.0111258144491045,-0.0265774431581876,0.0170357494823021,0.668068174355275
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ITGAX,Integrin alpha-X,37165,0.00201301811468178,0.00472339043770993,-0.00724482714322968,0.0112708633725932,0.669983032245533
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GNPDA1,Glucosamine-6-phosphate isomerase 1,37039,-0.00122459569912793,0.00291928219408854,-0.00694638879954148,0.00449719740128562,0.674868400206656
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FLRT2,Leucine-rich repeat transmembrane protein FLRT2,39745,-0.0010495069405783,0.00250969081076567,-0.00596850092967901,0.00386948704852241,0.675819877675976
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CRHR1,Corticotropin-releasing factor receptor 1,39581,0.00230401222529117,0.0055447977738466,-0.00856379141144817,0.0131718158620305,0.677761951789248
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PLA2G15,Phospholipase A2 group XV,39909,-0.000979402015309119,0.00236233149756874,-0.00560957175054386,0.00365076771992562,0.678446681471022
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ATF4,Cyclic AMP-dependent transcription factor ATF-4,36958,-0.00123151188995791,0.00299393137355141,-0.00709961738211867,0.00463659360220285,0.680832872651276
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ZP3,Zona pellucida sperm-binding protein 3,37039,0.00943450933297809,0.0229610628367141,-0.0355691738269816,0.0544381924929378,0.681158655163767
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TPPP2,Tubulin polymerization-promoting protein family member 2,37165,-0.00286695901973228,0.00699813590250368,-0.0165833053886395,0.0108493873491749,0.682051208593242
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MAG,Myelin-associated glycoprotein,37035,-0.00168952983713987,0.00413007212199492,-0.00978447119624992,0.00640541152197017,0.682487614401841
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ATP1B3,Sodium/potassium-transporting ATPase subunit beta-3,37017,0.00148626327633238,0.00367263874765597,-0.00571210866907332,0.00868463522173808,0.685715354966287
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CNST,Consortin,39864,-0.00389811914656503,0.00964613040666575,-0.0228045347436299,0.0150082964504998,0.686135601174204
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TNPO1,Transportin-1,37165,-0.0012780829375537,0.00316343712686868,-0.00747841970621631,0.00492225383110892,0.686206581541222
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DTX2,Probable E3 ubiquitin-protein ligase DTX2,37035,-0.00226793849448708,0.00561657195115369,-0.0132764195187483,0.00874054252977415,0.686370704935441
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NLGN1,Neuroligin-1,37035,-0.00243038949898848,0.00602217864996902,-0.0142338596529278,0.0093730806549508,0.686533196135257
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,EGFLAM,Pikachurin,37378,0.00109584676908658,0.00272883189855205,-0.00425266375207543,0.0064443572902486,0.687998837184293
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FOS,Proto-oncogene c-Fos,36927,0.00126140789101393,0.00314963926994447,-0.00491188507807724,0.00743470086010509,0.688800123401469
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PADI4,Protein-arginine deiminase type-4,39452,-0.00250653383409103,0.00628012667235244,-0.0148155821119018,0.00980251444371975,0.689809117121057
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,OPLAH,5-oxoprolinase,37039,-0.00246155288603074,0.00617036242519936,-0.0145554632394215,0.00963235746736,0.689950028447029
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SMPDL3B,Acid sphingomyelinase-like phosphodiesterase 3b,37364,0.00272538489856443,0.00683238050158421,-0.0106660808845406,0.0161168506816695,0.689978770514716
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NCF2,Neutrophil cytosol factor 2,39839,-0.00288616880496588,0.00740617446822968,-0.0174022707626961,0.0116299331527643,0.696765326242789
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,BCAT1,"Branched-chain-amino-acid aminotransferase, cytosolic",37433,-0.00103750863003585,0.00266596162212108,-0.00626279340939317,0.00418777614932146,0.697157513262595
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DOCK9,Dedicator of cytokinesis protein 9,36987,-0.00398547811334857,0.0103995922895079,-0.0243686790007841,0.016397722774087,0.701552421977676
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ITIH5,Inter-alpha-trypsin inhibitor heavy chain H5,37364,-0.00151435651559787,0.00395482621784941,-0.00926581590258272,0.00623710287138697,0.701789896997049
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ITGA11,Integrin alpha-11,39862,0.00115988152606141,0.00303309098656194,-0.0047849768076,0.00710473985972282,0.702163036935134
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DSG2,Desmoglein-2,39854,0.000907855411994762,0.0023799556542156,-0.00375685767026782,0.00557256849425734,0.702867784546214
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,KIR3DL2,Killer cell immunoglobulin-like receptor 3DL2,36958,-0.00283740042654667,0.00744047155116013,-0.0174207246668205,0.0117459238137272,0.702952075816037
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FBP1,"Fructose-1,6-bisphosphatase 1",39864,-0.00247156467844132,0.00649379526184872,-0.0151994033916648,0.0102562740347822,0.703502138311062
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CBLN4,Cerebellin-4,40026,-0.00104298888907952,0.00276643206335819,-0.00646519573326157,0.00437921795510253,0.706166733496649
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,KRT6C,"Keratin, type II cytoskeletal 6C",37017,0.00135547922146863,0.00359583766555977,-0.00569236260302852,0.00840332104596577,0.70621101122057
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CD3D,T-cell surface glycoprotein CD3 delta chain,36987,-0.00115516179710692,0.00308342171716353,-0.00719866836274745,0.0048883447685336,0.707937001660581
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,COMP,Cartilage oligomeric matrix protein,39725,-0.00110225090015836,0.00298653271572144,-0.00695585502297237,0.00475135322265566,0.71207766183293
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MNDA,Myeloid cell nuclear differentiation antigen,39837,-0.0032108346550001,0.00870184520692988,-0.0202664512605827,0.0138447819505825,0.7121451395231
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PDIA2,Protein disulfide-isomerase A2,36958,0.00129609884116597,0.00353932442086159,-0.00564097702372274,0.00823317470605469,0.714222128124641
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,VSIG10L,V-set and immunoglobulin domain-containing protein 10-like,37017,0.00108747863566147,0.0029851354888851,-0.00476338692255333,0.00693834419387626,0.715641410711138
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,UXS1,UDP-glucuronic acid decarboxylase 1,39473,0.00169689906307158,0.00466758980150823,-0.00745157694788455,0.0108453750740277,0.716199505279748
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FABP3,"Fatty acid-binding protein, heart",37433,-0.00158744664002587,0.00436881218660125,-0.0101503185257643,0.00697542524571258,0.716342484182156
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SRPX,Sushi repeat-containing protein SRPX,37433,0.00110337292700856,0.00303881613828638,-0.00485270670403276,0.00705945255804987,0.716541053260763
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ALPP,"Alkaline phosphatase, placental type",39784,0.0034162231186633,0.00943763144777721,-0.01508153451898,0.0219139807563066,0.717372627557292
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PDCL2,Phosducin-like protein 2,36958,-0.00171110649059052,0.00473401616006293,-0.0109897781643139,0.00756756518313283,0.717769482591326
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ISM2,Isthmin-2,37433,0.00142274707269952,0.00396027514102854,-0.00633939220371643,0.00918488634911547,0.719410220652977
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CEP290,Centrosomal protein of 290 kDa,37165,-0.00166019730512848,0.00463498413334049,-0.0107447662064759,0.00742437159621888,0.720208049709157
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,KRT19,"Keratin, type I cytoskeletal 19",39838,-0.00208809909978061,0.0058330049134535,-0.0135207887301495,0.00934459053058825,0.72036300946988
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FRMD7,FERM domain-containing protein 7,37035,-0.00107355881159621,0.00300900856464051,-0.0069712155982916,0.00482409797509918,0.72126104531484
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DIPK1C,Divergent protein kinase domain 1C,37035,-0.00136496062627083,0.00382980982451478,-0.0088713878823198,0.00614146662977814,0.721543529118472
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ZP4,Zona pellucida sperm-binding protein 4,36958,-0.00102164187176766,0.00286900143695307,-0.00664488468819568,0.00460160094466036,0.721773902583403
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,EXTL1,Exostosin-like 1,37017,-0.00150043199351612,0.00426029379616426,-0.00985060783399808,0.00684974384696584,0.724701571432324
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NME1,Nucleoside diphosphate kinase A,37052,0.000672528931104545,0.00194399016442124,-0.00313769179116109,0.00448274965337018,0.729383668863387
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,37378,-0.00100967609238076,0.00294296610234465,-0.00677788965297627,0.00475853746821474,0.731542772701323
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,HS6ST2,Heparan-sulfate 6-O-sulfotransferase 2,37052,0.000996723660437034,0.00291457905508374,-0.00471585128752709,0.00670929860840116,0.732372445820474
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GRP,Gastrin-releasing peptide,37039,0.00157032394205191,0.00463454008903949,-0.0075133746324655,0.0106540225165693,0.734742755360906
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MSTN,Growth/differentiation factor 8,39581,-0.00155042578147959,0.0046347878957171,-0.0106346100570851,0.00753375849412594,0.737992228174077
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NAGPA,N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase,37120,0.000643837485759848,0.0019275928567878,-0.00313424451354425,0.00442191948506395,0.738376435196012
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IL31,Interleukin-31,37052,-0.00169554242447433,0.00511598251036864,-0.0117228681447969,0.00833178329584821,0.740332007548285
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CHEK2,Serine/threonine-protein kinase Chk2,39581,-0.000983758675968926,0.00299315661851495,-0.00685034564825824,0.00488282829632038,0.742410042750252
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,BIN2,Bridging integrator 2,39854,-0.00262760341317237,0.00800022402454627,-0.0183080425012831,0.0130528356749383,0.742582373629727
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CDK1,Cyclin-dependent kinase 1,36958,0.00105289073741115,0.00322650555255505,-0.00527106014559676,0.00737684162041905,0.744183381151908
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SPESP1,Sperm equatorial segment protein 1,37433,0.000845999998095158,0.00259809506120019,-0.00424626632185722,0.00593826631804753,0.744714485111499
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,RAB44,Ras-related protein Rab-44,37364,-0.00121794305469412,0.00376311297713446,-0.00859364448987767,0.00615775838048943,0.746205719229024
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PSPN,Persephin,39862,-0.00271965810149241,0.00840551425196928,-0.0191944660353522,0.0137551498323674,0.746278114317913
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FZD10,Frizzled-10,37035,0.00169996136311573,0.00536095402516102,-0.00880750852619985,0.0122074312524313,0.75117234723971
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CLNS1A,Methylosome subunit pICln,37035,0.000950971698677,0.00301442659111219,-0.00495730441990289,0.00685924781725689,0.752407167326856
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ITGB6,Integrin beta-6,39583,0.000830907209638557,0.00265047083131723,-0.00436401561974321,0.00602583003902032,0.753909391723606
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SHC1,SHC-transforming protein 1,36958,-0.00321764363998534,0.0103021089782769,-0.0234097772374081,0.0169744899574374,0.75479575169735
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CENPF,Centromere protein F,37165,-0.00150475826632143,0.00482052678089725,-0.01095299075688,0.00794347422423717,0.754926560140436
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IL24,Interleukin-24,39583,0.00131375996890692,0.00421825887797983,-0.00695402743193354,0.00958154736974738,0.755465697135972
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SPTLC1,Serine palmitoyltransferase 1,37384,-0.000990557514568887,0.00318335037675226,-0.00722992425300332,0.00524880922386554,0.755677526768833
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NFATC1,"Nuclear factor of activated T-cells, cytoplasmic 1",39862,-0.00271603147999257,0.0087501326334684,-0.0198662914415906,0.0144342284816055,0.756261678609562
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CNGB3,Cyclic nucleotide-gated cation channel beta-3,36987,-0.00150971329036009,0.00488260552399637,-0.011079620117393,0.0080601935366728,0.757172484421844
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FAM3C,Protein FAM3C,39842,-0.000795892003825449,0.00258565583282837,-0.00586377743616906,0.00427199342851816,0.758230545774893
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PSRC1,Proline/serine-rich coiled-coil protein 1,39473,0.00162500044272422,0.00528584472958291,-0.00873525522725829,0.0119852561127067,0.758524055821672
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MORF4L1,Mortality factor 4-like protein 1,37165,0.0011071474629118,0.00360343517041208,-0.00595558547109588,0.00816988039691948,0.758659587291432
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,HDAC9,Histone deacetylase 9,36987,-0.00174509182117835,0.00573341567561567,-0.0129825865453851,0.00949240290302835,0.760849238920783
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FGF7,Fibroblast growth factor 7,36958,-0.00215167336121734,0.00709344880242182,-0.0160548330139641,0.0117514862915294,0.761641319663381
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,VIM,Vimentin,39581,-0.0031752802579721,0.0104706605108208,-0.0236977748591808,0.0173472143432366,0.761699542305177
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CEP112,Centrosomal protein of 112 kDa,37017,-0.00126237971358012,0.00416341317726601,-0.00942266954102149,0.00689791011386125,0.761736232498865
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DBH,Dopamine beta-hydroxylase,37426,0.00293538476223774,0.00970597818769206,-0.0160883324856387,0.0219591020101142,0.762328470873751
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,UPK3BL1,Uroplakin-3b-like protein 1,37145,-0.00145979697258152,0.00484861366413765,-0.0109630797542913,0.00804348580912827,0.763361919504478
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TMED4,Transmembrane emp24 domain-containing protein 4,37017,0.00150091669041792,0.00502258650838265,-0.00834335286601209,0.0113451862468479,0.765071871530454
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PI16,Peptidase inhibitor 16,37441,-0.000635297750577843,0.00212645618328707,-0.0048031518698205,0.00353255636866481,0.76512856901452
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,LILRA4,Leukocyte immunoglobulin-like receptor subfamily A member 4,37017,-0.00134905218064796,0.00453026873280031,-0.0102283788969366,0.00753027453564066,0.765870936789713
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PPT1,Palmitoyl-protein thioesterase 1,37035,-0.00206686594519654,0.00699395607396328,-0.0157750198501646,0.0116412879597715,0.767600017949294
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,RASGRF1,Ras-specific guanine nucleotide-releasing factor 1,36958,-0.00114166153380479,0.00387814110287413,-0.00874281809543809,0.00645949502782851,0.768469384641875
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,BTNL10,Butyrophilin-like protein 10,36958,0.00103185937818333,0.00351836978126463,-0.00586414539309534,0.007927864149462,0.769314547870955
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CHMP6,Charged multivesicular body protein 6,37433,-0.00147717844855297,0.00505087737085672,-0.0113768980954321,0.0084225411983262,0.769939582897699
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PDGFRA,Platelet-derived growth factor receptor alpha,39864,0.00073183920732183,0.00250606656046085,-0.00418005125118144,0.0056437296658251,0.770269732621593
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,BHLHE40,Class E basic helix-loop-helix protein 40,36987,-0.00185143317781521,0.00637072431985337,-0.0143380528447278,0.0106351864890974,0.771349761731558
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NRTN,Neurturin,39583,-0.00128598033680028,0.00443521261084993,-0.00997899705406616,0.00740703638046559,0.771859961827921
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ZNF174,Zinc finger protein 174,37052,-0.000982773955345162,0.00340035090698397,-0.00764746173303373,0.00568191382234341,0.772569593205485
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MAP1LC3B2,Microtubule-associated proteins 1A/1B light chain 3 beta 2,37017,-0.00165609427962722,0.00574799448743466,-0.0129221634749992,0.00960997491574471,0.773261804639934
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,BACH1,Transcription regulator protein BACH1,39862,-0.00189650773582028,0.00661214457229127,-0.0148563110975112,0.0110632956258706,0.774252422354959
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SIRT5,"NAD-dependent protein deacylase sirtuin-5, mitochondrial",39485,-0.00139297989787637,0.00488653277096112,-0.0109705841289602,0.00818462433320742,0.77559805419526
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,C9orf40,Uncharacterized protein C9orf40,37378,0.00201313583188017,0.00706205081350517,-0.01182848376259,0.0158547554263503,0.775599544540681
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,EPGN,Epigen,37364,-0.00126638185668234,0.00444537693147786,-0.00997932064237895,0.00744655692901426,0.775743398808217
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,AHSA1,Activator of 90 kDa heat shock protein ATPase homolog 1,37364,0.00169922018525113,0.00601529720827873,-0.0100907623429752,0.0134892027134774,0.777577383972168
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ERMAP,Erythroid membrane-associated protein,37052,-0.00111420172445506,0.00396811935443529,-0.00889171565914822,0.00666331221023811,0.778877135587392
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,RFC4,Replication factor C subunit 4,37364,-0.000533516523455112,0.00190436507855422,-0.00426607207742138,0.00319903903051116,0.779363233304851
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CD2AP,CD2-associated protein,39864,-0.00158218315986464,0.00565659566837605,-0.0126691106698817,0.00950474435015241,0.779706769166978
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,VCPKMT,Protein-lysine methyltransferase METTL21D,36958,-0.00214606142156834,0.00770539005415095,-0.0172486259277042,0.0129565030845675,0.780621975551251
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GIPR,Gastric inhibitory polypeptide receptor,37052,0.00112697856091213,0.004068542184763,-0.00684736412122335,0.00910132124304761,0.781785885038616
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CBX2,Chromobox protein homolog 2,37017,0.000998546181896637,0.00360950793918388,-0.00607608937890377,0.00807318174269705,0.782058359944716
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SERPINB5,Serpin B5,39581,-0.00120193993739384,0.0043468478224733,-0.0097217616694415,0.00731788179465382,0.782161243572909
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,AMDHD2,N-acetylglucosamine-6-phosphate deacetylase,37433,-0.000627150480614808,0.00227176082449477,-0.00507980169662455,0.00382550073539494,0.78250341756905
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TAP1,Antigen peptide transporter 1,37165,0.0014282526871701,0.00524924136774124,-0.00886026039360274,0.0117167657679429,0.785559002639625
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,KLK12,Kallikrein-12,39473,-0.0033420343534113,0.0122983877400671,-0.0274468743239429,0.0207628056171203,0.785821129527575
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,STX3,Syntaxin-3,37384,-0.000910002038907483,0.0033847323353496,-0.0075440774161927,0.00572407333837773,0.788045407557045
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,RHOC,Rho-related GTP-binding protein RhoC,39668,-0.00282451886926633,0.0105192083145698,-0.0234421671658231,0.0177931294272904,0.78830982542754
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FLT3LG,Fms-related tyrosine kinase 3 ligand,40054,-0.000794248986232457,0.0029731376442528,-0.00662159876896794,0.00503310079650302,0.789363478798794
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TIMP2,Metalloproteinase inhibitor 2,37433,0.000606082009991538,0.00227047152331706,-0.0038440421757099,0.00505620619569297,0.789518619532286
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SATB1,DNA-binding protein SATB1,37408,-0.000712863800428302,0.0026727325616209,-0.00595141962120527,0.00452569202034866,0.789690953199985
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SNAPIN,SNARE-associated protein Snapin,37408,-0.00137203120614781,0.00516604090437542,-0.0114974713787236,0.00875340896642801,0.790561652688505
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SH3GL3,Endophilin-A3,37079,-0.00195668254298131,0.00737318682868998,-0.0164081287272137,0.0124947636412511,0.790722319163824
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GLA,Alpha-galactosidase A,37084,-0.000889930247362332,0.00336970825666832,-0.00749455843043225,0.00571469793570758,0.791709198094399
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,BCL7A,B-cell CLL/lymphoma 7 protein family member A,36958,0.00148587940326692,0.00567754240165469,-0.00964210370397626,0.0126138625105101,0.793547817184046
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DLGAP5,Disks large-associated protein 5,37408,0.00122199558053777,0.00467444899711852,-0.00793992445381452,0.0103839156148901,0.793772423840557
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CHGA,Chromogranin-A,37433,-0.00180870010698477,0.00697635483303701,-0.0154823555797373,0.0118649553657678,0.795437426741116
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NTRK3,NT-3 growth factor receptor,40005,-0.00048738456953117,0.00190087312664869,-0.0042130958977626,0.00323832675870026,0.79764497047403
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ALDH2,"Aldehyde dehydrogenase, mitochondrial",37364,-0.00115886833797406,0.00454376641125458,-0.010064650504033,0.00774691382808492,0.798691643529133
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,APOBR,Apolipoprotein B receptor,37039,-0.000954555194685303,0.00378264920593417,-0.00836854763831628,0.00645943724894568,0.800773729863492
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ADAMTS15,A disintegrin and metalloproteinase with thrombospondin motifs 15,39784,0.000974327335838162,0.00390008257612588,-0.00666983451336856,0.00861848918504488,0.802728048309555
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MMP1,Interstitial collagenase,39310,-0.00202805640288948,0.00819214201081122,-0.0180846547440795,0.0140285419383005,0.804477233739509
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,USP28,Ubiquitin carboxyl-terminal hydrolase 28,37384,0.000795808524702442,0.00321547884805126,-0.00550653001747802,0.00709814706688291,0.804530460943337
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FHIP2A,FHF complex subunit HOOK interacting protein 2A,37017,-0.00102017127716806,0.00413270814649732,-0.00912027924430281,0.00707993668996668,0.80502586647652
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TFF1,Trefoil factor 1,39785,0.00161649575151689,0.00670913382593425,-0.0115334065473142,0.014766398050348,0.809605062496947
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GPR101,Probable G-protein coupled receptor 101,36987,-0.00134558587555745,0.00559370775666343,-0.0123092530786178,0.00961808132750287,0.809904964377076
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,USP47,Ubiquitin carboxyl-terminal hydrolase 47,37017,0.00186421914765896,0.0077735413340701,-0.0133719218671184,0.0171003601624364,0.810476682526441
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MAP1LC3A,Microtubule-associated proteins 1A/1B light chain 3A,36987,-0.000686560233634733,0.00287533750414946,-0.00632222174176767,0.0049491012744982,0.811283373813014
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,LECT2,Leukocyte cell-derived chemotaxin-2,37433,0.00137189816766939,0.00574742403317997,-0.00989305293736334,0.0126368492727021,0.811343432629416
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TMED10,Transmembrane emp24 domain-containing protein 10,37017,-0.00107544147166568,0.00453328877634635,-0.00996068747330453,0.00780980452997318,0.812480453147122
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ITGAV,Integrin alpha-V,40026,0.000348284798542909,0.00147557690387007,-0.00254384593304243,0.00324041553012825,0.813410076934122
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,HK2,Hexokinase-2,39581,-0.000572492238412861,0.00244304117720753,-0.00536085294573963,0.00421586846891391,0.814727273755274
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DSG3,Desmoglein-3,39960,0.000695143586478617,0.00297417205691757,-0.00513423364507982,0.00652452081803705,0.815200086388638
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,UBAC1,Ubiquitin-associated domain-containing protein 1,39784,0.000715967702616478,0.00307321868870587,-0.00530754092724702,0.00673947633247998,0.815787709632184
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MMP13,Collagenase 3,39485,0.00066566790023379,0.00286596593004572,-0.00495162532265582,0.0062829611231234,0.816334065385742
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CCL28,C-C motif chemokine 28,39811,-0.00122575379110202,0.00531531290768284,-0.0116437670901604,0.00919225950795634,0.817622293085911
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,RECK,Reversion-inducing cysteine-rich protein with Kazal motifs,37039,0.000426802857700391,0.00186248877466279,-0.00322367514063868,0.00407728085603946,0.818750232280027
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FAM3D,Protein FAM3D,37378,0.00169635722358578,0.00743257614976277,-0.0128714920299493,0.0162642064771208,0.819468761903504
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DEFB116,Beta-defensin 116,36987,0.00157078522442641,0.00690827859980536,-0.0119694408311921,0.0151110112800449,0.820133968536121
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DCTN2,Dynactin subunit 2,39784,0.00192516860009548,0.008475740263599,-0.0146872823165586,0.0185376195167495,0.820318810229112
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TGFBR3,Transforming growth factor beta receptor type 3,40048,-0.000640102165468334,0.00282041719805263,-0.00616811987365149,0.00488791554271483,0.820463149079774
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ERBB2,Receptor tyrosine-protein kinase erbB-2,39909,0.00049825033544592,0.00223887798167334,-0.00388995050863383,0.00488645117952567,0.823892744383884
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,BCL2L15,Bcl-2-like protein 15,37052,0.00112028329940287,0.00503661561044965,-0.00875148329707845,0.0109920498958842,0.823984320570975
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,KLK15,Kallikrein-15,37347,-0.000995509831748207,0.00448755608912387,-0.00979111976643098,0.00780010010293457,0.8244434657018
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MANEAL,"Glycoprotein endo-alpha-1,2-mannosidase-like protein",36958,0.000995093001956062,0.00452373466741357,-0.00787142694617454,0.00986161295008667,0.82589672695786
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PDIA5,Protein disulfide-isomerase A5,36958,0.0011986777768455,0.00547442832294807,-0.00953120173613271,0.0119285572898237,0.826685052491325
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CDKL5,Cyclin-dependent kinase-like 5,36987,0.00101564547936352,0.00470309429521208,-0.00820241933925215,0.0102337102979792,0.82902804443936
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PNLIP,Pancreatic triacylglycerol lipase,37441,-0.00116973162795035,0.00545532780328969,-0.0118621741223981,0.00952271086649744,0.830222731431684
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DCLRE1C,Protein artemis,36958,-0.000580620082962158,0.00276600093731765,-0.00600198192010476,0.00484074175418044,0.833738691589674
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DENR,Density-regulated protein,37052,-0.00106638466739475,0.00514983087483284,-0.0111600531820671,0.00902728384727761,0.835956993501759
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SCGB2A2,Mammaglobin-A,37017,-0.000576326149995899,0.00280278397392371,-0.00606978273888637,0.00491713043889458,0.837085998938105
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PFDN4,Prefoldin subunit 4,36958,-0.000993915010007774,0.00484964270702734,-0.0104992147157814,0.00851138469576581,0.837617477882809
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IFNL2,Interferon lambda-2,36987,0.0011288776606811,0.00553076027995699,-0.0097114124880346,0.0119691678093968,0.838271526390922
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CRLF1,Cytokine receptor-like factor 1,39927,0.00047279461252156,0.00232924146856293,-0.00409251866586178,0.0050381078909049,0.839151496844895
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ALMS1,Alstrom syndrome protein 1,37165,-0.000811831122750143,0.00400109106121905,-0.00865396960273949,0.0070303073572392,0.839214392907773
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SIGLEC15,Sialic acid-binding Ig-like lectin 15,39485,-0.00144032848530014,0.00710133117408274,-0.0153589375865023,0.012478280615902,0.839274348823761
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MCAM,Cell surface glycoprotein MUC18,39927,-0.000586562500023451,0.00291835559089835,-0.00630653945818422,0.00513341445813732,0.840708345438828
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IL36G,Interleukin-36 gamma,37017,0.00120524156122741,0.00599754982563681,-0.0105499560970207,0.0129604392194756,0.840736354152015
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IMPG1,Interphotoreceptor matrix proteoglycan 1,36987,0.000532434778913614,0.0026800941695402,-0.00472054979338517,0.0057854193512124,0.842529669852452
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MMP3,Stromelysin-1,39854,-0.000839040634107287,0.00425171947205599,-0.00917241079933703,0.00749432953112246,0.843562825004008
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,QSOX1,Sulfhydryl oxidase 1,37182,0.000735353186109634,0.00374470526088598,-0.00660426912522688,0.00807497549744615,0.844322439420539
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,RASA1,Ras GTPase-activating protein 1,39485,-0.000561888806105563,0.00291637278656773,-0.00627797946777831,0.00515420185556718,0.847222270559523
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CNTN4,Contactin-4,39854,-0.000406133278559462,0.00212818958732197,-0.00457738486971051,0.00376511831259159,0.8486572082054
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FSTL3,Follistatin-related protein 3,39799,-0.00050863151412599,0.00267771788449213,-0.00575695856773057,0.00473969553947859,0.849351022253764
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SLC1A4,Neutral amino acid transporter A,37035,0.000853858953710245,0.00459470836665073,-0.00815176944492518,0.00985948735234567,0.852576791381629
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SCN4B,Sodium channel subunit beta-4,37039,0.00068211897024367,0.00368563736831893,-0.00654173027166144,0.00790596821214878,0.853173135718505
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ARID3A,AT-rich interactive domain-containing protein 3A,36987,-0.000657021303662605,0.00355371076764497,-0.00762229440824674,0.00630825180092153,0.853323529808633
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CCL25,C-C motif chemokine 25,40054,0.000819480468126168,0.00444899200239206,-0.00790054385656226,0.0095395047928146,0.853863072674161
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CDSN,Corneodesmosin,39988,-0.000690916854565154,0.00377666842878631,-0.00809318697498632,0.00671135326585601,0.85484466820354
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ARNT,Aryl hydrocarbon receptor nuclear translocator,39583,0.00060603815004391,0.00337031815132864,-0.00599978542656022,0.00721186172664804,0.857299101491268
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CACNB1,Voltage-dependent L-type calcium channel subunit beta-1,36987,0.000921744679735536,0.00524404353346625,-0.00935658064585832,0.0112000700053294,0.860477478051473
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,F12,Coagulation factor XII,37449,-0.000646311537690187,0.00369168889088474,-0.00788202176382428,0.00658939868844391,0.861025629189329
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,RBM25,RNA-binding protein 25,36958,0.000710855995029088,0.00407010410050365,-0.00726654804195806,0.00868826003201624,0.861354980023655
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ANXA10,Annexin A10,39485,0.00122025080499994,0.00699875140653109,-0.012497301951801,0.0149378035618009,0.861590588519984
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MASP1,Mannan-binding lectin serine protease 1,39709,-0.000363686437296777,0.00209900109660294,-0.00447772858663855,0.00375035571204499,0.862444218196191
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CPA1,Carboxypeptidase A1,40048,0.000893445276375954,0.00527711144560762,-0.00944969315701497,0.0112365837097669,0.865558274066923
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SERPINI2,Serpin I2,37378,0.000862770377440581,0.00509974692615916,-0.00913273359783137,0.0108582743527125,0.865658333530459
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SPACA5_SPACA5B,Sperm acrosome-associated protein 5,37408,0.000443524496416373,0.00265172632401774,-0.0047538590986584,0.00564090809149115,0.867168936281785
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,LRFN2,Leucine-rich repeat and fibronectin type-III domain-containing protein 2,37035,-0.000722452819792724,0.00432606366632882,-0.0092015376057972,0.00775663196621175,0.86737257772108
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,RABEPK,Rab9 effector protein with kelch motifs,39473,0.000886049492028804,0.0053679446005228,-0.00963512192499588,0.0114072209090535,0.86889646583576
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ID4,DNA-binding protein inhibitor ID-4,37165,0.000642791944496415,0.00395476220534408,-0.00710854197797798,0.00839412586697081,0.870886107272745
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IGFBP7,Insulin-like growth factor-binding protein 7,40048,-0.000424146089872178,0.00261641155157188,-0.00555231273095307,0.00470402055120871,0.871221371163122
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CBLIF,Cobalamin binding intrinsic factor,39842,0.000989898723694059,0.00612756964416039,-0.0110201377788603,0.0129999352262484,0.871663581059293
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IL11,Interleukin-11,39583,-0.00089372695512352,0.00555919698800162,-0.0117897530516067,0.0100022991413597,0.872280182309714
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DLL4,Delta-like protein 4,37039,-0.00119674671308678,0.00765681415658179,-0.0162041024599871,0.0138106090338135,0.875800323529129
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TPBGL,Trophoblast glycoprotein-like,37035,-0.000560080862198164,0.0036288398158301,-0.00767260690122517,0.00655244517682884,0.877342779898428
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MPIG6B,Megakaryocyte and platelet inhibitory receptor G6b,39904,-0.00101276458918032,0.00685432929939321,-0.014447250015991,0.0124217208376304,0.882537616689643
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,KIR3DL1,Killer cell immunoglobulin-like receptor 3DL1,39473,0.0015771594280311,0.0107445094507601,-0.0194820790954588,0.022636397951521,0.883301665160681
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CTLA4,Cytotoxic T-lymphocyte protein 4,37433,-0.000375676838828567,0.00263522194998956,-0.00554071186080811,0.00478935818315097,0.886639926727399
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,UPB1,Beta-ureidopropionase,37433,0.00115828000931941,0.00819873311561643,-0.0149112368972888,0.0172277969159276,0.887654410935426
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MAGEA3,Melanoma-associated antigen 3,37165,0.00105503331884592,0.00748351783111689,-0.0136126616301432,0.015722728267835,0.887887140186414
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,KHDC3L,KH domain-containing protein 3,36958,0.00080629702537773,0.00592581755249089,-0.0108083053775044,0.0124208994282599,0.891771899098172
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TNNI3,"Troponin I, cardiac muscle",39581,0.00102124147797006,0.00751993611827831,-0.0137178333138554,0.0157603162697955,0.891977539362152
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,REG1B,Lithostathine-1-beta,40048,0.000651026625629236,0.004847929646643,-0.00885091548179105,0.0101529687330495,0.89317523109994
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,LYPD1,Ly6/PLAUR domain-containing protein 1,39485,-0.000770679222044254,0.0057712663212682,-0.0120823612117299,0.0105410027676414,0.893770200731088
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,EPN1,Epsin-1,37165,-0.000506408884521371,0.00384706307236335,-0.00804665250635353,0.00703383473731079,0.895274839229251
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ADGRE2,Adhesion G protein-coupled receptor E2,39927,0.000325978796360472,0.00250441585725457,-0.00458267628385848,0.00523463387657942,0.896440197546734
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ARHGEF10,Rho guanine nucleotide exchange factor 10,37408,-0.00108192885911246,0.00834749106414455,-0.0174430113448358,0.0152791536266109,0.896875916004419
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IL25,Interleukin-25,36899,-0.000391757501239766,0.00305918041659984,-0.00638775111777546,0.00560423611529593,0.898103761288831
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GRIK2,"Glutamate receptor ionotropic, kainate 2",37408,-0.00044422041746738,0.00351513117576894,-0.0073338775219745,0.00644543668703974,0.899437930755405
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GKN1,Gastrokine-1,39119,0.000313485998415747,0.0025071621995587,-0.00460055191271931,0.00522752390955081,0.900496550192947
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,BST1,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 2,40005,0.000490186905314173,0.00414502914132664,-0.00763407021168604,0.00861444402231439,0.90586393215464
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DNAJA1,DnaJ homolog subfamily A member 1,36958,-0.000485053695821524,0.00411661163596634,-0.00855361250231555,0.0075835051106725,0.906205445909652
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,F3,Tissue factor,39927,0.000282215598123288,0.00242307075550505,-0.00446700308266661,0.00503143427891319,0.907281337482809
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,BRME1,Break repair meiotic recombinase recruitment factor 1,36987,-0.000419932825705738,0.00363402173293713,-0.00754261542226251,0.00670274977085103,0.908006245009415
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SAT2,Thialysine N-epsilon-acetyltransferase,37165,0.000731093851750949,0.0063588331077495,-0.0117322190394381,0.01319440674294,0.908468291238646
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IL9,Interleukin-9,37165,0.000587468336813141,0.00511331596589243,-0.00943463095633601,0.0106095676299623,0.908534127997922
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CTNNA1,Catenin alpha-1,36987,-0.000357677747834671,0.00313532672701873,-0.00650291813279138,0.00578756263712203,0.909176203266301
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,APOA2,Apolipoprotein A-II,37441,-0.000476738464790559,0.00424244166516326,-0.00879192412851054,0.00783844719892942,0.910528843540046
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,BMPER,BMP-binding endothelial regulator protein,37120,-0.000221415046622655,0.00200356672169898,-0.00414840582115265,0.00370557572790735,0.9120062404923
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CD3G,T-cell surface glycoprotein CD3 gamma chain,37052,0.000894085821909567,0.00810126787868039,-0.014984399220304,0.0167725708641231,0.912122626678121
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GGA1,ADP-ribosylation factor-binding protein GGA1,39485,-0.000667470994052127,0.00625676351900779,-0.0129307274913074,0.0115957855032032,0.915044287538515
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,EPB41L5,Band 4.1-like protein 5,37035,-0.000599743796489888,0.00574841351869674,-0.0118666342931355,0.0106671467001557,0.916907428466068
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FEN1,Flap endonuclease 1,39473,0.000573435415185681,0.00557076381074732,-0.0103452616538791,0.0114921324842504,0.918014621493779
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SCIN,Adseverin,36987,-0.000671384768909443,0.0065985039833054,-0.013604452576188,0.0122616830383691,0.918958233036905
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,LRP2,Low-density lipoprotein receptor-related protein 2,37035,-0.000317218490113918,0.00320509855642153,-0.00659921166070012,0.00596477468047228,0.921161146383437
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,RBM19,Probable RNA-binding protein 19,37017,0.000419000846210758,0.00424216094068507,-0.00789563459753198,0.00873363628995349,0.921321904675377
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MB,Myoglobin,40048,-0.000449660016827355,0.00462677400385975,-0.00951813706439246,0.00861881703073775,0.922579484144599
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CEMIP2,Cell surface hyaluronidase,37052,0.000275403517617726,0.00285199541048826,-0.00531450748693927,0.00586531452217472,0.923073157649163
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CD164L2,CD164 sialomucin-like 2 protein,37035,0.000303535723187806,0.00329620615076406,-0.00615702833230974,0.00676409977868535,0.926630802236248
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PRKCQ,Protein kinase C theta type,39583,-0.000354434715096141,0.00387495408090724,-0.00794934471367433,0.00724047528348205,0.927121812013916
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SCP2,Non-specific lipid-transfer protein,39473,-0.000634468208305318,0.00696203959673302,-0.014280065817902,0.0130111294012914,0.927388462537288
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,LRRFIP1,Leucine-rich repeat flightless-interacting protein 1,37364,-0.000383547422289783,0.00431147030701726,-0.00883402922404361,0.00806693437946404,0.929115198561143
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CST1,Cystatin-SN,35636,0.000796239409859152,0.00901640694095889,-0.0168759181944203,0.0184683970141386,0.929631747595943
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GUCY2C,Heat-stable enterotoxin receptor,37165,0.000666227948808919,0.00765078113631053,-0.0143293030783597,0.0156617589759776,0.930609448424761
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PRKD2,Serine/threonine-protein kinase D2,37017,0.000354621834767321,0.00408050329203697,-0.00764316461762513,0.00835240828715978,0.930747238035411
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,C19orf12,Protein C19orf12,39485,0.000491921615262927,0.00580049391018378,-0.0108770464486973,0.0118608896792231,0.932416034404578
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CDH6,Cadherin-6,39864,-0.000287538381883544,0.00339712159021598,-0.00694589669870686,0.00637081993493977,0.932547249819401
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PYDC1,Pyrin domain-containing protein 1,37039,0.000305864574942118,0.00367173493197254,-0.00689073589172406,0.00750246504160829,0.933612304562012
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SESTD1,SEC14 domain and spectrin repeat-containing protein 1,39485,-0.000467297453069327,0.00575266600753149,-0.011742522827831,0.0108079279216924,0.935258921903122
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ERBB4,Receptor tyrosine-protein kinase erbB-4,39909,0.000169316813312076,0.00212562434354627,-0.00399690690003862,0.00433554052666277,0.936512566446881
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PXDNL,Peroxidasin-like protein,37364,-0.000416547142883167,0.00530232717135769,-0.0108091083987442,0.00997601411297791,0.937384320520875
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PRL,Prolactin,40005,0.000530203812363062,0.00676041361386972,-0.0127202068708216,0.0137806144955477,0.937488797600175
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,AMIGO1,Amphoterin-induced protein 1,37035,-0.000347551121288028,0.00447026005308674,-0.00910926082533804,0.00841415858276198,0.938030164657105
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CD99,CD99 antigen,39854,-0.000130898258815321,0.00170724979450891,-0.00347710785605279,0.00321531133842215,0.938885437533561
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SLAMF7,SLAM family member 7,39862,-0.000392811434975303,0.00514733384187335,-0.0104815857650471,0.00969596289509647,0.939170581967567
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,AHSP,Alpha-hemoglobin-stabilizing protein,39832,-0.000576798915504385,0.00760635629294012,-0.015485257249667,0.0143316594186582,0.939554365261186
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,39473,0.000211995316632026,0.00311506203929986,-0.0058935262803957,0.00631751691365975,0.945742782416656
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CYTH3,Cytohesin-3,36958,-0.000428550980833646,0.00644466097824761,-0.013060086498199,0.0122029845365317,0.946983116550193
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CSPG4,Chondroitin sulfate proteoglycan 4,37433,-0.000172202461692256,0.00292497461340433,-0.00590515270396474,0.00556074778058023,0.95305401287336
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FGF5,Fibroblast growth factor 5,39583,-0.000166453947415627,0.00295865002165116,-0.0059654079898519,0.00563250009502064,0.955135318562431
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,F10,Coagulation factor X,37441,-0.000132422758144959,0.0023616391173273,-0.00476123542810647,0.00449638991181656,0.955284960885849
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MN1,Transcriptional activator MN1,37035,0.000296203186090492,0.0052975315088156,-0.0100869585711881,0.0106793649433691,0.955411615477518
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CRH,Corticoliberin,39451,-0.000420503125775681,0.00776683850019752,-0.0156435065861628,0.0148025003346115,0.956823651582208
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SGSH,N-sulphoglucosamine sulphohydrolase,37261,-0.000244184646591681,0.0049203750144361,-0.00988811967488644,0.00939975038170308,0.960420176177061
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,KHK,Ketohexokinase,37039,-0.000278439179657795,0.00575898570833242,-0.0115660511679893,0.0110091728086737,0.961439116049619
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FOSB,Protein fosB,39485,-0.00016748839814098,0.00348925048727473,-0.00700641935319945,0.00667144255691749,0.961715856879909
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SOWAHA,Ankyrin repeat domain-containing protein SOWAHA,37035,0.000182027399096097,0.00422539940865032,-0.00809975544185853,0.00846381024005073,0.965638944645487
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CLGN,Calmegin,37035,0.000149810632757137,0.00390784557376089,-0.0075095666918142,0.00780918795732847,0.969420478038935
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SOD3,Extracellular superoxide dismutase,37441,0.000203380311739061,0.00542527583640976,-0.0104301603276241,0.0108369209511022,0.970096815965949
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ADAMTS4,A disintegrin and metalloproteinase with thrombospondin motifs 4,37052,0.000117791921535259,0.00324959869260575,-0.006251421515972,0.00648700535904252,0.971085046234674
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GSTA3,Glutathione S-transferase A3,39473,0.000241086692523498,0.00682720357009192,-0.0131402323048567,0.0136224056899037,0.971830882862824
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,OMP,Olfactory marker protein,36987,0.00014951857019737,0.00433948289007601,-0.00835586789435161,0.00865490503474635,0.972514539654303
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FUCA1,Tissue alpha-L-fucosidase,39924,-0.000189530532853707,0.00718530230468079,-0.014272723050028,0.0138936619843206,0.978956543385583
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CST5,Cystatin-D,39555,0.000123638840638331,0.00483598415441185,-0.00935489010200889,0.00960216778328556,0.97960348892887
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SULT1A1,Sulfotransferase 1A1,40005,0.00026708782601507,0.0115045810662164,-0.022281891063769,0.0228160667157992,0.981478438078516
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PHLDB2,Pleckstrin homology-like domain family B member 2,36958,-0.000171676309188602,0.00814553779476663,-0.0161369303869312,0.015793577768554,0.983185257418636
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,H2AP,Huntingtin-interacting protein M,36958,6.71391997925779e-05,0.0044651907500865,-0.00868463467037696,0.00881891306996211,0.988003583074328
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,RPS10,40S ribosomal protein S10,37017,-5.67554822183966e-05,0.00383031003568831,-0.00756416315216748,0.00745065218773068,0.988178031280713
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TMED1,Transmembrane emp24 domain-containing protein 1,37165,-6.97030178003811e-05,0.00482585474843801,-0.00952837832473887,0.00938897228913811,0.988476241852096
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CSF2RA,Granulocyte-macrophage colony-stimulating factor receptor subunit alpha,39745,-5.81953751207734e-05,0.00537163829867449,-0.0105866064405228,0.0104702156902812,0.991356165545535
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MYH7B,Myosin-7B,36958,3.5853094392389e-05,0.00392150062193671,-0.00765028812460356,0.00772199431338834,0.992705423593266
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,BABAM1,BRISC and BRCA1-A complex member 1,37052,2.08776050996894e-05,0.00264498848084527,-0.00516329981735704,0.00520505502755642,0.99370226742619
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,RPGR,X-linked retinitis pigmentosa GTPase regulator,37035,2.13685541373733e-05,0.00365762490517509,-0.0071475762600058,0.00719031336828055,0.995338718604875
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DCC,Netrin receptor DCC,37035,-3.28297598096877e-06,0.00202432875495219,-0.00397096733568727,0.00396440138372533,0.998706047626996
